03/2009
‫התשס"ט‬/'‫ט‬
‫רשומות‬
ISRAEL STATE RECORDS
‫ד' בתשרי התש"ע‬
September 22, 2009
‫יומן הפטנטים והמדגמים‬
PATENTS AND DESIGNS JOURNAL
PATENTS
Applications filed
Applications accepted
Patents granted
Patents renewed
Patents not in force
Patents renewed for 20 years
Applications patent for extension
Notices
Changes in particulars entered
in register
Corrigenda
Country codes
Indices of applications accepted
DESIGNS
Designs registered
Designs renewed
Designs void
‫עמוד‬
Page
3
205
436
437
439
440
441
442
‫פטנטים‬
446
447
i
‫בקשות שהוגשו‬
‫בקשות שקובלו‬
‫פטנטים שניתנו‬
‫פטנטים שחודשו‬
‫פטנטים שתוקפם פקעו‬
‫פטנטים שחודשו לעשרים שנה‬
‫בקשות להארכת פטנטים‬
‫הודעות‬
‫שינויים בפרטים רשומים‬
‫בפנקס‬
‫תיקוני טעויות‬
‫קודים למדינות‬
‫מפתחות לבקשות שקובלו‬
449
460
461
‫מדגמים‬
‫מדגמים שנרשמו‬
‫מדגמים שחודשו‬
‫מדגמים שבוטלו‬
445
‫ידיעות כלליות‬
:‫ וכו' בענייני פטנטים ומדגמים יש לשלוח אל‬,‫ מסמכים‬,‫מכתבים‬
‫ ירושלים‬,‫ מלחה‬,5 ‫ בנין‬,‫ ירושלים‬,‫ גנים טכנולוגיים‬,‫רשם הפטנטים והמדגמים‬
‫ ירושלים והיא פתוחה‬,‫ מלחה‬,5 ‫ בנין‬,‫לשכת הפטנטים נמצאת בגנים טכנולוגיים ירושלים‬
.12:30 -‫ ו‬8:30 ‫לציבור בימי חול שאינם ערבי שבת או מועד בין השעות‬
‫ שקלים בעד כל‬2.50 ‫לשכת הפטנטים מספקת תצלומים של פירוטים ושרטוטים במחיר של‬
.‫עמוד או חלק ממנו‬
'‫א גרות ללשכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הלשכה בבנק הדואר מס‬
‫ יש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה‬. 0-24145-2
.‫שולמה‬
GENERAL INFORMATION
Letters, documents, etc. concerning Patents and Designs should be addressed to:
The Commissioner of Patents and Designs, Jerusalem Technology Park, Building 5, Malcha,
Jerusalem
The Patent Office is located at Jerusalem Technology Park, Building 5, Malcha, Jerusalem and
is open to the public on weekdays, except on Fridays or on the eves of holydays, from 08:30 to
12:30 hrs.
The Patent Office supplies photocopies of specifications and drawings at the rate of NIS 2.50
per page or part thereof.
Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of the
Office, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office together
with the application for the action for which the fee has been paid.
Copyright by the State of Israel. No
Extracts may be published except with the
permission of the Patent Office.
‫זכות היוצרים בתקצירים אלה שמורה‬
‫ אין להעתיק מת‬,‫למדינת ישראל‬
‫קצירים‬
.‫אלה אלא ברשות לשכת הפטנטים‬
Price per single issue (incl. VAT) : NIS 96.
.₪ 96 ).‫מ‬.‫ע‬.‫ לכל חוברת בודדת (כולל מ‬:‫מחיר‬
Annual subscription (incl. VAT):
NIS 1,152.
Available at the Distribution Service of
Government Publications, 29 B-Street,
Hakirya, Tel-Aviv.
2
.₪ 1,152 ).‫מ‬.‫ע‬.‫דמי חתימה לשנה (כולל מ‬
:‫אפשר להשיג אצל‬
'‫ רחוב ב‬,‫שרות ההפצה של פרסומי הממשלה‬
.‫אביב‬-‫ תל‬,‫ הקריה‬,29 '‫מס‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
NOTICE UNDER SECTION 16 OF THE
PATENTS LAW, 5727-1967
In the following there are listed new
Applications complying with the
Provisions of rule 32(a) of the Patent
Regulations, 5728-1968
‫ לחוק הפטנטים‬16 ‫הודעה לפי סעיף‬
1967 - ‫תשכ"ז‬
‫להלן רשימת בקשות חדשות‬
‫הממלאות אחר הדרישות שנקבעו‬
,‫(א) לתקנות הפטנטים‬32 ‫בתקנה‬
:1968–‫תשכ"ח‬
Particulars of the applications are
given in the following order:
‫פרטי הבקשות מובאים לפי‬
:‫סדר זה‬
Number and date of application
And the first four symbols of the
International Classification
‫מספר הבקשה – ותאריך הגשתה‬
‫וארבעה הסמנים הראשונים של‬
‫הסיווג הבינלאומי‬
Title of invention
(as proposed by applicant)
‫שם האמצאה (כפי שהוצע ע"י‬
)‫המבקש‬
‫המבקש‬
Applicant
Priority right: Convention country –
Number and date of
Foreign application
– ‫ מדינת האיגוד‬:‫דין קדימה‬
‫תאריך ומספר‬
‫בקשת החוץ‬
International Application Number
‫מספר בקשה בינלאומית‬
International Publication Number
‫מס' פרסום בינלאומי‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
3
16/07/2007
DIVIDER/COMBINER WITH
COUPLED SECTION
WERLATONE, INC.
US
11/458332
18/07/2006
16/07/2007
H03K )2009.01(
184629
‫ מאחד עם חלק מקושר‬/‫מחלק‬
A47D )2009.01(
184630
‫לוח זיכרון‬
‫נסים עובדיה‬
MEMORIAL SCREEN
NISSIM OVADIA
17/01/2006
PHARMACEUTICAL COMPOSITIONS
CONTAINING A Wht3a PROTEIN
KYOTO UNIVERSITY
2005JP
18/01/2005
010189
PCT/JP/2006/300517
WO/2006/077824
16/07/2007
A SLIDING GATE SYSTEM
NOAM RIMON
4
Wht3a ‫תכשירי רוקחות המכילים חלבון‬
A61N )2009.01(
184632
SYSTEMS AND METHODS FOR
REMOVAL OF URINE
MED-I-DYNAMIX FLUID
MONITORING LTD.
16/07/2007
A61K )2009.01(
184631
‫מערכות ושיטות לסילוק שתן‬
‫דינמיקס ניטור נוזלים בע"מ‬-‫י‬-‫מד‬
E06B )2009.01(
184633
‫מערכת שער הזחה‬
‫נעם רימון‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
07/02/2006
H04K )2009.01(
184634
INTELLIGENT DEMODULATION
SYSTEMS AND METHODS IN AN
OFDMA MULTICELL NETWORK
ADAPTIX, INC.
US
11/062890
22/02/2005
PCT/US/2006/004350
WO/2006/091373
26/01/2006
‫מערכות דה–אפנון חכמות ושיטות ברשת‬
‫ רב תאית‬OFDMA
184635
‫מכונת תערובת ציר אנכי לעיבוד‬
‫תערובות‬
VERTICAL-AXIS MIXING MACHINE FOR
PROCESSING MIXES
TONCELLI DARIO
IT
TV2005A000020 08/02/2005
PCT/EP/2006/050463
WO/2006/084792
26/01/2006
184636
METHOD FOR PRODUCING ARTICLES
WHICH ARE NOT FLAT USING
AGGLOMERATES OF INORGANIC
AGGREGATES AND HARDENING
RESINS AND RESULTANT ARTICLES
TONCELLI DARIO
IT
TV2005A000019 08/02/2005
PCT/EP/2006/050470
WO/2006/084794
12/09/1997
184637
RECOMBINANT HUMAN ? GALACTOSIDASE
SHIRE HUMAN GENETIC THERAPIES,
INC.
US
08/712614
13/09/1996
PCT/US/1997/016603
WO/1998/011206
September 22, 2009
–‫ד' בתשרי התש"ע‬
B01F )2009.01(
B28B )2009.01(
‫שיטה לייצור פריטים לא שטוחים‬
‫באמצעות ערמה של הצטברות‬
‫אנאורגני ושרף מקשיח ופריטים‬
‫הנובעים מכך‬
C12N )2009.01(
‫ריקומביננט אנושי ? – גאלאקטוסידאז‬
5
16/07/2007
CONTROLLED BLEEDER FOR POWER
SUPPLY
MICROSEMI CORP - ANALOG MIXED
SIGNAL GROUP LTD
US
60/807503
17/07/2006
20/02/2006
H02M )2009.01(
184638
‫נגד עומס מבוקר לספק כח‬
‫ אנאלוג מיקסד סינגל‬- ‫מיקרוסמי קורפ‬
‫גרופ בע"מ‬
PROCESS FOR THE PRODUCTION OF
2-(2-AMINOPHENYL)BICYCLOPROPANE DERIVATIVES
SYNGENTA PARTICIPATIONS AG
CH
0302/05
21/02/2005
PCT/EP/2006/001508
WO/2006/087223
24/01/2006
SUPERMARKET TROLLEY
WIETH FRANZ
DE
202005001770.1
PCT/DE/2006/000105
WO/2006/081793
16/02/2006
–2(–2 ‫תהליך לייצור תולדות של‬
‫אמינופניל)–ביציקלופרופן‬
G07F )2009.01(
184640
‫עגלת סופרמרקט‬
03/02/2005
C12Q )2009.01(
184641
HUMAN AUTISM SUSCEPTIBILITY
GENE ENCODING A KINASE AND
USES THEREOF
INTEGRAGEN
US
60/653502
17/02/2005
PCT/IB/2006/000469
WO/2006/087634
6
C07C )2009.01(
184639
‫גן אנושי לרגישות לאוטיזם המקודד לקינאז‬
‫ושימוש בו‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
16/07/2007
184642
PROCESS FOR THE PREPARATION
OF NON-STEROIDAL
GLUCOCORTICOID RECEPTOR
MODULATORS
PFIZER PRODUCTS, INC.
US
60/243873
27/10/2000
30/01/2006
‫תהליך להכנת מודולטורים של רצפטור‬
‫לא–סטרואידלי של גלוקוקורטיקואיד‬
184643
INHIBITORS OF OF
DIACYLGLYCEROL
ACYLTRANSFERASE (DGAT)
F. HOFFMANN-LA ROCHE AG
US
60/650671
07/02/2005
PCT/EP/2006/000786
WO/2006/082010
16/01/2006
September 22, 2009
184645
–‫ד' בתשרי התש"ע‬
G06F )2009.01(
‫תקשורת בעזרת איקונים‬
‫זלנגו בע"מ‬
ICONIC COMMUNICATION
ZLANGO LTD
IL
166322
16/01/2005
60/644021
18/01/2005
US
PCT/IL/2006/000061
WO/2006/075334
COMMUNICATIONS NETWORK
SYSTEM AND METHODS FOR USING
SAME
ZLANGO LTD
IL
166322
16/01/2005
60/644021
18/01/2005
US
PCT/IL/2006/000062
WO/2006/075335
C07C )2009.01(
‫מעכבים של דיאצילגליצרול אצילטרנספרז‬
)DGAT(
184644
16/01/2006
C07C )2009.01(
H04L )2009.01(
‫מערכת תקשורת רשתית ושיטות שימוש‬
‫בה‬
‫זלנגו בע"מ‬
7
06/09/2005
A61H )2009.01(
189826
‫מכונה לבניית כושר עם תמיכה בולמת‬
‫רעידות‬
FITNESS MACHINE HAVING A
VIBRATION ABSORBING SUPPORT
POWER PLATE INTERNATIONAL
LTD
PCT/NL/2005/000642
WO/2007/030000
15/09/2006
SULPHONAMIDE DERIVATIVES
BIOTIE THERAPIES CORPORATION
FI
20055498
16/09/2005
PCT/FI/2006/050395
WO/2007/034035
22/09/2005
C07C )2009.01(
190012
‫נגזרות סולפונאמיד‬
A61K )2009.01(
190024
STABILIZED PROTEASE
COMPOSITION
TROBIO AB
‫תרכובת פרוטואזה מאוזנת‬
PCT/SE/2005/001391
WO/2007/035143
15/09/2005
INTEGRATED COIL APPARATUS
AND METHOD FOR USING SAME
IVIVI TECHNOLOGIES, INC.
US
11/223073
10/09/2005
PCT/US/2005/032974
WO/2007/030122
8
A61N )2009.01(
190036
‫התקן סליל מוכלל ושיטה לשימוש בו‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
12/09/2006
190102
‫עיבוד תמונה רפואי‬
‫ טכנולוגיות בע"מ‬.‫פי‬.‫וי‬.‫די‬
MEDICAL IMAGE PROCESSING
D.V.P. TECHNOLOGIES LTD.
US
60/715572
12/09/2005
PCT/IB/2006/053243
WO/2007/031946
22/09/2005
G06T )2009.01(
190108
H04N )2009.01(
‫גלישה טלוויזיונית‬
TELEVISION SURFING
NDS LIMITED
PCT/IL/2005/001019
WO/2007/034467
14/09/2006
190143
CONTAINER AND BLANK FOR THE
PRODUCTION THEREOF
SEDA S.P.A.
DE
202005014738.9 19/09/2005
PCT/EP/2006/008983
WO/2007/033794
14/09/2006
190193
REINFORCED PLASTIC PIPE
HONEYWELL INTERNATIONAL INC.
US
11/228935
16/09/2005
PCT/US/2006/035878
WO/2008/033134
September 22, 2009
–‫ד' בתשרי התש"ע‬
B65D )2009.01(
‫מיכל והתקן לייצורו‬
B32B )2009.01(
‫צינור פלסטיק מחוזק‬
9
28/09/2006
C07D )2009.01(
190225
PYRAZOLO [1,5-ALPHA]PYRIMIDINYL
DERIVATIVES USEFUL AS
CORTICOTROPIN-RELEASING FACTOR
(CRF) RECEPTOR ANTAGONISTS
]‫–אלפא‬1,5[‫תולדות פירזולו‬
‫פירימידיניל השימושיות‬
‫כאנטגוניסטים של הרצפטור‬
‫לפקטור שחרור קורטיקוטרופין‬
)CRF(
SMITHKLINE BEECHAM (CORK) LIMITED
GB
0519957.5
30/09/2005
US
PCT/US2005/37576 19/10/2005
PCT/EP/2006/009531
WO/2007/039264
26/09/2006
ORGANOMETALLIC COMPOUNDS
AND METHODS OF USE THEREOF
PRAXAIR TECHNOLOGY, INC.
US
60/721804
29/09/2005
11/501075
09/08/2006
US
PCT/US/2006/037414
WO/2007/041089
26/09/2006
‫תרכובות אורגנומטליות ושיטות לשימוש‬
‫בהן‬
C07D )2009.01(
190227
PHENYL-[1,2,4]-OXADIAZOL-5-ONE
DERIVATIVES WITH PHENYL
GROUP, PROCESSES FOR THEIR
PREPARATION AND THEIR USE AS
PHARMACEUTICALS
SANOFI AVENTIS
EP
05021235.6 29/09/2005
PCT/EP/2006/009304
WO/2007/039178
10
C07F )2009.01(
190226
‫–און‬5–‫]–אוקסאדיאזול‬1,2,4[–‫נגזרות פניל‬
‫ תהליכים להכנתן‬,‫עם קבוצה פנילית‬
‫ושימוש שלהן כתכשירים רפואיים‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
26/09/2006
C07D )2009.01(
190228
– 1 ,2 ,4–‫נגזרות פניל–ופירינידיל‬
,‫אוקסאדיאזולון עם קבוצה פנילית‬
‫תהליכים להכנתן ושימוש שלהן‬
‫כתכשירים רפואיים‬
PHENYL-AND PYRIDYL-1,2,4OXADIAZOLONE DERIVATIVES
WITH PHENYL GROUP, PROCESSES
FOR THEIR PREPARATION AND
THEIR USE AS PHARMACEUTICALS
SANOFI AVENTIS
EP
05021235.6 29/09/2005
PCT/EP/2006/009298
WO/2007/039172
13/09/2006
190229
METHOD FOR AMIDATING
POLYPEPTIDES WITH BASIC
AMINOACID C- TERMINALS BY MEANS
OF SPECIFIC ENDOPROTEASES
SANOFI-AVENTIS DEUTSCHLAND
GMBH
DE
102005046113.1 27/09/2005
PCT/EP/2006/008903
WO/2007/036299
18/03/2008
190262
A GAS PHAS SYNTHESIS METHOD
OF MONO CRYSTALLINE NANOSIZED SUPER HARD MATERIALS
AND RESULTING PRODUCTS
ZARUEV VASILY
18/03/2008
A61B )2009.01(
‫מתקן עזר לאיש מוגבל‬
‫עוזי עזרא חבושה‬
190264
–‫ד' בתשרי התש"ע‬
H01F )2009.01(
‫פרופסור אולג פיגובסקי‬
A DEVICE TO AID THE DISABLED
UZI EZRA HAVOSHA
September 22, 2009
–C ‫שיטה למרכוז פוליפפטידים עם‬
‫טרמינלים של חומצה אמינית בסיסית‬
‫באמצעות אנדופרוטאזות ספציפיות‬
‫שיתת הסינתזה בפזה גזית של חומרים‬
‫מונו בדולחיים קשים במיוחד בגודל ננו‬
‫ותוצרת סופית‬
190263
18/03/2008
C07K )2009.01(
H01R )2009.01(
11
‫ נייח הכולל תאורת חירום‬/‫שקע נייד‬
‫ולילה ומערכות הגנה והתרעה‬
‫עצמון דקל‬
‫אאאאאאאאאאאאאאאאאאאאאאאאאאאאאא‬
DAN KATZ
21/09/2006
SYSTEM AND METHOD FOR SOLUBILITY
CURVE AND METASTABLE ZONE
DETERMINATION
AVANTIUM INTERNATIONAL B.V.
NL
PCT/NL2005/000688 21/09/2006
PCT/NL/2006/000466
WO/2007/025087
18/03/2008
12
H01L )2009.01(
‫בקרת צבע לתאורה סורקת דינמי‬
‫ אנאלוג מיקסד סינגל‬- ‫מיקרוסמי קורפ‬
‫גרופ בע"מ‬
G09F )2009.01(
190269
PATHWAY MARKER, ESPECIALLY
FIRE ESCAPE MARKER IN A FLOOR
OR WALL
JORMA PARKKARI
FI
20055539
06/10/2005
PCT/FI/2006/050430
WO/2007/039673
14/03/2000
‫מערכת ושיטה לקביעה של עקומת‬
‫מסיסות ואזור מטא–יציב‬
190268
COLOR CONTROL FOR DYANMIC
SCANNING BACKLIGHT
MICROSEMI CORP - ANALOG MIXED
SIGNAL GROUP LTD
US
60/908709
29/03/2007
05/10/2006
G01N )2009.01(
190266
‫ במיוחד סמן נתיב ברצפה או‬,‫סמן של נתיב‬
‫בקיר למילוט מאש‬
C12N )2009.01(
190270
September 22, 2009
–‫ד' בתשרי התש"ע‬
AKT NUCLEIC ACIDS,
POLYPEPTIDES, AND USES
THEREOF
AVENTIS PHARMACEUTICALS INC.
US
60/125108
19/03/1999
PCT/US/2000/006574
WO/2000/056866
22/09/2005
‫ פוליפפטידים‬AKT ‫חומצות נוקלאיות של‬
‫ושימושים שלהם‬
190271
METHOD FOR TRANSFERRING ONE
OR MORE GENETIC TRAITS FROM A
PLANT OF THE PURPLE-FLOWERED
CAPSICUM SPECIES TO A PLANT OF
THE WHITE-FLOWERED CAPSICUM
SPECIES
ENZA ZADEN BEHEER B.V.
A01H )2009.01(
‫שיטה להעברת תכונה גנרית אחת או יותר‬
‫מצמחי פלפלת מזנים בעלי פרחים סגולים‬
‫לצמחי פלפלת מזנים בעלי פרחים לבנים‬
PCT/EP/2005/054759
WO/2007/038980
07/09/2006
190272
PRINTED THERMOFORMABLE
LAMINATE WITH INCREASED
SECURITY AGAINST FORGERY
ALCAN TECHNOLOGY &
MANAGEMENT LTD.
EP
05405560.3 27/09/2005
PCT/EP/2006/008739
WO/2007/036289
27/09/2006
September 22, 2009
‫ציפוי מודפס הניתן לעצוב בחום עם‬
‫הבטחה מוגברת למניעת זיוף‬
190273
–‫ד' בתשרי התש"ע‬
B32B )2009.01(
C07D )2009.01(
13
BENZOTHIADIAZOLYPHENYLALKYLAMINE
DERIVATIVES FOR USE IN THE TREATMENT
OF CONDITIONS AMELIORATED BY
MONOAMINE REUPTAKE
WYETH
US
60/721693
PCT/US/2006/037962
WO/2007/041258
28/09/2006
29/09/2005
14
‫מכשיר ושיטה להחלפת מפרק באופן‬
‫פולשני מינימלי‬
C07D )2009.01(
190275
7-[2-[4-(6-FLUORO-3-METHYL-1,2BENZISOXAZOL-5-YL)-1PIPERAZINYL]ETHYL]-2-(1PROPYNYL)-7H-PYRAZOLO-[4,3-e][1,2,4]-TRIAZOLO-[1,5-c]-PYRIMIDIN5 AMINE
SCHERING CORPORATION
US
60/720027
23/09/2005
PCT/US/2006/037003
WO/2007/038284
12/09/2006
A61B )2009.01(
190274
APPARATUS AND METHOD FOR
MINIMALLY INVASIVE TOTAL JOINT
REPLACEMENT
ALEXANDRIA RESEARCH
TECHNOLOGIES LLC
US
60/721450
28/09/2005
11/535916
27/09/2006
US
PCT/US/2006/038434
WO/2007/038776
21/09/2006
‫נגזרות של‬
‫בנוזיתיאדיאזוליפנילאלקילאמין‬
‫לשימוש בטיפול במצבים‬
‫המשתפרים ע"י ספיגת מונואמין‬
–2,1–‫–מתיל‬3–‫–פלואורו‬6(–4[–2[–7
–]‫–פיפרזיניל]אתיל‬1–)‫–איל‬5–‫בנזיסוקסאזול‬
e–[–3,4[–‫–פירזולו‬H7–)‫–פרופיניל‬1(–2
‫ אמין‬5–‫]–פירימידין‬c–5,1[–‫[]–טריאזולו‬4,2,1
G06M )2009.01(
190276
September 22, 2009
–‫ד' בתשרי התש"ע‬
MECHANICAL DOSES COUNTER FOR
A POWDER INHALER
AVENTIS PHARMA LIMITED
GB
0519151.5
20/09/2005
PCT/GB/2006/050287
WO/2007/034237
28/09/2006
‫מונה מנות מכאני למשאף המיועד לשימוש‬
‫עם אבקה‬
190277
ARIL-SUBSTITUTED NITROGENCONTAINING HETEROCYCLIC
COMPOUND
BANYU PHARMACEUTICAL CO.,
LTD.
2005JP
30/09/2005
288545
PCT/JP/2006/319912
WO/2007/037513
22/09/2006
‫תרכובת הטרוציקלית בעלת חנקן מותמר‬
‫באריל‬
190278
TETRAHYDRO-CYCLOPENTYL
PYRAZOLE CANNABINOID
MODULATORS
JANSSEN PHARMACEUTICA NV
US
60/720029
23/09/2005
PCT/US/2006/037348
WO/2007/035945
27/09/2006
190279
THIENO[2,3-B]PYRIDINE-5CARBONITRILES AS PROTEIN
KINASE INHIBITORS
WYETH
US
60/720821
27/09/2005
PCT/US/2006/037502
WO/2007/038519
22/09/2006
September 22, 2009
190280
–‫ד' בתשרי התש"ע‬
C07D )2009.01(
C07D )2009.01(
‫מודולטורים של טטרהידרו–ציקלופנטיל‬
‫פירזול קנאבינויד‬
C07D )2009.01(
‫–קרבוניטרילים‬5–‫ פירידין‬B[ –3 ,2[‫תיאנו‬
‫כמעכבים לפרוטאין קינאז‬
C07D )2009.01(
15
FUSED HETEROCYCLIC
COMPOUNDS USEFUL AS KINASE
MODULATORS
BRISTOL-MYERS SQUIBB COMPANY
US
60/719519
22/09/2005
11/524996
21/09/2006
US
PCT/US/2006/037056
WO/2007/038314
19/09/2006
16
‫מודולציה של ביטוי של רצפטור‬
‫לגלוקוקורטיקויד‬
C07D )2009.01(
190282
ACYLATED SPIROPIPERIDINE
DERIVATIVES AS MELANOCORTIN-4
RECEPTOR MODULATORS
MERCK & CO. INC.
US
60/721678
29/09/2005
PCT/US/2006/037196
WO/2007/041052
19/09/2006
C12N )2009.01(
190281
MODULATION OF
GLUCOCORTICOID RECEPTOR
EXPRESSION
JOHNSON & JOHNSON
PHARMACEUTICAL RESEARCH
&DEVELOPMENT, LLC
US
60/718685
19/09/2005
PCT/US/2006/036527
WO/2007/035759
25/09/2006
‫תרכובות הטרוציקליות מאוחות‬
‫המשמשות כמודולטורים לקינאז‬
‫נגזרות ספירופיפרידין שעברו אצילציה‬
4–‫כווסתים לקולטן מלאנוקורטין‬
C12N )2009.01(
190283
September 22, 2009
–‫ד' בתשרי התש"ע‬
MODULATION OF GLUCAGON
RECEPTOR EXPRESSION
JOHNSON & JOHNSON
PHARMACEUTICAL RESEARCH
&DEVELOPMENT, LLC
US
60/718684
19/09/2005
PCT/US/2006/036545
WO/2007/035771
27/09/2006
‫מודולציה של ביטוי של רצפטור לגלוקגון‬
190284
MILNACIPRAN FOR THE LONGTERM TREATMENT OF
FIBROMYALGIA SYNDROME
CYPRESS BIOSCIENCE, INC.
US
60/721722
28/09/2005
PCT/US/2006/037714
WO/2007/038620
18/07/2006
‫מילנציפראן לטיפול ארוך טווח בתסמונת‬
‫פיברומיאלגיה‬
190285
SUPPORT ARM, CYLINDRICALPARABOLIC SOLAR COLLECTOR
SUPPORT AND METHOD OF
PRODUCING SAID ARM
SENER, INGENIERIA Y SISTEMAS,
S.A.
ES
200502280
19/09/2005
PCT/ES/2006/000414
WO/2007/034008
26/10/2006
NEW CYCLIC PEPTIDE COMPOUNDS
ASTELLAS PHARMA INC.
US
60/730011
26/10/2005
60/751204
19/12/2005
US
PCT/JP/2006/321924
WO/2007/049803
September 22, 2009
190287
–‫ד' בתשרי התש"ע‬
F24J )2009.01(
‫זרוע תמיכה לקולט שמש צילינדרי מעוגל‬
‫והשיטה לייצורו‬
190286
29/09/2006
C07C )2009.01(
C07K )2009.01(
‫תרכובות פפטיד ציקליות חדשות‬
F26B )2009.01(
17
A METHOD OF AND SYSTEM FOR
CONTROLLING A KILN
AUSTRALIAN CHOICE TIMBER
SUPPLIES PTY LTD
AU
2005905414 30/09/2005
PCT/AU/2006/001424
WO/2007/035995
04/10/2006
18
C12N )2009.01(
‫שיטה לקבלת תאי שריר אנושיים‬
‫ושימושיהם‬
A61M )2009.01(
190290
SAFETY NEEDLE WITH LOCKOUT
MECHANISM
TYCO HEALTHCARE GROUP LP
US
60/719761
22/09/2005
PCT/US/2006/037278
WO/2007/035923
22/09/2006
‫פיגמנטים פולטי אור הסגורים בקפסולה‬
190289
METHOD FOR OBTAINING HUMAN
SMOOTH MUSCULAR CELLS AND
USES THEREOF
INSTITUT DES VAISSEAUX ET DU
SANG OF
FR
0509557
19/09/2005
PCT/FR/2006/002144
WO/2007/034069
22/09/2006
C09B )2009.01(
190288
ENCAPSULATED LUMINESCENT
PIGMENTS
CIBA SPECIALTY CHEMICALS
HOLDING INC.
EP
05109465.4 12/10/2005
PCT/EP/2006/067037
WO/2007/042438
19/09/2006
‫שיטה ומערכת לשליטה בתנור‬
‫מחט בטיחותית עם מנגנון השבתה‬
A61M )2009.01(
190291
September 22, 2009
–‫ד' בתשרי התש"ע‬
NON-AXIAL RETURN SPRING FOR
SAFETY NEEDLE
TYCO HEALTHCARE GROUP LP
US
60/719762
22/09/2005
PCT/US/2006/037288
WO/2007/035924
09/10/2006
‫קפיץ נסיגה שאינו צירי למחט בטיחותית‬
190292
PYRIDOPYRIMIDINONE INHIBITORS
OF P13Ka
EXELIXIS, INC.
US
60/724571
07/10/2005
60/743719
23/03/2006
US
PCT/US/2006/039734
WO/2007/044813
02/10/2006
190293
NITROGEN-CONTAINING
HETEROCYCLIC COMPOUND AND
PHARMACEUTICAL APPLICATION
THEREOF
ONO PHARMACEUTICAL CO., LTD.
2005JP
03/10/2005
289542
2006-093266 30/03/2006
JP
PCT/JP/2006/319732
WO/2007/040208
05/10/2006
September 22, 2009
190294
–‫ד' בתשרי התש"ע‬
C07D )2009.01(
Ka13P ‫פירידופירימידינונים מעכבי‬
C07D )2009.01(
‫תרכובת הטרוציקלית המכילה חנקן‬
‫ויישומיה הרוקחיים‬
A01N )2009.01(
19
–3 ‫תכשירים קוטלי עשבים המבוססים על‬
‫–[ציקלו פרופיל‬N–[[4–‫פניל אוראצילים ו‬
‫–מתוקסי‬2–]‫אמינו)–קרבוניל]פניל]סולפוניל‬
‫בנזואיד‬
HERBICIDAL COMPOSITIONS BASED
ON 3-PHENYLURACILS AND N-[[4[(CYCLOPROPYLAMINO)CARBONYL]PHENYL]SULFONYL]-2METHOXYBENZAMIDE
BASF SE
EP
05022222.3 12/10/2005
PCT/EP/2006/067061
WO/2007/042447
22/09/2006
COMBINATION THERAPY
COMPRISING SUBSTITUTED
OXAZOLIDINONES FOR THE
PREVENTION AND TREATMENT OF
CEREBRAL CIRCULATORY DISORDERS
BAYER HEALTHCARE AG
DE
102005047558.2 04/10/2005
PCT/EP/2006/009204
WO/2007/039134
04/10/2006
‫תרופה משולבת המכילה‬
‫אוקסאזולידונינים מותמרים למניעה‬
‫וטיפול באי סדרים של זרימת דם מוחית‬
20
A24D )2009.01(
190296
CIGARETTES HAVING HOLLOW
FIBERS
PHILIP MORRIS PRODUCTS S.A.
US
11/241978
04/10/2005
PCT/IB/2006/003884
WO/2007/054826
29/09/2006
C07D )2009.01(
190295
‫סיגריות בעלות סיבים חלולים‬
A01N )2009.01(
190297
September 22, 2009
–‫ד' בתשרי התש"ע‬
FUNGICIDES AND BIOREGULATORY
MIXTURES
BASF SE
DE
102005048430.1 07/10/2005
PCT/EP/2006/066870
WO/2007/042404
02/11/2006
190298
DISPENSING DEVICE
BOEHRINGER INGELHEIM PHARMA
GMBH & CO. KG
EP
05026285.6 02/12/2005
06000276.3
09/01/2006
EP
PCT/EP/2006/010536
WO/2007/062726
19/03/2008
190299
190300
SYSTEM AND METHOD FOR WATER
DESALINATION AND OTHER USES
S.D.E. LTD.
19/09/2006
September 22, 2009
190301
–‫ד' בתשרי התש"ע‬
B05B )2009.01(
‫מתקן חלוקה‬
A47K )2009.01(
‫מערכת ושיטת ניקוי‬
‫אבירם מן‬
CLEANING SYSTEM AND METHOD
AVIRAM MANN
19/03/2008
‫קוטלי פטריות ותערובות לבקרה‬
‫ביולוגית‬
B01D )2009.01(
‫מערכת ושיטה להתפלת מים ושימושים‬
‫אחרים‬
‫ אנרגיה בע"מ‬.‫אי‬.‫די‬.‫אס‬
A61K )2009.01(
21
‫מודולטורים להתמיינות של תאי‬
‫אוסטאוקלסט‬
‫ניצוצות ייזום והשקעות בע"מ‬
MODULATION OF OSTEOCLAST
DIFFERENTIATION
NITZOZOT LTD
US
60/717762
19/09/2005
PCT/IL/2006/001095
WO/2007/034477
19/09/2006
PROCESS FOR SEPARATING
SOLUTES AND WATER FROM
AQUEOUS SOLUTIONS WITH GAS
RECYCLING
WATER SCIENCE LIMITED
GB
0519087.1
19/09/2005
PCT/GB/2006/050296
WO/2007/034241
19/03/2008
C02F )2009.01(
190302
‫תהליך להפרדת מומסים ומים מתמיסות‬
‫מיימיות יחד עם מיחזור גז‬
A PAINLESSLY HAND-HELD
APPARATUS USEFUL FOR
DETECTION AND QUANTIZATION OF
AN ANALYTE AND METHODS
THEREOF
SINDOLOR MEDICAL LTD
19/03/2008
22
‫מכשיר ידני לזיהוי וכימות של חומרים‬
‫שונים ללא כאב‬
‫סינדולור מדיקל בע"מ‬
H04M )2009.01(
190304
METHOD OF FORWARDING
ETHERNET PACKETS IN
TELECOMMUNICATIONS
NETWORKS
ECI TELECOM LTD.
29/09/2006
A61B )2009.01(
190303
‫שיטה למסירת מנות נתונים מסוג‬
‫ ברשתות תקשורת‬ETHERNET
‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
A61K )2009.01(
190305
September 22, 2009
–‫ד' בתשרי התש"ע‬
CONTROLLED RELEASE,
PHARMACEUTICAL COMPOSITION OF
VENLAFAXINE HYDROCHLORIDE,
AND PROCESS FOR PREPARATION
THEREOF
VALPHARMA S.A.
IT
FI2005A000206 30/09/2005
PCT/EP/2006/066906
WO/2007/039569
10/10/2006
‫תכשיר רפואי של שחרור מבוקר של‬
‫ ותהליך להכנתו‬,‫ונלפקסין הידרוכלוריד‬
C07D )2009.01(
190306
‫מעכבי קינאז‬
KINASE INHIBITORS
TAKEDA SAN DIEGO, INC.
US
60/724619
07/10/2005
PCT/US/2006/039667
WO/2007/044779
21/09/2006
190307
BULLET-PROOF STRUCTURE
COSIMO CIOFFI
IT
FI2005A000210 07/10/2005
PCT/IB/2006/002622
WO/2007/042877
07/08/1998
190308
USE OF ANTIBODY THAT BINDS
INTEGRIN av ? 6 TO PREPARE A
MEDICAMENT FOR TREATING
KIDNEY FIBROSIS
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
60/055060
08/08/1997
PCT/US/1998/016439
WO/1999/007405
05/10/2006
September 22, 2009
190309
–‫ד' בתשרי התש"ע‬
F41H )2009.01(
‫מבנה חסין כדורים‬
C07K )2009.01(
av ?6 ‫שימוש בנוגדן שקושר אינטגרין‬
‫להכין תרופה לטיפול בלייפת הכליה‬
H01J )2009.01(
23
OPTICAL FIBER ASSEMBLY
WRAPPED ACROSS GIMBAL AXES
RAYTHEON COMPANY
US
11/243562
05/10/2005
PCT/US/2006/039426
WO/2007/044684
15/10/2006
‫הרכבת סיבים אופטיים עטופים על פני ציר‬
‫מאוזן‬
COMPOSITIONS FOR SILENCING THE
EXPRESSION OF VDAC1 AND USES
THEREOF
BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
US
60/724794
11/10/2005
PCT/IL/2006/001176
WO/2007/043049
21/09/2006
24
VDAC1 ‫תכשירים להשתקת הביטוי של‬
‫והשימוש בהם‬
‫ הרשות‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬
‫למחקר ופיתוח‬
C12N )2009.01(
190311
NUCLEIC ACID CONSTRUCTS,
PHARMACEUTICAL COMPOSITIONS
AND METHODS OF USING SAME FOR
TREATING CANCER
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
US
60/719178
22/09/2005
PCT/IL/2006/001110
WO/2007/034487
21/09/2006
C12N )2009.01(
190310
‫ תכשירים‬,‫קונסטרקטים של חומצות גרעין‬
‫רוקחיים ושימוש בהם לטיפול בסרטן‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים‬
A61K )2009.01(
190312
September 22, 2009
–‫ד' בתשרי התש"ע‬
IMMUNOGENIC FRAGMENTS OF TCELL RECEPTOR CONSTANT
DOMAINS AND PEPTIDES DERIVED
THEREFROM
QUINTANA FRANCISCO J.
US
60/719342
22/09/2005
PCT/IL/2006/001112
WO/2007/034489
19/03/2008
‫מקטעים אימונוגניים של המתחם הקבוע‬
‫ ופפטידים הנגזרים מהם‬T ‫בקולטני תאי‬
.‫קווינטנה פרנסיסקו ח‬
190313
ACTUATOR POSITION CONTROL
DEVICE USING A FAIL FREEZE
SERVO-VALVE
HISPANO-SUIZA
FR
0753960
21/03/2007
26/09/2006
‫התקן לשליטה על מיקום מפעיל בעל‬
‫שסתום מנוע סרוו עם מנגנון כשל–קפיאה‬
190314
MODIFIED SHOTGUN AND
MODIFIED SHOTGUN SHELL
AMMUNITION
RACHO,JEFF
US
60/720791
27/09/2005
60/740946
30/11/2005
US
60/742413
05/12/2005
US
11/526446
25/09/2006
US
PCT/US/2006/037782
WO/2007/120180
27/09/2006
ILLUMINATED GOLF FLAGPOLE
WILLETT, RICHARD
US
60/721561
28/09/2005
PCT/US/2006/037969
WO/2007/038711
September 22, 2009
190316
–‫ד' בתשרי התש"ע‬
F41A )2009.01(
‫רובה ציד מותאם ותחמושת מותאמת עבור‬
‫רובה ציד‬
190315
19/03/2008
F16K )2009.01(
A63B )2009.01(
‫מוט–דגל מואר לגולף‬
B23B )2009.01(
25
CUTTER TOOL AND CUTTER INSERT
THEREFOR
NO SCREW LTD
IL
183721
06/06/2007
184091
20/06/2007
IL
184742
19/07/2007
IL
186569
10/10/2007
IL
23/09/2006
‫כלי לחיתוך ותוספת חיתוך בתוכו‬
‫בלי בורג בע"מ‬
SUSTAINED-RELEASE ANTIMICROBIAL
PLASTIC COMPOSITION WITH LOW
RATE OF ELUTION
BAYER INNOVATION GMBH
DE
102005048131.0 06/10/2005
PCT/EP/2006/009265
WO/2007/039156
23/10/2006
26
‫תכשיר פלסטי אנטי–מיקרוביאלי בעל‬
‫שחרור מושהה עם קצב השטפה איטי‬
A61M )2009.01(
190318
DISPENSING DEVICE, STORAGE
DEVICE AND METHOD FOR
DISPENSING A FORMULATION
BOEHRINGER INGELHEIM PHARMA
GMBH & CO. KG
EP
05026286.4 02/12/2005
06000866.1
17/01/2006
EP
PCT/EP/2006/010197
WO/2007/062721
20/09/2006
C08K )2009.01(
190317
‫ התקן אחסון ושיטה לנתינת‬,‫התקן נתינה‬
‫פורמולציה‬
A61K )2009.01(
190319
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫ננו חלקיקים לנשיאה מכוונת של חומרים‬
‫פעילים‬
NANOPARTICLES FOR TARGETED
DELIVERY OF ACTIVE AGENTS
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
US
60/718333
20/09/2005
PCT/IL/2006/001098
WO/2007/034479
25/10/2006
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים‬
190320
SYRINGE ASSIST FOR INFUSION
PUMP
CURLIN MEDICAL INC.
US
11/262258
28/10/2005
PCT/US/2006/041595
WO/2007/053387
28/09/2006
‫מזרק עזר למשאבת אינפוזיה‬
190321
COMPOSITIONS CONTAINING
SARATIN
BIOVASCULAR, INC.
US
60/721754
28/09/2005
PCT/US/2006/038141
WO/2007/038749
08/09/2006
NUTRIENT MEDIUM FOR THE
CULTIVATION OF A CELL CULTURE
CELLCA GMBH
DE
102005046225.1 28/09/2005
PCT/EP/2006/008761
WO/2007/036291
September 22, 2009
190323
–‫ד' בתשרי התש"ע‬
C08L )2009.01(
‫תכשירים המכילים סראטין‬
190322
29/09/2006
A61M )2009.01(
C12N )2009.01(
‫מצע תזונתי לתרבות תרבית תאים‬
A61K )2009.01(
27
‫ערכה לנתינת תרופות שלא דרך‬
‫המעיים‬
KIT FOR THE PARENTERAL
ADMINISTRATION OF DRUGS
INFA S.A.
IT
MI2005A001826 29/09/2005
PCT/IB/2006/002702
WO/2007/036792
22/09/2006
MODULAR CLONING VECTOR
PLASMIDS
INTREXON CORPORATION
US
11/233246
22/09/2005
PCT/US/2006/036992
WO/2007/038276
21/09/2006
‫פלסמידי וקטור שיבוט מודולריים‬
VEHICULAR WINDOW SYSTEM
28
‫תהליך להכנת הלופינט‬
A46B )2009.01(
190326
DENTAL TOOL FOR CREATING GAP
BETWEEN TEETH, WITH DEVICE TO
TRANSPORT FLUIDS AND TOOTH
PASTE
YEHOSHOUA TABOR
20/03/2008
C07D )2009.01(
190325
A PROCESS FOR THE PREPARATION
OF HALOFENATE
METABOLEX, INC.
US
60/720300
23/09/2005
11/525200
20/09/2006
US
PCT/US/2006/036928
WO/2007/038243
20/03/2008
C12N )2009.01(
190324
‫מפסק שיניים בעל מנגנון להובלת נוזלים‬
‫ומשחות שיניים‬
‫יהושע תבור‬
B60J )2009.01(
190327
‫מערכת חלון לרכב‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫רומן רשקובן‬
ROMAN RASHKOVAN
20/03/2008
190328
,‫ חד פעמי‬,‫אלמנט מכסה רב שימושי‬
‫למאפרה‬
‫אלי כהן‬
A MULTI-USE DISPOSABLE
ASHTRAY COVER ELEMENT
ELI COHEN
20/03/2008
190329
190330
3-ALKYL-5-(4-ALKYL-5-OXOTETRAHYDROFUTRAN-2YL)PYRROLIDIN-2-ONE
DERIVATIVES AS INTERMEDIATES
IN THE SYNTHESIS OF RENIN
INHIBITORS
NOVARTIS AG
GB
0521083.6
17/10/2005
PCT/EP/2006/009970
WO/2007/045420
04/10/2006
September 22, 2009
C07D )2009.01(
–‫–אוקסו‬5–‫–אלקיל‬4(–5–‫–אלקיל‬3 ‫תולדות‬
‫–און‬2–‫–יל)פירולידינ‬2–‫טטרהידרופוטראנ‬
‫כחומרי ביניים בסינתזה של מעכבי רנין‬
190331
–‫ד' בתשרי התש"ע‬
H02M )2009.01(
‫קבל להספק גבוה המקורר באמצעות‬
‫הולכה לצדדים‬
‫סלם פאסיב קומפוננטס בע"מ‬
SIDEWAYS CONDUCTION COOLED
HIGH-POWER CAPACITOR
CELEM PASSIVE COMPONENTS LTD
16/10/2006
B67B )2009.01(
C07D )2009.01(
29
DEUTERATED INHIBITORS OF THE
GASTRIC H+, K+-ATPASE WITH
ENHANCED THERAPEUTIC
PROPERTIES
AUSPEX PHARMACEUTICALS, INC.
US
60/724160
06/10/2005
60/741316
01/12/2005
US
PCT/US/2006/038819
WO/2007/041630
19/10/2006
30
‫ ושימושים‬IL13 ‫נוגדנים של בני אדם כנגד‬
‫טיפוליים‬
C07K )2009.01(
190333
PROCESS AND INTERMEDIATES FOR
THE SYNTHESIS OF CASPOFUNGIN
SANDOZ AG
EP
05024961.4 15/11/2005
PCT/EP/2006/010867
WO/2007/057141
13/11/2006
C07K )2009.01(
190332
HUMAN ANTIBODIES AGAINST IL13
AND THERAPEUTIC USES
NOVARTIS AG
GB
0521509.0
21/10/2005
0616666.4
22/08/2006
GB
PCT/EP/2006/010098
WO/2007/045477
13/11/2006
H, +K–+–‫מעכבים שעברו דיוטרציה ל‬
‫ של מערכת העיכול בעלי תכונות‬ATPase
‫טיפוליות מוגברות‬
‫תהליך ותוצרי ביניים לסינטזת קספופונגין‬
C07D )2009.01(
190334
September 22, 2009
–‫ד' בתשרי התש"ע‬
PYRIDYLSULFONAMIDE
DERIVATIVES, THEIR
MANUFACTURE AND USE AS
ANTINEOPLASTIC AGENTS
F. HOFFMANN-LA ROCHE AG
EP
05025733.6 25/11/2005
PCT/EP/2006/010847
WO/2007/059872
20/03/2008
‫ ייצורן ושימושן‬,‫תולדות פירידילסולפונאמיד‬
‫כחומרים למניעת גדילת תאים סרטניים‬
MINIATURE DISPOSABLE OR
PARTIALLY REUSABLE DOSING
PUMPS
THOMAS PHILIP
05/10/2006
‫משאבות מנה מיניאטוריות חד פעמיות או‬
‫ברות שימוש חוזר חלקי‬
‫טומס פיליפ‬
C07D )2009.01(
190336
IMIDAZOPYRIDINE DERIVATIVES
AS A2B ADENOSINE RECEPTOR
ANTAGONISTS
LABORATORIOS ALMIRALL, S.A.
ES
P200502433 06/10/2005
PCT/EP/2006/009620
WO/2007/039297
02/06/2006
‫תולדות אימידאזופירידין כאנטגוניסטים‬
‫ אדנוזין‬B2A ‫לרצפטור של‬
190337
AXIAL FLOW PUMP WITH MULTIGROOVED ROTOR
HEARTWARE, INC.
US
11/243722
05/10/2005
US
PCT/US2005/35964 06/10/2005
US
PCT/US2005/42495 22/11/2005
PCT/US/2006/021544
WO/2007/040663
05/10/2006
September 22, 2009
F04B )2009.01(
190335
190338
–‫ד' בתשרי התש"ע‬
A61M )2009.01(
‫משאבה צירית בעלת רוטור מחורץ‬
C07C )2009.01(
31
BIPHENYLOXYACETIC ACID
DERIVATIVES FOR THE TREATMENT
OF RESPIRATORY DISEASE
ASTRAZENECA AB
GB
0520324.5
06/10/2005
0525082.4
09/12/2005
GB
0602800.5
11/02/2006
GB
PCT/GB/2006/003697
WO/2007/039741
03/10/2006
–1 ,2–)‫–כלורופניל‬2(–5–‫משטר מתן ל‬
–‫–מתיל‬3–‫–מתוקסי‬8–‫–פלואורו‬7–‫דיהידרו‬
‫]בנזודיאזפין‬B][1,4–3,4[‫פיראזולו‬
32
C07D )2009.01(
190340
HETEROCYCLIC AMIDE
DERIVATIVES USEFUL AS
MICROBIOCIDES
SYNGENTA PARTICIPATIONS AG
EP
05023222.2 25/10/2005
06004191.0
02/03/2006
EP
PCT/EP/2006/010185
WO/2007/048556
14/10/2003
C07D )2009.01(
190339
REGIMEN OF ADMINISTRATION FOR
5-(2-CHLOROPHENYL)-1,2-DIHYDRO7-FLUORO-8-METHOXY-3-METHYLPYRAZOLO [3,4B][1,4]BENZODIAZEPINE
F. HOFFMANN-LA ROCHE AG
US
60/727020
14/10/2005
PCT/EP/2006/067005
WO/2007/042430
23/10/2006
‫תולדות חומצה ביפנילאוקסיאצטית‬
‫לטיפול במחלה נשימתית‬
‫תולדות אמיד הטרוציקלי השימושיות‬
‫כקוטלי מיקרובים‬
C07D )2009.01(
190341
September 22, 2009
–‫ד' בתשרי התש"ע‬
HETEROCYCLOCARBOXAMIDE
DERIVATIVES
SYNGENTA PARTICIPATIONS AG
GB
0224316.0
18/10/2002
PCT/EP/2003/011388
WO/2004/035589
12/10/2006
‫נגזרות של הטרוציקלוקרבוקסמיד‬
B24B )2009.01(
190342
‫ליטוש כימי–מכני של מצעי‬
‫רותניום‬/‫נחושת‬
CMP OF COPPER/RUTHENIUM
SUBSTRATES
CABOT MICROELECTRONICS
CORPORATION
US
11/259645
26/10/2005
PCT/US/2006/039956
WO/2007/050313
20/03/2008
G01B )2009.01(
190343
SYSTEM AND METHOD FOR HEIGHT
MEASUREMENT
CAMTEK LTD.
US
60/895988
21/03/2007
20/03/2008
‫שיטה ומערכת למדידת גובה‬
‫קמטק בע"מ‬
190344
POWER-ELECTRONIC CIRCUIT
ARRANGEMENT FOR A ROTATING
FIELD MACHINE
RENK AKTIENGESELLSCHAFT
DE
102007013462.4 21/03/2007
20/03/2008
September 22, 2009
190345
–‫ד' בתשרי התש"ע‬
G06F )2009.01(
‫מערך מעגל כח–אלקטרוני עבור מכונת‬
‫שדה מסתובבת‬
G08B )2009.01(
33
THEFT-PROTECTING ASSEMBLY
FOR RECHRGEABLE HAND-HELD
ELECTRONIC DEVICES
MEIR AVGANIM
30/10/2006
‫מיכלול להגנה בפני גניבות של מכשירים‬
‫אלקטרוניים ניידים נטענים‬
‫מאיר אבגנים‬
PHARMACEUTICAL PREPARATION
HAVING EXCELLENT
PHOTOSTABILITY
NISSAN CHEMICAL INDUSTRIES,
LTD.
2005JP
31/10/2005
316758
PCT/JP/2006/321632
WO/2007/052592
18/09/2006
‫תכשיר רפואי בעל פוטוסטאביוליות‬
‫מצויינת‬
34
–‫מודולטורים של הקסאהידרו‬
‫ציקלוהפטאפירזול קנבינויד‬
C07D )2009.01(
190348
HEXAHYDRO CYCLOOCTYL
PYRAZOLE CANNABINOID
MODULATORS
JANSSEN PHARMACEUTICA NV
US
60/719884
23/09/2005
PCT/US/2006/037350
WO/2007/044215
18/09/2006
C07D )2009.01(
190347
HEXAHYDROCYCLOHEPTAPYRAZOLE
CANNABINOID MODULATORS
JANSSEN PHARMACEUTICA NV
US
60/720253
23/09/2005
PCT/US/2006/036158
WO/2007/038036
22/09/2006
A61K )2009.01(
190346
‫מודולטורים של הקסאהידרו ציקלואוקטיל‬
‫פירזול קנבינויד‬
C07D )2009.01(
190349
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫מודולטורים של טטראהידרו–אינדזוליל‬
‫קנבינויד‬
TETRAHYDRO-INDAZOLYL
CANNABINOID MODULATORS
JANSSEN PHARMACEUTICA NV
US
60/719772
23/09/2005
PCT/US/2006/036248
WO/2007/038045
19/09/2006
190350
BENZOTHIAZOLE CYCLOBUTYL
AMINE DERIVATIVES AND THEIR
USE AS HISTAMINE-3 RECEPTORS
LIGANDS
ABBOTT LABORATORIES
US
60/719516
22/09/2005
11/518132
08/09/2006
US
PCT/US/2006/036422
WO/2007/038074
19/09/2006
‫נגזרות של בנזותיאזול ציקלובוטיל אמין‬
‫והשימוש בהן כליגנדים של רצפטורים של‬
3–‫היסטמין‬
190351
METHOD AND ANGLED SHEET
MATERIAL AND JOINT
INDUSTRIAL ORIGAMI, INC.
US
60/720417
23/09/2005
PCT/US/2006/036698
WO/2007/038154
20/03/2008
METHOD FOR CONSOLIDATING
BLOCKS OR SLABS MADE OF BUILDING
MATERIAL
E04B )2009.01(
‫שיטה לגיבוש לבנים או אריחים‬
‫העשויים מחומר בנייה‬
12/04/2007
20/03/2008
190353
C06B )2009.01(
‫התקן‬
DEVICE
September 22, 2009
B21D )2009.01(
‫שיטה וחומר מלווח זוויתי ומחבר‬
190352
AROS S.R.L.
IT
VR2007A000054
C07D )2009.01(
–‫ד' בתשרי התש"ע‬
35
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
22/09/2006
‫רפאל מערכות לחימה מתקדמות בע"מ‬
A61B )2009.01(
190354
‫מערך אלקטרודה‬
ELECTRODE ARRAY
BRAINSCOPE COMPANY, INC.
US
60/719943
23/09/2005
PCT/US/2006/037045
WO/2007/038305
12/09/2006
CONTROL SYSTEM FOR AN ARC
FURNACE
ADVANCED MINERAL RECOVERY
TECHNOLOGIES LTD
GB
0519163.0
20/09/2005
PCT/GB/2006/003357
WO/2007/034138
23/09/2005
F27B )2009.01(
190355
‫מערכת בקרה עבור כבשן‬
B32B )2009.01(
190356
COMPOSITIONS FOR
IMPREGNATING PAPER PRODUCTS
AND NATURAL FABRICS AND
METHODS, PROCESSES AND
ASSEMBLAGES THEREFOR
ECOLOGY COATING, INC.
‫תכשירים להספגת מוצרי נייר ומרקמים‬
‫ תהליכים והרכבים עבורם‬,‫טבעיים ושיטות‬
PCT/US/2005/034299
WO/2007/040493
21/09/2006
36
H04H )2008.04(
190357
September 22, 2009
–‫ד' בתשרי התש"ע‬
METHOD AND DEVICE FOR
PROCESSING A DVB-H (DIGITAL,
VIDEO BROADCASTINGHANDHELD) COMPLIANT
TRANSPORT STREAM
UDCAST,
EP
05291979.2 23/09/2005
PCT/EP/2006/066603
WO/2007/039479
22/09/2006
190358
INDAZOLES, BENZOTHIAZOLES,
BENZOISOTHIAZOLES,
BENZISOXAZOLES,
PYRAZOLOPYRIDINES,
ISOTHIAZOLOPYRIDINES, AND
PREPARATION AND USES THEREOF
MEMORY PHARMACEUTICALS
CORPORATION
US
60/719552
23/09/2005
PCT/US/2006/037142
WO/2007/038367
25/09/2006
190359
CONJUGATES OF
THERAPEUTICALLY ACTIVE
COMPOUNDS
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
US
60/719175
22/09/2005
PCT/IL/2006/001118
WO/2007/034495
20/03/2008
190360
BALLISTIC ARMOR
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫ התואם‬H–DVB ‫שיטה ומערכת לעיבוד‬
‫לרצף שנשלח‬
C07D )2009.01(
,‫ בנזותיאזולים‬,‫אינדאזולים‬
,‫ בנזאיזוקסאזולים‬,‫בנזואיזותיאזולים‬
,‫ איזותיאזולופירידינים‬,‫פיראזולופירידינים‬
‫הכנתם ושימושים בהם‬
A61K )2009.01(
‫צימודים של חומרים תראפויטים פעילים‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים‬
F41H )2009.01(
‫שריון בליסטי‬
37
‫פלסן סאסא בע"מ‬
PLASAN SASA LTD.
21/09/2006
A61B )2009.01(
190361
‫התקן‬
A DEVICE
SMART SURGICAL APPLIANCES LTD
GB
0519259.6
21/09/2005
PCT/GB/2006/003533
WO/2007/034203
21/09/2006
‫בלון מסועף ותומכן‬
‫בלון בע"מ‬-‫בי‬
BIFURCATED BALLOON AND STENT
B-BALLOON LTD
US
60/719737
21/09/2005
60/750024
12/12/2005
US
PCT/IL/2006/001111
WO/2007/034488
22/09/2006
A SYSTEM AND METHOD TO
TRANSLATE EMAILS AND SMS
38
C12N )2009.01(
190363
CELL POPULATIONS HAVING
IMMUNOREGULATORY ACTIVITY,
METHOD FOR ISOLATION USES
CELLERIX, S.L.
EP
05077186.4 23/09/2005
PCT/EP/2006/009244
WO/2007/039150
23/03/2008
A61F )2009.01(
190362
‫אוכלוסיות תאים שלהם פעילות‬
‫ שיטה לבידוד ושימושים‬,‫אימונורגולוטורית‬
G06F )2009.01(
190364
‫מערכת ושיטה לתרגום אימיילים‬
‫ומיסרונים‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫שלמה ארן‬
SHLOMO ARAN
23/03/2008
190365
INFLATABLE REFRIGERATOR AND
FREEZER
AVRAHAM KLANSS
23/03/2008
‫מקרר ומקפיא מתנפח‬
‫אברהם קלאנס‬
190366
A DEVICE FOR POCKETS IN
FOOTWEAR
UZI EZRA HAVOSHA
20/09/2006
‫עוזי עזרא חבושה‬
FOOD ROASTING DEVICE, METHOD
AND KIT
GREEN GROWTH COFFEE, INC.
US
60/718977
21/09/2005
60/726426
13/10/2005
US
PCT/US/2006/036601
WO/2007/038113
190368
PATTERN DIVERSITY TO SUPPORT A
MIMO RECEIVER AND ASSOCIATED
METHODS
September 22, 2009
–‫ד' בתשרי התש"ע‬
A43B )2009.01(
‫מתקן לכיסים בהנעלה‬
190367
22/09/2006
A47J )2009.01(
A47J )2009.01(
‫ שיטה וערכה לצליית מזון‬,‫התקן‬
G01S )2009.01(
‫מגוון תבניות לתמיכה במקלט רב–קלט‬
‫ ) ושיטות קשורות‬MIMO( ‫ופלט‬
39
INTERDIGITAL TECHNOLOGY
CORPORATION
US
11/233329
22/09/2005
11/326042
05/01/2006
US
PCT/US/2006/037074
WO/2007/038326
20/09/2006
WIRELESS COMMUNICATION
METHOD AND SYSTEM FOR
SUPPORTING CALL CONTINUITY
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/720270
23/09/2005
PCT/US/2006/036986
WO/2007/038272
25/09/2006
B67D )2009.01(
‫שיטה ומערכת להושטה של מוצר ממיכל‬
‫שומר צורה‬
B65B )2009.01(
190371
DEVICE FOR WINDING TAPES
SHLOMO ESHED
GB
0519367.7
23/09/2005
40
‫שיטה לתקשורת אלחוטית ומערכת‬
‫לתמיכה ברצף שיחה‬
190370
METHOD AND ASSEMBLY FOR
DISPENSING A PRODUCT FROM A
FORM-RETAINING CONTAINER
AFA POLYTEK B.V.
NL
1030018
23/09/2005
06010958.4
28/05/2006
EP
PCT/EP/2006/009268
WO/2007/039158
21/09/2006
H04Q )2008.04(
190369
‫התקן לליפוף סרטים‬
‫שלמה אשד‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
PCT/IL/2006/001114
WO/2007/034491
23/06/2006
190372
BIARYL SUBSTITUTED
HETEROCYCLE INHIBITORS OF
LTA4H
DECODE GENETICS EHF
US
60/719016
21/09/2005
PCT/US/2006/024393
WO/2007/040682
27/12/2005
‫ הטרוצ'יקלים מותמרים‬LTA4H ‫מנועי‬
‫ביארילים‬
190373
IMPROVED PROCESS FOR THE
RECOVERY OF SULPHATE OF POTASH
(SOP) FROM SULPHATE RICH
BITTERN
COUNCIL OF SCIENTIFIC AND
INDUSTRIAL RESEARCH
IN
3014DEL2005 10/11/2005
PCT/IN/2005/000441
WO/2007/054953
21/09/2006
23/03/2008
September 22, 2009
–‫ד' בתשרי התש"ע‬
B43L )2009.01(
‫מכשיר–תיאום ומערכת המספקים ממשק‬
‫למדייה להעברת חומרים חינוכיים‬
190375
METHOD AND APPARATUS FOR
UTILIZATION OF LOCATION
DETERMINING SIGNAL SAMPLES IN
NOISY ENVIRONMENTS
C01D )2009.01(
‫תהליך משופר להפקת גפרית אשלג‬
‫מאנפית עשירת גפרית‬
190374
ADAPTABLE DEVICE AND SYSTEM
TO PROVIDE AN INTERFACE FOR
MEDIA IMPARTING EDUCATIONAL
MATERIAL
EDU BARKAI
US
60/719190
22/09/2005
PCT/IL/2006/001109
WO/2007/034486
C07D )2009.01(
‫אדו ברקאי‬
G01S )2009.01(
‫שיטה ומערכת לניצול דוגמיות אותות‬
‫הגדרת מיקום בסביבה רועשת‬
41
‫ אל) בע"מ‬.‫ אס‬.‫ איי‬. ‫מרבל ישראל ( אמ‬
MARVELL ISRAEL(M.I.S.L.) LTD.
US
60/896104
21/03/2007
23/03/2008
‫שיטה ומערכת להגדרת מיקומם העושה‬
‫שימוש בפתרונות היבריד‬
METHOD AND APPARATUS FOR
DETERMINING LOCATION USING A
HYBRID SOLUTION
‫ אל) בע"מ‬.‫ אס‬.‫ איי‬. ‫מרבל ישראל ( אמ‬
MARVELL ISRAEL(M.I.S.L.) LTD.
US
60/896098
21/03/2007
60/912551
18/04/2007
US
23/03/2008
POOL CLEANER WITH INTEGRAL
CHLORINE GENERATOR
AQUATRON, INC.
42
‫שיטה ומערכת להגדרת מיקומם העושה‬
‫שימוש בפתרונות היבריד‬
‫ אל) בע"מ‬.‫ אס‬.‫ איי‬. ‫מרבל ישראל ( אמ‬
G07F )2009.01(
190378
SAFE DEVICE FOR COLLECTING
COINS AND SAFE METHOD FOR
TRANSFERRING AND EMPTYING
COIN BOXES
THALES
FR
0509775
23/09/2005
PCT/EP/2006/066646
WO/2007/033996
23/09/2005
G06F )2009.01(
190377
METHOD AND APPARATUS FOR
DETERMINING LOCATION USING A
HYBRID SOLUTION
MARVELL ISRAEL(M.I.S.L.) LTD.
US
60/896098
21/03/2007
60/912551
18/04/2007
US
22/09/2006
G06F )2009.01(
190376
‫אמצעי בטוח לאיסוף מטבעות ושיטה‬
‫בטוחה להחלפת וריקון קופסאות מטבעות‬
E04H )2009.01(
190379
‫מנקה בריכה עם גנרטור כלור אינטגרלי‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
PCT/US/2005/034233
WO/2007/040490
21/09/2006
190380
METHOD AND APPARATUS FOR
MANAGING CACHE PARTITIONING
QUALCOMM INCORPORATED
US
11/233575
21/09/2005
PCT/US/2006/036938
WO/2007/035904
28/09/2006
‫שיטה ומערכת לניהול חלוקת אזורי אחסון‬
190381
MIXTURE OF IRON AND COPPER
SALTS MASKING METTALIC TASTE
BAYER CONSUMER CARE AG.
EP
05292120.2 11/10/2005
PCT/EP/2006/009434
WO/2007/042153
24/03/2008
190382
DETECTING PROSTATE CANCER
VERIDEX, LLC
US
11/734763
12/04/2007
24/03/2008
190383
LOCAL VASCULAR DELIVERY OF
PROBUCOL ALONE OR IN
COMBINATION WITH SIROLIMUS TO
TREAT RESTENOSIS, VULNERABLE
PLAQUE, AAA AND STROKE
September 22, 2009
–‫ד' בתשרי התש"ע‬
G06F )2009.01(
A61K )2009.01(
‫תערובת מלחי ברזל ונחושת הממסכים‬
‫טעם מתכתי‬
A61B )2009.01(
‫אבחון סרטן הפרוסטטה‬
A61K )2009.01(
‫נתינה מקומית וסקולרית של פרובוקול‬
‫לבד או בשילוב עם סירולימוס לטיפול‬
‫ ושבץ‬AAA ,‫ פלק פגיע‬,‫ברסטנוסיס‬
43
CORDIS CORPORATION
US
11/692744
24/03/2008
28/03/2007
THE MAGNETIC-FIELD METHOD FOR
PROPULSIVE FORCE ACTIVATION
AND MAGNETIC- FIELD
PROPULSIVE DEVICES
KHMELNIK SOLOMON
29/09/2006
‫חמלניק סולומון‬
A61K )2009.01(
‫שיטות להכנת פולימרים עם קבוצות אמינו‬
‫קצוניות תוך כיד שימוש במלחי אמין‬
‫מוגנים‬
C12N )2009.01(
190521
NUCLEIC ACIDS ENCODING
MODIFIED CYTOCHROME P450
ENZYMES AND METHODS OF USE
THEREOF
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
44
‫שיטת השדה המגנטי לזירת כח הינא‬
‫והמגנטי לזירת מכשיר הינא‬
190415
METHODS FOR PREPARING
POLYMERS HAVING TERMINAL
AMINE GROUPS USING PROTECTED
AMINE SALTS
ENZON PHARMACEUTICALS, INC.
US
11/242656
04/10/2005
PCT/US/2006/038562
WO/2007/044319
05/10/2006
B63H )2009.01(
190384
‫חומצות גרעין המקודדות לאנזימי צ'טוכרום‬
‫ משונים ושיטות לשימוש בהן‬P450
September 22, 2009
–‫ד' בתשרי התש"ע‬
US
60/724525
60/762700
US
PCT/US/2006/039433
WO/2007/044688
07/10/2005
27/01/2006
15/10/2006
190562
METHOD AND SYSTEM FOR
TREATING ORGANICALLY
CONTAMINATED WASTE WATER
RONI WEISSMAN
US
60/723986
06/10/2005
PCT/IL/2006/001172
WO/2007/039910
15/11/2006
‫שיטה ומערכת לטיפול בשפכים המכילים‬
‫זיהום אורגני‬
‫רוני ויסמן‬
190705
190706
ISOLATED NUCLEIC ACID WHICH
ENCODES A SUCROSE
FLUORESCENT INDICATOR,
SUCROSE BIOSENSORS AND
METHODS OF USING THE SAME
CARNEGIE INSTITUTION OF
WASHINGTON
September 22, 2009
–‫ד' בתשרי התש"ע‬
C12N )2009.01(
‫תהליך להכנת שורת תאים אנושיים‬
‫קבועה‬
A METHOD FOR THE PRODUCTION OF
A PERMANENT HUMAN CELL LINE
CEVEC PHARMACEUTICALS GMBH
DE
102005054628.5 16/11/2005
PCT/DE/2006/002004
WO/2007/056994
14/10/2005
C02F )2009.01(
A01H )2009.01(
‫חומצת גרעין מבודדת המקודדת אינדקטור‬
‫ חיישן מן החי‬,‫לפלוארנות של סוכרוז‬
‫לסוכרוז ושיטות לשימוש בהם‬
45
PCT/US/2005/036951
WO/2007/046786
13/10/2006
DIURETIC-LIKE COMPOUND
ANALOGS AND PHARMACEUTICAL
COMPOSITIONS FOR REGULATION
OF CENTRAL NERVOUS SYSTEM
DISORDERS CONTAINING THE SAME
NEUROTHERAPEUTICS PHARMA,
INC
US
60/727564
17/10/2005
PCT/US/2006/040108
WO/2007/047447
19/10/2006
‫אנולוגים דמיוו תרכובת משתנת ותכשירי‬
‫רוקחות לויסות אי–סדרים של מערכת‬
‫העצבים המרכזית המכילים אותם‬
‫כרומנונים ושימושם כמאפנני רצפטורים‬
‫של גלוטמט מטבוטרופי‬
C07J )2009.01(
190743
IMPROVED METHOD FOR THE
PRODUCTION OF BETULINIC ACID
BOEHRINGER INGELHEIM PHARMA
GMBH & CO. KG
EP
05109482.9 12/10/2005
PCT/EP/2006/067309
WO/2007/042542
46
C07D )2009.01(
190740
CHROMENONES AND THEIR USE AS
MODULATORS OF METABOTROPIC
GLUTAMATE RECEPTORS
MERZ PHARMA GMBH & CO. KGAA
US
60/729312
21/10/2005
PCT/GB/2006/003888
WO/2007/045876
12/10/2006
C07D )2009.01(
190710
‫שיטה משופרת ליצור חומצה בטולינית‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
09/11/2006
190920
COMPOUNDS FOR THE TREATMENT
OF METABOLIC DISORDERS
WELLSTAT THERAPEUTICS
CORPORATION
US
60/734803
09/11/2005
PCT/US/2006/060727
WO/2007/567714
18/10/2006
190921
ANTENNA ARRANGEMENT
BLUESKY POSITIONING LIMITED
EP
05109729.3 19/10/2005
PCT/FI/2006/050448
WO/2007/045725
30/05/2006
190922
INPUT-DEVICE MOVEMENT TO
CURSOR MOVEMENT CORRELATOR
AVOCENT HUNTSVILLE CORP.
US
11/250406
17/10/2005
PCT/US/2006/021181
WO/2007/046879
25/10/2006
190924
METHOD FOR COLLATING
DOCUMENTS AND DEVICE FOR
CARRYING OUT THIS METHOD
MEGASPIREA PRODUCTION S.A.S.
FR
0510923
26/10/2005
PCT/FR/2006/002394
WO/2007/048923
September 22, 2009
–‫ד' בתשרי התש"ע‬
A61K )2009.01(
‫תרכובות לטיפול בהפרעות מטבוליות‬
H01Q )2009.01(
‫סידור אנטנה‬
G06F )2009.01(
‫מתאם של תנועות מכשיר הזנה עם‬
‫תנועות סמן‬
B65B )2009.01(
‫שיטה למיון מסמכים והתקן לבצע את‬
‫השיטה‬
47
16/11/2006
A PHARMACEUTICAL COMPOSITION
CONTAINING A TISSUE PROTEIN
THE UNIVERSITY OF TENNESSEE
RESEARCH FOUNDATION
US
60/737194
16/11/2005
PCT/US/2006/044344
WO/2007/059211
24/10/2006
B65B )2009.01(
‫מכשירים ושיטות השימושיות לאישור‬
‫קניות הקשורות עם כלי רכב‬
‫פטרהטק אינטרנשיונל בע"מ‬
A61K )2009.01(
190935
4-(3-AMINOPYRAZOLE)PYRIMIDINE
DERIVATIVES FOR USE AS
TYROSINE KINASE INHIBITORS IN
THE TREATMENT OF CANCER
ASTRAZENECA AB
US
60/731299
28/10/2005
60/803061
24/05/2006
US
PCT/GB/2006/003978
WO/2007/049041
48
‫תכשיר רוקחות המכיל חלבון רקמה‬
190934
DEVICES AND METHODS USEFUL
FOR AUTHORIZING PURCHASES
ASSOCIATED WITH A VEHICLE
PETRATEC INTERNATIONAL LTD
US
60/729215
24/10/2005
60/762498
27/01/2006
US
60/790533
10/04/2006
US
PCT/IL/2006/001222
WO/2007/049274
26/10/2006
A61K )2009.01(
190926
‫–אמינופיראזול)פירימידין‬3(–4 ‫נגזרות‬
‫לשימוש כמעכבי טירוזין קינאז בטיפול‬
‫בסרטן‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
20/10/2006
190936
IAP BIR DOMAIN BINDING
COMPOUNDS
AEGERA THERAPEUTICS INC.
US
60/729727
25/10/2005
60/830662
14/07/2006
US
PCT/CA/2006/001721
WO/2007/048224
16/10/2006
190939
APPARATUS FOR DELIVERY OF
PRESSURISED GAS
COMPUMEDICS LIMITED
AU
2005905836 21/10/2005
PCT/AU/2006/001513
WO/2007/045017
19/10/2006
190944
APERTURED CONDITIONING BRUSH
FOR CHEMICAL MECHANICAL
PLANARIZATION SYSTEMS
TBW INDUSTRIES, INC.
US
60/728126
19/10/2005
11/582711
18/10/2006
US
PCT/US/2006/041166
WO/2007/047996
September 22, 2009
–‫ד' בתשרי התש"ע‬
A61K )2009.01(
BIR IAP ‫תרכובות קושרות‬
A61M )2009.01(
‫מתקן לאספקת גז בלחץ‬
B24B )2009.01(
‫מברשת התאמה עם פתח למערכות‬
‫פלנריזציה כימיות מכניות‬
49
12/10/2006
‫זיהוי תוך גופי של מוות תאי‬
JN VIVO DETECTION OF APOPTOSIS
IMMUNOCHEMISTRY
TECHNOLOGIES, LLC
US
60/729227
21/10/2005
PCT/US/2006/040047
WO/2007/050319
19/10/2006
‫מוחק לדיסק קשיח‬
A61K )2009.01(
190951
METHOD OF ACTING UPON
ORGANISM BY TARGETED
DELIVERY OF BIOLOGICALY
ACTIVE SUBSTANCES INTO
MITOCHONDRIA,
PHARMACEUTICAL COMPOSITION
FOR CARRYING OUT SAID METHOD,
AND COMPOUND USED FOR THE
PURPOSE
50
G06F )2009.01(
190950
HARD DRIVE ERASER
ENSCONCE DATA TECHNOLOGY,
INC.
US
60/728320
20/10/2005
PCT/US/2006/040805
WO/2007/047802
24/07/2006
G01N )2009.01(
190949
‫שיטה להכוונת חומר פעיל ביולוגית לתוך‬
‫ תכשיר רוקחי המיישם‬,‫המיטוכונדריה‬
‫שיטה זו ותרכובות למטרה זו‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
LIMITED LIABILITY COMPANY
"MITOTECHNOLOGY"
RU
2005132217 18/10/2005
PCT/RU/2006/000394
WO/2007/046729
20/10/2006
PIPERAZINE DERIVATIVES AS
ANTIMALARIAL AGENTS
ACTELION PHARMACEUTICALS
LTD.
WO
IB05/53457 21/10/2005
PCT/IB/2006/053868
WO/2007/046075
09/10/2006
‫תולדות פיפראזיניות כגורם נגד מלריה‬
190953
CYCLOPROPYLACETIC ACID
DERIVATIVES AND USE THEREOF
BAYER HEALTHCARE AG
DE
102005050498.1 21/10/2005
PCT/EP/2006/009723
WO/2007/045367
20/10/2006
190954
MODIFIED PROTEASES THAT
INHIBIT COMPLEMENT ACTIVATION
CATALYST BIOSCIENCES, INC.
US
60/729817
21/10/2005
PCT/US/2006/041165
WO/2007/047995
September 22, 2009
C07D )2009.01(
190952
–‫ד' בתשרי התש"ע‬
C07C )2009.01(
‫תולדות חומצה ציקלו פרופיל אצטית‬
‫ושימושיה‬
A61K )2009.01(
‫פרוטיאזות שונות המעכבות שפעול‬
‫משלים‬
51
17/10/2006
DICARBOXYLIC ACID DERIVATIVES
AND THEIR USE
BAYER HEALTHCARE AG
DE
102005050376.4 21/10/2005
PCT/EP/2006/009996
WO/2007/045433
20/10/2006
‫תולדות חומצות דיקרבוקסיליות‬
‫ושימושיהן‬
F16L )2009.01(
190956
FITTING FOR TUBE AND PIPE
SWAGELOK COMPANY
US
11/255499
20/10/2005
11/375843
14/03/2006
US
PCT/US/2006/041214
WO/2007/048021
23/10/2006
C07C )2009.01(
190955
‫מתאם עבור שפופרת וצינור‬
H01M )2009.01(
190958
‫סוללות יוני ליתיום‬
LITHIUM ION BATTERIES
ALTAIRNANO, INC.
US
60/729100
21/10/2005
60/748124
06/12/2005
US
PCT/US/2006/060164
WO/2007/048142
09/11/2006
MOLDED SHAVING AID
COMPOSITIONS, COMPONENTS AND
METHOD OF MANUFACTURE
THE GILLETTE COMPANY
US
60/735758
09/11/2005
PCT/US/2006/043611
WO/2007/056509
52
B26B )2009.01(
190959
‫ רכיבים ושיטה‬,‫תכשיר מעוצב לגילוח‬
‫ליצורו‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
08/11/2006
C07K )2009.01(
190960
‫אנטגוניסטים של ניורופילין‬
NEUROPILIN ANTAGONISTS
GENENTECH, INC.
US
60/734798
08/11/2005
60/820561
27/07/2006
US
PCT/US/2006/043516
WO/2007/056470
30/10/2006
C07D )2009.01(
190961
SUBSTITUTED
CYCLOALKYLPYRROLONES AS
ALLOSTERIC MODULATORS OF
GLUCOKINASE
JANSSEN PHARMACEUTICA NV
US
60/732414
01/11/2005
PCT/US/2006/042925
WO/2007/053765
27/04/2008
‫ציקלואלקילפירולונים מותמרים‬
‫המשמשים כמודולטורים אלוסטרים של‬
‫גלוקוקינאז‬
191062
ANGULAR DISPLACEMENT
DERIVATIVE METHOD FOR
ULTRASOUND SEQUENCE
ANALYSIS
BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
06/11/2006
‫שיטה הנגזרת מזווית ציר לניתוח רצף‬
‫אולטראסוני‬
‫ הרשות‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬
‫למחקר ופיתוח‬
191488
AQUEOUS HERBICIDAL
COMPOSITION BASED ON A
SUSPENSION CONCENTRATE
COMPRISING HERBICIDES AND
SAFENER
BAYER CROPSCIENCE AG
EP
05025149.5
17/11/2005
102006030326.1 30/06/2006
DK
PCT/EP/2006/010591
WO/2007/057107
September 22, 2009
–‫ד' בתשרי התש"ע‬
G01N )2009.01(
A01N )2009.01(
‫תכשירים קוטלי עשבים מימיים‬
‫מבוססים על תרכיז של תרחיף המכיל‬
‫חומרים קוטלי עשבים ומגן‬
53
09/11/2007
INTRAUTERINE ULTRASOUND AND
METHOD FOR USE
GYNESONICS, INC.
US
60/758727
12/01/2006
60/821009
01/08/2006
US
PCT/US/2007/060285
WO/2007/112144
12/06/2007
A61B )2009.01(
191526
‫אולטרסאונד תוך–רחמי ושיטה לשימוש‬
F16D )2009.01(
191638
ELECTRICALLY-OPERATED SHAFT
BRAKE WITH MANUAL POSITIVE
LOCK AND ROTARY RELEASE AND
AUTOMATIC RESET FEATURE
MOOG INC
‫מוט עצר המופעל על–ידי חשמל בעל‬
‫ שחרור סיבובי‬,‫נעילה פוזיטיבית ידנית‬
‫ומאפיין איפוס אוטומטי‬
PCT/US/2007/013722
27/11/2006
B66F )2009.01(
191689
‫מגבה‬
A SCISSOR JACK
QUADDRO TECHNOLOGIES (PTY)
LTD
ZA
2005/09554 28/11/2005
2006/01531
22/02/2006
ZA
2006/02326
22/03/2006
ZA
2006/02455
27/03/2006
ZA
PCT/IB/2006/054465
WO/2007/096714
54
September 22, 2009
–‫ד' בתשרי התש"ע‬
29/11/2006
191710
GLUCOCORTICOID RECEPTOR
MODULATORS AS
ANTIINFLAMMATORY AGENTS
F. HOFFMANN-LA ROCHE AG
US
60/749180
09/12/2005
PCT/EP/2006/069059
WO/2007/065828
22/11/2006
12/12/2006
27/11/2006
C12N )2009.01(
‫ ודהפיגמנטציה של העור‬VA siRNA ‫רצפי‬
191735
–‫ד' בתשרי התש"ע‬
G06F )2009.01(
‫ מערכות ומוצרים המשלבים תוכנת‬,‫שיטות‬
‫מחשב לאספקת סידרת ניהול‬
191728
ANTI-MYOSIN VA siRNA AND SKIN
DEPIGMENTATION
PIERRE FABRE DERMOCOSMETIQUE
FR
0512553
12/12/2005
PCT/EP/2006/069618
WO/2007/068704
September 22, 2009
‫מאפננים לרצפטור לגלוקוקורטיקואיד‬
‫כסוכנים אנטידלקתיים‬
191727
METHODS, SYSTEMS, AND
COMPUTER INTEGRATED PROGRAM
PRODUCTS FOR SUPPLY CHAIN
MANAGEMENT
THE BOEING COMPANY
US
60/740356
29/11/2005
11/343425
30/01/2006
US
PCT/US/2006/045232
WO/2007/064549
C07D )2009.01(
G02B )2009.01(
55
OPTICAL INSTRUMENT COMPRISING
AN INPUT CAVITY WHEREIN IS
ARRANGED A MIRROR
THALES
FR
0553620
28/11/2005
PCT/FR/2006/051234
WO/2007/060376
28/11/2006
‫מערכת ושיטה למניעת רכישת מידע ללא‬
‫הרשאה‬
G21F )2009.01(
191901
CERAMIC RADIATION SHIELDING
COMPOSITION CONTAINING AN
OXIDE-PHOSPHATE CERAMIC
CEMENT MATRIX
CO-OPERATIONS, INC
US
11/295708
06/12/2005
11/441833
26/05/2006
US
PCT/US/2006/046722
WO/2008/060292
56
G06F )2009.01(
191799
[SVC] SYSTEM AND METHOD FOR
PREVENTING UNAUTHORIZED
ACQUISITION OF INFORMATION
IBM CORPORATION
2005JP
28/11/2005
341712
PCT/JP/2006/323748
WO/2007/061119
06/12/2006
‫מכשיר אופטי המכיל חלל מקבל אשר בו‬
‫נמצאת מראה‬
‫תכשיר קרמי מגן קרינה המכיל מטריצת‬
‫מלט קרמי תחומצתית–פוספטית‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
23/11/2006
A61P )2009.01(
191971
POLYMORPHS OF A C-MET/HGFR
INHIBITOR
PFIZER PRODUCTS INC.
US
60/742676
05/12/2005
PCT/IB/2006/003383
WO/2007/066185
04/01/2007
HGFR/MET–C ‫פולימורפים של מעכב‬
SYSTEM AND METHOD FOR LOW
POWER WORDLINE LOGIC FOR A
MEMORY
QUALCOMM INCORPORATED
US
60/756100
04/01/2006
60/756856
06/01/2006
US
11/402483
11/04/2006
US
PCT/US/2007/060117
WO/2007/012093
22/03/2007
‫מערכת ושיטה ללוגיקת קו–מילולי בכוח‬
‫נמוך לזיכרון‬
192297
BENZIMIDAZOLE DERIVATIVES AND
THEIR USE FOR MODULATING THE
GABAA RECEPTOR COMPLEX
NEUROSEARCH A/S
DK
PA200600426 24/03/2006
DK
PA200601327 12/10/2006
PCT/EP/2007/052766
WO/2007/110374
25/12/2006
September 22, 2009
G11C )2009.01(
191973
‫תולדות בנזימידאזול והשימוש בהן לאפנון‬
AA GABA ‫קומפלקס קולטן‬
192298
–‫ד' בתשרי התש"ע‬
C07D )2009.01(
A61P )2009.01(
57
HETEROCYCLIC JANUS KINASE 3
INHIBITORS
ASTELLAS PHARMA INC.
2005JP
28/12/2005
378858
PCT/JP/2006/326327
WO/2007/077949
27/12/2006
58
‫גורם טיפולי לסוכרת‬
C07D )2009.01(
192387
DIPHENYLUREA DERIVATIVES AND
THEIR USE AS CHLORIDE CHANNEL
BLOCKERS OR BKCA CHANNEL
MODULATORS
NEUROSEARCH A/S
DK
PA200600360 14/03/2006
PCT/EP/2007/052243
WO/2007/104719
05/01/2007
A61P )2009.01(
192369
THERAPEUTIC AGENT FOR
DIABETES
TAKEDA PHARMACEUTICAL
COMPANY LIMITED
JP
379407/2005 28/12/2005
061722/2006
07/03/2006
JP
PCT/JP/2006/326141
WO/2007/074884
09/03/2007
‫ הטרוציקליים‬JAK3 ‫מעכבי‬
‫תולדות דיפניל אוריאה ושימושן כחסמי‬
BKCA ‫ערוץ כלורידי או מאפנני ערוץ‬
A01N )2009.01(
192422
September 22, 2009
–‫ד' בתשרי התש"ע‬
AGROCHEMICAL FORMULATIONS
BASED ON MOLECULARLY
IMPRINTED ACRYLATES
BASF SE
EP
06100263.0 12/01/2006
PCT/EP/2007/050112
WO/2007/082802
19/12/2006
192465
GENIUS ADAPTIVE DESIGN
KAYS, STEVEN
US
60/755291
30/12/2005
60/756607
05/01/2006
US
60/778313
01/03/2006
US
60/783018
15/03/2006
US
60/786906
28/03/2006
US
60/852794
18/10/2006
US
PCT/US/2006/048704
WO/2007/081519
21/12/2006
192482
FITTING FOR METAL PIPE AND
TUBING
SWAGELOK COMPANY
US
11/324882
04/01/2006
PCT/US/2006/048786
WO/2007/081527
18/01/2007
September 22, 2009
192514
–‫ד' בתשרי התש"ע‬
‫הרכבים אגרוכימיים המבוססים על‬
‫אקרילטים המוטבעים באופן מוליקולרי‬
G06Q )2008.04(
‫תכנון גאונות הניתן להתאמה‬
F16L )2009.01(
‫אביזר עבור צנור מתכת וצנרת‬
G06F )2009.01(
59
SEMI-TRANSPARENT
HIGHLIGHTING OF SELECTED
OBJECTS IN ELECTRONIC
DOCUMENTS
MICROSOFT CORPORATION
US
11/344396
31/01/2006
PCT/US/2007/001545
WO/2007/089461
17/02/2006
‫הדגשה שקופה למחצה של חפצים‬
‫נבחרים במסמכים אלקטרוניים‬
A61F )2008.04(
192543
‫תותבת אנדולומינלית‬
ENDOLUMINAL PROSTHESIS
INVATEC S.R.L.
PCT/IT/2006/000086
WO/2007/094020
21/09/2006
DNT-SUCCINATE AND METHODS OF
PREPARATION THEREOF
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/761585
23/01/2006
60/771162
06/02/2006
US
PCT/US/2006/036974
WO/2007/084193
18/12/2006
‫דולקסטין סוקצינט ותהליכים להכנתם‬
‫טבע תעשיות פרמצבטיות בע"מ‬
A61K )2009.01(
192593
COMBINATION OF TRIAZINE
DERIVATIVES AND PPAR?
AGONISTS
POXEL SAS
FR
06/00345
13/01/2006
PCT/EP/2006/012186
WO/2007/079918
60
C07D )2009.01(
192552
‫קומבינציה של נגזרות טריאזין ואגוניסטים‬
?PPAR ‫של‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
18/12/2006
192594
COMBINATION OF TRIAZINE
DERIVATIVES AND HMG-COA
REDUCTASE INHIBITORS
POXEL SAS
FR
06/00343
13/01/2006
PCT/EP/2006/012184
WO/2007/079916
18/12/2006
‫קומבינציה של נגזרות טריאזין ומעכבים‬
COA–HMG ‫של רדוקטאז‬
192596
COMBINATION OF TRIAZINE
DERIVATIVES AND INSULIN
SECRETION STIMULATORS
POXEL SAS
FR
06/00342
13/01/2006
PCT/EP/2006/012182
WO/2007/079914
22/12/2006
USE OF TIOTROPIUM SALTS IN THE
TREATMENT OF MODERATE
PERSISTENT ASTHMA
BOEHRINGER INGELHEIM PHARMA
GMBH & CO. KG
EP
06100055.0 04/01/2006
PCT/EP/2006/070135
WO/2007/077162
September 22, 2009
–‫ד' בתשרי התש"ע‬
A61K )2009.01(
‫שימוש במלחי טיאוטרופיום לטיפול‬
‫באסטמה מתונה מתמדת‬
192613
CYCLOALKYLAMINES AS
MONOAMINE REUPTAKE
INHIBITORS
SEPRACOR INC.
US
60/756550
06/01/2006
PCT/US/2007/000376
WO/2007/081857
A61K )2009.01(
‫קומבינציה של נגזרות טריאזין ומעוררי‬
‫הפרשת אינסולין‬
192602
05/01/2007
A61K )2009.01(
A61K )2009.01(
‫ציקלואלקילאמינים כמעכבי ספיגה מחדש‬
‫של מונואמינים‬
61
04/01/2007
STEAM CIRCUIT IN A POWER
STATION
SIEMENS AKTIENGESELLSCHAFT
EP
06000183.1 05/01/2006
PCT/EP/2007/050081
WO/2007/077248
03/01/2007
PESTICIDAL MIXTURES
BASF SE
US
60/760532
PCT/EP/2007/050280
WO/2007/082841
07/02/2007
A61K )2009.01(
‫ הריאות או דרך‬,‫תכשיר לנתינה דרך הריר‬
‫הפה‬
A01N )2009.01(
192658
‫תערובות קוטלות מזיקים‬
20/01/2006
H04J )2009.01(
192669
AN APPARATUS AND METHOD FOR
FAST ACCESS IN A WIRELESS
COMMUNICATION SYSTEM
QUALCOMM INCORPORATED
US
60/771093
07/02/2006
PCT/US/2007/061793
WO/2007/092896
62
‫מסלול קיטור בתחנת כוח‬
192642
A COMPOSITION FOR MUCOSAL,
PULMONARY OR ORAL
ADMINISTRATION
THOMAS SKOLD
US
60/756359
05/01/2006
11/616658
27/12/2006
US
PCT/IB/2007/000027
WO/2007/077529
12/01/2007
F22G )2009.01(
192620
‫התקן ושיטה לגישה מהירה במערכת‬
‫תקשורת אלחוטית‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
22/01/2007
192678
COMPOSITIONS AND KITS FOR
TREATING AMYOTROPHIC
LATERAL SCLEROSIS
GENZYME CORPORATION
US
60/760377
20/01/2006
PCT/US/2007/001599
WO/2007/084743
10/01/2007
‫תכשירים וערכות לטיפול לטרשת לטרלי‬
‫עמיוטרופי‬
192693
UROTENSIN II RECEPTOR
ANTAGONISTS
JANSSEN PHARMACEUTICA NV
US
60/757692
10/01/2006
PCT/US/2007/000644
WO/2007/081995
17/01/2007
192696
NEURONAL NICOTINIC RECEPTOR
LIGANDS AND THEIR USE
ABBOTT LABORATORIES
US
60/759314
17/01/2006
PCT/US/2007/001193
WO/2007/084535
17/01/2007
192700
USE OF ELDERBERRY EXTRACT
HEALTHCARE BRANDS
INTERNATIONAL LIMITED
IL
173207
17/01/2006
PCT/GB/2007/000150
WO/2007/083123
18/01/2007
September 22, 2009
192718
–‫ד' בתשרי התש"ע‬
A61K )2009.01(
A61K )2009.01(
II ‫אנטגוניסטים לרצפטור אורוטנסין‬
A61K )2009.01(
‫ליגנדים של רצפטור ניקוטיני נוירונלי‬
‫ושימוש שלהם‬
A61K )2008.04(
‫שימוש בתמצית פרי הסמבוק‬
A61F )2009.01(
63
HARNESS FOR STRETCHING THE
PENIS
CVETANOVIC, MIODRAG
P19/01/2006
2006/0030
PCT/RS/2007/000001
WO/2007/084022
04/03/2007
‫ריתמה למתיחת הפין‬
METHOD AND APPARATUS FOR
LIGHT-BASED HAIR REMOVAL
USING INCOHERENT LIGHT PULSES
ALMA LASERS LTD
US
60/778403
03/03/2006
60/853428
23/10/2006
US
PCT/IL/2007/000275
WO/2007/099546
20/09/2006
‫שיטה ומתקן להסרת שיער בעזרת אור על‬
‫ידי פולסים של אור אינקוהרנטי‬
‫אלמה לייזרס בע"מ‬
64
‫מוצר לריכוך מים וניקוי צבע‬
D03J )2009.01(
192938
METHOD AND APPARATUS FOR
WEAVING
UNIVERSITY OF BRIGHTON
GB
0601376.7
24/01/2006
PCT/GB/2007/050035
WO/2007/085872
01/02/2007
C11D )2009.01(
192887
DYE SCAVENGING AND WATER
SOFTENING PRODUCT
ORLANDI S.P.A.
IT
MI2006A000096 20/01/2006
PCT/IT/2006/000667
WO/2007/083335
23/01/2007
A45D )2009.01(
192784
‫מכשיר ושיטה לאריגה‬
H05K )2009.01(
192986
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫ שיטה‬,‫מערכת הדמיה אופטימלית‬
‫ומדפסת שיכפול‬
OPTIMAL IMAGING SYSTEM AND
METHOD FOR A STENCIL PRINTER
SPEEDLINE TECHNOLOGIES, INC.
US
11/345727
02/02/2006
PCT/US/2007/002925
WO/2007/092325
29/01/2007
193020
DRUG DELIVERY SYSTEMS
CONTAINING WEAKLY BASIC
SELECTIVE SEROTONIN 5-HT3
BLOCKING AGENT AND ORGANIC
ACIDS
EURAND, INC.
US
60/762750
27/01/2006
PCT/US/2007/061217
WO/2007/090082
31/01/2007
‫מערכות לנתינת תרופות המכילות גורם‬
‫ בסיסי חלש‬HT–53 ‫חוסם ברירתי סרוטנין‬
‫וחומצות ארוגניות‬
193137
METHOD OF CHARACTERIZING A
BIOLOGICALLY ACTIVE COMPOUND
REGENETECH, INC.
US
60/764524
02/02/2006
PCT/US/2007/002626
WO/2007/092222
23/02/2006
A61K )2009.01(
193189
A SURGICAL ISOLATOR
OVAGEN INTERNATIONAL LIMITED
C12N )2009.01(
‫שיטה לאיפיון חומר פעיל ביולוגית‬
A61D )2009.01(
‫מבודד כירוגי‬
PCT/EP/2006/060241
WO/2007/095998
30/11/1998
September 22, 2009
193245
–‫ד' בתשרי התש"ע‬
G01N )2009.01(
65
PHARMACEUTICAL COMPOSITIONS
CONTAINING AN A? FRAGMENT
NEURALAB LIMITED
US
60/067740
02/12/1997
60/080970
07/04/1998
US
PCT/US/1998/025386
WO/1999/027944
22/12/2003
RADIATION CURABLE INK
SERICOL LIMITED
GB
0229825.5
GB
PCT/GB03/0028.34
PCT/GB/2003/005619
WO/2003/015988
23/03/2006
?A ‫תכשירי רוקחות המכילים קטע‬
B41M )2009.01(
193263
‫דיו הניתן לריפוי באמצעות קרינה‬
20/12/2002
01/07/2003
G06T )2009.01(
193290
SYSTEM FOR ANALYSIS OF MOTION
NDS LIMITED
‫מערכת לניתוח תנועה‬
PCT/GB/2006/001070
WO/2007/107685
09/02/2007
TREATMENT OF DUCHENNE
MUSCULAR DYSTROPHY
SUMMIT CORPORATION PLC
GB
0602767.6
10/02/2006
0617737.2
08/09/2006
GB
0623984.2
30/11/2006
GB
PCT/GB/2007/050056
WO/2007/091107
66
A61K )2009.01(
193314
‫טיפול במחלת ניוון שרירים דושן‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
09/02/2007
193315
TREATMENT OF DUCHENNE
MUSCULAR DYSTROPHY
SUMMIT CORPORATION PLC
GB
0602768.4
10/02/2006
0614690.6
24/07/2006
GB
0619281.9
29/09/2006
GB
0623983.4
30/11/2006
GB
PCT/GB/2007/050055
WO/2007/091106
21/02/2007
193356
USE OF RASAGILINE FOR THE
TREATMENT OF MULTIPLE SYSTEM
ATROPHY
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/775147
21/02/2006
60/874341
12/12/2006
US
PCT/US/2007/004884
WO/2007/098264
20/02/2007
193372
PHARMACEUTICAL COMPOSITION
COMPRISING OSELTAMIVIR
PHOSPHATE
A61K )2009.01(
‫טיפול במחלת ניוון שרירים דושן‬
A61K )2009.01(
‫רסג'לין כטיפול באטרופיה רב מערכתית‬
‫טבע תעשיות פרמצבטיות בע"מ‬
A61K )2009.01(
‫תכשיר רוקחות המכיל אוסלטמיביר‬
‫פוספט‬
F. HOFFMANN-LA ROCHE AG
2006JP
20/02/2006
042178
PCT/JP/2007/053081
WO/2007/097325
September 22, 2009
–‫ד' בתשרי התש"ע‬
67
07/03/2007
SYSTEM FOR THE EXPRESSION OF
ORTHOGONAL TRANSLATION
COMPONENTS IN EUBACTERIAL
HOST CELLS
THE SCRIPPS RESEARCH INSTITUTE
US
60/780973
09/03/2006
60/783497
17/03/2006
US
60/855336
29/10/2006
US
PCT/US/2007/005914
WO/2007/103490
15/02/2006
G06Q )2008.04(
193394
‫מערכת לביטוי רכיבי תרגום אורתוגונליים‬
‫בתאים פונדקאיים אובקטריאליים‬
B07C )2009.01(
193409
‫התקן מיון‬
SORTING INSTALLATION
PPG AG PERNER PUBLISHING
GROUP AG
PCT/EP/2006/001372
WO/2007/093189
13/08/2008
STORAGE FOR RADIOACTIVE
WASTE
NOVARENA TECHNOLOGIES LTD
20/02/2007
‫איחסון של חומר רדיו אקטיבי‬
‫נוברנה טכנולוגיות בע"מ‬
G06F )2009.01(
193436
DEVICE, SYSTEM AND METHOD OF
ACCESSING A SECURITY TOKEN
K.K. ATHENA SMARTCARD
SOLUTIONS
US
60/774660
21/02/2006
PCT/IL/2007/000226
WO/2007/096871
68
G21F )2009.01(
193434
‫ מערכת ושיטה לגישה לטוקן‬,‫התקן‬
‫אבטחה‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
21/03/2007
193467
SUBSTITUTED INDAZOLE
DERIVATIVES, THEIR
MANUFACTURE AND USE AS
PHARMACEUTICAL AGENTS
F. HOFFMANN-LA ROCHE AG
EP
06006008.4 23/03/2006
PCT/EP/2007/002487
WO/2007/107346
27/02/2007
‫ ייצורן‬,‫נגזרות מותמרות של אינדאזול‬
‫ושימושן כחומרי רוקחות‬
193483
193649
A SYSTEM AND METHOD OF
MANAGING ABSENTEEISM IN AN
ORGANISATION
DISCOVERY HOLDINGS LIMITED
ZA
2006/01934 07/03/2006
PCT/IB/2007/000541
WO/2007/102077
28/02/2007
September 22, 2009
–‫ד' בתשרי התש"ע‬
G06Q )2008.04(
‫מערכת ושיטה לניהול היעדרות בארגון‬
193664
STENT WITH VARIABLE FEATURES
TO OPTIMIZE SUPPORT AND
METHOD OF MAKING SUCH STENT
MEDINOL LTD.
US
11/366365
01/03/2006
PCT/IB/2007/000482
WO/2007/099439
C07D )2009.01(
‫– אונים‬2 – ‫– דיהידרו–אימידאזול‬1,5
5–‫ ו‬1 ‫ – אמינו בעמדות‬4 –‫המותמרים ב‬
4-AMINO-1,5-SUBSTITUTED 1,5 DIHYDRO - IMIDAZOL -2- ONES
F. HOFFMANN-LA ROCHE AG
EP
06110812.2 08/03/2006
PCT/EP/2007/051824
WO/2007/101802
07/03/2007
C07D )2009.01(
A61F )2009.01(
‫סטנט בעל מאפיינים הניתנים לשינוי על‬
‫מנת לייעל תמיכה ושיטה לייצור הסטנט‬
‫מדינול בע"מ‬
69
15/03/2007
VARENICLINE STANDARDS AND
IMPURITY CONTROLS
PFIZER PRODUCTS INC.
US
60/786543
27/03/2006
60/828142
04/10/2006
US
PCT/IB/2007/000722
WO/2007/110730
14/03/2007
‫סטנדרטים ובקרות אי–נקיונות של ורניקלין‬
‫שיטות ותכשירים למניעת ניצול רע של‬
‫מוצרים פרמצבטיים המיועדים למתן‬
‫פומית‬
‫תכשיר רוקחות המכיל אמינוסליצילת‬
‫כחומר פעיל‬
A61P )2009.01(
193799
NEW THERAPEUTIC COMBINATIONS
FOR THE TREATMENT OR
PREVENTION OF PSYCOTIC
DISORDERS
WYETH
US
60/785449
24/03/2006
60/788392
31/03/2006
US
PCT/US/2007/007210
WO/2007/111983
70
A61K )2009.01(
193776
A PHARMACEUTICAL COMPOSITION
CONTAINING AN
AMINOSALICYLATE ACTIVE AGENT
AGI THERAPEUTICS RESEARCH LTD.
US
11/371958
10/03/2006
PCT/IB/2007/002029
WO/2007/119177
23/03/2007
A61K )2009.01(
193766
METHOD AND COMPOSITIONS FOR
DETERRING ABUSE OF ORALLY
ADMINISTERED PHARMACEUTICAL
PRODUCTS
ACURA PHARMACEUTICALS, INC.
US
60/782448
15/03/2006
PCT/US/2007/006519
WO/2007/106550
07/03/2007
A61K )2009.01(
193688
‫צירופים טיפוליים חדשים לטיפול או מניעה‬
‫של אי סדרים פסיכוטיים‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
23/03/2007
A61P )2009.01(
193800
ENDOTHELIN AND ENDOTHELIN
RECEPTOR AGONISTS IN THE
TREATMENT OF METABOLIC
DISEASES
AMYLIN PHARMACEUTICALS, INC.
US
60/785447
23/03/2006
PCT/US/2007/007376
WO/2007/112069
23/03/2007
‫אגוניסטים של קולטן אנדותאלין‬
‫ואנדותאלין לטיפול במחלות חילוף חומרים‬
A61P )2009.01(
193841
METHODS FOR MODULATING
BLADDER FUNCTION
WYETH
US
60/785451
24/03/2006
PCT/US/2007/007387
WO/2007/112073
28/03/2007
‫שיטות לויסות פעילות שלפוחית השתן‬
193842
DIAGNOSTICS AND TREATMENTS
FOR TUMORS
GENENTECH, INC.
US
60/787720
29/03/2006
PCT/US/2007/065377
WO/2007/115045
07/03/2007
‫אבחונים וטיפולים עבור גידולים‬
193885
NEW AMINES
ACTELION PHARMACEUTICALS LTD.
WO
PCT/IB06/050724 08/03/2006
PCT/IB/2007/050758
WO/2007/102127
02/10/2006
September 22, 2009
193894
–‫ד' בתשרי התש"ע‬
C07K )2009.01(
C07D )2009.01(
‫אמינים חדשים‬
A61K )2009.01(
71
PHARMACEUTICAL COMPOSITIONS
CONTAINING LULICONAZOLE FOR
EXTERNAL USE
POLA PHARMA INC
2006JP
08/03/2006
062079
2006-215871 08/08/2006
JP
PCT/JP/2006/319708
WO/2007/102242
28/03/2007
A23K )2009.01(
‫תכשירי מדוראמיצין ושיטות‬
A23G )2008.04(
193946
PROTEIN-ENRICHED FROZERN
DESSERT
NESTEC S.A.
EP
06006298.1 27/03/2006
PCT/EP/2007/002495
WO/2007/110182
72
‫הרכבים בעלי עמידות לאור שלילית‬
193921
MADURAMICIN COMPOSITIONS
AND METHODS
ALPHARMA, INC.
US
60/909969
04/04/2007
PCT/US/2008/000576
WO/2008/123898
21/03/2007
G03F )2009.01(
193903
NEGATIVE PHOTORESIST
COMPOSITIONS
AZ ELECTRONIC MATERIALS USA
CORP
US
11/390716
28/03/2006
PCT/IB/2007/000899
WO/2007/110773
17/01/2008
‫תכשירי רוקחות המכילים לוליקונאזול‬
‫לשימוש חיצוני‬
‫לפתן קפוא מועשר בחלבון‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
23/03/2007
C07F )2009.01(
193948
2'-FLUORONUCLEOSIDE
PHOSPHONATES AS ANTIVIRAL
AGENTS
RFS PHARMA, LLC
US
60/785356
23/03/2006
PCT/US/2007/007304
WO/2007/112028
27/02/2007
‫'–פלואורונוקליאוזיד פוספונאטים‬2
‫כחומרים אנטי וירליים‬
193971
‫ננוחלקיקים מועשרים בחומר‬
‫המבוססים על חלבונים הידרופיליים‬
AGENT-ENRICHED NANOPARTICLES
BASED ON HYDROPHILIC PROTEINS
LTS LOHMANN THERAPIE-SYSTEME
GMBH
DE
102006011507.4 14/03/2006
PCT/EP/2007/001675
WO/2007/104422
14/03/2007
193973
BIORESORBABLE CONTROLLEDRELEASE COMPOSITION
LIDDS AB
DK
PA200600361 14/03/2006
PCT/EP/2007/002250
WO/2007/104549
17/04/2007
193984
COMPUTERIZED CROP GROWING
MANAGEMENT SYSTEM AND
METHOD
NETAFIM LTD
US
11/417263
04/05/2006
PCT/IL/2007/000481
WO/2007/129295
September 22, 2009
–‫ד' בתשרי התש"ע‬
A61K )2009.01(
A61K )2009.01(
‫תכשיר בעל שחרור מבוקר הנספג בגוף‬
G06Q )2009.01(
‫שיטה ומערכת ממוחשבת לניהול גידול‬
‫יבול‬
‫נטפים בע"מ‬
73
23/03/2007
MUCOSAL BIOADHESIVE SLOW
RELEASE CARRIER FOR
DELIVERING ACTIVE PRINCIPLES
BIOALLIANCE PHARMA
EP
06290480.0 24/03/2006
PCT/IB/2007/001662
WO/2007/110778
20/03/2007
‫נשא רירי דביק ביולוגית המשתחרר לאט‬
‫למתן חומרים פעילים‬
08/03/2007
‫תרכובות‬
‫טטראהידרופירידותיאנופירימידיניות‬
‫ושיטות לשימוש בהן‬
20/03/2006
A01N )2009.01(
194036
METHOD AND COMPOSITION FOR
PROTECTING NEURONAL TISSUE
FROM DAMAGE INDUCED BY
ELEVATED GLUTAMATE LEVELS
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
60/782516
16/03/2006
PCT/IL/2007/000297
WO/2007/105203
74
C07D )2009.01(
194028
TETRAHYDROPYRIDOTHIENOPYRIMIDINE
COMPOUNDS AND METHODS OF USE
THEREOF
BAYER HEALTHCARE AG
US
60/784146
PCT/US/2007/006927
WO/2007/109279
A61K )2009.01(
193987
‫שיטה ותכשיר להגנה על רקמה עצבית‬
‫מנזק שנגרם מרמות גבוהות של גלוטמאט‬
‫מור יישום מחקרים בע"מ‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
14/03/2007
194044
TETRAHYDROISOQUINOLINE
DERIVATIVES TO ENHANCE MEMORY
FUNCTION
ACTELION PHARMACEUTICALS LTD.
WO
PCT/IB06/050812 15/03/2006
PCT/IB/2007/050868
WO/2007/105177
15/03/2007
‫תולדות טטראהידרואיזוקווינולין‬
‫להגברת פעילות הזכרון‬
194066
THERAPEUTIC COMPOSITION FOR
TREATMENT OF TINNITUS
UWE STOLDT
DE
102006011922.3 15/03/2006
PCT/EP/2007/002294
WO/2007/104566
16/03/2007
16/09/2008
September 22, 2009
–‫ד' בתשרי התש"ע‬
CO7D )0(
‫תרכובות אימידזולותיאזול לטיפול במחלה‬
194136
CITRUS JUICE APPARATUS WITH
UNDESIRED MATERIAL RELEASE
DETECTOR AND RELATED
METHODS
JOHN BEAN TECHNOLOGIES
CORPORATION
US
11/859232
21/09/2007
A61K )2008.04(
‫תכשיר תרופתי לטיפול בטיניטוס‬
194076
IMIDAZOLOTHIAZOLE COMPOUNDS
FOR THE TREATMENT OF DISEASE
AMBIT BIOSCIENCES CORPORATION
US
60/743543
17/03/2006
PCT/US/2007/006613
WO/2007/109120
A61K )2009.01(
A47J )2009.01(
‫מסחטת פרי הדר עם גלאי שחרור חומר‬
‫בלתי רצוי ושיטות קשורות‬
75
02/04/2007
TREATMENT USING CITRULLINE
NESTEC S.A.
US
60/789330
04/04/2006
60/747493
17/05/2006
US
PCT/US/2007/008143
WO/2007/114903
21/03/2007
C07K )2009.01(
‫שיטות למניעה וטיפול במחלות‬
‫אמילוידוגניות‬
C07D )2009.01(
194237
SUBSTITUTED IMIDAZOLE 4CARBOXAMIDES AS
CHOLECYSTOKININ-1 RECEPTOR
MODULATORS
MERCK & CO. INC.
US
60/791961
14/04/2006
PCT/US/2007/008832
WO/2007/120655
76
‫טיפול בשימוש בציטרולין‬
194235
METHODS FOR PREVENTING AND
TREATING AMYLOIDOGENIC
DISEASES
WYETH
US
60/784575
21/03/2006
60/895303
16/03/2007
US
PCT/US/2007/064571
WO/2007/109749
10/04/2007
A61K )2009.01(
194202
‫קרבוקסאמידים מותמרים באימידאזול‬
‫ המשמשים כמודולטורים‬4 ‫בעמדה‬
1–‫לרצפטור כולציסטוקינין‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
11/04/2007
‫אנטגוניסטים לתעלות סידן מסוג פירידיל‬
T–‫אמיד סוג‬
PYRIDYL AMIDE T-TYPE CALCIUM
CHANNEL ANTAGONISTS
MERCK & CO, INC.
US
60/791372
12/04/2006
PCT/US/2007/008977
WO/2007/120729
08/08/2006
194254
SOLID ORAL COMPOSITIONS BASED
ON S-ADENOSYL METHIONINE AND/OR
NADH AND PROCESS FOR OBTAINING
THEM
GNOSIS SPA
IT
MI2006A000629 31/03/2006
PCT/IT/2006/000610
WO/2007/113885
22/03/2007
–‫ד' בתשרי התש"ע‬
A61K )2009.01(
‫הרכבים פומיים מוצקים המבוססים על‬
‫ ותהליך‬NADH ‫או‬/‫–אדנוזיל מתיונין ו‬S
‫להשגתם‬
194257
PROCESS FOR THE PREPARATION
OF A HOT-MELT EXTRUDED
LAMINATE
AUXILIUM PHARMACEUTICALS,
INC.
US
60/785590
24/03/2006
PCT/US/2007/064713
WO/2007/112285
September 22, 2009
C07D )2009.01(
194238
B32B )2008.04(
)‫שיטה להכנת לוחיות מרוקעות (למינטות‬
‫בחום‬
77
25/03/2007
S-ALKYLISOTHIOURONIUM
DERIVATIVES FOR THE TREATMENT
OF INFLAMMATORY DISEASES
MEDITOR PHARMACEUTICALS LTD.
US
60/784766
23/03/2006
PCT/IL/2007/000385
WO/2007/108004
22/03/2007
78
‫מדיטור פרמצבטיקה בע"מ‬
A61K )2009.01(
‫שימוש בחומרים דמויי דיגיטליס לטיפול‬
‫בהפרעות רגשיות‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים‬
A61K )2009.01(
194277
SOLID ORAL DOSAGE FORM
CONTAINING AN ENHANCER
MERRION RESEARCH III LIMITED
US
60/791231
07/04/2006
PCT/US/2007/008935
WO/2007/117706
05/04/2007
‫נגזרות של אס–אלקילאיזותיואורוניום‬
‫לטיפול במחלות דלקתיות‬
194275
USE OF DIGITALIS-LIKE
COMPOUNDS IN THE TREATMENT
OF AFFECTIVE DISORDERS
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
US
60/784782
23/03/2006
PCT/IL/2007/000379
WO/2007/108002
09/04/2007
A61K )2009.01(
194261
‫צורת מינון אוראלית מוצקה המכילה‬
‫מגדיל‬
A61K )2009.01(
194292
September 22, 2009
–‫ד' בתשרי התש"ע‬
SPIROCYCLIC HETEROCYCLIC
DERIVATIVES AND METHODS OF
THEIR USE
ADOLOR CORPORATION
US
60/790416
06/04/2006
11/696585
04/04/2007
US
PCT/US/2007/066071
WO/2007/118151
28/03/2007
‫תולדות ספירוציקליים הטרוציקליים‬
‫ושיטות לשימוש בהן‬
194293
PHARMACEUTICAL COMPOSITIONS
CONTAINING A CHOLEST-4-EN-3ONE DERIVATIVE
TROPHOS
FR
0602799
31/03/2006
PCT/FR/2007/000530
WO/2007/118967
22/03/2007
September 22, 2009
‫תכשירי רוקחות המכילים תולדה של‬
‫–און‬3–‫–אין‬4–‫כולסט‬
194308
METHOD AND APPARATUS FOR
MAINTAINING UPLINK
SYNCHRONIZATION AND
REDUCING BATTERY POWER
CONSUMPTION
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/785491
24/03/2006
PCT/US/2007/007117
WO/2007/111941
–‫ד' בתשרי התש"ע‬
A61K )2009.01(
H04B )2009.01(
‫שיטה ומערכת לשמירה על סינכרוניזציה‬
‫של קשר בין הארץ ללוויין והקטנת צריכת‬
‫כח סוללה‬
79
11/04/2007
BATTERY INCLUDING A FLUID
MANAGER
THE TECHNOLOGY PARTNERSHIP
PLC OF
US
60/790876
11/04/2006
60/817199
28/06/2006
US
60/860175
20/11/2006
US
PCT/US/2007/066404
WO/2007/121226
11/04/2007
H01M )2009.01(
‫סוללה הכוללת ניהול נוזלים המורכב‬
‫חיצונית לתא‬
H01M )2009.01(
194349
BATTERY INCLUDING A FLUID
MANAGER MOUNTED INTERNAL TO
CELL
THE TECHNOLOGY PARTNERSHIP
PLC OF
US
60/790876
11/04/2006
60/817199
28/06/2006
US
60/860175
20/11/2006
US
PCT/US/2007/066437
WO/2007/121244
80
‫סוללה המכילה מנהל נוזלים‬
194348
BATTERY INCLUDING A FLUID
MANAGER MOUNTED EXTERNAL
TO CELL
THE TECHNOLOGY PARTNERSHIP
PLC OF
US
60/790876
11/04/2006
60/817199
28/06/2006
US
60/860175
20/11/2006
US
PCT/US/2007/066415
WO/2007/121232
11/04/2007
H01M )2009.01(
194347
‫סוללה המכילה מנהל נוזלים המורכב‬
‫פנימית לתא‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
28/09/2008
194408
SYSTEM AND METHOD FOR
CONTROLLED OUTPUT OF A
DIFFERNCE FREQUNECY
GENERATOR
RAMOT AT TEL-AVIV UNIVERSITY
LTD.
28/09/2008
‫מערכת ושיטה לתפוקה מבוקרת ממחולל‬
‫הפרש תדרים‬
‫אביב בע"מ‬-‫רמות ליד אוניברסיטת תל‬
194411
TECHNIQUE FOR SELECTIVELY
CHANGING DISPERSION IN OPTICAL
COMMUNICATION CHANNELS
ECI TELECOM LTD.
28/09/2008
TECHNIQUE FOR COMBATING
LOOPS IN COMMUNICATION
NETWORK
ECI TELECOM LTD.
194570
–‫ד' בתשרי התש"ע‬
H04L )2009.01(
‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
REPETITIVE STROKE WORK SYSTEM
ASSAF MALUL
US
60/939372
22/05/2007
60/979873
15/10/2007
US
PCT/IL/2008/000009
WO/2008/142670
September 22, 2009
‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
‫טכנולוגיה להתגברות על לולאות ברשת‬
‫תקשורת‬
194418
15/05/2007
H04L )2009.01(
‫טכנולוגיה לשינוי סלקטיבי של דיספרסיה‬
‫בערוצי תקשורת אופטיים‬
194412
01/01/2008
H01H )2009.01(
B23D )2009.01(
‫מערכת עבודה בתנועה חוזרת‬
C07D )2009.01(
81
SUBSTITUTED
PYRAZOLOPYRIMIDINES
CEPHALON, INC.
US
60/800375
15/05/2006
11/803320
14/05/2007
US
PCT/US/2007/011619
WO/2008/063232
12/04/2007
‫ שיטה‬,‫נגזרות של אמינומתיל פירידין‬
‫להכנתן ושימושיהן הרפואיים‬
A61K )2009.01(
194694
METHODS FOR BONE
REGENERATION USING
ENDOTHELIAL PROGENITOR CELL
PREPARATINS
HEPACORE LTD.
US
60/792341
17/04/2006
PCT/IL/2007/000485
WO/2007/119240
82
C07D )2009.01(
194573
AMINOMETHYL PYRIDINE
DERIVATIVES, METHOD FOR
PREPARING SAME AND
THERAPEUTIC USE THEREOF
SANOFI-AVENTIS
FR
0603382
14/04/2006
PCT/FR/2007/000620
WO/2007/119001
17/04/2007
‫תרכובות פיראזולופירימידין מותמרות‬
‫שיטות לבנייה מחדש של עצמות על ידי‬
‫שימוש בתכשירי תאי אב אנדותליאליים‬
‫הפאקור בע"מ‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
18/04/2007
194722
A47C )2009.01(
‫מודול להשראת תנועה‬
‫אקטיב צ'ר בע"מ‬
MOVEMENT INDUCING MODULE
ACTIVE CHAIR LTD
PCT/IL/2007/000491
WO/2007/119242
30/05/2007
194746
TWO-PIECE, INTERNAL-CHANNEL
OSMOTIC DELIVERY SYSTEM FLOW
MODULATOR
INTARCIA THERAPEUTICS, INC.
US
60/809451
30/05/2006
PCT/US/2007/069990
WO/2007/140416
01/03/2007
‫מווסת זרם בעל שני חלקים עבור מערכת‬
‫אוטומטית למתן תרופות בערוץ פנימי‬
194797
VIDEO SEGMENTATION USING
STATISTICAL PIXEL MODELING
OBJECTVIDEO, INC.
US
60/792313
17/04/2006
PCT/US/2007/005238
WO/2007/126525
13/04/2007
A61K )2009.01(
194798
G06K )2009.01(
‫סגמנטציה של ווידאו באמצעות מודל‬
‫סטטיסטי של פיקסלים‬
A61K )2009.01(
TREATMENT OF MELANOMA
SCICLONE PHARMACEUITCALS,
INC.
US
60/793243
20/04/2006
PCT/US/2007/009049
WO/2007/123847
‫טיפול במלנומה‬
20/03/2007
F25D )2009.01(
September 22, 2009
194801
–‫ד' בתשרי התש"ע‬
83
INSTALLATION FOR THE
TEMPERATURE TREATMENT OF
PRODUCTS STORED ON PALLETS OR
SIMILAR
FROMFROID
FR
0603570
21/04/2006
0752825
23/01/2007
FR
PCT/FR/2007/050955
WO/2007/122334
29/03/2007
‫התקן עבור טיפול בטמפרטורה למוצרים‬
‫המאוחסנים על גבי משטחים או דומיהם‬
C09D )2009.01(
194802
COATING COMPOSITION FOR
PRODUCING MAGNETICALLY
INDUCED IMAGES
SICPA HOLDING S.A.
EP
06113891.3 12/05/2006
PCT/EP/2007/052993
WO/2007/131833
25/06/2007
‫תכשיר ציפוי ליצור דמויות מושרות‬
‫מגנטיות‬
PROCESS FOR PREPARING TRIALLYL
CYANURATE
EVONIK DEGUSSA GMBH
DE
102006034257.7 21/07/2006
PCT/EP/2007/056316
WO/2008/009540
11/05/2007
‫תהליך להכנת טריאליל ציאנוראט‬
C07D )2009.01(
194804
HETEROAROYL-SUBSTITUTED
ALANINES WITH A HERBICIDAL
ACTION
BASF SE
EP
06114239.4 19/05/2006
PCT/EP/2007/054562
WO/2007/134984
84
C07D )2009.01(
194803
‫אלאנינים מותמרים בהטרוארואיל בעלי‬
‫פעילות קוטלת עשבים‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
09/05/2007
194806
ANTI-VIRAL PYRIMIDINE
NUCLEOSIDE DERIVATIVES
UNIVERSITY COLLEGE CARDIFF
CONSULTANTS LIMITED
GB
0609178.9
09/05/2006
PCT/GB/2007/001677
WO/2007/129083
13/04/2007
‫תולדות פירימידין–נוקלאוזיד אנטי–וירליות‬
194807
CONFIGURABLE PARALLEL
COMPUTATION OF CYCLIC
REDUNDANCY CHECK (CRC) CODES
THE QUEEN'S UNIVERSITY OF
BELFAST
GB
0607976.8
22/04/2006
PCT/GB/2007/001371
WO/2007/122384
23/04/2007
INHIBITORS OF 11-BETAHYDROXYSTEROID
DEHYDROGENASE 1
ELI LILLY & CO.
US
60/745475
24/04/2006
PCT/US/2007/067182
WO/2007/127688
September 22, 2009
–‫ד' בתשרי התש"ע‬
C07D )2009.01(
‫–בטא–הדרוקסיסטרואיד‬11 ‫מעכבים של‬
1 ‫דהידרוגנאז‬
194818
COMPOUNDS AND COMPOSITIONS
AS HEDGEHOG PATHWAY
MODULATORS
IRM LLC
US
60/797949
05/05/2006
PCT/US/2007/068292
WO/2007/131201
H03M )2009.01(
‫חישוב מקבילי ניתן להתאמה של קוד‬
‫יתירות מחזורי‬
194810
04/05/2007
C07D )2009.01(
C07D )2009.01(
‫תרכובות ותכשירים כמאפננים של שביל‬
‫קיפוד‬
85
23/04/2007
METHOD AND APPARATUS FOR
COORDINATING TIMING IN A
WIRELESS LOCAL AREA NETWORK
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/794463
24/04/2006
PCT/US/2007/009884
WO/2007/127185
27/10/2008
‫שיטה ומערכת לתיאום תזמון ברשת‬
‫מקומית אלחוטית‬
G06F )2009.01(
194943
VERIFICATION OF DATA
TRANSMITTED BY COMPUTER
HUMAN INTERFACE SECURITY LTD.
05/05/2006
H04L )2009.01(
194903
‫אימות נתונים המשודרים ע"י מחשב‬
‫היומן אינטרפייס סקיוריטי בע"מ‬
C07C )2009.01(
194977
PROCESS FOR PREPARING
GABAPENTIN
PFIZER SCIENCE AND TECHNOLOGY
IRELAND LIMITED
‫תהליך להכנת גאבאפנטין‬
PCT/IE/2006/000049
WO/2007/129286
30/10/2008
ARTLLERY PROJECTILE WITH
SEPERATELY CONTROLLED
BOOSTER ACTUATION AND
FRAGMENT DISPERSION
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
02/11/2008
86
F42B )2009.01(
195003
‫קליע ארטילרי עם פיקוד נפרד של הפעלת‬
‫מאיץ ופיזור רסיסים‬
‫רפאל מערכות לחימה מתקדמות בע"מ‬
G02F )2009.01(
195050
September 22, 2009
–‫ד' בתשרי התש"ע‬
MODULATION OF FIBER LASER
PUMPED DIFFERENCE FREQUENCY
GENERATOR
ELBIT SYSTEMS ELECTRO-OPTICAL
ELOP LTD.
03/05/2007
‫אפנון של מחולל הפרש תדרים נשאב‬
‫בלייזר סיבי‬
‫אופטיקה אלאופ‬-‫אלביט מערכות אלקטרו‬
‫בע"מ‬
195065
MULTIBAND RADIO WITH
TRANSMITTER OUTPUT POWER
OPTIMIZATION
HARRIS CORPORATION
US
11/429837
08/05/2006
PCT/US/2007/010780
WO/2007/133474
04/11/2008
195090
A METHOD AND A DEVICE FOR PRESTRESSED ARMOR
GIGI SIMOVICH
04/11/2008
195091
AIR VEHICLE, AND SYSTEM AND
METHOD THEREFOR
ISRAEL AEROSPACE INDUSTRIES
LTD.
04/11/2008
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫רדיו רב–פסי עם אופטימיזצית כח שידור‬
‫פלט‬
F41H )2009.01(
‫שיריון דרוך ושיטה ליצורו‬
‫ג'יג'י סימוביץ‬
F41H )2009.01(
‫ ומערכת ושיטה עבורו‬,‫רכב אויר‬
‫התעשייה האוירית לישראל בע"מ‬
195099
ASYNCHRONOUS DYNAMIC
NETWORK DISCOVERY FOR LOW
POWER SYSTEMS
H01Q )2009.01(
H04L )2009.01(
‫גילוי אסינכרוני של מערכות תקשורת‬
‫עבור מערכות בעלות עוצמה נמוכה‬
87
HARRIS CORPORATION
US
11/937015
08/11/2007
03/05/2007
METHODS AND SYSTEMS FOR
BANDWIDTH ADAPTIVE N-TO-N
COMMUNICATION IN A
DISTRIBUTED SYSTEM
CITRIX ONLINE, L.L.C.
US
11/381702
04/05/2006
PCT/US/2007/010729
WO/2007/130511
26/04/2007
‫ ברוחב‬N–‫–ל‬N ‫שיטות ומערכות לתקשורת‬
‫פס ניתן להתאמה המערכת מבוזרת‬
REAL-TIME DETECTION OF
INFLUENZA VIRUS
THERANOS, INC.
88
‫ מכשיר ושיטה לאספקה של‬,‫התקן‬
‫פרסומות תוך שימוש ביישומי פרוטוקול‬
‫אלחוטי‬
‫אמוביי בע"מ‬
A61K )2009.01(
195107
APTAMERS DIRECTED TO MUC1
UNIVERSITY OF TORONTO
GB
0608778.7
04/05/2006
PCT/GB/2007/050234
WO/2007/129114
10/05/2007
G06F )2009.01(
195105
DEVICE, SYSTEM AND METHOD OF
DELIVERING TARGETED
ADVERTISEMENTS USING
WIRELESS APPLICATION PROTOCOL
AMOBEE LTD.
US
11/417143
04/05/2006
PCT/IL/2007/000514
WO/2007/129298
02/05/2007
G06F )2009.01(
195103
MUC1–‫אפטמרים מכוונים ל‬
B65D )2009.01(
195108
‫גילוי בזמן אמת של נגיף שפעת‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
US
60/799442
60/800939
US
11/746535
US
PCT/US/2007/068665
WO/2007/134166
10/05/2006
16/05/2006
09/05/2007
29/04/2007
195109
RETURN AND LIMITED MOTION IN
ENERGY CAPTURE DEVICES
DANIEL FARB
US
60/746375
04/05/2006
60/805875
22/06/2006
US
60/807489
16/07/2006
US
60/826927
26/09/2006
US
60/866070
16/11/2006
US
60/908693
29/03/2007
US
PCT/IL/2007/000523
WO/2007/129299
04/05/2007
195110
SUBSTITUTED SPIROCYCLIC CGRP
RECEPTOR ANTAGONISTS
MERCK & CO. INC.
US
60/799071
09/05/2006
PCT/US/2007/010952
WO/2007/133491
23/05/2007
195111
METHOD OF PREPARING 4HALOGENATED QUINOLINE
INTERMEDIATES
September 22, 2009
–‫ד' בתשרי התש"ע‬
F03B )2009.01(
‫תנועת החזר ותנועה מוגבלת במתקני‬
‫קליטת אנרגיה‬
A61K )2009.01(
‫ספירוציקליים מותמרים המשמשים‬
CGRP ‫כאנטגוניסטים לרצפטור‬
C07D )2009.01(
‫שיטה להכנת תוצרי ביניים של קווינולין‬
‫ עם הלוגן‬4 ‫המותמר בעמדה‬
89
WYETH
US
60/802759
PCT/US/2007/012211
WO/2007/139797
14/05/2007
23/05/2006
METHOD AND DEVICE FOR
CONTROLLING A REMOTE VEHICLE
IROBOT CORPORATION
US
60/747183
12/05/2006
PCT/US/2007/068911
WO/2008/060690
25/05/2007
90
‫שיטה והתקן עבור שליטה על רכב מרוחק‬
A61K )2009.01(
195113
PYRIDINONE AND PYRIDAZINONE
DERIVATIVES AS INHIBITORS OF
POLY(ADP-RIBOSE)POLYMERASE
(PARP)
ISTITUTO DI RICERCHE DI
BIOLOGIA MOLECOLARE P.
ANGELETTI SPA
GB
0610680.1
31/05/2006
PCT/GB/2007/050295
WO/2007/138351
04/05/2007
H04B )2009.01(
195112
‫נגזרות של פירידינון ופירידאזינון‬
)‫–ריבוז‬ADP(‫המשמשות כמעכבים של פולי‬
)PARP( ‫פולימרז‬
C12N )2009.01(
195114
September 22, 2009
–‫ד' בתשרי התש"ע‬
PANCREATIC ISLET-LIKE CELLS
OPEXA THERAPEUTICS
US
60/746584
05/05/2006
PCT/US/2007/068303
WO/2007/131209
04/05/2007
195115
T-CELL VACCINE
OPEXA THERAPEUTICS
US
60/746611
60/747903
US
PCT/US/2007/068304
WO/2007/131210
G01N )2009.01(
T–‫תרכיב תא‬
05/05/2006
22/05/2006
04/05/2007
195116
ACTUATION OF PARALLEL
MICROFLUIDIC ARRAYS
CYTONOME, INC.
US
60/798154
05/05/2006
PCT/US/2007/010959
WO/2007/130647
17/06/2007
195117
SUPER-PYROELECTRIC FILMS AND
PROCESS OF THEIR PREPARATION
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
60/813692
15/06/2006
PCT/IL/2007/000731
WO/2007/144892
30/04/2007
September 22, 2009
‫תאים לבלביים דומים לתאי אי‬
195118
–‫ד' בתשרי התש"ע‬
B07C )2009.01(
‫הנעה של מערכים מיקרופלואידים‬
‫מקבילים‬
H01L )2009.01(
‫פילמים בעלי תכונות פירואלקטריות‬
‫מצויינות ותהליך להכנתם‬
‫ידע חברה למחקר ופיתוח בע"מ‬
H04L )2009.01(
91
RADIO LINK FAILURE DETECTION
PROCEDURES IN LONG TERM
EVOLUTION UPLINK AND
DOWNLINK AND APPARATUS
THEREFOR
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/798119
05/05/2006
PCT/US/2007/010394
WO/2007/130324
07/05/2007
‫שיטה להפעלת מסוף‬
A61B )2009.01(
195122
INTRAMEDULLARY
TRANSILLUMINATION APPARATUS,
SURGICAL KIT AND METHOD FOR
ACCURATE PLACEMENT OF
LOCKING SCREWS IN LONG BONE
INTRAMEDULLARY RODDING
JG MEDICAL PRODUCTS LLC
US
60/797986
05/05/2006
11/744844
05/05/2007
US
PCT/US/2007/068387
WO/2007/131231
92
H04L )2009.01(
195121
TERMINAL ACTIVATION METHOD
SAGEM MONETEL
FR
06/04195
11/05/2006
PCT/EP/2007/054410
WO/2007/131905
07/05/2007
‫פרוצדורות לגילוי כשל בקישור רדיו‬
‫בהתפתחות לטווח רחוק של קישור‬
‫מהארץ ללוויין וקישור מהלוויין לארץ‬
‫ומערכת עבורן‬
‫ ערכת כלי‬,‫התקן לשיקוף תוך העצם‬
‫ניתוח ושיטה למיקום מדויק של ברגי‬
‫קיבוע בתמיכה–תוך–עצמית של עצמות‬
‫ארוכות‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
09/05/2007
195124
IMAGING SYSTEMS AND METHODS
FOR RECOVERING OBJECT
VISIBILITY
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION LTD.
US
60/798737
09/05/2006
PCT/IL/2007/000560
WO/2007/129326
29/05/2007
‫מערכות ושיטות להדמיה לשחזור ראות‬
‫של חפץ‬
‫מוסד הטכניון למחקר ופתוח בע"מ‬
195125
195126
SUBSTITUTED 5-PHENYLAMINO1,3,4-OXADIAZOLE-2YLCARBONYLAMINO-4-PHENOXYCYCLOHEXANECARBOXYLIC ACID AS INHIBITOR
OF ACETYL COENZYME A
DIACYLGLYCEROL
ACYLTRANSFERASE
ASTRAZENECA AB
US
60/809298
30/05/2006
PCT/GB/2007/001990
WO/2007/138311
September 22, 2009
–‫ד' בתשרי התש"ע‬
A61P )2009.01(
‫–אוקסאדיאזול כמעכבי‬1,3,4 ‫נגזרות‬
DGAT1
1,3,4-OXADIAZOLE DERIVATIVES AS
DGAT1 INHIBITORS
ASTRAZENECA AB
US
60/809297
30/05/2006
PCT/GB/2007/001981
WO/2007/138304
29/05/2007
G06T )2009.01(
A61P )2009.01(
–5 ‫חומצה קרבוקסילית מותמרת‬
–2–‫–אוקסאדיאזול‬1,3,4–‫פנילאמינו‬
‫–פנוקסי–ציקלוהקסאן‬4–‫אילקרבונילאמינו‬
A ‫כמעכב של אצטיל קואנזים‬
‫דיאצילגליצרול אצטילטרנספראז‬
93
02/05/2007
SECURING CARD TRANSACTIONS
SECURANT INC
US
60/746172
05/05/2006
60/892621
02/03/2007
US
PCT/IL/2007/000535
WO/2007/129306
08/05/2007
E06B )2009.01(
‫נגזרות אזאספירו מותמרות‬
A61K )2009.01(
195135
USE OF FLIBANSERIN FOR THE
TREATMENT OF POSTMENOPAUSAL SEXUAL DESIRE
DISORDERS
BOEHRINGER INGELHEIM PHARMA
GMBH & CO. KG
US
60/746817
09/05/2006
60/830987
14/07/2006
US
PCT/EP/2007/054380
WO/2007/128802
94
‫אבטחת פעולות כרטיס אשראי‬
195132
SUBSTITUTED AZASPIRO
DERIVATIVES
NEUROGEN CORPORATION
US
60/746680
08/05/2006
11/745448
07/05/2007
US
PCT/US/2007/011135
WO/2007/133561
07/05/2007
G06Q )2008.04(
195127
‫שימוש בפליבנסרין לטיפול באי–סדרים‬
‫של חשק מיני לאחר הבלות‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
02/05/2007
H04L )2009.01(
195136
SELECTING A COMMAND NODE IN A
HETEROGENEOUS
COMMUNICATION SYSTEM
LUCENT TECHNOLOGIES INC.
US
11/433835
12/05/2006
PCT/US/2007/010598
WO/2007/133453
02/05/2007
‫בחירת נקודת מפגש פקודתית במערכת‬
‫תקשורת הטרוגנית‬
H04L )2009.01(
195137
EVENT CONTEXT TRANSFER IN A
HETEROGENEOUS
COMMUNICATION SYSTEM
LUCENT TECHNOLOGIES INC.
US
11/433754
12/05/2006
PCT/US/2007/010543
WO/2007/133448
03/05/2007
G01N )2009.01(
195139
DEHYDRATION TOILET HAVING AN
INFUSION ODOR CAPTURING STEAM
AND WATER RECOVERY SYSTEM
STEVEN LUMBERT
US
11/382336
PCT/US/2007/068131
WO/2007/133954
‫שירותים עם מנגנון להוצאת המים בעלי‬
‫אדים ללכידת ריחות ומערכת לקבלת‬
‫המים בחזרה‬
09/05/2006
26/04/2007
September 22, 2009
‫העברת תוכן אירוע במערכת תקשורת‬
‫הטרוגניות‬
195140
–‫ד' בתשרי התש"ע‬
F03B )2009.01(
95
PRODUCTION OF ELECTRIC ENERGY
FROM SEA WAVES
CONSTANTINOS, A. HATZILAKOS
GR
20060100482 08/05/2006
PCT/GR/2007/000023
WO/2007/129126
09/05/2007
‫ייצור אנרגיה חשמלית מגלי ים‬
‫שימוש בג'ינסנוסידים ומיצויים המכילים‬
‫אותם‬
USE OF GINSENOSIDES AND
EXTRACTS CONTAINING THEM
BAYER CONSUMER CARE AG.
EP
06290814.0 17/05/2006
PCT/EP/2007/004088
WO/2007/131677
21/05/2007
‫ארילאימידאזולון מותמר וטריאזולון‬
‫כמעכבי קולטני וזופרסין‬
H04L )2009.01(
195146
BI-DIRECTIONAL RLC NONPERSISTENT MODE FOR LOW
DELAY SERVICES
TELEFONAKTIEBOLAGET LM
ERICSSON (PUBL)
US
60/800760
16/05/2006
11/684020
09/03/2007
US
PCT/EP/2007/054273
WO/2007/131880
96
A61K )2009.01(
195142
SUBSTITUTED ARYLIMIDAZOLONE
AND TRIAZOLONE AS INHIBITORS OF
VASOPRESSIN RECEPTORS
BAYER HEALTHCARE AG
DE
102006024024.3 23/05/2006
PCT/EP/2007/004615
WO/2007/134862
03/05/2007
A61K )2008.04(
195141
‫בקר חיבור רדיו דו–כיווני המופעל בצורת‬
‫לא מתמיד עבור שירותי השהיה נמוכה‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
22/05/2007
195147
PREPARATION OF POLYMER
CONJUGATES OF THERAPEUTIC,
AGRICULTURAL AND FOOD
ADDITIVE COMPOUNDS
ELAN PHARMACEUTICALS, INC.
US
60/802349
22/05/2006
PCT/US/2007/069464
WO/2007/137260
23/05/2007
30/05/2007
–‫ד' בתשרי התש"ע‬
A61K )2009.01(
–‫–טריהידרוקסי‬5,4,3–‫–אלקוקסי‬2
‫ ושימוש‬,‫ הכנתם‬,‫אלקילאמיד–בנזאזפינים‬
‫בהם והרכבים המכילים אותם‬
195149
CCR5 ANTAGONIST FOR
ENHANCING IMMUNE
RECONSTITUTION AND TREATING
OPPORTUNISTIC INFECTION IN HIV
PATIENTS
PFIZER PRODUCTS INC.
US
60/804480
12/06/2006
60/821974
10/08/2006
US
60/888387
06/02/2007
US
PCT/IB/2007/001508
WO/2007/144720
September 22, 2009
‫הכנת קוניוגאטים של פולימרים‬
‫ חקלאיות ושל תוספי‬,‫מתרכובות רפואיות‬
‫מזון‬
195148
2-ALKOXY-3,4,5-TRIHYDROXYALKYLAMIDE-BENZAZEPINES, THE
PREPARATION AND USE THEREOF
AND COMPOSITIONS CONTAINING
THE SAME
SANOFI-AVENTIS
FR
0604733
24/05/2006
PCT/FR/2007/000866
WO/2007/135293
A61K )2009.01(
A61K )2009.01(
‫ להגברת‬CCR5 ‫אנטגוניסט של‬
‫הרקונסטיטוציה החיסונית וטיפול‬
HIV ‫בזיהומים אופורטוניסים בחולי‬
97
09/05/2007
USE OF SYK TYROSINE KINASE
INHIBITORS FOR THE TREATMENT
OF CELL PROLIFERATIVE
DISORDERS
NEW ERA BIOTECH LTD.
US
60/799103
09/05/2006
PCT/IB/2007/002471
WO/2007/129226
08/05/2007
98
G06F )2009.01(
‫חיישני טמפרטורה עם אלמנט מגנטי‬
A61K )2009.01(
195155
DELAYED-RELEASE
GLUCOCORTICOID TREATMENT OF
RHEUMATOID DISEASE
NITEC PHARMA AG
US
60/835093
03/08/2006
PCT/EP/2007/006894
WO/2008/015018
06/06/2007
SYK ‫שימוש במעכבים של תירוזין קינאז‬
‫לטיפול במחלות של התרבות תאים‬
195154
MAGNETIC ELEMENT
TEMPERATURE SENSORS
THERMAL SOLUTIONS, INC.
US
60/798591
09/05/2006
60/818385
05/07/2006
US
60/836448
09/08/2006
US
11/619066
02/01/2007
US
60/919345
22/03/2007
US
11/745348
07/05/2007
US
PCT/US/2007/068483
WO/2007/134061
03/08/2007
A61K )2009.01(
195152
‫טיפול במחלת שגרון באמצעות‬
‫גלוקוקורטיקואיד בשחרור–מושהה‬
C07K )2009.01(
195156
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫פוליפפטידים מיוצבים של פקטור גידול‬
‫דמוי–אינסולין‬
STABILIZED INSULIN-LIKE GROWTH
FACTOR POLYPEPTIDES
NOVARTIS AG
US
60/812349
09/06/2006
60/862244
20/10/2006
US
60/897187
24/01/2007
US
PCT/US/2007/070468
WO/2007/146689
10/05/2007
195157
USE OF NON-CATALYTIC FORM OF
HEPARANASE AND PEPTIDES
THEREOF FOR REVERSING THE
ANTI-COAGULANT EFFECTS OF
HEPARINOIDS
50% THE MEDICAL RESEARCH
FUND AT THE TEL AVIV SOURASKY
MEDICAL CENTER
IL
175571
11/05/2006
PCT/IL/2007/000564
WO/2007/132445
06/11/2008
‫שימוש בתצורה לא–קטליטית של הפרנאז‬
‫ופפטידים הנגזרים ממנו לביטול פעילות‬
‫אנטי–קרישתית של הפרינואידים‬
‫ קרן מחקרים ופיתוח תשתיות שליד‬50%
‫אביב ע"ש סוראסקי‬-‫המרכז הרפואי תל‬
195167
CABIN ATTACHMET DEVICE AND
METHOD
PLASAN SASA LTD.
IL
192447
25/06/2008
11/05/2007
195216
PREPARATION OF ANTIBODY OR
ANTIBODY FRAGMENT-TARGETED
IMMUNOLIPOSOMES AND USES
THEREOF
September 22, 2009
–‫ד' בתשרי התש"ע‬
A61K )2009.01(
F42D )2009.01(
‫מכשיר ושיטה לחיבור תא נוסעים‬
‫פלסן סאסא בע"מ‬
A61K )2009.01(
–‫תהליכים להכנת נוגדנים או קטעי‬
‫נוגדנים–מכוונים אימונוליפוסומים‬
‫ושימושים בהם‬
99
GEORGETOWN UNIVERSITY
US
60/800163
15/05/2006
60/844352
14/09/2006
US
PCT/US/2007/011407
WO/2007/142781
10/05/2007
PROTEIN KINASE INHIBITORS AND
USES THEREOF
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/799914
12/05/2006
PCT/US/2007/011285
WO/2007/133622
15/05/2007
‫מעכבי קינאזים חלבוניים וניצולם‬
‫–דיאמינו פירימידינים כמעכבי קינאז של‬4,2
‫מחזור התא‬
100
D01F )2009.01(
195242
FIRE RETARDANT JACKET FOR
TUBING
OMEGA FLEX, INC.
US
11/382960
12/05/2006
PCT/US/2007/011165
WO/2007/133574
15/05/2007
A61K )2009.01(
195218
2,4-DIAMINO PYRIMIDINES AS CELL
CYCLE KINASE INHIBITORS
BOEHRINGER INGELHEIM PHARMA
GMBH & CO. KG
EP
06113967.1 15/05/2006
PCT/EP/2007/054723
WO/2007/132010
09/05/2007
A61K )2009.01(
195217
‫מעכבי בעירה לעטיפת צינורות‬
A61K )2009.01(
195243
September 22, 2009
–‫ד' בתשרי התש"ע‬
USE OF A FUSION MOLECULE FOR
THE PREPARATION OF A
MEDICAMENT FOR TREATING
RHEUMATOID ARTHRITIS
ZYMOGENETICS INC.
US
60/747270
15/05/2006
PCT/US/2007/068982
WO/2007/134326
14/05/2007
‫שימוש במולקולה מאחדת להכנת תרופה‬
‫לטיפול בדלקת פרקים שגרונית‬
195244
INHIBITORS OF HUMAN
IMMUNODEFICIENCY VIRUS
REPLICATION
BOEHRINGER INGELHEIM PHARMA
GMBH & CO. KG
US
60/747311
16/05/2006
PCT/CA/2007/000845
WO/2007/131350
14/05/2007
September 22, 2009
‫מעכבי שכפול נגיף האיידס‬
195245
SUBSTITUTED PROLINAMIDES,
PRODUCTION THEREOF AND THEIR
USE AS DRUGS
BOEHRINGER INGELHEIM PHARMA
GMBH & CO. KG
EP
06113977.0 16/05/2006
07102566.2
16/02/2007
EP
PCT/EP/2007/054631
WO/2007/131982
–‫ד' בתשרי התש"ע‬
B05B )2009.01(
C07D )2009.01(
‫ ייצורם ושימושם‬,‫פרולינאמידים מותמרים‬
‫כתרופות‬
101
16/05/2007
A61M )2009.01(
195246
‫מרסס‬
ATOMISER
BOEHRINGER INGELHEIM PHARMA
GMBH & CO. KG
DE
102006023657.2 18/05/2006
102006043637.7
18/09/2006
DE
PCT/EP/2007/004418
WO/2007/134794
16/05/2007
A61M )2009.01(
195247
‫משאף‬
INHALER
BOEHRINGER INGELHEIM PHARMA
GMBH & CO. KG
DE
102006023662.9 18/05/2006
PCT/EP/2007/004416
WO/2007/134792
16/05/2007
B05B )2009.01(
195248
‫מרסס‬
ATOMISER
BOEHRINGER INGELHEIM PHARMA
GMBH & CO. KG
DE
102006023657.2 18/05/2006
102006043637.7
18/09/2006
DE
PCT/EP/2007/004417
WO/2007/134793
17/05/2007
102
H04L )2009.01(
195263
September 22, 2009
–‫ד' בתשרי התש"ע‬
MAC ADDRESS LEARNING IN A
DISTRIBUTED BRIDGE
CORRIGENT SYSTEMS LTD.
US
11/419444
19/05/2006
PCT/IL/2007/000601
WO/2007/135666
21/05/2007
195379
REVERSION OF OF MALIGNANT
PHENOTYPE WITH 9-HYDROXY
ELLIPTICINE DERIVATIVES
ECOLE NORMALE SUPERIEURE DE
CACHAN OF
EP
06290822.3 22/05/2006
60/838860
21/08/2006
US
PCT/IB/2007/001307
WO/2007/135538
13/06/2007
195382
IL-17 AND IL-23 ANTAGONISTS AND
METHODS OF USING THE SAME
ZYMOGENETICS INC.
US
60/804602
13/06/2006
60/824665
06/09/2006
US
60/828277
05/10/2006
US
60/891410
23/02/2007
US
PCT/US/2007/071152
WO/2007/147019
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫לימוד כתובת מקינטוש בגשר מבוזר‬
‫קוריג'נט מערכות בע"מ‬
A61K )2009.01(
‫הפיכה של פנוטיפ ממאיר באמצעות‬
‫–הידרוקסי אליפטיציניות‬9 ‫תולדות‬
C07K )2009.01(
‫ ושיטות‬IL–23–‫ ו‬IL–17 ‫אנטגוניסטים של‬
‫לשימוש בהם‬
103
22/05/2007
‫גלאיי חום אינפרא–אדום הכוללים חלל‬
‫שניתן לכוון בצורה מדויקת‬
TUNABLE FINESSE INFRARED
CAVITY THERMAL DETECTORS
REGENTS OF THE UNIVERSITY OF
MINNESOTA,
US
60/802751
23/05/2006
PCT/US/2007/012213
WO/2008/108784
11/06/2007
104
‫תולדות פניל–פיראזול כליגנדים לא‬
‫סטרואידים של קולטן גלוקוקוריקואיד‬
G06F )2008.04(
195507
DEVICE TO SHIELD AGAINST
INTERFERENCE FROM ELECTRICAL
APPLIANCES
SAGEM MONETEL
FR
0604952
02/06/2006
PCT/FR/2007/000906
WO/2007/141410
25/05/2007
C07D )2009.01(
195492
PHENYL-PYRAZOLE DERIVATIVES
AS NON-STEROIDAL
GLUCOCORICOID RECEPTOR
LIGANDS
GLAXO GROUP LIMITED
GB
0611587.7
12/06/2006
0625457.7
20/12/2006
GB
0710217.1
29/05/2007
GB
PCT/EP/2007/055724
WO/2007/144327
31/05/2007
G01J )2009.01(
195415
‫התקן להגנה נגד הפרעות נגרמות על ידי‬
‫מכשירי חשמל‬
G06F )2009.01(
195523
September 22, 2009
–‫ד' בתשרי התש"ע‬
HANDOVER OF A BACKWARDCOMPATIBLE MOBILE UNIT
LUCENT TECHNOLOGIES INC.
US
11/421874
02/06/2006
PCT/US/2007/012531
WO/2007/142892
13/06/2007
‫העברה של יחידה ניידת המותאמת לאחור‬
195530
PROCESS FOR ENHANCING PLANT
GROWTH
CIBA HOLDING INC.
EP
06115868.9 22/06/2006
PCT/EP/2007/055793
WO/2007/147758
08/06/2007
29/06/2007
30/11/2008
H04L )2009.01(
MIMO– ‫שיטה ומערכת למנגנון בחירה בין‬
SIMO–LFDM–‫ ו‬OFDM
195609
–‫ד' בתשרי התש"ע‬
C25D )2009.01(
‫אריזת אנודה מצופה בדיל לתאים בסיסיים‬
195606
METHOD AND APPARATUS FOR
SELECTION MECHANISM BETWEEN
OFDM-MIMO AND LFDM-SIMO
QUALCOMM INCORPORATED
US
60/818223
29/06/2006
PCT/US/2007/072538
WO/2008/003087
September 22, 2009
‫תהליך להגברת גדילה של צמח‬
195534
TIN-PLATED ANODE CASINGS FOR
ALKALINE CELLS
EVEREADY BATTERY COMPANY,
INC.
US
60/811825
08/06/2006
11/811092
08/06/2007
US
PCT/US/2007/013628
WO/2007/146192
A01G )2009.01(
B01D )2009.01(
105
‫מיכל לתגובה במים‬
WATER REACTION TANK
JERRY HANNA
CA
2,634672
09/06/2008
02/12/2008
ESCAPE PARACHUTES & METHODS
OF ESCAPE THERE THROUGH
MICHA BLOCH
09/11/2006
‫מצנחי מילוט ושיטת מילוט באמצעותם‬
‫מיכה בלוך‬
‫מערכת ושיטה להכנת לוחות המשמשים‬
‫לקירות‬
106
H01P )2009.01(
195810
A BROADBAND SWITCHED
MULTIPLEXER
TELEDYNE DEFENCE LIMITED
GB
0611445.8
09/06/2006
0613215.3
04/07/2006
GB
PCT/GB/2007/002092
WO/2007/141528
12/06/2007
E04C )2009.01(
195714
SYSTEM AND METHOD FOR
MAKING WALLBOARD
JOHN CONBOY
US
60/736123
09/11/2005
11/345349
01/02/2006
US
PCT/US/2006/043757
WO/2007/056562
07/06/2007
B64D )2009.01(
195659
‫מרבב רחב פס עם מתג‬
C07D )2009.01(
195813
September 22, 2009
–‫ד' בתשרי התש"ע‬
SUBSTITUTED
AMINOPYRAZOLOPYRIDINES AND
SALTS THEREOF, THEIR
PREPARATIONS AND
PHARMACEUTICAL COMPOSITIONS
COMPRISING THEM
BAYER SCHERING PHARMA AG
EP
06090109.7 13/06/2006
07090020.4
15/02/2007
EP
PCT/EP/2007/005432
WO/2007/144204
05/07/2007
‫אמינופיראזולו פירידינים מותמרים‬
‫ הכנתם ותכשירי רוקחות‬,‫ומלחיהם‬
‫המכילים אותם‬
195819
MODULATORS OF METABOLISM
AND THE TREATMENT OF
DISORDERS RELATED THERETO
ARENA PHARMACEUTICALS, INC.
US
60/819500
06/07/2006
PCT/US/2007/015681
WO/2008/005576
08/06/2007
10/12/2008
–‫ד' בתשרי התש"ע‬
C12N )2009.01(
‫פלח שלייתי ושימוש בו עבור תרבית תאי‬
‫גזע‬
195841
WATERCRAFT FLOATATION
SYSTEM AND METHOD
September 22, 2009
‫אפננים המשפיעים על מטבוליזם וטיפול‬
‫במחלות הקשורות למטבוליזם‬
195826
PLACENTAL NICHE AND USE
THEREOF TO CULTURE STEM CELLS
ANTHROGENESIS CORPORATION
US
60/812366
09/06/2006
PCT/US/2007/013507
WO/2007/146123
C07D )2009.01(
B63B )2009.01(
‫מערכת ושיטה להצפת כלי שיט‬
107
‫מאיר נורמונד בומן‬
MEIR NORMUND BUMAN
10/12/2008
A METHOD AND DEVICE FOR
IDENTIFYING THE LOCATION OF A
MOBILE TELEPHONE USER
CLARITON NETWORKS LTD
15/06/2007
‫שיטה והתקן לזיהוי מיקומו של משתמש‬
‫בטלפון נייד‬
‫קלריטון נטוורקס בע"מ‬
H04L )2009.01(
‫שיטה לתקשורת ברשת אלחוטית המכילה‬
)LAN( ‫רשת מקומית‬
‫אלווריון בע"מ‬
C07C )2009.01(
195958
PHENYLACETIC ACID DERIVATIVES
AS COX-2 INHIBITORS
NOVARTIS AG
US
60/805784
26/06/2006
108
‫תכשירי רוקחות לטיפול בבעיות‬
‫פסיכולוגיות המכילים אנטאגוניסטים‬
M1 ‫לקולטן מוסקריני‬
195918
A METHOD FOR COMMUNICATION
IN A WIRELESS NETWORK
COMPRISING A LOCAL AREA
NETWORK (LAN)
ALVARION LTD.
25/06/2007
A61K )2009.01(
195857
PHARMACEUTICAL COMPOSITIONS
FOR TREATING PSYCHOLOGICAL
CONDITIONS COMPRISING
MUSCARINIC RECEPTOR M1
ANTAGONISTS
THERACOS, INC
US
60/805066
16/06/2006
60/829225
12/10/2006
US
11/763145
14/06/2007
US
PCT/US/2007/071356
WO/2007/147123
14/12/2008
G08B )2009.01(
195847
–2 ‫תולדות חומצה פנילאצטית כמעכבי‬
COX
September 22, 2009
–‫ד' בתשרי התש"ע‬
PCT/US/2007/071979
WO/2008/002853
14/06/2007
195959
METFORMIN R-(+)LIPOATE AS AN
ANTIDIABETIC AGENT FOR
CONTROL OF DIABETIC
HYPERGLYCEMIA AND DIABETIC
COMPLICATIONS
INDIGENE PHARMACEUTICALS, INC.
US
60/814250
16/06/2006
PCT/US/2007/014034
WO/2007/149313
06/08/2007
196006
SYNCHRONIZATION BETWEEN
WIRELESS DEVICES WHILE SAVING
PORWER
MICROSOFT CORPORATION
US
60/835618
04/08/2006
11/529880
29/09/2006
US
PCT/US/2007/017520
WO/2008/019140
29/06/2007
196034
METHOD AND SYSTEMS FOR
EFFICIENT DELIVERY OF
PREVIOUSLY STORED CONTENT
CITRIX SYSTEMS INC.
US
11/428058
30/06/2006
PCT/US/2007/072490
WO/2008/005840
21/06/2007
196039
INTERPRETATION OF GEOLOGIC
DEPOSITIONAL SYSTEMS
TERRASPARK GEOSCIENCES, L.P.
September 22, 2009
–‫ד' בתשרי התש"ע‬
C07D )2009.01(
‫)ליפואט כגורם‬+(–R ‫מטפורמין‬
‫אנטיסוכרתי לשליטה על היפרגליקמיה‬
‫וסיבוכים סוכרתיים‬
H04L )2009.01(
‫סנכרון בין התקנים אל–חוטיים תוך כדי‬
‫חסכון באנרגיה‬
H04L )2009.01(
‫שיטה ומערכות להעברה יעילה של תוכן‬
‫שנשמר קודם לכן‬
G01V )2009.01(
‫אינטרפטציה למערכות של מרבצים‬
‫גיאולוגיים‬
109
US
60/815630
60/815625
US
60/815961
US
PCT/US/2007/071733
WO/2008/005690
18/06/2007
21/06/2006
21/06/2006
21/06/2006
AIR CLEANER WITH PULSE JET
REVERSE CLEANING
DONALDSON COMPANY, INC.
US
60/814744
19/06/2006
60/848320
29/09/2006
US
60/921173
30/03/2007
US
PCT/US/2007/014187
WO/2007/149388
18/06/2007
‫מנקה אוויר עם ניקוי פעימת סילון הפוכה‬
‫ רקמת‬,‫ במיוחד לעיסוי‬,‫מכשיר לטיפול‬
‫החיבור של העור‬
H04L )2009.01(
196075
SYSTEMS AND METHODS FOR
COORDINATING SUPPLEMENTARY
SERVICES FOR VOICE TELEPHONE
CALLS IN A CENTRALIZED FASHION
110
B01D )2009.01(
196063
DEVICE FOR TREATING, IN
PARTICULAR MASSAGING, THE
CONNECTIVE TISSUE OF THE SKIN
LOUISIN RESEARCH AND
DEVELOPMENT LIMITED
FR
0605423
19/06/2006
PCT/FR/2007/001008
WO/2007/147964
20/07/2007
B01D )2009.01(
196061
‫מערכות ושיטות לתיאום שירותים‬
‫משלימים עבור שיחות טלפון קוליות באופן‬
‫מרוכז‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
QUALCOMM INCORPORATED
US
60/832568
21/07/2006
11/780440
19/07/2007
US
PCT/US/2007/074046
WO/2008/011610
18/12/2008
196079
SECURITY WITHIN INTEGRATED
CIRCUITS
NDS LIMITED
21/12/2008
‫בטחון במעגלים משולבים‬
196083
AN EAR CLEANING DEVICE AND
METMOD
YOTAM NADAM
21/12/2008
‫ישראל סוריאן פרידמן‬
CONFETTI AND METHOD FOR
TOSSING NON-NEGLIGIBLE-WEIGHT
OBJECTS ON CELEBRATORS
DROR DAKAR KARAGULA
–‫ד' בתשרי התש"ע‬
H01H )2009.01(
‫קונפטי ושיטה לזריית חפצים בעלי מזקל‬
‫זניח על חוגגים‬
196090
HANDHELD PHOTOCOSMETIC
DEVICE
PALOMAR MEDICAL
TECHNOLOGIES, INC.
US
60/816743
27/06/2006
60/857154
06/11/2006
US
PCT/US/2007/014949
WO/2008/002625
September 22, 2009
A61B )2009.01(
‫מכשיר ושיטה לניקוי אוזניים‬
196084
27/06/2007
H01H )2009.01(
‫דרור דקר קרגולה‬
A61B )2009.01(
‫מתקן פוטוקוסמטי באחיזת יד‬
111
21/12/2008
A61B )2009.01(
196092
‫התקן ניקוי הגוף‬
‫הידרו לוק בע"מ‬
BODY CLEANING IMPLEMENT
HYDRO LOCK LTD.
22/06/2007
A METHOD OF CONTROLLING
MOBILE UNIT RESPONSE MESSAGES
ON AN ACCESS CHANNEL
LUCENT TECHNOLOGIES INC.
US
11/427639
29/06/2006
PCT/US/2007/014639
WO/2008/005206
22/12/2008
‫שיטה לבקרת מסר מענה של יחידה ניידת‬
‫בערוץ גישה‬
‫שיטה ומערכת לחיפוש של מידע בנוגע‬
‫למושאי מטרה‬
‫עדי געש‬
112
G09F )2009.01(
196117
PROTECTION MEANS ON TRAFFIC
WAYS
OUTIMEX AG
DE
102007063511.9 27/12/2007
23/12/2008
G06F )2009.01(
196115
METHOD AND SYSTEM OF
SEARCHING FOR INFORMATION
PERTAINING TARGET OBJECTS
ILAN SIMON
22/12/2008
H04H )2009.01(
196104
‫אמצעי הגנה בדרכי תנועה‬
B41J )2009.01(
196125
September 22, 2009
–‫ד' בתשרי התש"ע‬
A METHOD AND SYSTEM FOR
OPERATING A KEYBOARD WITH
MULTI FUNCITIONAL KEYS, USING
FINGERPINTS RECOGNITION
BEJAMIN ZIMCHONI
23/12/2008
‫שיטה ומערכת להפעלה של לוח מקשים‬
‫ באמצעות זיהוי טביעות‬,‫מרובי פעולות‬
‫אצבעות‬
196126
196127
PROLYL HYDROXYLASE
INHIBITORS AND METHODS OF USE
THE PROCTER & GAMBLE
COMPANY
US
60/816522
26/06/2006
PCT/US/2007/014832
WO/2008/002576
27/06/2007
196128
HUMAN PROTEIN TYROSINE
PHOSPHATASE INHIBITORS AND
METHODS OF USE
THE PROCTER & GAMBLE
COMPANY
US
60/816730
27/06/2006
PCT/US/2007/014822
WO/2008/002569
27/06/2007
196129
HUMAN PROTEIN TYROSINE
PHOSPHATASE INHIBITORS AND
METHODS OF USE
THE PROCTER & GAMBLE
COMPANY
September 22, 2009
–‫ד' בתשרי התש"ע‬
B65D )2009.01(
‫חפיסת סיגריות‬
‫נור האש טכניקום בע"מ‬
CIGARETTE PACKAGE
NUR HAESH TECHNICOM LTD.
26/06/2007
‫בנימין צמחוני‬
C07C )2009.01(
‫מעכבי פרוליל הידרוקסילאז ושיטות‬
‫לשימוש בהם‬
C07D )2009.01(
‫מעכבי חלבון טירוזין פוספטאז אנושי‬
‫ושיטות לשימוש בהם‬
C07D )2009.01(
‫מעכבי חלבון טירוזין פוספטאז אנושי‬
‫ושיטות לשימוש בהם‬
113
US
60/816731
60/816730
US
60/816825
US
PCT/US/2007/014823
WO/2008/002570
27/06/2007
27/06/2006
27/06/2006
27/06/2006
HUMAN PROTEIN TYROSINE
PHOSPHATASE INHIBITORS AND
METHODS OF USE
THE PROCTER & GAMBLE
COMPANY
US
60/816825
27/06/2006
PCT/US/2007/014824
WO/2008/002571
26/06/2007
114
‫מעכבי חלבון טירוזין פוספטאז אנושי‬
‫ושיטות לשימוש בהם‬
A61K )2009.01(
196132
ALPHANIZOMENON FLOS AQUAE
PREPARATION, EXTRACTS AND
PURIFIED COMPONENTS THEREOF
FOR THE TREATMENT OF
NEUROLOGICAL
NEURODEGENERATIVE AND MOOD
DISORDERS
NUTRATEC S.R.L.
US
60/816593
27/06/2006
PCT/EP/2007/005622
WO/2008/000430
27/06/2007
C07D )2009.01(
196130
‫ תמציות‬,‫תכשיר אלפאניזומנון פלוס אקווה‬
‫ומרכיבים טהורים שלו לטיפול באי–סדרים‬
‫ ניוונים–עצביים ומצבי–רוח‬,‫ניורולוגיים‬
A61K )2009.01(
196133
September 22, 2009
–‫ד' בתשרי התש"ע‬
EXTRACTS OF APHANIZOMENON
FLOS AQUAE AND NUTRITIONAL,
COSMETIC AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THE
SAME
NUTRATEC S.R.L.
US
60/816594
27/06/2006
PCT/EP/2007/005623
WO/2008/000431
13/07/2007
‫תמציות של אפהניזומנון פלוס אקווה‬
‫ קוסמטיים ורוקחיים‬,‫ותכשירים מזינים‬
‫המכילים אותן‬
C12N )2009.01(
196134
‫משרן מוות תאי‬
CELL DEATH INDUCER
CHUGAI SEIYAKU KABUSHIKI
KAISHA
2006JP
13/07/2006
193053
PCT/JP/2007/063946
WO/2008/007755
19/06/2007
196135
CHASSIS FRAME OF A RAIL VEHICLE
BOMBARDIER TRANSPORTATION
GMBH
DE
102006029835.7 27/06/2006
PCT/EP/2007/056077
WO/2008/000657
17/07/2007
196136
AMINOINDANE DERIVATIVE OR
SALT THEREOF
ASTELLAS PHARMA INC.
2006JP
18/07/2006
195307
PCT/JP/2007/064072
September 22, 2009
–‫ד' בתשרי התש"ע‬
B61F )2009.01(
‫מסגרת שלדה של כלי רכב על מסילה‬
C07C )2009.01(
‫נגזרת אמינואינדאן או מלח שלה‬
115
WO/2008/010481
11/06/2007
APPARATUS AND METHOD FOR
CALIBRATION OF GAIN AND/OR
PHASE IMBALANCE AND/OR DC
OFFSET IN A COMMUNICATION
SYSTEM
SIERRA MONOLITHICS, INC.
US
60/816240
23/06/2006
11/590278
30/10/2006
US
PCT/US/2007/013634
WO/2008/002389
23/12/2008
B42D )2009.01(
‫התקן אלקטרוני נישא בעל תיפקוד‬
‫היסטורי ומטרה להציג ערכי משתנים על‬
‫בסיס מדידות הנעשות באמצעות חיישן‬
A61K )2009.01(
196141
OSMOTIC DELIVERY SYSTEMS AND
PISTON ASSEMBLIES
INTARCIA THERAPEUTICS, INC.
US
60/821830
09/08/2006
116
‫או חוסר איזון‬/‫מערכת ושיטה לכיול רווח ו‬
‫ במערכת תקשורת‬DC ‫או איזון‬/‫פאזי ו‬
196140
PORTABLE ELECTRONIC DEVICE
HAVING A HISTORY FUNCTION AND
INTENDED TO DISPLAY THE VALUE
OF VARIABLES ON THE BASIS OF
MEASUREMENTS MADE BY A
SENSOR
ETA SA MANUFACTURE
HORLOGERE SUISSE
EP
07150448.4 27/12/2007
08/08/2007
H04B )2009.01(
196139
‫מערכות למתן באופן אוסמטי ומכלולי‬
‫בוכנה‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
60/930205
US
PCT/US/2007/017634
WO/2008/021133
15/05/2007
25/07/2007
196142
PROCESS FOR PREPARING
AMIDRAZONES
BASF SE
EP
06118365.3 03/08/2006
PCT/EP/2007/057645
WO/2008/015133
13/08/2007
196143
THIOPHENE-SULFONIC ACID
PICOLYL AMIDES
BASF SE
EP
06119331.4 22/08/2006
PCT/EP/2007/058348
WO/2008/022937
12/07/2007
196144
NON-NUCLEOSIDE REVERSE
TRANSCRIPTASE INHIBITORS
F. HOFFMANN-LA ROCHE AG
US
60/832482
21/07/2006
PCT/EP/2007/057155
WO/2008/009613
27/06/2007
196147
SYSTEM AND METHOD OF USING A
MULTI-VIEW DISPLAY
GULFSTREAM AEROSPACE
CORPORATION
US
60/817748
30/06/2006
11/648567
01/02/2007
US
PCT/US/2007/014862
September 22, 2009
–‫ד' בתשרי התש"ע‬
C07C )2009.01(
‫תהליך להכנת אמידראזונים‬
C07D )2009.01(
–‫פיקוליל אמידים של חומצה תיאופן‬
‫סולפונית‬
C07C )2009.01(
‫מעכבי רברס טרנסקריפטאז שאינם‬
‫נוקליאוזידים‬
G09G )2009.01(
‫מערכת ושיטה לשימוש בצג רב–מבטי‬
117
WO/2008/005247
28/06/2007
PHARMACEUTICAL COMPOSITIONS
CONTAINING MONOCLONAL ANTI
IDIOTYPIC ANTI-CA-125 ANTI-BODY
AND ALUMINIUM DERIVATIVES
MENARINI INTERNATIONAL
OPERATIONS LUXEMBOURG S.A.
IT
FI2006A000163 29/06/2006
PCT/EP/2007/056465
WO/2008/000789
27/06/2007
C07D )2009.01(
‫פיפרדינים מותמרים שמגבירים פעילות‬
‫ ושימושים שלהם‬P53
C01B )2009.01(
196153
CARBON NITRIDE PREPARATION
METHOD
CARBODEON LTD OY
FI
20060682
13/07/2006
PCT/FI/2007/000192
WO/2008/006935
118
–‫תכשירים רפואיים המכילים נוגדן חד‬
CA–125 ‫שבטי אנטי אידיוטייפי אנטי‬
‫ונגזרות אלומיניום‬
196152
SUBSTITUTED PIPERIDINES THAT
INCREASE P53 ACTIVITY AND THE
USES THEREOF
SCHERING CORPORATION
US
60/817753
30/06/2006
PCT/US/2007/014958
WO/2008/005268
13/07/2007
A61K )2009.01(
196148
‫שיטה להכנת פחמן ניטרידי‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
05/05/2007
PHARMACEUTICAL PREPARATIONS
FOR CONTRACEPTION AND FOR
PREVENTING THE RISK OF
CONGENITAL MALFORMATIONS
BAYER SCHERING PHARMA AG
EP
06014002.7 06/07/2006
06016950.5
14/08/2006
EP
PCT/EP/2007/003982
WO/2008/003363
28/06/2007
‫תכשירי רוקחות למניעת היריון ולמניעת‬
‫הסיכון של פגמים מולדים‬
196155
METHOD FOR TESTING THE REALTIME CAPABILITY OF A SYSTEM
INCHRON GMBH
DE
102006031013.6 03/07/2006
PCT/EP/2007/005732
WO/2008/003427
27/06/2007
196156
BEAD IMMOBILISATION METHOD
AND BEAD ARRAYS MADE
THEREBY
SWINBURNE UNIVERSITY OF
TECHNOLOGY
AU
2006903471 28/06/2006
PCT/AU/2007/000895
WO/2008/000031
21/06/2007
196157
CATIONIC POLYMER STABILIZED
MICROCAPSULE COMPOSITION
COLGATE-PALMOLIVE COMPANY
US
11/479679
30/06/2006
PCT/US/2007/071782
WO/2008/005693
September 22, 2009
A61K )2009.01(
196154
–‫ד' בתשרי התש"ע‬
G06F )2009.01(
‫שיטה לבחינת יכולת של מערכת בזמן‬
‫אמת‬
G01N )2009.01(
‫שיטה להדממת אגל ומערכי אגלים‬
‫המיוצרים באמצעות שיטה זו‬
C11D )2009.01(
‫הרכב מיקרו–כמוסה המיוצב בפולימר‬
‫קטיוני‬
119
28/06/2007
GASTROINTESTINAL PROSTHESES
SLIMEDICS LTD.
US
60/817071
29/06/2006
PCT/IL/2007/000799
WO/2008/001381
19/07/2007
120
‫ שיטה ומערכת ניידת לעיבוד‬,‫מנגנון‬
‫גורמים המשפיעים על הסוכר בדם‬
B62D )2009.01(
‫מתקן גרירת רכב הניתן להקטנה עבור‬
‫איחסון ברכב‬
H04N )2009.01(
196161
REMOVAL OF SHADOWS FROM
IMAGES IN A VIDEO SIGNAL
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
24/12/2008
A61B )2009.01(
196160
VEHICLE-TOWING APPARATUS
WHICE IS COMPACTABLE FOR
STORAGE IN A VEHICLE
AVRAHAM ELKAYAM
24/12/2008
‫תותבים לדרכי העיכול‬
‫סלימדיקס בע"מ‬
196159
MOBILE APPARATUS, METHOD AND
SYSTEM FOR PROCESSING BLOOD
SUGAR AFFECTING FACTORS
CROSS TECHNOLOGY SOLUTIONS
AB
SE
0601580-4
19/07/2006
PCT/EP/2007/057495
WO/2008/009737
24/12/2008
A61F )2009.01(
196158
‫הורדת צל מתמונות בתוך אות וידאו‬
‫רפאל מערכות לחימה מתקדמות בע"מ‬
H04N )2009.01(
196162
September 22, 2009
–‫ד' בתשרי התש"ע‬
A SYSTEM FOR USING THREEDIMENSIONAL MODELS TO ENABLE
IMAGE COMPARISONS
INDEPENDENT OF IMAGE SOURCE
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
25/05/2007
–‫מערכת המשתמשת במודלים תלת‬
‫ממדיים לאפשר השוואת תמונות ללא‬
‫תלות במקור התמונות‬
‫רפאל מערכות לחימה מתקדמות בע"מ‬
196165
A METHOD FOR THE TARGETED
EXECUTION OF A REACTION TAKING
PLACE ALONGSIDE SEVERAL
COMPETING CHEMICAL REACTIONS
LONZA AG
DE
102006031652.5 08/07/2006
PCT/EP/2007/004673
WO/2008/006420
25/12/2008
196166
PROCESS SYSTEM AND METHOD
FOR REWARDING CUSTOMERS,
COMPUTER-READABLE MEDIUM
AND COMPUTER-IMPLEMENTED
METHOD FOR CONTROLLING AND
OPERATING SUCH PROCESS
C07C )2009.01(
‫שיטה להוצאה לפועל מכוונת של‬
‫ראקציה המתרחשת לצד כמה‬
‫ראקציות כימיות מתחרות‬
G07B )2009.01(
,‫ מערכת ושיטה לתגמול לקוחות‬,‫תהליך‬
‫אמצעי נקרא–מחשב ושיטה מבוססת‬
‫מחשב לבקרת והפעלת תהליך זה‬
‫עו"ד מאיר דהאן‬
29/06/2007
196167
BICYCLIC COMPOUNDS AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
KINEX PHARMACEUTICALS, LLC
US
11/480163
29/06/2006
September 22, 2009
–‫ד' בתשרי התש"ע‬
C07D )2009.01(
‫תרכובות ביציקליות ותכשירי רוקחות‬
‫המכילים אותן‬
121
PCT/US/2007/015271
WO/2008/002674
29/06/2007
BIARYL COMPOUNDS AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
KINEX PHARMACEUTICALS, LLC
US
11/480174
29/06/2006
60/923496
13/04/2007
US
PCT/US/2007/015273
WO/2008/002676
27/06/2007
C07J )2009.01(
‫תולדות חומצת מרה ותכשירי רוקחות‬
‫המכילים אותן‬
A61K )2009.01(
196172
ACTIVATED MYELOID CELLS FOR
PROMOTING TISSUE REPAIR AND
DETECTING DAMAGED TISSUE
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
60/806055
28/06/2006
60/807264
13/07/2006
US
122
‫תרכובות ביאריל ותכשירי רוקחות‬
‫המכילים אותן‬
196169
BILE ACID DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
INTERCEPT PHARMACEUTICALS,
INC.
US
60/816635
27/06/2006
PCT/US/2007/014829
WO/2008/002573
28/06/2007
C07C )2009.01(
196168
‫תאי מיאלואיד משופעלים לעידוד תיקון‬
‫רקמות ולגילוי רקמות פגועות‬
‫ידע חברה למחקר ופיתוח בע"מ‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
PCT/IL/2007/000797
WO/2008/001379
28/06/2007
196173
USE OF AGENTS THAT ACT ON T
CELLS FOR TREATMENT OF AGERELATED MACULAR
DEGENERATION
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
60/806041
28/06/2006
PCT/IL/2007/000798
WO/2008/001380
25/06/2007
196174
METHOD FOR ADSORPTION OF
FLUID CONTAMINANTS AND
REGENERATION OF THE
ADSORBENT
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION LTD.
US
60/816643
27/06/2006
PCT/IL/2007/000765
WO/2008/001354
03/07/2007
196175
PROCESS FOR PRODUCTION OF
ALCOHOL COMPOUND
SUMITOMO CHEMICAL COMPANY,
LIMITED
2006JP
04/07/2006
184254
PCT/JP/2007/063289
September 22, 2009
–‫ד' בתשרי התש"ע‬
A61K )2009.01(
T ‫שימוש בתרכובות הפועלות של תאי‬
‫לטיפול בניוון במקולה הקשור לגיל‬
‫ידע חברה למחקר ופיתוח בע"מ‬
C02F )2009.01(
‫שיטה לספיחת מזהמים פלואידיים‬
‫ולמיחזור החומר הסופח‬
‫מוסד הטכניון למחקר ופתוח בע"מ‬
C07C )2009.01(
‫הליך לייצור תרכובת אלכוהול‬
123
WO/2008/004544
03/07/2007
PROCESS FOR PRODUCTION OF
ALCOHOL COMPOUND
SUMITOMO CHEMICAL COMPANY,
LIMITED
2006JP
04/07/2006
184253
PCT/JP/2007/063288
WO/2008/004543
29/06/2007
DIPHOSPHINE LIGANDS
SOLVIAS AG
CH
01051/06
PCT/EP/2007/056556
WO/2008/000815
124
‫הליך לייצור תרכובת אלכוהול‬
A61L )2009.01(
196177
THIN FILM MULTILOCULAR
STRUCTURE MADE OF COLLAGEN,
MEMBER FOR TISSUE
REGENERATION CONTAINING THE
SAME, AND METHOD FOR
PRODUCING THE SAME
KYOTO UNIVERSITY
2006JP
30/06/2006
180802
PCT/JP/2007/063516
WO/2008/001952
29/06/2007
C07C )2009.01(
196176
‫מבנה שכבה רב תאית דקה עשוייה‬
,‫ איבר לחידוש רקמה המכילה אותו‬,‫מקולגן‬
‫ושיטה לייצורו‬
C07F )2009.01(
196178
‫ליגנדים של דיפוספין‬
30/06/2006
September 22, 2009
–‫ד' בתשרי התש"ע‬
28/06/2007
196179
IDENTIFICATION AND USE OF GPRC
VARIANTS IN THE TREATMENT AND
DIAGNOSIS OF PARKINSON'S
DISEASE
EXONHIT THERAPEUTICS SA
US
60/817082
29/06/2006
PCT/EP/2007/056504
WO/2008/000803
25/12/2008
GPRC ‫זיהוי ושימוש של וריאנטים של‬
‫בטיפול ובדיאגנוזה של מחלת פרקינסון‬
196180
196181
SUBSTITUTED N-PHENYLMETHYL-5OXO-PROLINE-2-AMIDES AS P2X7RECEPTOR ANTAGONISTS AND
THEIR METHODS OF USE
GLAXO GROUP LIMITED
GB
0613473.8
06/07/2006
0622825.8
15/11/2006
GB
0705263.2
19/03/2007
GB
0711439.0
13/06/2007
GB
PCT/EP/2007/056675
WO/2008/003697
03/07/2007
September 22, 2009
–‫ד' בתשרי התש"ע‬
C07D )2009.01(
‫–אמידים‬2–‫–אוקסו–פרולינ‬5–‫–פנילמתיל‬N
‫מותמרים כאנטגוניסטים של רצפטור‬
‫ ושיטות לשימושם‬X2P7
196182
SPUTTER TARGET ASSEMBLIES
HAVING A CONTROLLED SOLDER
THICKNESS
PRAXAIR TECHNOLOGY, INC.
US
11/480831
06/07/2006
G08B )2009.01(
‫מכשיר זיהוי מיקום‬
POSITION DETECTING DEVICE
WACOM CO., LTD.
P2007JP
28/12/2007
340099
03/07/2007
C07K )2009.01(
H01J )2009.01(
‫התקנים למטרת מתיז בעלי עובי הלחמה‬
‫מבוקר‬
125
PCT/US/2007/015411
WO/2008/005461
22/08/2006
METHODS OF TREATING SURFACES
WITH IONIC ORGANOSILICON
COMPOSITIONS
RANKA, SEEMA, AJAY
IN
1069/MUM/2006 07/07/2006
PCT/IN/2006/000304
WO/2008/004242
29/06/2007
C12Q )2009.01(
‫תעתיקים ספציפיים לפרוטאז ושימושם‬
‫לדיאגנוסטיקה וריפוי של סרטן הערמונית‬
A61K )2009.01(
196185
INHALANT FORMULATION
CONTAINING SULFOALKYL ETHER
CYCLODEXTRIN AND
CORTICOSTEROID
CYDEX PHARMACEUTICALS, INC.
US
11/479979
30/06/2006
PCT/US/2006/062346
WO/2008/005053
126
‫שיטות לטיפול במשטחים עם תרכובות‬
‫אורגנוסיליקון יוני‬
196184
PROSTATE SPECIFIC TRANSCRIPTS
AND THE USE THEREOF FOR
PROSTATE CANCER THERAPEUTICS
AND DIAGNOSTICS
EXONHIT THERAPEUTICS SA
US
60/817686
03/07/2006
PCT/EP/2007/056584
WO/2008/003656
19/12/2006
B32B )2009.01(
196183
‫הרכב לשאיפה המכיל סולפואלקיל אתר‬
‫ציקלודקסטרין וקורטיקוסטרואיד‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
06/07/2007
196186
EXPANDABLE VASCULAR
ENDOLUMINAL PROSTHESES
PRESCIENT MEDICAL INC.
US
60/818508
06/07/2006
60/851755
16/10/2006
US
11/822336
05/07/2007
US
PCT/US/2007/015579
WO/2008/005535
18/07/2007
196187
NF-kB INHIBITOR
OTSUKA PHARMACEUTICAL CO.,
LTD.
2006JP
20/07/2006
198116
2006-285169 19/10/2006
JP
PCT/JP/2007/064613
WO/2008/010601
28/06/2007
196188
FIBER OPTIC SENSOR USING A
BRAGG FIBER
THE BOARD OF TRUSTEES OF THE
LELAND STANFORD JUNIOR
UNIVERSITY
US
60/817514
29/06/2006
60/837891
14/08/2006
US
PCT/US/2007/072419
WO/2008/003071
September 22, 2009
–‫ד' בתשרי התש"ע‬
A61F )2009.01(
‫תותבות וסקולריות אנדולומינאליות‬
‫הניתנות להרחבה‬
A61K )2009.01(
kB–NF ‫מעכב‬
G01D )2009.01(
‫חיישן סיב אופטי המשתמש בסיב‬
BRAGG
127
27/06/2007
METHODS AND SYSTEMS FOR
MONITORING AND CONTROLLING
BODY TEMPERATURE OF A GROUP
OF HOMOTHERMIC ORGANISMS
THE STATE OF ISRAEL, MINISTRY
OF AGRICULTURE AND RURAL
DEVELOPMENT, AGRICULTURAL
RESEARCH ORGANIZATION,
VOLCANI CENTER
US
60/816618
27/06/2006
PCT/IL/2007/000783
WO/2008/001367
20/07/2007
‫שיטות ומערכות לבקרת טמפרטורת גוף‬
‫של קבוצת בעלי חיים הומותרמיים‬
‫ משרד החקלאות ופיתוח‬,‫מדינת ישראל‬
‫ מרכז‬,‫ מינהל המחקר החקלאי‬,‫הכפר‬
‫וולקני‬
AIRCRAFT
BURKHARD WIGGERICH
DE
102006029603.6
PCT/DE/2007/000592
WO/2008/000203
128
C07D )2009.01(
196190
NOVEL CHROMENE AND
THIOCHROMENE CARBOXAMIDE
DERIVATIVES, METHODS FOR
PREPARING SAME AND
THERAPEUTIC APPLICATIONS OF
SAME
PIERRE FABRE MEDICAMENT
FR
0606682
21/07/2006
PCT/EP/2007/057511
WO/2008/009741
31/03/2007
A01K )2009.01(
196189
‫תולדות כרומן ותיאוכרומן קרבוקסאמיד‬
‫ שיטות להכנתן ויישומיהן‬,‫חדשות‬
‫הטיפוליים‬
B64C )2009.01(
196192
‫כלי טייס‬
26/06/2006
September 22, 2009
–‫ד' בתשרי התש"ע‬
28/06/2007
196193
A COLD INFUSION PROCESS FOR
FORTIFING COFFEE BEANS
VOYAVA REPUBLIC LLC.
US
60/806082
28/06/2006
60/820454
26/07/2006
US
60/820448
26/07/2006
US
PCT/US/2007/072384
WO/2008/003054
14/06/2007
‫תהליך מיזוג קר להעשרת פולי קפה‬
196194
AN-ANTI-VIRAL COMPOSITION FOR
THE TOPICAL TREATMENT OF
HERPES LABIALIS (COLD SORES)
AND METHOD FOR USE THEREOF
REDOX PHARMACEUTICAL CORP.
US
60/805921
27/06/2006
11/762542
13/06/2007
US
PCT/US/2007/071222
WO/2008/002777
05/07/2007
September 22, 2009
–‫ד' בתשרי התש"ע‬
A61K )2009.01(
‫תכשיר אנטי–ויראלי לטיפול מקומי‬
‫בהרפס לביאליס (פצעי קור) ושיטה‬
‫לשימוש בו‬
196195
WIRELESS COMMUNICATION
METHOD OF SELECTING AN
ENHANCED UPLINK TRANSPORT
FORMAT COMBINATION BY
SETTING A SCHEDULING GRANT
PAYLOAD TO THE HIGHEST
PAYLOAD THAT CAN BE
TRANSMITTED
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/818848
06/07/2006
A23L )2009.01(
H04B )2009.01(
‫שיטת תקשורת אלחוטית לבחירת שילוב‬
‫מערך להעברה מוגברת ללווין באמצעות‬
‫קביעת תיזמון למתן מטען ייעודי למטען‬
‫הייעודי הגבוה ביותר שניתן לשדר‬
129
PCT/US/2007/015496
WO/2008/005503
03/07/2007
TDMA CHANNEL ACCESS
SCHEDULING WITH NEIGHBOR
INDIRECT ACKNOWLEDGMENT
ALGORITHM (NBIA) FOR AD-HOC
NETWORKS
HARRIS CORPORATION
US
11/428862
06/07/2006
PCT/US/2007/072765
WO/2008/005994
28/06/2007
‫ עם אלגוריתם‬TDMA ‫תזמון גישה לערוץ‬
HOC– ‫אישור עקיף של שכן עבור רשתות‬
AD
130
‫אבטחה מיקרו–אופטית ומערכת להצגת‬
‫דמות‬
C12Q )2009.01(
196198
A METHOD OF MODIFYING A
MACROMOLECULE WITHOUT PRIOR
EXTRACTION FROM A SAMPLE
VERIDEX, LLC
US
60/817876
29/06/2006
60/828790
10/10/2006
US
PCT/US/2007/015329
WO/2008/002680
03/07/2007
G02B )2009.01(
196197
MICRO-OPTIC SECURITY AND
IMAGE PRESENTATION SYSTEM
VISUAL PHYSICS, LLC
US
60/817297
28/06/2006
11/770592
28/06/2007
US
PCT/US/2007/072406
WO/2008/008635
29/06/2007
H04L )2009.01(
196196
‫שיטה לשינוי מולקולת ענק ללא מיצוי‬
‫קודם מדוגמה‬
H04L )2009.01(
196199
September 22, 2009
–‫ד' בתשרי התש"ע‬
SYSTEM AND METHOD FOR
VARIABLE FORWARD ERROR
CORRECTION (FEC) PROTECTION
HARRIS CORPORATION
US
11/428689
05/07/2006
PCT/US/2007/072742
WO/2008/005981
05/07/2007
‫מערכת ושיטה עבור הגנת משתנה‬
‫לשליחת תיקון טעות‬
196200
POLYMORPHIC FORM OF FLUORO-7(2,2,2TRIFLUOROETHOXY)PHENOXATHIN10,10-DIOXIDE
CeNeRx BIoPHARMA, INC.
US
60/819078
07/07/2006
PCT/US/2007/015533
WO/2008/008273
18/06/2007
196202
INDAZOLE DERIVATIVES FOR THE
TREATMENT OF HSP90-INDUCED
DISEASES
MERCK PATENT GMBH
DE
102006030479.9 01/07/2006
PCT/EP/2007/005338
WO/2008/003396
25/12/2008
September 22, 2009
196203
–‫ד' בתשרי התש"ע‬
A61P )2009.01(
–7–‫צורה פולימורפית של פלואורו‬
–‫–טריפלואורואתוקסי)פנוקסטין‬2,2,2(
‫–דיאוקסיד‬10,10
C07D )2009.01(
‫תולדות אינדזול לטיפול במחלות‬
HSP90 ‫מושרות‬
B41J )2009.01(
131
‫מערכת ושיטה לפרק חשמל סטטי‬
‫במדפסת‬
‫מתן דיגיטל פרינטינג בע"מ‬
SYSTEM AND METHOD FOR
DISCHARGING STATIC IN A PRINTER
MATAN DIGITAL PRINTING LTD.
29/06/2007
INSULATING WINDOW
INCORPORATING PHOTOVOLTAIC
CELLS AND A PRESSURE
EQUALIZATION SYSTEM
VISIONWALL CORPORATION
CA
2551356
30/06/2006
PCT/CA/2007/001163
WO/2008/000084
26/06/2007
‫חלון מבודד המכיל תאים פוטו–ואלטאיים‬
‫ומערכת להשוואת לחצים‬
132
‫שימור של מוצרים שהם פירות או ירקות‬
C07D )2009.01(
196206
ISOINDOLINE DERIVATIVES FOR
THE TREATMENT OF ARRHYTHMIAS
ASTRAZENECA AB
US
60/830243
12/07/2006
60/913367
23/04/2007
US
PCT/SE/2007/000683
WO/2008/008022
05/07/2007
A01N )2009.01(
196205
PRESERVING PRODUCTS FOR
HARVEST FRUITS AND
VEGETABLES
INVERSIONES NAPOLEON
LIMITADA
CL
1651/2006
27/06/2006
PCT/EP/2007/056372
WO/2008/000741
12/07/2007
E06B )2009.01(
196204
‫נגזרות איזואינדולין לטיפול בהפרעות קצב‬
‫לב‬
C07D )2009.01(
196207
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫תרכובות פירימידו מאוחות‬
FUSED PYRIMIDO COMPOUNDS
ASTRAZENECA AB
US
60/818878
06/07/2006
PCT/GB/2007/002490
WO/2008/003958
10/07/2007
196208
METHODS FOR CANCER
TREATMENT USING TAK1
INHIBITORS
ASTRAZENECA AB
US
60/806845
10/07/2006
PCT/GB/2007/002568
WO/2008/007072
02/08/2007
27/06/2007
–‫ד' בתשרי התש"ע‬
A61K )2009.01(
ALPHA––‫גורמים נקשרים מכווני–מטרה ל‬
‫ ושימושים שלהם‬PDGFR
196210
USE OF STILBENE DERIVATIVES
FOR TREATMENT AND PREVENTION
OF AQUATIC MOLD INFECTIONS
THE STATE OF ISRAEL, MINISTRY
OF AGRICULTURE AND RURAL
DEVELOPMENT, AGRICULTURAL
RESEARCH ORGANIZATION,
VOLCANI CENTER
US
60/816619
27/06/2006
PCT/IL/2007/000784
WO/2008/001368
September 22, 2009
‫שיטות לטיפול בסרטן המשתמשות‬
TAK1 ‫במעכבי‬
196209
TARGETED BINDING AGENTS
DIRECTED TO PDGFR-ALPHA AND
USES THEREOF
ASTRAZENECA AB
US
60/835647
03/08/2006
PCT/US/2007/075117
WO/2008/112003
C12Q )2009.01(
A61K )2009.01(
‫שימוש בתולדות סטילבן לטיפול ומניעה‬
‫של זיהומים פטרייתיים ביצורים מימיים‬
‫ משרד החקלאות ופיתוח‬,‫מדינת ישראל‬
‫ מרכז‬,‫ מינהל המחקר החקלאי‬,‫הכפר‬
‫וולקני‬
133
03/07/2007
PRESERVATION AND CONTROLLED
DELIVERY/RELEASE OF
SPERMATOZOA
SPERMVITAL AS
GB
0613288.0
04/07/2006
60/807716
19/07/2006
US
PCT/NO/2007/000256
WO/2008/004890
29/05/2007
I.B.R ISRAELI BIOTECHNOLOGY
RESEARCH LTD
IL
176668
02/07/2006
PCT/IL/2007/000648
WO/2008/004206
‫תכשירי קרטנואידים המועילים להלבנת‬
‫העור‬
'‫ ישראלי ביוטכנולוגי ריסרץ‬.‫אר‬.‫בי‬.‫איי‬
‫בע"מ‬
B32B )2009.01(
‫בידוד תרמי של חבילות‬
‫פוטרמן יזום ניהול ושיווק‬
B42D )2009.01(
196214
BOOK AND METHOD FOR
MANUFACTURE THEREOF
JONGBLOED B.V.
NL
1032073
28/06/2006
PCT/NL/2007/000163
134
A61K )2009.01(
196213
THERMAL INSULATION OF
PACKAGES
PUTERMAN DISTRIBUTORS
28/06/2007
‫ העברה מבוקרת‬/‫שימור ושחרור מבוקר‬
‫של תאי זרע‬
196212
CAROTENOID COMPOSITIONS
USEFUL FOR WHITENING SKIN
25/12/2008
A01N )2009.01(
196211
‫ספר ושיטה לייצורו‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
WO/2008/002130
29/06/2007
196215
CONTAINER FOR THE STORGE OF
PRODUCTS
JANNY SARL
FR
0605910
30/06/2006
PCT/FR/2007/001109
WO/2008/000971
24/04/2007
196217
CONCEPT FOR COMBINING
MULTIPLE PARAMETRICALLY
CODED AUDIO SOURCES
FRAUNHOFER-GESELLSCHAFT ZUR
FORDERUNG DER ANGEWANDTEN
FORSCHUNG E.V.
US
60/819419
07/07/2006
11/739544
24/04/2007
US
PCT/EP/2007/003598
WO/2008/003362
06/07/2007
196218
A BOUNCING CRADLE HAVING A
BASE FRAME
BABY BJORN AB
SE
0601502-8
07/07/2006
PCT/SE/2007/000675
WO/2008/004958
06/07/2007
196219
A BOUNCING CRADLE
September 22, 2009
–‫ד' בתשרי התש"ע‬
B65D )2009.01(
‫מיכל לאחסון מוצרים‬
H04N )2009.01(
‫מושג לשילוב מקורות שמע מרובים‬
‫המקודדים פרמטרית‬
A47D )2009.01(
‫עריסה מקפצת עם מסגרת תחתית‬
A47D )2009.01(
‫עריסה מקפצת‬
135
BABY BJORN AB
SE
0601501-0
PCT/SE/2007/000676
WO/2008/004959
07/07/2006
12/07/2007
RATE-ENHANCED CMP
COMPOSITIONS FOR DIELECTRIC
FILMS
CABOT MICROELECTRONICS
CORPORATION
US
11/491612
24/07/2006
PCT/US/2007/015872
WO/2008/013678
10/07/2007
CMP METHOD FOR METALCONTAINING SUBSTRATES
136
‫הרכבים מוגברי–קצב לליטוש כימי–מכאני‬
‫עבור שכבות די–אלקטריות‬
C09K )2009.01(
196221
GALLIUM AND CHROMIUM IONS
FOR OXIDE REMOVAL RATE
ENHANCEMENT
CABOT MICROELECTRONICS
CORPORATION
US
11/491055
21/07/2006
PCT/US/2007/015714
WO/2008/013668
06/07/2007
C09K )2009.01(
196220
‫יוני כרום וגליום עבור הגברת קצב הסרת‬
‫תחמוצת‬
C09K )2009.01(
196222
‫שיטת ליטוש כימי–מכאני עבור מצעים‬
‫המכילים מתכת‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
CABOT MICROELECTRONICS
CORPORATION
US
60/830233
12/07/2006
PCT/US/2007/015555
WO/2008/008282
08/07/2007
196223
RAPID DIAGNOSTIC DEVICES BASED
ON MOLECULAR IMPRINTED
POLYMERS
INFIGO DIAGNOSTICS LTD.
US
60/806783
09/07/2006
PCT/IL/2007/000851
WO/2008/007359
28/06/2007
‫התקנים לאבחון מהיר המבוססים על‬
‫הטבעה מולקולרית בפולימרים‬
‫אינפיגו דיאגנוסטיקה בע"מ‬
196224
SYSTEM AND METHOD FOR
TRACELESS BIOMETRIC
IDENTIFICATION
INNOVYA RESEARCH &
DEVELOPMENT LTD
US
11/478404
29/06/2006
PCT/IL/2007/000790
WO/2008/001373
03/07/2007
PHOSPHONATE AND PHOSPHINATE
COMPOUNDS AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
BRISTOL-MYERS SQUIBB COMPANY
US
60/818912
06/07/2006
11/769964
28/06/2007
US
PCT/US/2007/072708
WO/2008/005964
September 22, 2009
196227
–‫ד' בתשרי התש"ע‬
G07C )2009.01(
‫מערכת ושיטה לזיהוי ביומטרי ללא עקבות‬
196226
28/06/2007
G01N )2009.01(
‫אינווייה מחקר ופיתוח בע"מ‬
C07F )2009.01(
‫תרכובות פוספונט ופוספינט ותכשירי‬
‫רוקחות המכילים אותן‬
C12N )2009.01(
137
METHODS FOR DIFFERENTIATING
UMBILICAL CORD MATRIX CELLS
INTO HEPATOCYTE-LIKE CELLS
THE UNIVERSITY OF KANSAS
US
60/817251
28/06/2006
PCT/US/2007/015219
WO/2008/002662
18/07/2007
REAR VIEW MIRROR FOR A
VEHICLE
YOSEF BREGMAN
138
‫–הידרוקסיתיובנזאמיד של‬4 ‫תולדות‬
‫תרופות‬
C07D )2009.01(
196229
HYDROGEN SULFIDE DERIVATIVES
OF NON-STEROIDAL ANTIINFLAMMATORY DRUGS
ANTIBE THERAPEUTICS INC.
US
60/807639
18/07/2006
60/887188
30/01/2007
US
PCT/CA/2007/001289
WO/2008/009127
28/12/2008
C07D )2009.01(
196228
4-HYDROXYTHIOBENZAMIDE
DERIVATIVES OF DRUGS
ANTIBE THERAPEUTICS INC.
US
60/807639
18/07/2006
60/887188
30/01/2007
US
PCT/CA/2007/001273
WO/2008/009118
18/07/2007
‫שיטות להתמיינות של תאי מטריצה של‬
‫חבל הטבור לתאי דימוי–הפטוציט‬
–‫תולדות מימן גופריתי של תרופות אנטי‬
‫דלקתיות סטרואידיות‬
B60R )2009.01(
196230
‫ראי לצפיה אחורית לכלי רכב‬
‫יוסף ברגמן‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
02/08/2007
196233
CHEMICAL PROCESS FOR
PREPARATION OF AROMATIC
CYCLOPROPANE ESTERS AND
AMIDES
ASTRAZENECA AB
GB
0615619.4
05/08/2006
PCT/SE/2007/000706
WO/2008/018822
02/08/2007
‫תהליך כימי להכנת אסטרים ואמידים של‬
‫ציקלופרופאן ארומטי‬
196234
A PROCESS FOR THE PREPARATION
OF OPTICALLY ACTIVE
CYCLOPROPYLAMINES
ASTRAZENECA AB
GB
0615620.2
05/08/2006
PCT/SE/2007/000707
WO/2008/018823
28/12/2008
ORAL CAVITY INSERTION
INSTRUMENT AND
PHARYNGOSCOPE APPARATUS
TSUNODA KOICHI
2007JP
27/12/2007
338336
September 22, 2009
–‫ד' בתשרי התש"ע‬
A61B )2009.01(
‫מכשיר להחדרה לחלל הפה ומכשיר‬
‫להסתכלות בלוע‬
196236
METHOD AND SYSTEM FOR
AUTOMATICALLY PERFORMING A
STUDY OF A MULTIDIMENSIONAL
SPACE
SAM STATHIS
US
60/805983
28/06/2006
C07C )2009.01(
‫תהליך להכנת ציקלופרופילאמינים‬
‫פעילים אופטית‬
196235
26/06/2007
C07C )2009.01(
G06F )2009.01(
‫שיטה ומערכת לביצוע אוטומטי של לימוד‬
‫מרחב רב מימדי‬
139
11/766672
US
PCT/US/2007/072134
WO/2008/002918
21/06/2007
11/06/2007
ARRANGEMENT FOR DETERMINING
THE OPERATIONAL CHARACTERISTICS
OF A HIGH-FREQUENCY POWER
AMPLIFIER
ROHDE & SCHWARZ GMBH & CO. KG
DE
102006031053.5 05/07/2006
PCT/EP/2007/005133
WO/2008/003385
01/06/2007
G01R )2009.01(
‫התקן לקביעת מאפיינים תפעוליים של‬
‫מגבר כוח לתדירות גבוהה‬
G11C )2009.01(
196239
METHOD OF ERROR CORRECTION IN
A MULTI-BIT-PER-CELL FLASH
MEMORY
140
‫התקן לקביעת מאפיינים תפעוליים של‬
‫מגבר כוח לתדירות גבוהה‬
196238
ARRANGEMENT FOR DETERMINING
THE OPERATIONAL CHARACTERISTICS
OF A HIGH-FREQUENCY POWER
AMPLIFIER
ROHDE & SCHWARZ GMBH & CO. KG
DE
102006031046.2 05/07/2006
PCT/EP/2007/004887
WO/2008/003376
04/07/2007
G01R )2009.01(
196237
‫שיטה לתיקון טעות בזיכרון פלאש רב‬
‫ביטים לתא‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
RAMOT AT TEL AVIV UNIVERSITY
LTD.
US
60/806534
04/07/2006
11/607945
04/12/2006
US
PCT/IL/2007/000830
WO/2008/004226
19/07/2006
196240
FLUID FLOW LABYRINTH
NETAFIM LTD.
WO
PCT/IB2006/052473
PCT/IB/2006/052473
WO/2008/010026
‫מעבר זרימה טורבולנטי‬
‫נטפים בע"מ‬
19/07/2006
29/06/2007
196241
A METHOD FOR DETECTING
NUCLEIC ACIDS
ROSETTA GENOMICS LTD.
US
60/806404
30/06/2006
60/822371
14/08/2006
US
60/850455
10/10/2006
US
60/871095
20/12/2006
US
PCT/IB/2007/003732
WO/2008/029295
28/06/2007
196242
INTRADERMAL NEEDLE-LESS
INJECTION DEVICE
PERF-ACTION TECHNOLOGIES LTD.
US
60/816866
28/06/2006
60/907564
09/04/2007
US
September 22, 2009
A01G )2009.01(
–‫ד' בתשרי התש"ע‬
C12Q )2009.01(
‫שיטה לקביעת חומצות גרעין‬
‫רוזטה ג'נומיקס בע"מ‬
A61M )2009.01(
‫התקן הזרקה תת–עורי ללא מחט‬
141
PCT/IL/2007/000796
WO/2008/001378
13/07/2007
FUSED HETEROCYCLIC
DERIVATIVES AND METHODS OF
USE
AMGEN INC.
US
60/830882
14/07/2006
PCT/US/2007/016068
WO/2008/008539
14/12/2001
142
H04L )2009.01(
‫הפקה ויישום פרוטוקול וממשך תקשורת‬
‫להעברת אות בקצב נתונים גבוה‬
H04L )2009.01(
196245
GENERATING AND IMPLEMENTING
A COMMUNICATION PROTOCOL
AND INTERFACE FOR HIGH DATA
RATE SIGNALTRANSFER
QUALCOMM INCORPORATED
US
60/255833
15/12/2000
PCT/US/2001/047807
WO/2002/049314
14/12/2001
‫נגזרות הטרוציקליות מאוחות ושיטות‬
‫שימוש‬
196244
GENERATING AND IMPLEMENTING
A COMMUNICATION PROTOCOL
AND INTERFACE FOR HIGH DATA
RATE SIGNALTRANSFER
QUALCOMM INCORPORATED
US
60/255833
15/12/2000
PCT/US/2001/047807
WO/2002/049314
14/12/2001
C07D )2009.01(
196243
‫הפקה ויישום פרוטוקול וממשך תקשורת‬
‫להעברת אות בקצב נתונים גבוה‬
H04L )2009.01(
196246
September 22, 2009
–‫ד' בתשרי התש"ע‬
GENERATING AND IMPLEMENTING
A COMMUNICATION PROTOCOL
AND INTERFACE FOR HIGH DATA
RATE SIGNALTRANSFER
QUALCOMM INCORPORATED
US
60/255833
15/12/2000
PCT/US/2001/047807
WO/2002/049314
14/12/2001
‫הפקה ויישום פרוטוקול וממשך תקשורת‬
‫להעברת אות בקצב נתונים גבוה‬
196247
GENERATING AND IMPLEMENTING
A COMMUNICATION PROTOCOL
AND INTERFACE FOR HIGH DATA
RATE SIGNALTRANSFER
QUALCOMM INCORPORATED
US
60/255833
15/12/2000
PCT/US/2001/047807
WO/2002/049314
09/07/2007
‫הפקה ויישום פרוטוקול וממשך תקשורת‬
‫להעברת אות בקצב נתונים גבוה‬
196248
SECURE HEAD-UP DISPLAY
THALES
FR
0606308
11/07/2006
PCT/EP/2007/056951
WO/2008/006798
25/06/2007
196249
SHUT-OFF DEVICE
FRIATEC AKTIENGESELLSCHAFT
Country
Number
Date
International application number
September 22, 2009
–‫ד' בתשרי התש"ע‬
H04L )2009.01(
G01C )2009.01(
‫תצוגת התראות בטיחות‬
F16K )2009.01(
‫התקן סגירה‬
143
International publication number
23/07/2007
C10M )2009.01(
196250
‫תכשיר לסיכה‬
LUBRICANT COMPOSITION
CIBA HOLDING INC.
US
60/834383
31/07/2006
PCT/EP/2007/057552
WO/2008/015116
30/07/2007
SOLUBLE EPOXIDE HYDROLASE
INHIBITORS
ARETE THERAPEUTICS, INC.
US
60/834902
01/08/2006
PCT/US/2007/074763
WO/2008/016884
11/07/2007
C12N )2009.01(
‫תהליך ייצור גליקופרוטאינים‬
G06K )2009.01(
196253
SPECTRAL BIOMETRICS SENSOR
TODD DOUCET
US
11/458607
19/07/2006
11/458619
19/07/2006
US
PCT/US/2007/073886
WO/2008/111994
144
‫מעכבי אפוקסיד הידרוקסילאז מסיסים‬
196252
PRODUCTION OF GLYCOPROTEINS
WYETH
US
60/830658
13/07/2006
PCT/US/2007/015767
WO/2008/008360
19/07/2007
A61K )2009.01(
196251
‫חיישן ביומטריה ספקטראלי‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
19/07/2007
196254
MULTIBIOMETRIC MULTISPECTRAL
IMAGER
LUMIDIGM, INC.
US
60/832233
19/07/2006
PCT/US/2007/073894
WO/2008/100329
30/07/2007
196255
SPATIAL-SPECTRAL FINGERPRINT
SPOOF DETECTION
LUMIDIGM, INC.
US
11/461244
31/07/2006
11/461253
31/07/2006
US
PCT/US/2007/074747
WO/2008/108871
13/07/2007
196256
4-AMINO-4-OXOBUTANOYL
PEPTIDES AS INHIBITORS OF VIRAL
REPLICATION
ACHILLION PHARMACEUTICALS,
INC.
US
60/830488
13/07/2006
60/945786
22/06/2007
US
PCT/US/2007/016018
WO/2008/008502
17/07/2007
196257
CALCANEAL PLATE
ORTHO-HELIX SURGICAL DESIGNS,
INC.
September 22, 2009
–‫ד' בתשרי התש"ע‬
G06K )2009.01(
‫סורק מולטי ביומטרי מולטי ספקטראלי‬
G06K )2009.01(
‫חשיפת תרמית טביעת אצבע‬
‫ספקטראלית–מרחבית‬
C07K )2009.01(
‫–אוקסובוטאנואילים‬4–‫–אמינו‬4 ‫פפטידים‬
‫כמעכבי שכפול ויראלי‬
A61B )2009.01(
‫פלטת עצם העקב‬
145
US
60/831647
60/880910
US
11/879118
US
PCT/US/2007/016185
WO/2008/011018
29/06/2007
18/07/2006
17/01/2007
16/07/2007
‫תוית ניתנת לזיהוי של חומצה נוקלאית‬
DETECTABLE NUCLEIC ACID TAG
AMBIT BIOSCIENCES CORPORATION
US
60/806422
30/06/2006
PCT/US/2007/015089
WO/2008/005310
06/07/2007
‫עמידות בפני קימחון אבקי והיעדר‬
SATIVUS CUCUMIS–‫נמק ב‬
H01Q )2009.01(
196261
MULTI-ANTENNA SYSTEM FOR
DIFFERENTIAL WIRELESS
COMMUNICATION DEVICES
IN4TEL LTD.
US
60/817380
30/06/2006
PCT/IL/2007/000807
WO/2008/001384
146
C12N )2009.01(
196260
RESISTANCE TO POWDERY MILDEW AND
ABSENCE OF NECROSIS IN CUCUMIS
SATIVUS
ENZA ZADEN BEHEER B.V.
EP
PCT/EP2006/064033 07/07/2006
PCT/EP/2007/056911
WO/2008/003783
28/06/2007
C12Q )2009.01(
196258
‫מערכת מרובת אנטנות למכשירי תקשורת‬
‫אלחוטית משתנים‬
‫ טל בע"מ‬4 ‫אין‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
30/06/2006
196262
SURVEILLANCE METHOD AND
SYSTEM USING OBJECT BASED
RULE CHECKING
ULTRAWAVES DESIGN HOLDING
B.V.
G08B )2009.01(
‫שיטה ומערכת למעקב על בסיס בקרת‬
‫תנאי מבוסס אובייקטים‬
PCT/NL/2006/050160
WO/2008/002128
28/06/2007
196263
SYSTEM AND METHOD FOR
MANAGEMENT OF PROPERTY DATA
AND PROCESSES
ZAID ORNIR LTD
US
60/817559
29/06/2006
PCT/IL/2007/000789
WO/2008/001372
29/12/2008
196264
A ZIPPER SYSTEM WITH 3 SETS OF
TEETH
CHAGIM NEHALIM LTD.
September 22, 2009
–‫ד' בתשרי התש"ע‬
B65D )2009.01(
A61B )2009.01(
‫ מערכות שיניים‬3 ‫רוכסן בעל‬
‫חגים נחלים בע"מ‬
196266
A FOLDED CUSHION FOR BACK
SUPPORT
‫אורניב בע"מ‬-‫זייד‬
‫ ייצור מוצרי אריזה‬-1990 ‫ימ"א‬
196265
30/12/2008
‫שיטה ומערכת לניהול מידע ותהליכים‬
‫לנכסים‬
‫קופסה בעלת פינות מחוזקות‬
BOX WITH REINFORCED CORNERS
IMA 1990-PACKAGING PRODUCTS
MANUFACTURE
30/12/2008
G06Q )2009.01(
A61B )2009.01(
‫כרית תמיכה מתקפלת לגב‬
147
‫מיכל טייכמן‬
MICHAL TAICHMAN
27/07/2007
INDOLE DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
MITSUBISHI TANABE PHARMA
CORPORATION
US
60/820604
27/07/2006
60/886178
23/01/2007
US
PCT/JP/2007/065213
WO/2008/013322
11/07/2007
C07H )2009.01(
196267
‫תולדות אינדול ותכשירי רוקחות המכילים‬
‫אותן‬
C12N )2009.01(
196268
‫שיטות בדיקה‬
ASSAY METHODS
TRELLIS BIOSCIENCES, INC.
US
60/830507
12/07/2006
60/839174
21/08/2006
US
60/848112
29/09/2006
US
60/911483
12/04/2007
US
PCT/US/2007/073293
WO/2008/008858
03/08/2007
PROCESS FOR PREPARING
CLOPIDOGREL BISULPHATE
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
148
C07D )2009.01(
196270
‫תהליך להכנת קלופידוגרל ביסולפאט‬
‫טבע תעשיות פרמצבטיות בע"מ‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
US
60/835551
60/858127
US
60/877987
US
PCT/US/2007/017324
WO/2008/019053
03/08/2006
09/11/2006
28/12/2006
09/11/2006
196272
SOLID COMPOSITIONS COMPRISING
TADALAFIL AND AT LEAST ONE
CARRIER
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/819215
07/07/2006
PCT/US/2006/043664
WO/2008/005039
10/07/2006
196273
STABLE FORMULATION
COMPRISING A COMBINATION OF A
MOISTURE SENSITIVE DRUG AND A
SECOND DRUG AND
MANUFACTURING PROCEDURE
THEREOF
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
A61K )2009.01(
‫תרכובות מוצקות המכילות טדלפיל‬
‫ולפחות נשא אחד‬
‫טבע תעשיות פרמצבטיות בע"מ‬
A61K )2009.01(
‫פורמולציה יציבה המכילה שילוב של‬
‫תרופה רגישה ללחות ותרופה נוספת‬
‫ותהליך הכנתה‬
‫טבע תעשיות פרמצבטיות בע"מ‬
PCT/US/2006/026899
WO/2008/008057
07/08/2007
September 22, 2009
196274
–‫ד' בתשרי התש"ע‬
C07C )2009.01(
149
AMINO ALCOHOL DERIVATIVE AND
IMMUNOSUPPRESSIVE AGENT
HAVING SAME AS AN ACTIVE
INGREDIENT
KYORIN PHARMACEUTICAL CO.,
LTD.
2006JP
08/08/2006
215281
PCT/JP/2007/065426
WO/2008/018447
07/08/2007
S1P ‫תולדות אמינו פוספאט וקולטן מאפנן‬
‫בעל מרכיב פעיל זהה‬
150
A61B )2009.01(
196277
METHODS, COMPOSITIONS,, UNIT
DOSAGE FORMS, AND KITS FOR
PHARMACOLOGIC STRESS TESTING
WITH REDUCED SIDE EFFECTS
ADENOBIO N.V.
US
60/818928
05/07/2006
11/772684
02/07/2007
US
PCT/EP/2007/005923
WO/2008/003479
12/06/2007
C07F )2009.01(
196275
AMINO PHOSPHATE DERIVATIVE
AND S1P RECEPTOR MODULATOR
HAVING SAME AS AN ACTIVE
INGREDIENT
KYORIN PHARMACEUTICAL CO.,
LTD.
2006JP
08/08/2006
215280
PCT/JP/2007/065397
WO/2008/018427
04/07/2007
‫תולדות אמינו אלכוהולית וגורם‬
‫אימיונוסופרסיבי בעל מרכיב פעיל זהה‬
‫ צורות ליחידת מנה‬,‫ תכשירים‬,‫שיטות‬
‫וערכות בעלי תופעות לוואי מופחתות‬
‫לבדיקת לחץ פרמקולוגי‬
A61K )2009.01(
196280
September 22, 2009
–‫ד' בתשרי התש"ע‬
USE OF AMPK-ACTIVATING
IMIDAZOLE DERIVATIVES,
PREPARATION PROCESS THEREFOR
AND PHARMACEUTICAL
COMPOSITIONS COMPRISING THEM
MERCK PATENT GMBH
FR
06/06415
13/07/2006
PCT/EP/2007/005164
WO/2008/006432
04/07/2007
,AMPK ‫שימוש בנגזרות אימידזול מפעילות‬
‫תהליך להכנתן ותכשירים המכילים אותן‬
196282
COMPOSITIONS AND METHODS FOR
ENHANCING THE EFFICACY OF IL-2
MEDIATED IMMUNE RESPONSES
MERCK PATENT GMBH
US
60/818741
06/07/2006
60/856139
02/11/2006
US
PCT/EP/2007/005904
WO/2008/003473
29/06/2007
196283
SYSTEM AND METHOD FOR
COLLECTING NETWORK
PERFORMANCE INFORMATION
EMBARQ HOLDINGS COMPANY LLC
US
11/479751
30/06/2006
60/839333
22/08/2006
US
11/583288
19/10/2006
US
11/583765
19/10/2006
US
60/897543
26/01/2007
US
60/905624
07/03/2007
US
60/922246
05/04/2007
US
11/809536
31/05/2007
US
PCT/US/2007/015311
WO/2008/097254
September 22, 2009
–‫ד' בתשרי התש"ע‬
A61K )2009.01(
‫תכשירים ושיטות להגברת היעילות של‬
IL2 ‫תגובות חיסוניות מתווכות על ידי‬
H04L )2009.01(
‫מערכת ושיטה לאיסוף מידע על ביצועי‬
‫רשת‬
151
29/06/2007
SYSTEM AND METHOD FOR
ADJUSTING CODEC SPEED IN A
TRANSMISSION PATH DURING CALL
SET-UP DUE TO REDUCED
TRANSMISSION PERFORMANCE
EMBARQ HOLDINGS COMPANY LLC
US
11/479751
30/06/2006
60/839333
22/08/2006
US
11/583288
19/10/2006
US
11/583765
19/10/2006
US
60/897543
26/01/2007
US
60/905624
07/03/2007
US
60/922246
05/04/2007
US
11/809882
31/05/2007
US
PCT/US/2007/015299
WO/2008/030292
29/06/2007
‫מערכת ושיטה להתאמת מהירות‬
‫מפענח בערוץ שידור במהלך ביסוס‬/‫מקודד‬
‫תקשורת עקב ביצועי שידור פחותים‬
H04J )2009.01(
196285
SYSTEM AND METHOD FOR
MANAGING SUBSCRIBER USAGE OF
A COMMUNICATIONS NETWORK
EMBARQ HOLDINGS COMPANY LLC
US
11/479751
30/06/2006
60/839333
22/08/2006
US
11/583288
19/10/2006
US
11/583765
19/10/2006
US
152
H04L )2009.01(
196284
‫שיטה ומערכת לניהול שימוש מנוי ברשת‬
‫תקשורות‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
60/897543
US
60/905624
US
60/922246
US
11/809405
US
PCT/US/2007/015252
WO/2008/005393
26/01/2007
07/03/2007
05/04/2007
31/05/2007
04/07/2006
196288
METHOD AND DEVICE FOR
RETRIEVING INFORMATION FROM
AN OPTICAL RECORD CARRIER AT
VARIOUS READING SPEEDS
KONINKLIJKE PHILIPS
ELECTRONICS N.V.
G11B )2009.01(
‫שיטה והתקן לאחזור מידע מנשא רשומה‬
‫אופטית במהירויות קריאה מגוונות‬
PCT/IB/2006/052246
WO/2008/004032
02/07/2007
196289
BENZIMIDAZOLE CANNABINOID
AGONISTS BEARING A
SUBSTITUTED HETEROCYCLIC
GROUP
JANSSEN PHARMACEUTICA NV
EP
06116564.3 04/07/2006
PCT/EP/2007/056619
WO/2008/003665
31/12/2008
196290
INLINE FLUID CONTROL DEVICE
MEDIMOP MEDICAL PROJECTS LTD.
September 22, 2009
–‫ד' בתשרי התש"ע‬
A61K )2009.01(
‫בנזימידאזולים אגוניסטים לקנאבינואיד‬
‫בעלי קבוצה הטרוציקלית מותמרת‬
A61B )2009.01(
‫התקן לבקרת נוזלים בקו ישר‬
‫מדימופ פרויקטים רפואיים בע"מ‬
153
31/12/2008
MEASUREMENT EQUIPMENT FOR
MEASURING ACCOMMODATING
INTRAOCULAR LENSES
NULENS LTD.
05/07/2007
‫ציוד מדידה למדידת עדשות תוך עיניות‬
‫מסתגלות‬
‫ניולנס בע"מ‬
C07K )2009.01(
196292
CSF3R POLYPEPTIDES, THEIR
PREPARATION AND USES THEREOF
LABORATOIRES SERONO SA
EP
06116704.5 06/07/2006
60/832177
19/07/2006
US
PCT/EP/2007/056846
WO/2008/003763
31/12/2008
H01B )2009.01(
196291
‫ הכנתם והשימוש‬CRF3R ‫פוליפפטידים‬
‫בהם‬
B65D )2009.01(
196293
‫נשא בקבוקים‬
‫אלעד יעקב אגבר‬
BOTTLE HOLDER
ELAD J. EGBER
05/07/2007
AUTOMATIC GENERATION OF
VIDEO FROM STRUCTURED
CONTENT
SUNDAYSKY LTD.
US
60/806626
06/07/2006
PCT/IL/2007/000843
WO/2008/004237
154
G11B )2009.01(
196294
‫יצירה אוטומטית של מידע חוזי מתוכן‬
) CONTENT STRUCTURED( ‫מובנה‬
‫סנדייסקי בע"מ‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
05/07/2007
H04N )2009.01(
196295
‫יצירה אוטומטית של מידע חוזי מתוכן‬
‫מובנה‬
)CONTENT STRUCTURED (
AUTOMATIC GENERATION OF
VIDEO FROM STRUCTURED
CONTENT
SUNDAYSKY LTD.
US
60/806626
PCT/IL/2007/000842
WO/2008/004236
‫סנדייסקי בע"מ‬
06/07/2006
03/07/2007
196296
MANUFACTURE, METHOD, AND USE
OF ACTIVE SUBSTANCE-RELEASING
MEDICAL PRODUCTS FOR
PERMANENTLY KEEPING BLOOD
VESSELS OPEN
HEMOTEQ AG
DE
102006030586.8 03/07/2006
PCT/DE/2007/001173
WO/2008/003298
05/07/2007
196297
AIRCRAFT BRAKING CONTROL
MEGGITT AEROSPACE LIMITED
GB
0613286.4
05/07/2006
PCT/GB/2007/002513
WO/2008/003971
07/07/2006
196298
AN ENANTIOSELECTIVE SYSTHESIS
OF PYRROLIDINE-SUBSTITUTED
FLAVONES. AND INTERMEDIATES
THEREOF
PIRAMAL LIFE SCIENCES LIMITED
September 22, 2009
–‫ד' בתשרי התש"ע‬
A61L )2009.01(
‫ שיטה ושימוש של מתקנים‬, ‫ייצור‬
‫רפואיים המוציאים חומרים לשם קיום‬
‫כלי–דם פתוחים באופן קבוע‬
B64C )2009.01(
‫בקר בלימת כלי טייס‬
C07D )2009.01(
‫סינתזה אננטיו–סלקטיבית של פלבונים‬
‫ ותיווכיהם‬,‫מותמרים בפירולידין‬
155
PCT/IB/2006/052294
WO/2008/007169
23/05/2001
MEDICAMENT FOR THE
TREATMENT OF HAPATITIS C
UNIVERSITA DEGLI STUDI DI
CAGLIARI
US
60/206585
23/05/2000
PCT/US/2001/016671
WO/2001/090121
02/07/2007
07/08/2007
C07D )2009.01(
‫תיאופנים מותמרים בפיראזולאלקנאמיד‬
‫כריאגנטים המגבירים תגובה מתווכת על‬
AMPA ‫ידי קולטני‬
04/07/2006
C07D )2009.01(
196303
PURIFICATION PROCESS OF
MONTELUKAST AND ITS AMINE
SALTS
ESTEVE QUIMICA, S.A.
EP
06118690.4 09/08/2006
60/836856
09/08/2006
US
PCT/EP/2007/058180
156
C ‫תכשיר רפואי לטיפול בצהבת מסוג‬
196302
PYRAZOLEALKANAMIDE
SUBSTITUTED THIOPHENES AS
AMPA POTENTIATORS
N.V. ORGANON
EP
06116592.4
PCT/EP/2007/005851
WO/2008/003452
C12N )2009.01(
196301
‫תהליך לטיהור מונטלוקסט ומלחיו‬
‫האמינים‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
WO/2008/017669
03/08/2007
196304
‫תקשורת אל–חוטית המבוססת על‬
‫פורמאט רשת‬
WEB FORMAT-BASED WIRELESS
COMMUNICATIONS
MICROSOFT CORPORATION
US
11/465328
17/08/2006
PCT/US/2007/017417
WO/2008/021032
11/07/2007
196305
A METHOD AND APPARATUS FOR
MANUFACTURING A
TRANSVERSELY ORIENTED FILM OF
THERMOPLASTIC POLYMER
MATERIAL AND PRODUCTS
OBTAINABLE BY THE SAME MTHOD
OLE-BENDT RASMUSSEN
GB
0613969.5
13/07/2006
PCT/EP/2007/057119
WO/2008/006858
31/07/2007
September 22, 2009
–‫ד' בתשרי התש"ע‬
B29C )2009.01(
‫שיטה ומערכת לייצור פילם מונחה רוחבית‬
‫של חומר פולימרי תרמופלסטי ומוצרים‬
‫המתקבלים ע"י השיטה‬
196306
AQUEOUS SOLUTIONS OF OPTICAL
BRIGHTENERS
CLARIANT FINANCE (BVI) LIMITED
EP
06118570.8 08/08/2006
PCT/EP/2007/057909
WO/2008/017623
H04L )2009.01(
C08L )2009.01(
‫תמיסות מימיות של מבהירים אופטיים‬
157
02/07/2007
INHIBITION OF ALPHA-SYNUCLEIN
AGGREGATION
ZAPALOID LIMITED
US
60/806511
03/07/2006
PCT/GB/2007/002469
WO/2008/003943
31/12/2008
158
B65D )2009.01(
‫שיטה ומערכת לאריזה הכוללת חריצים‬
‫שנעשו באמצעות לייזר‬
H01B )2009.01(
196311
PLAYHOUSE HAVING
PHOTOVOLTAIC CELL FOR
POWERING ELECTRICAL
COMPONENTS THEREOF
TOYMONSTER INTELLECTUAL
PROPERTY LIMITED
31/12/2008
‫עיכוב הצטברות אלפא–סינוקלין‬
196309
METHOD AND APPARATUS FOR
LASER SCORED PACKAGING
KRAFT FOODS GLOBAL BRANDS
LLC
US
11/969680
04/01/2008
31/12/2008
C07K )2009.01(
196307
‫בית משחק בעל תא פוטוולטאי עבור‬
‫הספקת כוח לרכיבים חשמליים בו‬
G02B )2009.01(
196312
September 22, 2009
–‫ד' בתשרי התש"ע‬
LUMINESCENT SOLAR
CONCENTRATORS
GREEN-SUN ENERGY LTD.
05/07/2007
‫מרכז קרני שמש זוהר‬
‫גירין סאן אנרגי בע"מ‬
196313
PHENYL SUBSTITUTED
HETEROARYL-DERIVATIVES AND
USE THEREOF AS ANTI-TUMOR
AGENTS
BOEHRINGER INGELHEIM PHARMA
GMBH & CO. KG
EP
06116826.6 07/07/2006
PCT/EP/2007/056860
WO/2008/003770
05/07/2007
196314
PROTEASE SCREENING METHODS
AND PROTEASES IDENTIFIED
THEREBY
TORREY PINES INSTITUTE FOR
MOLECULAR STUDIES
US
60/818804
05/07/2006
60/818910
05/07/2006
US
PCT/US/2007/015571
WO/2008/045148
03/07/2007
196315
MEDICAMENT FOR THE
ENHANCEMENT OF COGNITIVE
FUNCTION AND
NEUROPROTECTION
EGIS GYOGYSZERGYAR Nyilvanosan
Mukodo Reszvenytarsasag
September 22, 2009
–‫ד' בתשרי התש"ע‬
A61K )2009.01(
‫תולדות הטרואריליות מותמרות בפניל‬
‫ושימושן כגורמים אנטי–גידולים‬
C12N )2009.01(
‫שיטות לסריקת פרוטיאז ופרוטיאזות‬
‫המזוהות באמצעות השיטות הללו‬
A61K )2009.01(
‫תרופה להגברת התפקוד הקוגניטיבי‬
‫והגנה נוירונית‬
159
HU
P0600555
PCT/HU/2007/000059
WO/2008/004013
01/01/2009
03/07/2006
A METHOD FOR AVOIDING
COLLISIONS AND A COLLISION
AVOIDANCE SYSTEM
ISRAEL AEROSPACE INDUSTRIES
LTD.
US
11/968405
02/01/2008
27/06/2007
‫התעשייה האוירית לישראל בע"מ‬
B64D )2009.01(
‫מכלול עוגן עבור תדלוק בזמן טיסה‬
C07D )2009.01(
196318
(S)-(-)-AMLODIPINE CAMSYLATE
DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING
HANMI PHARM. CO., LTD.
10-2006KR
21/07/2006
0068401
PCT/KR/2007/003444
WO/2008/010659
160
‫שיטה והתקן למניעת התנגשויות‬
196317
DROGUE ASSEMBLY FOR IN-FLIGHT
REFUELLING
FLIGHT REFUELLING LIMITED
GB
0613386.2
05/07/2006
PCT/GB/2007/002410
WO/2008/003933
16/07/2007
G08B )2009.01(
196316
‫)–(–)–אמלודיפין קמסילט‬S( ‫תולדות‬
‫ותכשירי רוקחות המכילים אותן‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
13/07/2007
196319
METHODS FOR DETERMINING A
HUMAN SUBJECT'S PROPENSITY TO
DEVELOP A VASCULAR DISORDER
UNIVERSITY OF IOWA RESEARCH
FOUNDATION
US
60/831018
13/07/2006
60/840073
23/08/2006
US
PCT/US/2007/073514
WO/2008/008986
18/07/2007
16/07/2007
–‫ד' בתשרי התש"ע‬
C07D )2009.01(
‫–אתילקווינולונים‬N ‫תולדות ואנאלוגים של‬
‫–אתילאזאקווינולונים‬N–‫ו‬
196321
PYRAZOLES AS GLUCOKINASE
ACTIVATORS
F. HOFFMANN-LA ROCHE AG
US
60/832907
24/07/2006
60/930819
18/05/2007
US
PCT/EP/2007/057315
WO/2008/012227
September 22, 2009
‫שיטות לקביעת נטיה מוקדמת של אדם‬
‫לפיתוח הפרעה וסקולרית‬
196320
DERIVATIVES AND ANALOGS OF NETHYLQUINOLONES AND NETHYLAZAQUINOLONES
GLAXO GROUP LIMITED
US
60/807850
20/07/2006
60/913057
20/04/2007
US
07381041.8
18/05/2007
EP
PCT/EP/2007/057422
WO/2008/009700
C07K )2009.01(
C07D )2009.01(
‫פיראזולים כמשפעלי גלוקוקינאז‬
161
04/07/2007
IMPROVED PROCESS FOR THE
CULTURING OF CELLS
DSM IP ASSETS B.V.
EP
06014671.9 14/07/2006
07002571.3
06/02/2007
EP
PCT/EP/2007/005915
WO/2008/006494
17/07/2007
C07D )2009.01(
‫תרכובות ספירופיפרידין טריציקליות‬
‫ ייצורן ושימושן כמאפננים של‬,‫חדשות‬
‫פעילות רצפטור לכימוקין‬
C07D )2009.01(
196324
PROCESS FOR MANUFACTURING
3(R)-(2-HYDROXY-2,2-DITHIEN-2YLACETOXY)-1-(3PHENOXYPROPYL)-1AZONIABICYCLO[2.2.2]OCTANE
BROMIDE
LABORATORIOS ALMIRALL, S.A.
ES
P200601951 21/07/2006
PCT/EP/2007/006278
WO/2008/009397
162
‫תהליך משופר לגידול תאים בתרבית‬
196323
NOVEL TRICYCLIC
SPIROPIPERIDINE COMPOUNDS,
THEIR SYNTHESIS AND THEIR USES
AS MODULATORS OF CHEMOKINE
RECEPTOR ACTIVITY
ASTRAZENECA AB
US
60/831776
19/07/2006
PCT/SE/2007/000694
WO/2008/010765
16/07/2007
C12M )2009.01(
196322
–2,2–‫–הידרוקסי‬R)–(2(3 ‫תהליך לייצור‬
–3(–1–)‫–ילאצטוקסי‬2–‫דיתיאנ‬
–1–)‫פנוקסיפרופיל‬
‫]אוקטן ברומיד‬2.2.2[‫אזוניאביציקלו‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
16/04/2007
B01D )2009.01(
196325
OIL SHALE DERIVED POLLUTANT
CONTROL MATERIALS AND
METHODS AND APPARATUSES FOR
PRODUCING AND UTILIZING THE
SAME
BATTELLE ENERGY ALLIANCE, LLC
US
11/460547
27/07/2006
PCT/US/2007/066709
WO/2008/014027
06/07/2007
‫שמן צפחה המופק מחומרי פיקוח זיהום‬
‫ושיטות ומכשירים להפקתו ושימוש בו‬
196326
LUNG CANCER DIAGNOSTIC ASSAY
UNIVERSITY OF KENTUCKY RESEARCH
FOUNDATION
US
60/806778
08/07/2006
US
PCT/US2006/060796 10/11/2006
PCT/US/2007/072943
WO/2008/008708
17/07/2007
196327
ASYMMETRIC HYDROGENATION OF
1,1,1-TRIFLUOROACETONE
F. HOFFMANN-LA ROCHE AG
EP
06117928.9 27/07/2006
PCT/EP/2007/057372
WO/2008/012240
01/01/2009
September 22, 2009
196328
–‫ד' בתשרי התש"ע‬
G01N )2009.01(
‫בדיקה לאבחון סרטן ריאות‬
C07C )2009.01(
–1,1,1 ‫הידרוגנציה אסימטרית של‬
‫טריפלואורואצטון‬
E02B )2009.01(
163
LOCK WITH EMERGENCY
UNLOCKING MECHANISM
HOMEGATE LTD
13/07/2007
‫מנעול עם מנגנון פתיחת חרום‬
‫הומגייט בע"מ‬
A NOVEL POPULATION OF
MULTIPOTENT CARDIAC PRECURSOR
CELLS DERIVED FROM HUMAN
BLASTOCYSTS DERIVED STEM CELLS
CELLARTIS AB
DK
PA200600970
60/830334
US
PCT/EP/2007/006239
WO/2008/006605
11/07/2007
164
C07D )2009.01(
196330
A2A ‫תולדות פורין כאגוניסטים של‬
A61K )2009.01(
196331
METHOD OF IMMUNIZATION
AGAINST THE FOUR SEROTYPES OF
DENGUE
SANOFI PASTEUR
FR
0606324
12/07/2006
60/829361
13/10/2006
US
PCT/FR/2007/051641
WO/2008/007021
01/01/2009
‫אוכלוסיית תאים מולטיפוטנטיים‬
‫פרקורסורים של הלב שמופקים‬
‫מבלסטוציטים אנושיים שהופקו מתאי‬
‫גזע‬
13/07/2006
13/07/2006
PURINE DERIVATIVES AS A2A
AGONISTS
NOVARTIS AG
EP
06117168.2 13/07/2006
PCT/EP/2007/006156
WO/2008/006563
11/07/2007
C12N )2009.01(
196329
‫שיטה לחיסון כנגד ארבע סרוטיפים של‬
‫דנגה‬
B32B )2009.01(
196332
September 22, 2009
–‫ד' בתשרי התש"ע‬
COMPOSITION FOR CONSTRUCTION
ELEMENTS
MOSHE YANAI
06/07/2007
‫תרכובות ליסודות בניה‬
‫משה ינאי‬
196333
METHOD AND SYSTEMS FOR
LOCATING A SOURCE OF PARTICLE,
MOLECULE, OR FRAGMENT OF
MOLECULE
MASSIMO VERGASSOLA
US
11/481944
07/07/2006
06291133.4
07/07/2006
EP
PCT/IB/2007/003059
WO/2008/007225
01/01/2009
‫שיטה ומערכות עבור איתור מקור של‬
‫ מולקולה או פרגמנט של מולקולה‬,‫חלקיק‬
196334
SELECTIVE REJECTION OF TOUCH
CONTACTS IN AN EDGE REGION OF
A TOUCH SURFACE
APPLE INC.
US
61/019220
04/01/2008
12/242772
30/09/2008
US
05/07/2007
01/01/2009
September 22, 2009
C07D )2009.01(
‫–דיאונים מותמרים בעמדות‬2 ,1–‫ציקלובוטן‬
‫–כמוקין‬CXC ‫ כליגנדים של קולטן‬4–‫ ו‬3
196336
–‫ד' בתשרי התש"ע‬
A61B )2009.01(
‫פסילה סלקטיבית של מגעים באזורי‬
‫השוליים של משטח מגע‬
196335
3,4-DI-SUBSTITUTED
CYCLOBUTENE-1,2-DIONES AS CXCCHEMOKINE RECEPTOR LIGANDS
SCHERING CORPORATION
US
60/819541
07/07/2006
PCT/US/2007/015671
WO/2008/005570
G05D )2009.01(
A62B )2009.01(
165
THREE-DIMENSIONAL IMAGE
RECONSTRUCTION USING DOPPLER
ULTRASOUND
BIOSENSE WEBSTER, INC.
US
11/969504
04/06/2008
06/07/2007
‫בניה מחדש של תמונה תלת מימדית‬
‫בעזרת אולטרה–סאונד דופלר‬
‫מעכבי טירוזין קינאז‬
TYROSINE KINASE INHIBITORS
MERCK & CO., INC.
US
60/819764
10/07/2006
PCT/US/2007/015675
WO/2008/008310
04/01/2009
"‫"ממזער קרינה סלולרית" "עצלן אלחוטי‬
COLLECTING SHEATH AND
METHOD OF USE THEREOF
166
G08B )2009.01(
‫מערכת אזעקה נגד פריצה וחיישן‬
‫רועי פרטס‬
A22C )2009.01(
196343
BONE FRACTURE DETECTION
SOREQ NUCLEAR RESEARCH
CENTER ISRAEL ATOMIC ENERGY
COMMISSION
US
61/006259
03/01/2008
05/07/2007
‫אמנון רוזן‬
196342
A BURGLARY ALARM SYSTEM AND
SENSOR
ROEI PORTAS
04/01/2009
H04B )2009.01(
196339
CELLULAR RADIATION REDACTOR
WIRELESS INDOLENT
AMNON ROZEN
04/01/2009
C07D )2009.01(
196337
‫זיהוי שבר בעצם‬
‫המרכז למחקר גרעיני נחל שורק הועדה‬
‫לאנרגיה אטומית‬
A61M )2009.01(
196344
‫נרתיק איסוף ושיטה לשימוש בו‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
ANGIOSLIDE LTD
US
60/818528
PCT/IL/2007/000844
WO/2008/004238
‫אנג'יוסלייד בע"מ‬
06/07/2006
05/07/2007
A61M )2009.01(
196345
COLLECTING SHEATH AND
METHOD OF USE THEREOF
ANGIOSLIDE LTD
US
60/818529
06/07/2006
PCT/IL/2007/000845
WO/2008/004239
19/06/2007
‫נרתיק איסוף ושיטה לשימוש בו‬
‫אנג'יוסלייד בע"מ‬
196347
PLATE-SHAPED STRUCTURAL
COMPONENT
DUCOSTONE GMBH (GERMANY)
DE
202006010610/3 07/07/2006
202007005496/3
13/04/2007
DE
PCT/DE/2007/000955
WO/2008/003276
05/01/2009
‫רכיב בעל מבנה שטוח‬
196348
HIGH-TORQUE ROTARY RADIAL
INTERNAL COMBUSTION PISTON
ENGINE
LEONID YAKHNIS
05/01/2009
September 22, 2009
–‫ד' בתשרי התש"ע‬
F02B )2009.01(
‫מנוע שריפה פנימית רוטורי בעל מומנט‬
‫גבוה‬
‫יאכניס לאוניד‬
196349
A METHOD OF OBTAINING
ELECTRIC ENERGY BY USING
DALIY ROTATION OF EARTH AND
THE DEVICE FOR ITS
IMPLEMENTATION
VLADIMIR SAKHAROV
E04C )2009.01(
G01V )2009.01(
‫שיטה להפקת אנרגיה חשמלית באמצעות‬
‫סיבוב יומי של כדור הארץ והמתקן ליישום‬
‫שיטה זו‬
‫ולדימיר סחרוב‬
167
05/01/2009
A METHOD TO ENABLE OPTIMIZING
TOWARDS GOALS
CLICKSOFTWARE TECHNOLOGIES
LTD
US
12/344886
29/12/2008
26/07/2007
‫שיטה לייעול תהליכים‬
‫קליקסופטוור טכנולוגיות בע"מ‬
‫פרודראג של תרכובת סינאמיד‬
‫שיטה ומערכת לניבוי זמן העברת מים‬
‫חמים במערכת חימום מים‬
‫גל חיזוי מים בע"מ‬
G01J )2009.01(
196353
MEANS AND METHODS FOR RAPID
DROPLET AND AEROSOLS
INFECTION ANALYSIS
OPTICUL DIAGNOSTICS LTD
168
F24D )2009.01(
196352
METHOD AND SYSTEM FOR
PREDICTING HOT WATER FLOW
DURATION IN A WATER HEATING
SYSTEM
GAL WATER PREDICTIONS LTD.
05/01/2009
C07D )2009.01(
196351
PRODRUG OF CINNAMIDE
COMPOUND
EISAI R&D MANAGEMENT CO., LTD.
2006JP
28/07/2006
206007
60/820761
28/07/2006
US
2006-331274 08/12/2006
JP
60/869259
08/12/2006
US
PCT/JP/2007/064637
WO/2008/013213
05/01/2009
G06F )2009.01(
196350
‫התקן ושיטה לאנליזה מהירה של זיהומים‬
‫אירוסולים‬
‫אופטיקאל דיאגנוסטיקה בע"מ‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
05/01/2009
196354
METHOD FOR SECURING A GOLDEN
ARTICLE TO ROUGH STONE
ABRAHAM YESHAYAHU TABISAL
16/07/2007
‫שיטה לקבע חפץ זהוב לאבן ירושלמית‬
‫אברהם ישעיהו טביסל‬
196355
EP2 AGONISTS
PFIZER PRODUCTS, INC.
US
60/833907
60/941923
US
PCT/IB/2007/002044
WO/2008/015517
A44C )2009.01(
C07D )2009.01(
EP2 ‫אגוניסטים של‬
28/07/2006
04/06/2007
05/07/2007
196358
AN ORAL PHARMACEUTICAL
COMPOSITION OF AN
ANILINOPYRIMIDINE, ITS
PREPARATION AND USE THEREOF
ARES TRADING S.A.
US
60/818831
06/07/2006
06116903.3
10/07/2006
EP
PCT/EP/2007/056859
WO/2008/003769
10/04/2007
‫תכשיר רוקחי למתן דרך הפה של‬
‫ הכנתו ושימושו ברפואה‬,‫אנילינופירימידין‬
196359
CONE-BEAM CT
ARINETA LTD.
A61K )2009.01(
A61B )2009.01(
‫ עם קרן בצורת כונוס‬CT ‫מערכת‬
‫ארינטה בע"מ‬
PCT/IL/2007/000462
WO/2008/122971
September 22, 2009
–‫ד' בתשרי התש"ע‬
169
05/07/2007
METHOD FOR PRODUCING INSULIN
ANALOGS HAVING A DIBASIC B CHAIN
TERMINUS
SANOFI-AVENTIS DEUTSCHLAND
GMBH
DE
102006031955.9 11/07/2006
PCT/EP/2007/005933
WO/2008/006497
10/07/2007
DICARBOXYLIC ACID FOAMABLE
VEHICLE AND PHARMACEUTCAL
COMPOSITIONS THERE OF
FOAMIX LTD
170
A61K )2009.01(
‫שיטות משולבות לטיפול בסרטן‬
‫רמות ליד אוניברסיטת תל אביב בע"מ‬
H01S )2009.01(
196362
OPTICAL APPARATUS
SOREQ NUCLEAR RESEARCH
CENTER
US
60/818303
05/07/2006
PCT/IL/2007/000818
WO/2008/004218
05/07/2007
‫שיטה להפקת אנלוגים של אינסולין‬
‫ עם קצה ובו שתי‬B ‫בעלי שרשרת‬
‫קבוצות חד–ערכיות להתמרה‬
196361
COMBINATION METHODS OF
TREATING CANCER
SEPAL PHARMA LTD.
US
60/819375
10/07/2006
PCT/IL/2007/000863
WO/2008/007367
02/07/2007
C07K )2009.01(
196360
‫מתקן אופטי‬
‫המרכז למחקר גרעיני‬
A61K )2009.01(
196363
‫קצפים כנשאים של חומצות‬
‫דיקרבוקסיליות וישומן כחומרים‬
‫פרמצבטיים‬
‫פואמיקס בע"מ‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
US
60/818634
PCT/IB/2007/003759
WO/2008/038147
05/07/2006
18/06/2007
196364
AMINOINDAZOLYLUREA
DERIVATIVES
MERCK PATENT GMBH
DE
102006033140.0
PCT/EP/2007/005339
WO/2008/009335
‫נגזרות של אמינו אינדזול אוראה‬
18/07/2006
06/01/2009
196365
APPARATUS AND METHOD FOR
TRANSFERRING POWER FROM A
STATIONARY UNIT TO A MOBIL
UNIT
EINAM YIZHAK AMOTZ
US
61/019301
07/01/2008
08/07/2007
18/08/2006
‫עינם יצחק אמוץ‬
–‫ד' בתשרי התש"ע‬
A61B )2009.01(
‫התקן משולב לדגימת ובדיקת דם ושיטה‬
‫לשימוש בו‬
‫רפידאקס בע"מ‬
196367
USE OF HPPD INHIBITORS IN THE
TREATMENT OF DEPRESSION
AND/OR WITHDRAWAL SYMPTOMS
ASSOCIATED WITH ADDICTIVE
DRUGS
SYNGENTA LIMITED
H01R )2009.01(
‫מתקן ושיטה להעברת כח מיחידה נייחת‬
‫ליחידה ניידת‬
196366
INTERGRATED BLOOD SAMPLING
AND TESTING DEVICE AND
METHOD OF USE THEREOF
RAPIDX LTD.
US
60/818541
06/07/2006
PCT/IL/2007/000856
WO/2008/149333
September 22, 2009
A61K )2009.01(
A61K )2009.01(
‫או‬/‫ לטיפול בדיכאון ו‬HPPD ‫שימוש במעכבי‬
‫נסיגת סימפטומים הקשורים לסמים‬
‫ממכרים‬
171
PCT/GB/2006/003099
WO/2008/020150
06/07/2007
‫אנליזה של דוגמאות מח באמצעות מדידות‬
‫זמניות‬
ANALYSIS OF BRAIN PATTERNS
USING TEMPORAL MEASURES
THE REGENTS OF THE UNIVERSITY
OF MINNESOTA
US
60/818931
06/07/2006
60/851599
13/10/2006
US
PCT/US/2007/015545
WO/2008/005513
06/07/2007
A61B )2009.01(
196369
C12N )2009.01(
196370
TEMPERATURE-RESPONSIVE
MICROCARRIER
ORGANOGENESIS INC.
US
60/806679
06/07/2006
PCT/US/2007/015554
WO/2008/005520
06/07/2007
‫מיקרו נשא המגיב לטמפרטורה‬
EFFICIENT PROCESS FOR
PURIFICATION OF HIGH MOLECULAR
WEIGHT HYALURONIC ACID
RELIANCE LIFE SCIENCES PVT. LTD.
IN
1065/MUM/2006 06/07/2006
IN
MUM/2006/1874 13/11/2006
PCT/IN/2007/000289
WO/2008/035372
07/01/2009
172
C12P )2009.01(
196371
‫תהליך יעיל לטיהור חומצה היאלורונית‬
‫בעלת משקל מולקולרי גבוה‬
A63B )2009.01(
196374
September 22, 2009
–‫ד' בתשרי התש"ע‬
PASSIVE TRAINER FOR
REHABILITATING AND TREATING
INCONTINENCE AND METHODS
THEREOF
ELIAHU ELIACHAR
07/01/2009
‫מכשיר אימון פסיבי ושיטה לשיקום חוסר‬
‫איפוק שלאחר ניתוח‬
‫דן שדה הוכשטטר‬
196376
‫אטם משופר לחבקי צינורות‬
IMPROVED PIPE COUPLING SEAL
KRAUSZ INDUSTRIES
DEVELOPMENT LTD.
12/07/2007
‫קראוס תעשיות פיתוח בע"מ‬
196377
‫מוסד הטכניון למחקר ופתוח בע"מ‬
196378
HYDROELECTRIC POWER STATION
AND APPARATUSES AND METHODS
IMPLEMENTED THEREIN
DSME LTD.
31/07/2007
September 22, 2009
–‫ד' בתשרי התש"ע‬
F03B )2009.01(
‫תחנת כוח הידרואלקטרית ומתקנים‬
‫ושיטות המיושמים בה‬
‫אי בע"מ‬.‫ אמ‬.‫ אס‬.‫די‬
196379
RECOMBINANT OR TRANSGENIC
FACTOR VII COMPOUND HAVING A
MAJORITY OF GLYCAN,
BIANTENNARY, BISIALYLATED AND
NON-FUCOSYLATED FORMS
LFB BIOTECHNOLOGIES SOCIETE
PAR ACTIONS SIMPLIFIEE
UNIPERSONNELLE
FR
0607016
01/08/2006
G06F )2009.01(
‫קטגוריזציה של טקסט תוך שימוש בידע‬
‫חיצוני‬
TEXT CATEGORIZATION USING
EXTERNAL KNOWLEDGE
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION LTD.
US
11/457341
13/07/2006
PCT/IL/2007/000881
WO/2008/007379
07/01/2009
F16L )2009.01(
A61K )2009.01(
‫ רקומביננטית או‬VII ‫תרכובת פקטור‬
,‫טרנסגנית עם רוב צורות גליקאן‬
‫ ביסיאלטיות ואל–פוקוסילטיות‬,‫ביאנטנריות‬
173
PCT/FR/2007/001324
WO/2008/015339
25/07/2007
METHOD OF GRINDING AN
INDEXABLE INSERT AND GRINDING
WHEEL FOR CARRYING OUT THE
GRINDING METHOD
ERWIN JUNKER MASCHINENFABRIK
GMBH
DE
102006035845.7 01/08/2006
PCT/EP/2007/057687
WO/2008/015144
04/07/2007
‫שיטה להשחזת אינסרט הניתן למדידה‬
‫וגלגל השחזה לביצוע שיטת ההשחזה‬
,H2–‫טיפול אנטי–סרטני הכולל חוסם‬
‫לפחות גורם אחד אנטי דלקתי וגורם‬
‫ציטוטוקסי‬
‫תילתן פרמה בע"מ‬
G06F )2009.01(
196382
ELECTRONIC CIRCUITRY AND
METHOD FOR DETERMINATION OF
AMPLITUDES OF RECEIVED
SIGNALS
ELTA SYSTEMS LTD.
IL
176788
11/07/2006
PCT/IL/2007/000835
WO/2008/007358
174
A61K )2009.01(
196381
ANTI-CANCER THERAPY
COMPRISING AN H2-BLOCKER, AT
LEAST ONE ANTIINFLAMMATORY
AGENT AND A CYTOTOXIC AGENT
TILTAN PHARMA LTD.
US
60/819164
07/07/2006
60/880107
12/01/2007
US
PCT/IL/2007/000836
WO/2008/004231
04/07/2007
B24B )2009.01(
196380
‫מעגלים חשמליים ושיטה לקביעת עוצמות‬
‫של אותות מתקבלים‬
‫אלתא מערכות בע"מ‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
08/01/2009
196385
PREVENTION AND TREATMENT OF
AGE AND/OR CHRONIC EXCESSIVE
OXIDATIVE STRESS-INDUCED
DISEASES
DR. AHARON HOFFMAN
12/07/2007
‫ עבור מחלות שנגרמו על‬REDOX ‫תרפית‬
OXIDATION ‫ידי‬
‫ד"ר אהרון הופמן‬
196386
SYSTEM AND METHOD FOR
VISUALIZING MUSIC AND OTHER
SOUNDS
MASTER KEY, LLC
US
60/830386
12/07/2006
11/827264
11/07/2007
US
PCT/US/2007/015822
WO/2008/008395
25/08/2006
METHOD AND DEVICE FOR
REDUCING EXPOSURE TO
UNDESIRABLE ELECTROMAGNETIC
RADIATION
THERAPY PRODUCTS, INC. DBA
ERCHONIA MEDICAL
US
11/487045
14/07/2006
PCT/US/2006/033625
WO/2008/008078
196388
A CATHETER
ASH ACCESS TECHNOLOGY, INC.
September 22, 2009
–‫ד' בתשרי התש"ע‬
G09B )2009.01(
‫מערכת ושיטה להמחשת מוסיקה וקולות‬
‫אחרים‬
196387
09/07/2007
A61K )2009.01(
H01Q )2009.01(
‫שיטה והתקן להפחתת חשיפה לקרינה‬
‫אלקטרומגנטית לא רצויה‬
A61M )2009.01(
‫צנתר‬
175
US
60/819927
11/528733
US
PCT/US/2007/015283
WO/2008/008221
13/07/2007
11/07/2006
27/09/2006
COMPOSITIONS CONTAINING AN
ANTIFUNGAL COMPOUND AND AN
IRON CHELATING COMPOUND AND
USES THEREOF
LOS ANGELES BIOMEDICAL
RESEARCH INSTITUTE AT HARBOR
UCLA MEDICAL CENTER
US
60/831099
13/07/2006
60/897620
26/01/2007
US
60/904075
27/02/2007
US
PCT/US/2007/016065
WO/2008/008537
12/07/2007
H04L )2009.01(
‫שיטה למיתוג מופעים בהעברה ללוויין‬
‫במערכת תקשורת אל–חוטית‬
C07D )2009.01(
196391
PYRROLOPYRIMIDINES FOR
PHARMACEUTICAL COMPOSITIONS
DEVELOGEN
AKTIENGESELLSCHAFT
EP
06014297.3 10/07/2006
PCT/EP/2007/006109
WO/2008/006547
176
‫תכשירים המכילים תרכובת נגד פטריות‬
‫וקלאטור ברזל וניצולם‬
196390
METHOD OF SWITCHING MODES OF
UPLINK TRANSMISSION IN A
WIRELESS COMMUNICATION
SYSTEM
LUCENT TECHNOLOGIES INC.
US
11/485761
13/07/2006
PCT/US/2007/015918
WO/2008/008449
10/07/2007
A61K )2009.01(
196389
‫פירולופירימידינים עבור תכשירי רוקחות‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
06/08/2007
196392
USE OF GLUCOCORTICOID
RECEPTOR ANTAGONISTS FOR
TREATMENT OF INFECTIOUS
CONDITIONS
N.V. ORGANON
EP
06118587.2 08/08/2006
PCT/EP/2007/058134
WO/2008/017658
17/07/2007
‫שימוש באנטגוניסטים לקולטן‬
‫גלוקוקורטיקואיד לטיפול בתנאים זיהומיים‬
196393
AMBIENT TEMPERATURE THERMAL
ENERGY AND CONSTANT PRESSURE
CRYOGENIC ENGINE
MDI MOTOR DEVELOPMENT
INTERNATIONAL S.A.
FR
0606647
21/07/2006
PCT/EP/2007/057380
WO/2008/009681
10/07/2007
196394
IMPLANTABLE SUSTAINED DRUG
DELIVERY DEVICE FOR RELEASING
ACTIVE AGENTS TO THE
OSTEOMEATAL COMPLEX
YU-FEN CHI
US
60/819825
10/07/2006
11/775157
09/07/2007
US
PCT/US/2007/015813
WO/2008/008389
September 22, 2009
–‫ד' בתשרי התש"ע‬
A61K )2009.01(
F01B )2009.01(
‫אנרגיה תרמית של טמפרטורת החדר‬
‫ומנוע מקפיא בלחץ קבוע‬
A61K )2009.01(
‫התקן למתן מושהה של תרופה הניתן‬
‫להשתלה עבור שחרור חומרים פעילים‬
‫לקומפלקס האוסטיאומיתלי‬
177
09/07/2007
METHOD FOR PRODUCING A BONE
PROSTHESIS OR A PRE-IMPLANT
SIMULATION, AND EQUIPMENT
USED
2INGIS S.A.
EP
06116963.7 11/07/2006
PCT/EP/2007/056957
WO/2008/006802
11/07/2007
–‫שיטה לייצור תותבת עצם או חיקוי טרום‬
‫שתל והציוד שמשתמשים בו‬
‫הרכבים עם שחרור מבוקר‬
C07K )2009.01(
196397
PRLR-SPECIFIC ANTIBODY AND
USES THEREOF
XOMA TECHNOLOGY LTD.
US
60/838648
18/08/2006
60/946360
26/06/2007
US
PCT/US/2007/076160
WO/2008/022295
178
A61K )2009.01(
196396
CONTROLLED-RELEASE
FORMULATIONS
MUTUAL PHARMACEUTICAL
COMPANY INC
US
60/819914
11/07/2006
60/859772
17/11/2006
US
PCT/US/2007/015897
WO/2008/008434
17/08/2007
A61C )2009.01(
196395
‫ ושימושים בו‬PRLR–‫נוגדן ספציפי ל‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
26/07/2007
196399
ONLINE ARABIC HANDWRITING
RECOGNITION
BGN TECHNOLOGIES LTD.
US
60/833900
27/07/2006
PCT/IL/2007/000940
WO/2008/012824
15/07/2007
11/06/2007
‫אן טכנולוגיות בע"מ‬.‫ג'י‬.‫בי‬
–‫ד' בתשרי התש"ע‬
A01N )2009.01(
–‫ג'לים הידרוקולואידיים מיובשים‬
‫מחושמלים בעלי מבנה ונקבוביות ייחודיים‬
196401
CONNECTIVITY FAULT
MANAGEMENT (CFM) IN NETWORKS
WITH LINK AGGREGATION GROUP
CONNECTIONS
CORRIGENT SYSTEMS LTD.
US
11/483650
11/07/2006
PCT/IL/2007/000702
WO/2008/007353
September 22, 2009
‫זיהוי מקוון של כתב יד בערבית‬
196400
DRIED ELECTRIFIED
HYDROCOLLOID GELS HAVING
UNIQUE STRUCTURE AND
POROSITY
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
US
60/830608
14/07/2006
PCT/IL/2007/000888
WO/2007/007383
G06K )2009.01(
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים‬
G06F )2009.01(
‫) ברשתות‬CFM( ‫ניהול תקלות חיבוריות‬
‫עם קישורי קבוצת מצבור קווי תקשורת‬
‫קוריג'נט מערכות בע"מ‬
179
10/07/2007
XINAFOATE SALT OF A
SUBSTITUTED 5-OXAZOL-2-YLQUINOLINE COMPOUND
SCHERING CORPORATION
US
60/830057
11/07/2006
PCT/US/2007/015715
WO/2008/008327
07/09/2007
‫בקרה על זכויות יפויי כח‬
G06F )2009.01(
‫שאילתות באישור בטיחות‬
C07K )2009.01(
196410
VACCINES FOR MALARIA
THE UNITED STATES OF AMERICA,
AS REPRESENTED BY THE
SECRETARY OF THE ARMY
GB
0614254.1
18/07/2006
0614473.7
20/07/2006
GB
0614476.0
20/07/2006
GB
0615115.3
28/07/2006
GB
PCT/EP/2007/057296
WO/2008/009650
180
H04L )2009.01(
196408
SECURITY AUTHORIZATION
QUERIES
MICROSOFT CORPORATION
US
11/530438
08/09/2006
PCT/US/2007/077641
WO/2008/030876
16/07/2007
–5 ‫מלח קסינפואטי של תרכובת‬
‫–איל–קווינולין‬2–‫אוקסאזול‬
196407
CONTROLLING THE DELEGATION
OF RIGHTS
MICROSOFT CORPORATION
US
11/530446
08/09/2006
PCT/US/2007/077898
WO/2008/031043
05/09/2007
C07D )2009.01(
196402
‫חיסונים עבור מלריה‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
10/07/2007
196411
ANTI-COCAINE COMPOSITIONS AND
TREATMENT
COLUMBIA UNIVERSITY
US
60/819569
10/07/2006
PCT/US/2007/015762
WO/2008/008358
28/06/2007
11/07/2007
06/07/2007
A61F )2009.01(
‫תותב טרשתי לטיפול בהזדקנות ראיה ואי‬
‫ התקנים הקשורים‬,‫סדרים עיניים נוספים‬
‫לכך ושיטות‬
196414
–‫ד' בתשרי התש"ע‬
H02K )2009.01(
,‫אלמנט פעיל עבור מכונה אלקטרומגנטית‬
‫שיטה לייצורו ומכונה אלקטרומגנטית‬
‫הכוללת אלמנט פעיל כזה‬
196413
SCLERAL PROSTHESIS FOR
TREATING PRESBYOPIA AND OTHER
EYE DISORDERS AND RELATED
DEVICES AND METHODS
REFOCUS GROUP, INC.
US
60/819995
11/07/2006
PCT/US/2007/015774
WO/2008/008366
September 22, 2009
‫תכשירים נגד קוקאין וטיפול‬
196412
ACTIVE ELEMENT FOR AN
ELECTROMAGNETIC MACHINE
PRODUCTION METHOD THEREOF
AND ELECTROMAGNETIC MACHINE
INCLUDING ONE SUCH ACTIVE
ELEMENT
MESSIER-DOWTY SA
FR
0606335
12/07/2006
PCT/FR/2007/001088
WO/2008/006953
A61K )2009.01(
C12M )2009.01(
181
PHOTOBIOREACTOR SYSTEMS AND
METHODS FOR TREATING CO2ENRICHED GAS AND PRODUCING
BIOMASS
‫מערכות ושיטות של פוטוביוראקטורים‬
‫ ולייצור‬CO2–‫לטיפול בגאז מועשר ב‬
‫ביומאסה‬
GREENFUEL TECHNOLOGIES CORP.
US
60/819976
10/07/2006
PCT/US/2007/015513
WO/2008/008262
12/07/2007
H04B )2009.01(
196415
‫מערכת ניטור‬
MONITORING SYSTEM
IMPRENDITORE PTY LIMITED
AU
2006903740 12/07/2006
2007902358
04/05/2007
AU
PCT/AU/2007/000958
WO/2008/006155
28/07/2006
C09C )2009.01(
196416
COATING OF INORGANIC PIGMENTS
WITH ALDEHYDE OR KETONE
RESINS
INXEL TRADEMARK & PATENTS
SAGL
‫ציפוי פיגמנטים אנאורגנים עם שרפי‬
‫אלדהיד או קטון‬
PCT/IT/2006/000588
WO/2008/012848
09/07/2007
182
C07D )2009.01(
196417
September 22, 2009
–‫ד' בתשרי התש"ע‬
TARTRATE SALT OF (7S)-7-[(5FLUORO-2-METHYL-BENZYL)OXY]2-[(2R)-2-METHYLPIPERAZIN-1-YL]6,7-DIHYDRO-5HCYCLOPENTA[b]PYRIDINE
PFIZER PRODUCTS INC.
US
60/830890
14/07/2006
PCT/IB/2007/002025
WO/2008/010073
27/07/2007
–2–‫–פלואורו‬S)–7–[(57( ‫מלח טרטרט של‬
–R)–22([–2–]‫מתיל–בנזיל)אוקסי‬
–H5–‫–דיהידרו‬6,7–]‫–יל‬1–‫מתילפיפראזינ‬
‫] פירידין‬b[‫ציקלופנטא‬
196418
THIENO[3,2-C]PYRIDINE-7CARBOXYLIC ACID DERIVATIVES
F. HOFFMANN-LA ROCHE AG
US
60/836360
08/08/2006
PCT/EP/2007/057748
WO/2008/017594
19/07/2007
196419
ANALYSIS UNIT INTENDED TO BE
USED IN ANALYSIS APPARATUS
BIOCODE HYCEL FRANCE SA
FR
06/06685
21/07/2006
PCT/FR/2007/001241
WO/2008/009821
04/06/2007
September 22, 2009
196420
–‫ד' בתשרי התש"ע‬
C07D )2009.01(
–7–‫]פירידינ‬C–2,3[‫תולדות חומצה תיאנו‬
‫קרבוקסילית‬
B01L )2009.01(
‫יחידת אנאליזה המיועדת לשימוש‬
‫באנאליזה‬
A01K )2009.01(
183
METHOD AND INSTALLATION FOR
TREATING AN AQUEOUS EFFLUENT,
IN ORDER TO EXTRACT AT LEAST
ONE DISSOLVED GASEOUS
COMPOUND; APPLICATION TO
AQUACULTURE IN RECIRCULATED
AQUEOUS MEDIUM
INSTITUT NATIONAL DES SCIENCES
APPLIQUEES
US
60/830343
13/07/2006
0702308
29/03/2007
FR
PCT/FR/2007/000920
WO/2008/006950
11/01/2009
‫מכלול מתנייד ויישום למכשירים מתניידים‬
‫אפרים דרורי‬
184
A61F )2009.01(
196422
ANNULOPLASTY SYSTEM AND
SURGICAL METHOD
TIGRAN KHALAPYAN
US
60/807119
12/07/2006
PCT/US/2007/073356
WO/2008/008889
30/07/2007
F16H )2009.01(
196421
MOVABLE ASSEMBLY AND
APPLICATION TO MOVABLE
DEVICES
EFFRAYIM DRORI
12/07/2007
‫שיטה והתקן לטיפול בנביעה מימית לשם‬
‫מיצוי של לפחות תרכובת גזית מומסת‬
‫אחת ממנה; יישום לטיפוח מקור מים‬
‫בסביבה מימית ממוחזרת‬
‫מערכת ושיטה לתיקון כירורגי של שסתום‬
‫לב‬
A61K )2009.01(
196426
September 22, 2009
–‫ד' בתשרי התש"ע‬
MICROPARTICULATES BASED ON
AN AMPHIPHILIC COPOLYMER,
PROCESSES FOR THE PREPARATION
THEREOF AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THE
SAME
FLAMEL TECHNOLOGIES
FR
0653191
28/08/2006
PCT/EP/2007/006722
WO/2008/025425
26/07/2007
196427
MODULATORS OF CHEMOKINE
RECEPTOR ACTIVITY,
CRYSTALLINE FORMS THEREOF
AND PROCESSES TO PRODUCE THE
SAME
BRISTOL-MYERS SQUIBB COMPANY
US
60/834235
28/07/2006
60/896026
21/03/2007
US
11/782742
25/07/2007
US
PCT/US/2007/074377
WO/2008/014360
11/01/2009
196428
METHOD AND SYSTEM FOR
PERSONALITY ANALYSIS IN
ACCORDANCE WITH THE
PALMISTRY
TAMAR ZOHAR SHIR
06/07/2007
September 22, 2009
C07D )2009.01(
‫ גבישים‬,‫מאפנני פעילות קולטן הכימוקין‬
‫שלהם ותהליכים לייצורם‬
G09B )2009.01(
‫שיטה ומערכת לאבחון אישיות על–פי‬
‫תורת הכירולוגיה‬
‫תמר זוהר שיר‬
196430
–‫ד' בתשרי התש"ע‬
‫חלקיקי–מיקרו המבוססים על קופולימר‬
‫ תהליכים להכנתם ותכשירי‬,‫אמפיפילי‬
‫רוקחות המכילים אותם‬
C10L )2009.01(
185
USE OF COMPOUNDS REVEALING
THE EFFICIENCY OF FILTERABILITY
ADDITIVES IN HYDROCARBON
DISTILLATES, AND SYNERGIC
COMPOSITION CONTAINING SAME
TOTAL RAFFINAGE MARKETING
FR
06/06254
10/07/2006
PCT/FR/2007/001153
WO/2008/006965
30/06/2007
‫סינתזה קטליטית רג'יו–סלקטיבית של‬
‫בנזימידאזולים ואזאבנזימידאזולים‬
‫באמצעות פלדיום‬
A61K )2009.01(
196432
NANOPARTICULATE
FORMULATIONS OF MODAFINIL
ELAN PHARMA INTERNATIONAL
LIMITED
US
60/807126
12/07/2006
60/882740
29/12/2006
US
60/908067
26/03/2007
US
PCT/US/2007/073336
WO/2008/008879
186
C07D )2009.01(
196431
A REGIOSELECTIVE PALLADIUM
CATALYZED SYNTHESIS OF
BENZIMIDAZOLES AND
AZABENZIMIDAZOLES
SANOFI AVENTIS
EP
06014789.9 15/07/2006
PCT/EP/2007/005816
WO/2008/009348
12/07/2007
‫שימוש בתרכובות המגלות את היעילות‬
‫בכושר הסינון של תוספים בחומרים‬
‫ ותכשיר סינרגי‬,‫פחמימניים מזוקקים‬
‫המכיל אותן‬
‫פורמולציות ננו–חלקיקיות של מודפיניל‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
12/07/2007
196433
METHODS AND SYSTEMS FOR
COMPLIANCE CONFIRMATION AND
INCENTIVES
ARBITRON INC.
US
60/831744
12/07/2006
PCT/US/2007/073390
WO/2008/008911
12/07/2007
196434
MONITORING USAGE OF A
PORTABLE USER APPLIANCE
ARBITRON INC.
US
60/831744
12/07/2006
PCT/US/2007/073393
WO/2008/008913
12/07/2007
196435
METHODS AND SYSTEMS FOR
COMPLIANCE CONFIRMATION AND
INCENTIVES
ARBITRON INC.
US
60/831744
12/07/2006
PCT/US/2007/073376
WO/2008/008899
03/07/2007
196436
TWO COMPONENT PHOTODIODE
DETECTOR
AEROFLEX COLORADO SPRINGS,
INC.
US
11/456662
11/07/2006
PCT/US/2007/072780
WO/2008/082689
11/01/2009
September 22, 2009
196437
–‫ד' בתשרי התש"ע‬
G06F )2009.01(
‫מערכות ושיטות לתמרוץ ואישור של‬
‫תאימות‬
G06F )2009.01(
‫פיקוח על שימוש מכשיר מטלטל‬
G06F )2009.01(
‫מערכות ושיטות לתמרוץ ואישור של‬
‫תאימות‬
G01T )2009.01(
‫גלאי פוטודיאוד בעל שני רכיבים‬
B05B )2009.01(
187
A LIQUID DISPENSER
LUICELOOP (PTY) LTD.
ZA
2008/07174
‫מחלק נוזלי‬
20/08/2008
18/03/2007
FLOW DEFLECTION DEVICES AND
METHOD FOR ENERGY CAPTURE
MACHINES
DANIEL FARB
US
60/807828
20/07/2006
60/826927
26/09/2006
US
60/864792
08/11/2006
US
PCT/IL/2007/000348
WO/2008/010200
11/01/2009
METHOD OF GROOVING
SUPERALLOYS AND CUTTING
INSERT THEREFOR
ISCAR LTD.
11/01/2009
G01T )2009.01(
196438
‫מתקני הטיית זרימה ושיטה למכונות‬
‫תפיסת אנרגיה‬
B23C )2009.01(
196439
‫שיטה לחירוץ סגסוגות–על ושימת חיתוך‬
‫עבורה‬
‫ישקר בע"מ‬
B23G )2009.01(
196440
‫מנגנון כוונון‬
ADJUSTMENT MECHANISM
‫ישקר בע"מ‬
ISCAR LTD.
12/06/2007
188
G06Q )2009.01(
196441
September 22, 2009
–‫ד' בתשרי התש"ע‬
PRINCIPAL GUARANTEED SAVINGS
AND INVESTMENT SYSTEM AND
METHOD
RICHARD J. SIEGEL
US
11/456793
11/07/2006
PCT/US/2007/070953
WO/2008/014057
25/05/2001
‫חסכונות הון מובטחים ומערכת להשקעה‬
‫ושיטה‬
196444
PURIFICATION OF RNA BY A TRIPLE
HELIX FORMATION WITH AN
IMMOBILIZED OLIGONUCLEOTIDE
CENTELION
US
09/580923
26/05/2000
PCT/US/2001/017122
WO/2001/092511
09/07/2006
‫טיהור רנ"א על–ידי היווצרות סליל משולש‬
‫עם אוליגונוקלאוטיד מקובע‬
196445
WAVE ENERGY CONVERTER
AUSTRALIAN SUSTAINABLE
ENERGY CORPORATION PTY LTD.
AU
2006903707 11/07/2006
PCT/AU/2007/000940
WO/2008/006145
02/07/2007
196446
TRANS-DOUGLAS ENDOSCOPICAL
SURGICAL DEVICE (TED)
STARK MICHAEL
US
60/830356
13/07/2006
PCT/IL/2007/000821
WO/2008/007355
11/07/2007
September 22, 2009
196447
–‫ד' בתשרי התש"ע‬
C12N )2009.01(
E02D )2009.01(
‫התקן לשימוש באנרגיית גלים‬
A61B )2009.01(
‫התקן אנדוסקופי העובר דרך החלל על‬
‫שם דאגלאס‬
‫פרופ' מיכאל סטארק‬
A61K )2009.01(
189
ENHANCED STABILITY
PHENYLEPHRINE LIQUID
COMPOSITIONS
WYETH
US
11/487120
14/07/2006
PCT/US/2007/015771
WO/2008/008364
09/07/2007
‫הרכבים נוזליים של פנילאפרין עם יציבות‬
‫מוגברת‬
GEOGRAPHICAL INFORMATION
DISPLAY SYSTEM AND METHOD
RAYTHEON COMPANY
US
60/831093
14/07/2006
11/773260
03/07/2007
US
PCT/US/2007/073041
WO/2008/008724
17/07/2007
190
‫מערכת ושיטה להצגת מידע גיאוגרפי‬
H04J )2009.01(
196451
MULTIPLEXING OF DS1 TRAFFIC
ACROSS WIRED AND WIRELESS
ETHERNET DEVICES
MEMORYLINK CORP.
US
60/807664
18/07/2006
PCT/US/2007/073678
WO/2008/011405
11/07/2007
A61N )2009.01(
196450
‫ על פני התקן‬DS1 ‫שידו מרובב של תנועת‬
‫אתרנט חוטי ואלחוטי‬
G06F )2009.01(
196452
September 22, 2009
–‫ד' בתשרי התש"ע‬
SYSTEM AND METHOD FOR
PROVIDING REMOTE ACCESS TO
EVENTS FROM A DATABASE
ACCESS SYSTEM
RAYTHEON COMPANY
US
60/831036
14/07/2006
11/672460
07/02/2007
US
PCT/US/2007/073207
WO/2008/011309
11/07/2007
196453
METHOD AND ASSAY FOR
GLYCOSYLATION PATTERN
DETECTION RELATED TO CELL
STATE
PROCOGNIA (ISRAEL) LTD
US
60/830296
11/07/2006
PCT/IL/2007/000871
WO/2008/007373
12/01/2009
196454
COLLECTING DATA FROM
CELLULAR PHONES AND
REPORTING RELATED
INFORMATION
YOSSI KAPLAN
12/01/2009
196457
–‫ד' בתשרי התש"ע‬
‫שיטה להבחנת מצב תאי ע"י איתור‬
‫תצורות גליקוליזציה‬
‫פרוקוגניה (ישראל) בע"מ‬
G06F )2009.01(
‫עופר אבני‬
CORKSCREW AND METHOD OF USE
SHLOMO BEN-AVI
September 22, 2009
G01N )2009.01(
‫שיטה לאיסוף נתונים מטלפונים‬
‫סלולאריים ודיווח אינפורמציה קשורה‬
196455
13/07/2007
‫שיטה ומערכת לאספקת גישה מרחוק‬
‫לאירועים ממערכת גישה למאגר מידע‬
B65D )2009.01(
‫מתקן ושיטה לחילוץ פקקים‬
‫אבי‬-‫שלמה בן‬
H01G )2009.01(
191
IMPROVEMENTS IN THE
PRODUCTION OF ELECTROLYTIC
CAPACITOR
METALYSIS LIMITED
GB
0613984.4
13/07/2006
PCT/GB/2007/002660
WO/2008/007126
12/01/2009
H01S )2009.01(
‫מערכת לייזר שואבת המשתמשת בהיזון‬
‫חוזר לאמצעי שאיבה‬
B01D )2009.01(
196461
AIRCRAFT ENGINE INLET
PIVOTABLE BARRIER FILTER
AEROSPACE FILTRATION SYSTEMS,
INC.
US
60/807389
14/07/2006
PCT/US/2007/073125
WO/2008/076471
192
‫מערכת ושיטה למדידת מומס בדגימה‬
196460
PUMPED LASER SYSTEM USING
FEEDBACK TO PUMP MEANS
DANMARKS TEKNISKE
UNIVERSITET
EP
06388051.2 12/07/2006
60/830718
12/07/2006
US
PCT/DK/2007/000350
WO/2008/006371
10/07/2007
G01N )2009.01(
196458
SYSTEM AND METHOD FOR
MEASURING AN ANALYTE IN A
SAMPLE
LIFESCAN, INC.
US
61/021713
18/01/2008
12/349017
06/01/2009
US
10/07/2007
‫שיפורים ביצור קבל אלקטרוליטי‬
‫מסנן חוסם פתח הניתן לסיבוב על ציר‬
‫עבור מנוע של כלי טיס‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
11/07/2007
196464
PREPARATION OF FATTY ACID
ESTERS OF GLYCEROL FORMAL
AND ITS USE AS BIOFUEL
INSTITUT NUIVERSITARI DE
CIENCIA TECNOLOGIA
ES
P200601918 12/07/2006
PCT/EP/2007/057123
WO/2008/006860
13/06/2007
‫תכשיר חומצה אסטר שומנית של גליצרול‬
‫שומני ושימושו כביופיול‬
196466
HYDROGELS CONTAINING LOW
MOLECULAR WEIGHT ALGINATES
AND BIOSTRUCTURES MADE
THEREFROM
FMC BIOPOLYMER AS
US
60/830959
14/07/2006
PCT/EP/2007/055856
WO/2008/006658
13/07/2007
196470
ANTAGONIST ANTIBODY AGAINST
EPHA2 FOR THE TREATMENT OF
CANCER
SANOFI-AVENTIS
EP
06291160.7 18/07/2006
PCT/IB/2007/003074
WO/2008/010101
16/07/2007
196471
VACCINES FOR MALARIA
September 22, 2009
–‫ד' בתשרי התש"ע‬
C10L )2009.01(
A61K )2009.01(
‫הידרוג'לים המכילים אלג'ינטים בעלי‬
‫משקל מולקולרי נמוך ומבנים ביולוגיים‬
‫העשויים מהם‬
C07K )2009.01(
‫ לטיפול‬EPHA2 ‫נוגדן אנטגוניסטי כנגד‬
‫בסרטן‬
A61K )2009.01(
‫חיסונים למלריה‬
193
THE UNITED STATES OF AMERICA,
AS REPRESENTED BY THE
SECRETARY OF THE ARMY
GB
0614254.1
18/07/2006
0614473.7
20/07/2006
GB
0614476.0
20/07/2006
GB
0615115.3
28/07/2006
GB
PCT/EP/2007/057301
WO/2008/009652
12/07/2007
SEMICONDUCTOR DEVICE
NATIONAL UNIVERSITY
CORPORATION TOHOKU
UNIVERSITY
2006JP
13/07/2006
192440
PCT/JP/2007/063926
WO/2008/007748
12/07/2007
194
‫התקן מוליך למחצה‬
H01L )2009.01(
196473
TRANSISTOR AND
SEMICONDUCTOR DEVICE
NATIONAL UNIVERSITY
CORPORATION TOHOKU
UNIVERSITY
2006JP
13/07/2006
192815
PCT/JP/2007/063927
WO/2008/007749
12/07/2007
H01L )2009.01(
196472
‫התקן טרנזיסטור ומוליך למחצה‬
G06F )2009.01(
196475
September 22, 2009
–‫ד' בתשרי התש"ע‬
INJECTION DEVICE AND CASE WITH
REPORTING ABILITY
HENRY SCHEIN, INC.
US
11/485820
13/07/2006
11/485828
13/07/2006
US
11/485829
13/07/2006
US
PCT/US/2007/015922
WO/2008/008451
30/07/2007
196476
METHOD AND APPARATUS FOR
PROTECTING RFID TAGS FROM
POWER ANALYSIS
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
60/821515
04/08/2006
PCT/US/2007/074716
WO/2008/019246
19/07/2007
196477
METHOD OF FABRICATING
SEMICONDUCTOR DEVICES ON A
GROUP IV SUBSTRATE WITH
CONTROLLED INTERFACE
PROPERTIES AND DIFFUSION TAILS
CYRIUM TECHNOLOGIES
INCORPORATED
US
60/822138
11/08/2006
PCT/CA/2007/001278
WO/2008/017143
13/07/2007
196478
HUMANIZED ANTIBODY AGAINST
AMYLOID BETA
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫התקן הזרקה ואריזה עם יכולת דיווח‬
H04K )2009.01(
RFID ‫שיטה ומערכת להגנת תויות‬
‫מאנליזת כח‬
‫ידע חברה למחקר ופיתוח בע"מ‬
H01L )2009.01(
‫שיטה ליצור התקן מוליך למחצה על גבי‬
‫ בעל תכונות ממשק‬IV ‫מצע מקבוצת‬
‫מבוקרות ועקבות דיפוזיה‬
C07K )2009.01(
‫נוגדן אנושי נגד אמילואיד בתא‬
195
GENENTECH, INC.
EP
06014730.3
06020765.1
EP
60/943289
US
60/943499
US
PCT/US/2007/073504
WO/2008/011348
20/07/2007
14/07/2006
02/10/2006
11/06/2007
12/06/2007
PROCESS FOR THE PREPARATION
OF LEVETIRACETAM
ZACH SYSTEM S.P.A.
EP
06015439.0 25/07/2006
PCT/EP/2007/057503
WO/2008/012268
13/09/2001
196
‫תהליך להכנת לוויטיראסטם‬
C07K )2009.01(
196482
HUMAN COAGULATION FACTOR VII
VARIANTS, METHOD FOR
PRODUCING THEM, AND
PHARMACEUTICAL COMPOSITIONS
COMPRISING THEM
NOVO NORDISK HEALTH CARE AG
DK
PA200001361 13/09/2000
60/236455
29/09/2000
US
PCT/DK/2001/000596
WO/2002/022776
13/01/2009
C07D )2009.01(
196481
‫גרסאות משתנות של גורם קרישה‬
‫ שיטה להכנתן ותכשירי‬,‫ממקור אנושי‬
‫רוקחות המכילים אותן‬
H01H )2009.01(
196484
September 22, 2009
–‫ד' בתשרי התש"ע‬
CIRCUIT-BREAKER AND
COMMUNITATION METHOD FOR
MEDIUM-AND HIGH VOLTAGE A.C.
POWER NETWORK
IURII ONUFRIENKO
13/01/2009
196485
TACTILE TRANSPARENT
KEYBOARD
IGAL SHUSTERI
13/01/2009
196487
MEANS AND METHODS FOR
PROVIDING HIGH RESOLUTION MRI
ASPECT MAGNET TECHNOLOGIES
LTD.
September 22, 2009
196488
–‫ד' בתשרי התש"ע‬
B41J )2009.01(
‫יגאל שושטרי‬
AN OIL BLEND OF
SYNERGISTICALLY LOWERED
OXIDATION VALUE
SHEMEN INDUSTRIES LTD.
US
61/083435
24/07/2008
12/07/2007
‫ורי אונופריאנקו‬
‫מקלדת מגע שקופה למסכי מגע‬
196486
13/01/2009
‫מפסק מתח ושיטת מיתוג ברשתות‬
‫חשמל למתח גבוה ובינוני לזרם חילופין‬
C11C )2009.01(
‫תערובת שמנים עם הנמכה סינרגיסטית‬
‫של דרגת ההתחמצנות‬
‫שמן תעשיות בע"מ‬
G01V )2009.01(
MRI ‫אמצעים ושיטות להקנייה של‬
‫ברזולוציה חדה‬
‫אספקט טכנולוגיות מגנטים בע"מ‬
C23C )2009.01(
197
METHOD FOR DEPOSITING
ELECTRICALLY INSULATING
LAYERS
OERLIKON TRADING AG,
TRUBBACH
CH
01166/06
19/07/2006
PCT/EP/2007/057179
WO/2008/009619
11/12/2007
‫שיטה להנחת שכבות מבודדות חשמל‬
‫טבעת ושיטת ענידה‬
‫קציר‬-‫שלי אבנרי‬
RING AND METHOD FOR WEARING
YIFAT UNGIEROWICZ BLOCH
18/01/2009
PCT/US/2001/001537
13/07/2007
‫מחלק גז לביוראקטור של חלקיקים‬
‫מוערמים‬
198
C07D )2009.01(
196494
HETEROCYCLIC SUBSTITUTED
PIPERAZINE COMPOUNDS WITH
CXCR3 ANTAGONIST ACTIVITY
SCHERING CORPORATION
US
60/831053
14/07/2006
PCT/US/2007/015924
WO/2008/008453
29/08/2007
C12M )2009.01(
196492
GAS DISTRIBUTOR FOR A STACKED
PARTICLE BIOREACTOR
GEOSYNFUELS LLC
ZA
2006/05807 14/07/2006
2007/01408
30/01/2007
ZA
PCT/IB/2007/052815
WO/2008/010176
12/07/2007
A44C )2009.01(
196489
‫תרכובות פיפרזין מותמרות בהטרוציקלים‬
CXCR3–‫עם פעילות אנטגוניסטית ל‬
C07D )2009.01(
196497
September 22, 2009
–‫ד' בתשרי התש"ע‬
NOVEL AMINOPYRIDINE
DERIVATIVES HAVING AURORA A
SELECTIVE INHIBITORY ACTION
‫נגזרות אמינופירידין חדשות בעלות עיכוב‬
A ‫סלקטיבי לאורורה‬
BANYU PHARMACEUTICAL CO. LTD
2006JP
31/08/2006
236472
60/926086
25/04/2007
US
PCT/JP/2007/067250
WO/2008/026768
12/07/2007
196498
WIMAX ACCESS POINT NETWORK
WITH BACKHAUL TECHNOLOGY
DESIGNART NETWORKS LTD
US
60/830727
13/07/2006
60/843183
08/09/2006
US
60/843079
08/09/2006
US
PCT/IL/2007/000875
WO/2008/007375
14/01/2009
‫רשת ווימקס לעמדות גישה עם טכנולוגיית‬
‫העברה חוזרת‬
‫דזיינארט נטוורקס בע"מ‬
196499
THREAD RESTORER FOR SMALL
INTERNAL TREADS
SHILO TECHNOLOGIES LTD.
24/08/2004
‫שילה טכנולוגיות בע"מ‬
A DECK AND SYSTEM FOR DRIVING
FLUIDS THROUGH AN
EXTRACORPOREAL BLOOD CIRCUIT
KIT
THERAKOS, INC.
US
10/654670
03/09/2003
September 22, 2009
196501
–‫ד' בתשרי התש"ע‬
B23G )2009.01(
‫משחזר תבריגים להברגות פנימיות קטנות‬
196500
24/08/2004
H04B )2009.01(
G01N )2009.01(
‫משטח ומערכת להעברת נוזלים דרך‬
‫ערכה של מערכת דם חוץ–גופית‬
G01N )2009.01(
199
AN APPARATUS COMPRISING A
CASSETTE FOR CONTROLLING
MOVEMENT OF BLOOD AND
SEPARATED COMPONENTS, AND
METHD OF MAKING SUCH
CASSETTE
THERAKOS, INC.
US
10/654670
03/09/2003
24/08/2004
200
G01N )2009.01(
‫מנגנון סינון לשימוש בזרימה חוץ–גופית‬
C07K )2009.01(
196509
ANTIBODIES DIRECTED AGANIST
POLYPEPTIDES CAPABLE OF
BINDING TO LDCAM, AND
PHARMACEUTICAL COMPOSITIONS
COMPRISING THE SAME
IMMUNEX CORPORATION
US
60/095663
07/08/1998
PCT/US/1999/017906
WO/2000/008057
14/01/2009
‫משאבה פריסטלטית‬
196503
A FILTER ASSEMBLY FOR USE IN
EXTRACORPOREAL BODY FLUID
FLOW
THERAKOS, INC.
US
10/654670
03/09/2003
05/08/1999
G01N )2009.01(
196502
A PERISTALTIC PUMP APPARATUS
THERAKOS, INC.
US
10/654670
03/09/2003
24/08/2004
‫מכשיר הכולל דסקה לבקרה של זרימת‬
‫דם ומרכיבי דם נפרדים ושיטה לייצור‬
‫הדסקה‬
–‫נוגדנים כנגד פוליפפטידים הנקשרים ל‬
‫ ותכשירים רוקחיים המכילים‬LDCAM
‫אותם‬
F16L )2009.01(
196511
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫אטם למחבר פעמון לצינורות‬
BELL JOINT PIPE SEAL
KRAUSZ INDUSTRIES
DEVELOPMENT LTD.
14/01/2009
‫קראוס תעשיות פיתוח בע"מ‬
196515
METHOD AND DEVICE FOR
IMPROVING USER'S HEALTH
CONDITION
NETOGREEN LTD
15/01/2009
‫שיטה והתקן לשיפור מצבו הבריאותי של‬
‫המשתמש‬
‫נטוגרין בע"מ‬
196530
ANALYTE TESTING METHOD AND
SYSTEM
LIFESCAN SCOTLAND LTD.
US
61/021995
18/01/2008
61/022042
18/01/2008
US
61/059473
06/06/2008
US
07/04/2003
196532
IMMUNOLOGICAL METHODS AND
COMPOSITIONS FOR THE
TREATMENT OF ALZHEIMER'S
DISEASE
THE GOVERNING COUNCIL OF THE
UNIVERSITY OF TORONTO.
US
60/373,914
19/04/2002
PCT/CA/2003/000502
WO/2003/089460
18/01/2009
196566
DETECTION OF CURRENT LEAKAGE
THROUGH OPTO-SWITCHES
September 22, 2009
–‫ד' בתשרי התש"ע‬
A61B )2009.01(
G01N )2009.01(
‫שיטה ומערכת לבדיקת חומר מומס‬
C07K )2009.01(
‫תכשירים אימונולוגים לטיפול במחלת‬
‫אלצהיימר‬
‫מועצת המנהלים של אוניברסיטת‬
,‫טורונטו‬
H01H )2009.01(
‫זיהוי של דליפת זרם חשמלי דרך מתגים‬
‫אופטיים‬
201
BIOSENSE WEBSTER, INC.
US
12/017137
21/01/2008
18/01/2009
G09B )2009.01(
196568
‫מתקן פרסום‬
‫פרפרית בע"מ‬
ADVERTISEMENT DEVICE
PARPARIT LTD.
18/01/2009
WORKPIECE CLAMPING FIXTURE
EROWA AG
CH
00151/08
04/02/2008
18/01/2009
‫מתקן הידוק חפץ בתהליך ייצור במלחצת‬
‫מגב רצפה ושיטה עבורו‬
‫תומר דהאן‬
202
B60G )2009.01(
196574
SUSPENSION SYSTEM FOR VEHICLE
ASFIR LTD
19/01/2009
A47K )2009.01(
196573
A FLOOR WIPER AND METHOD
THEREFOR
TOMER DAHAN
19/01/2009
B23Q )2009.01(
196572
‫מערכת מתלים לכלי רכב‬
‫חברת מאיר אספיר בע"מ‬
A61B )2009.01(
196576
September 22, 2009
–‫ד' בתשרי התש"ע‬
A METHOD AND DEVICE TO
ADMINISTER MEDICINE VIA A
PACIFIER
UZI EZRA HAVOSHA
US
61/011204
16/01/2008
19/01/2009
196598
DOSING PUMP
TEFEN MANUFACTURE
&MARKETING PLASTIC PRODUCTS
1990 LTD
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫שיטה ומתקן להעברת תרופה דרך מוצץ‬
‫עידן חג'בי‬
F01L )2009.01(
‫משאבת מינון‬
1990 ‫תפן ייצור ושיווק מוצרי פלסטיק‬
‫בע"מ‬
203
NOTICE UNDER SECTION 26 OF THE
PATENTS LAW, 5727-1967
The applications, particulars of which are set
out below, have been accepted pursuant to
Section 17 of the Patents Law. Any person
wishing to oppose the grant of a patent on any
of the applications published here, may,
within three months from the date of this
journal, give to the Commissioner of Patents
notice under Section 30 of the Patents Law, in
the manner prescribed in regulations 57 et seq
of the Patents Regulations, 5728-1968
Particulars of the applications, where
applicable, are given in the following order:
[11] [21] Number of application
[54] Title of invention
[22] Application date
[31] [32] [33] Number and date of foreign
application – convention country.
*[51] Int.Cl.
[61] Application for patent of addition
[62] Divisional application
[71] Applicant
[72] Inventor
[87] International Publication Number
[74] Address for service
[57] Abridgement of invention (in the
language in which the specification is drawn
up)
*Note: As from Patents and Designs Journal
No.1/06, patent applications are classified
according to the Eighth Edition of the
International Patent Classification (2006)
204
- ‫ לחוק הפטנטים תשכ"ז‬26 ‫הודעה לפי סעיף‬
1976
‫הבקשות שפרטיהן מתפרסמים להלן קובלו‬
‫ כל המעונין‬.‫ לחוק הפטנטים‬17 ‫לפי סעיף‬
‫להתנגד למתן פטנט על פי בקשה מהבקשות‬
‫ תוך שלושה חדשים‬,‫המתפרסמות רשאי‬
‫ להגיש לרשם הפטנטים‬,‫מתאריך יומן זה‬
‫ לחוק‬30 ‫הודעת התנגדות לפי סעיף‬
‫ ואילך‬57 ‫הפטנטים בדרך הקבועה בתקנה‬
.1968 – ‫ תשכ"ח‬,‫לתקנות הפטנטים‬
‫פרטי הבקשות במידה ויישימים מובאים לפי‬
:‫סדר זה‬
‫מספר הבקשה‬
‫שם האמצאה‬
‫תאריך הבקשה‬
‫מספר ותאריך של בקשות החוץ – מדינת‬
‫האגוד‬
‫*סיווג בינלאומי – מהדורה שביעית‬
‫בקשה לפטנט מוסף‬
‫בקשת חלוקה‬
‫המבקש‬
‫הממציא‬
‫מס' פרסום של בקשה הבינלאומית‬
‫מען למסירת מסמכים‬
)‫תקציר האמצאה (בשפה בה ערוך הפירוט‬
'‫ החל מיומן הפטנטים והמדגמים מס‬:‫*הערה‬
‫ ניתן ציון לבקשות פטנטים הסיווג לפי‬1/06
‫המהדורה השמינית של הסיווג הבינלאומי‬
)2006 ‫של פטנטים (משנה‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
]11[]21[
]54[
TISSUE CHARACTERIZATION
BASED ON IMPEDANCE
IMAGES AND ON IMPEDANCE
MEASUREMENTS
]22[
]51[
]71[
05.10.1995
Int. Cl.(2008.04) G01N 27/02
MIRABEL MEDICAL SYSTEMS
LTD.
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
]74[
[57] Apparatus for aiding in identification
of tissue type for an anomalous tissue in an
impedance image comprising: means (14)
for providing a polychromic immitance
map of a portion of the body; means (62)
115525
‫אפיון רקמות על בסיס דמויות עכבה ועל‬
‫בסיס מדידות עכבה‬
‫ מגדל העמק‬,‫מירבל מדיקל סיסטמס בע"מ‬
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
,11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל אילון‬
‫רמת גן‬
for determining a plurality of polychromic
measures of an anomalous region of the
immitance image; and a display (16) which
displays an indication based on said
plurality of polychromic measures.
__________
September 22, 2009
–‫ד' בתשרי התש"ע‬
205
]11[]21[
]54[
SMALL CART FOR CAR FOR
EQUIPMENT AND PRODUCTS
]22[
]51[
]71[
]74[
23.01.1997
Int. Cl.(2008.04) B62B 3/02
AVRAHAM COHEN
AVRAHAM COHEN,
2/2 ALMOGIM ST. ASHDOD
120066
‫עגלת מוצרים וציוד לרכב‬
‫ אשדוד‬,‫אברהם כהן‬
,‫אברהם כהן‬
‫ אשדוד‬,2/2 ‫האלמוגים‬
[57] A vehicle storage compartment
comprising: a body (82) defining a volume
for placing objects therein; a plurality of
support legs (90) underneath said body,
said set of support legs being provided
with wheels (92) to enable rolling
transportation of said body along a
horizontal surface; at least one ancillary
leg (94) underneath said body and
provided with a wheel (96), said at least
one ancillary leg being located closer
towards an end of said body and
protruding from an underside to said body
a smaller distance than at least two of said
support legs, said at least one ancillary leg
and said at least two of said support legs
defining a plane angled with respect to said
horizontal surface along which said wheels
may be rolled; an openable and closeable
enclosure (102) located in a portion of a
vehicle; and a mounting structure
assembled in said enclosure and
comprising at least one support member
(105, 106) for supporting and fixing said
body.
__________
206
September 22, 2009
–‫ד' בתשרי התש"ע‬
]11[]21[
126376
‫הכנתם‬,‫תחליפי תא דם אדום שאינו תאי‬
‫והשימוש בהם‬
]54[
ACELLULAR RED BLOOD
PRODUCT CELL SUBSTITUTES,
THEIR PREPARATION AND USES
THEREOF
]22[
]31[
]51[
]71[
27.09.1998
60/014389
]32[ 28.03.1996
]33[ US
Int. Cl.(2008.04) A61K 38/42, A61P 7/00, C07K 148/05
NORTHFIELD LABORATORIES,
INC., U.S.A.
WO/1997/035883
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]87[
]74[
[57] An aqueous solution of
pyridoxylated, glutaraldehyde-polymerized
hemoglobin, having a tetramer content of
not more than 0.8% by weight based on the
weight of total hemoglobin in the solution
and having, based on the weight of total
hemoglobin in the solution, a molecular
weight distribution of 10 to 24%
hemoglobin polymer with a molecular
weight of about 128 kd, 18 to 30%
hemoglobin polymer with a molecular
weight of about 192 kd, and 45 to 70%
hemoglobin polymer with a molecular
weight of about 256 kd, determined by size
exclusion HPLC.
__________
]11[]21[
]54[
ARTIFICIAL VENTILATION
SYSTEM AND METHODS OF
CONTROLLING CARBON
DIOXIDE REBREATHING
]22[
]31[
]51[
]71[
]74[
30.10.1997
08/751316
]32[ 18.11.1996
Int. Cl.(2008.04) A61M 16/00
MEDLIS CORP., U.S.A.
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725
[57] A unilimb respiratory conduit for use
in an assisted ventilation system having an
inspiratory gas input and exhaust outlet,
comprising: an outer flexible tube (120),
an inner flexible tube (110), said outer
flexible tube and inner flexible tube each
September 22, 2009 –‫ד' בתשרי התש"ע‬
129586
‫מערכת אוורור מלאכותית ושיטות בקרת‬
‫שאיפת פחמן דו–חמצני חוזרת‬
]33[
US
,‫אגמון‬-‫סורוקר‬
‫ הרצליה פיתוח‬,14 ‫ רחוב שנקר‬,‫בית נולטון‬
having a proximal end and a distal end
(122); the outer diameter of said inner
flexible tube being smaller than the inner
diameter of said outer flexible tube, said
inner flexible tube being at least partially
disposed within said outer flexible tube,
207
said distal end of said inner flexible tube
being disposed within and in direct fluid
communication with said outer flexible
tube, and a proximal fitting (130), said
unilimb respiratory conduit having a distal
end and a proximal end, said proximal
fitting located at said proximal end of said
unilimb repiratory conduit, and comprising
an inner pipe (134) and an outer pipe (136)
maintained in fixed coaxial spaced
relationship by spacing means, said outer
pipe and inner pipe each having a proximal
end and a distal end, wherein said distal
end of said inner pipe is operably
connected to said proximal end of said
inner flexible tube and said distal end of
said outer pipe is operably connected to
said proximal end of said outer flexible
tube, said proximal end of said pipes
capable of being operably connected to an
inspiratory gas input of the assisted
ventilation system while said proximal end
of the other one of said pipes is
simultaneously operably connectable to an
exhaust outlet, and wherein said distal end
of said unilimb respiratory conduit can be
operably connected to an airway device
connected to a mammal, and wherein a
user may connect said proximal fitting to
an assisted ventilation system in order to
use said unilimb respiratory conduit to
provide inspiratory gases and exhaust
expiratory gases from a mammal, and may
disconnect said proximal fitting from the
assisted ventilation system after use.
__________
]11[]21[
]54[
PHARMACEUTICAL
COMPOSITIONS CONTAINING
CARBOXYLIC ACIDS AND
DERIVATIVES THEREOF
]22[
]31[
]51[
]71[
]87[
]74[
23.06.1998
121165
]32[ 26.06.1997
Int. Cl.(2008.04) A61K 31/20
SYNDROME X LTD.
WO/1999/000116
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
208
133540
‫תכשירים רוקחיים המכילים חומצות‬
‫קרבוכסיליות ותולדות שלהן‬
]33[
IL
‫ ירושלים‬,‫סינדרום אקס בע"מ‬
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
[57] Pharmaceutical composition for
treating an HNF-4 mediated disease state
comprising a therapeutically effective
amount of a compound which inhibits
HNF-4 controlled transcription
independently of PPARα activation.
__________
]11[]21[
134127
‫מאניפולד לאספקת נוזלים לקטטר‬
]54[
MANIFOLD FOR
CATHETERIZATION
]22[
]51[
]71[
20.01.2000
Int. Cl.(2008.04) A61B 1/00, A61M 25/18, 39/22
NACHUM BORIVKER
BORIS VARSHITSKY
]74[
NACHUM BORIVKER,
5/15 KARPAS ST., JERUSALEM
[57] Manifold for catheterization having
some fixed working positions and
comprising: a housing (2), when on the
external side of the housing are six ports
and on the internal side of the housing
there is a hollow chamber (21); a valve
stem (5) positioned within the said
chamber of the housing and being
‫נחום בוריבקר‬
‫ גילה‬,‫בוריס ורשיצקי‬
,‫נחום בוריבקר‬
‫ גילה‬5\15 ‫רח' כרפס‬
constructed from a body with an upper
handle in order to move in the axis
direction into one of two working levels
and for rotating around its axis, all that for
establishing one of the said fixed working
positions; the body of the said valve stem
having fluid flow pathways for connecting
with the said ports.
__________
September 22, 2009
–‫ד' בתשרי התש"ע‬
209
]11[]21[
136137
‫ מבודדים ושיטות‬hedgehog ‫חלבוני‬
‫להכנתם‬
]54[
HEDGEHOG ISOLATED
PROTEINS AND METHODS OF
GENERATING THEM
]22[
]31[
03.12.1998
60/067423
]32[ 03.12.1997
]33[ US
60/078935
20.03.1998
US
60/089685
17.06.1998
US
60/099800
10.09.1998
US
Int. Cl.(2008.04) A61K 38/18, A61P 25/00, C07K 144/35
BIOGEN IDEC MA INC., U.S.A.
CURIS, INC., U.S.A.
]51[
]71[
]87[
]74[
WO/1999/028343
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57] An isolated protein comprising an Nterminal amino acid and a C-terminal
amino acid, which protein is modified at
the N-terminus with at least one
hydrophobic moiety, wherein the protein is
a hedgehog protein selected from:
(a) a portion with an N-terminal cysteine
that is appended with at least one
hydrophobic moiety;
(b) a protein with an N-terminal amino
acid that is not a cysteine appended with at
least one hydrophobic moiety; and
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
(c) a protein with at least one hydrophobic
moiety substituted for the N-terminal
amino acid; wherein the hedgehog protein
is not modified with a sterol, and wherein
the hydrophobic moiety is selected from (i)
a peptide comprising at least one
hydrophobic amino acid, (ii) a
hydrophobic amino acid or (iii) a lipid
moiety.
__________
210
September 22, 2009
–‫ד' בתשרי התש"ע‬
]11[]21[
136216
‫פוליפפטידים וחומצות גרעין המקודדות‬
‫אותם‬
]54[
POLYPEPTIDES AND NUCLEIC
ACIDS ENCODING THE SAME
]22[
]31[
01.12.1998
60/067411
]32[ 03.12.1997
]33[ US
60/069334
11.12.1997
US
60/069335
11.12.1997
US
60/069278
11.12.1997
US
60/069425
12.12.1997
US
60/069696
16.12.1997
US
60/069694
16.12.1997
US
60/069702
16.12.1997
US
60/069870
17.12.1997
US
60/069873
17.12.1997
US
60/068017
18.12.1997
US
60/070440
05.01.1998
US
60/074086
09.02.1998
US
60/074092
09.02.1998
US
60/075945
25.02.1998
US
Int. Cl.(2008.04) C07K 14/47, C12N 15/12, 15/13, 15/62
GENENTECH, INC., U.S.A.
WO/1999/028462
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
[57] Isolated nucleic acid encoding an
amino acid sequence having at least 80%
sequence identity to the amino acid
sequence shown in Figure 2 (SEQ ID
NO:2) as shown in the specification, or the
The applications for division
from this application have
not yet been published
complement thereof, wherein said
sequence identity is determined over the
full length of the sequences being
compared.
,197835,197834,197826,178210
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
________
]11[]21[
September 22, 2009
–‫ד' בתשרי התש"ע‬
137424
211
‫מולקולות חומצות גרעין התואמות פנוטיפ‬
‫ חלש‬D ‫רזוס‬
]54[
NUCLEIC ACID MOLECULES
CORRELATED WITH THE
RHESUS WEAK D PHENOTYPE
]22[
]31[
]51[
]71[
18.12.1998
98101203.2
]32[ 23.01.1998
]33[ DE
Int. Cl.(2008.04) C07K 14/47, 16/18, C12N 15/12, C12Q 1/68, G01N 335/66
DRK BLUTSPENDEDIENST
BADEN-WURTTEMBERG-HESSEN
GEMEINNUTZIGE GMBH,
GERMANY
WO/1999/037763
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬
HERZLIYA 46733
]87[
]74[
[57] A nucleic acid molecule encoding a
Rhesus D antigen contributing to or
indicative of the weak D phenotype, said
nucleic acid molecule carrying at least one
missense mutation, as compared to the
wild type Rhesus D antigen, in its
transmembrane and/or intracellular
regions.
__________
]11[]21[
]54[
SCALE READING APPARATUS
]22[
]31[
]51[
]71[
12.10.2000
9924331.3
]32[ 15.10.1999
Int. Cl.(2008.04) G01B 7/28
RENISHAW PLC, UNITED
KINGDOM
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
[57] A rotary ring for use in scale reading
apparatus, the ring being provided on a
surface thereof with scale marks defining a
periodic pattern, said scale marks being
readable by a reading of the scale reading
apparatus, wherein an inner
circumferential surface of the ring is
provided by a tapered surface at an angle
212
138995
‫התקן לקריאת סקלה‬
]33[
GB
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
relative to the axis of the ring, and wherein
the ring is mountable on a shaft having a
central longitudinal axis and an axis of
rotation separate from said longitudinal
axis, said ring being mounted such that it is
concentric with said axis of rotation,
thereby providing compensation for
eccentricity of the shaft.
September 22, 2009
–‫ד' בתשרי התש"ע‬
__________
]11[]21[
139452
‫נוגדן מבודד בעל זיקה לאפיטופ של‬
‫ ושימוש‬,‫ תצמיד הכולל אותו‬,‫פיברונקטין‬
‫שלו בהכנת תרופה לטיפול במחלות‬
‫הקשורות אנגיוגנסיס‬
]54[
ISOLATED ANTIBODY WITH
AFFINITY TO EPITOPE OF
FIBRONECTIN, CONJUGATE
COMPRISING IT AND USE
THEREOF IN THE PREPARATION
OF A MEDICAMENT FOR
TREATING DISEASES
ASSOCIATED WITH
ANGIOGENESIS
]22[
]31[
11.05.1999
09/075338
]32[ 11.05.1998
]33[ US
09/300425
28.04.1999
US
Int. Cl.(2008.04) A61K 47/48, 49/16, C07K 16/18
EIDGENOSSISCHE TECHNISCHE
HOCHSCHULE ZURICH,
SWITZERLAND
WO/1999/058570
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]51[
]71[
]87[
]74[
[57] An isolated antibody with specific
affinity for a characteristic epitope of the
Extra Domain B (ED-B) domain of
fibronectin, wherein the antibody has an
affinity to said ED-B epitope in the
subnanomolar range and recognizes EDB(+) fibronectin.
__________
September 22, 2009
–‫ד' בתשרי התש"ע‬
213
]11[]21[
]54[
]22[
]31[
]51[
]71[
]87[
]74[
139571
HUMANIZED ANTIBODY THAT
‫נוגדן אנושי המתקשר לורוטוקסין תהליכים‬
BINDS TO VEROTOXIN,
‫להכנתו ותכשירי רוקחות המכילים אותו‬
METHODS FOR THE
PRODUCTION THEREOF AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING IT
19.05.1999
60/086570
]32[ 20.05.1998
]33[ US
Int. Cl.(2008.04) A61K 39/40, A61P 39/02, C07K 16/12, C12N 5/10, C12P 21/08
TEIJIN LIMITED, JAPAN
PDL BIOPHARMA, INC., U.S.A.
WO/1999/059629
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
[57] A humanized antibody that
specifically binds to VT2 and/or VT2
variant.
__________
]11[]21[
]54[
MECHANICAL STRESS INDUCED
GENES, EXPRESSION PRODUCTS
THEREFROM AND USES
THEREOF
]22[
]31[
]51[
]71[
14.05.1999
60/085673
]32[ 15.05.1998
Int. Cl.(2008.04) C12Q 1/68
QUARK PHARMACEUTICALS,
INC., U.S.A.
WO/1999/060164
JUDITH ABRAHAMS,
P.O.B. 4071,
NES ZIONA 70400
]87[
]74[
[57] An isolated nucleic acid molecule
comprising SEQ ID NO:32 encoding
protein 608 or a functional portion thereof,
or a nucleic acid molecule which is at least
139637
‫ מוצרי‬,‫גנים הנוצרים ממתח מכני‬
‫ביטוימהם ושימושים שלהם‬
]33[
US
,‫ מפעלים בע"מ‬.‫אי‬.‫בי‬.‫ קיו‬,‫יהודית אברהמס‬
‫ נס ציונה‬,4071 .‫ד‬.‫ ת‬,
substantially homologous or identical
thereto encoding a polypeptide having the
same function.
__________
214
September 22, 2009
–‫ד' בתשרי התש"ע‬
]11[]21[
139927
‫מערכת רשת הנוצרת בצורה אוטומטית‬
‫בעלת בינה מלאכותית מבוזרת להספקת‬
‫ מדידה‬,‫ חישה מרחוק‬,‫שירותי מולטימדיה‬
,‫ נוכחות מרחוק‬,‫ תנועה מרחוק‬,‫מרחוק‬
‫ניהול מרחוק תיקשורת ועיבוד נתונים‬
‫בנפח ומהירות גבוהים‬
]54[
AUTOPOIETIC NETWORK
SYSTEM ENDOWED WITH
DISTRIBUTED ARTIFICIAL
INTELLIGENCE FOR THE
SUPPLY OF HIGH VOLUME
HIGH-SPEED MULTIMEDIA,
TELESTHESIA, TELEMETRY,
TELEKINESIS, TELEPRESENCE,
TELEMANAGEMENT,
TELECOMMUNICATIONS AND
DATA PROCESSING SERVICES
]22[
]31[
]51[
]71[
21.05.1999
330544
]32[ 29.05.1998
]33[ NZ
Int. Cl.(2008.04) G06N 3/00, 5/00, H04L 12/00, 12/28, 29/06
INDRANET TECHNOLOGIES
LIMITED, NEW ZEALAND
WO/1999/063450
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]87[
]74[
[57] An autopoietic networked
communication, control and network
and/or environmental management system,
comprising: a plurality of cybernetic
devices, each device adapted to
communicate with other cybernetic
devices in a networked system; processing
means located on selected devices for
controlling said devices, the operation of
the processing means in governed by a
library of algorithms which includes a
plurality of algorithms defining
predetermined functions which mediate
local and remote activities of the
networked system wherein the library of
algorithms is stored in media readable by
the processing means included within
selected devices in the networked system
September 22, 2009
–‫ד' בתשרי התש"ע‬
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
and distributed according to the functional
requirements of at least part of the
networked system; a plurality of sensing
means adapted to sense parameters related
to an environment in which the activities
occur and output environmental data
representative of the environment to
corresponding devices, wherein the
processing means is programmed to
control the activities of the networked
system through selection and execution of
said algorithms and wherein the selection
process occurs in a hermeneutic fashion
according to iterative heuristic sequences
which are dependent on said
environmental data and wherein the result
of the selection is dependent on
satisfaction of set criteria.
215
,171558
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
________
]11[]21[
140017
‫פוליאנהדרים‬
]54[
POLYANHYDRIDES
]22[
]51[
]71[
]72[
]74[
30.11.2000
Int. Cl.(2008.04) A61K 47/34, 9/22, A61P 19/00, 35/00, C08G 63/00, 67/04
EFRAT BIOPOLYMERS LTD.
‫ אפרת‬,‫אפרת ביופולימריים בע"מ‬
ABRAHAM J. DOMB
‫אברהם דומב‬
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
[57] A biodegradable aliphatic
polyanhydride multiblock copolymer
comprising random ester or amide bonds
along the polymer chain, synthesized by
the polymerization of a polyanhydride
formed of an aliphatic dicarboxylic acid
with a degree of polymerization (n) of 20
to 10,000, reacted with a polyfunctional
organic molecule that contains at least two
functional groups selected from the group
consisting of hydroxyl, amino, carboxylic
acid, and combinations thereof.
__________
216
September 22, 2009
–‫ד' בתשרי התש"ע‬
]11[]21[
140217
HCV ‫חלקיקים של מעטפת חלבוני‬
‫ושימושם לחיסון‬
]54[
PARTICLES OF HCV ENVELOPE
PROTEINS AND THEIR USE FOR
VACCINES
]22[
]31[
23.06.1999
98870142.1
]32[ 24.06.1998
]33[ EP
99870033.0
22.02.1999
EP
Int. Cl.(2008.04) A61K 39/29, 393/95, 48/00, A61P 31/12, C07K 14/18, 16/10, C12N
15/51, 15/63, 7/00, G01N 335/76
INNOGENETICS N.V., BELGIUM
WO/1999/067285
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
[57] An oligomeric particle consisting of
purified HCV envelope proteins and
having a diameter of 5 to 100 nanometer.
__________
]11[]21[
]54[
]22[
]31[
]51[
]71[
]87[
]74[
141516
PHARMACEUTICAL
‫תכשיר רוקחות המכיל ציקלופפטיד‬
PREPARATION CONTAINING A
‫ותכשיר כמוטרפויטי או מעכב אנגיוגנזיס‬
CYCLOPEPTIDE AND A
CHEMOTHERAPEUTIC AGENT
OR AN ANGIOGENESIS
INHIBITOR
09.09.1999
19842415.9
]32[ 16.09.1998
]33[ DE
Int. Cl.(2008.04) A61K 317/068, 38/12, A61P 19/00, 27/00, 31/00, 35/00, 7/00, 9/00,
C07K 7/50, 7/64
MERCK PATENT GMBH,
GERMANY
WO/2000/015244
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
‫ הרצליה‬,2081 .‫ד‬.‫ ת‬, 10 ‫שדרות אבא אבן‬
HERZLIYA 46120
[57] Pharmaceutical preparation
comprising cyclo (Arg-Gly-Asp-D-PheNMe-Val) and one or more additional
compounds, wherein at least one of the
additional compounds is selected from the
September 22, 2009
–‫ד' בתשרי התש"ע‬
gorup consisting of chemotherapeutic
agents and angiogenesis inhibitors other
than cyclo (Arg-Gly-Asp-D-Phe-NMeVal); and the physiologically acceptable
salts thereof, wherein the
217
chemotherapeutics are selected from the
group consisting of:
(a) alkylating agents,
(b) antibiotics,
(c) antimetabolites,
(d) biologicals and immunomodulators,
(e) hormones and antagonists thereof,
(f) mustard gas derivatives,
(g) alkaloids,
(h) protein kinase inhibitors,
(i) others, selected from the group
consisting of Altretamine, Cladribine,
Gemcitabine, Leucovorine, Levamisole,
Pentostatine and lrinotecane.
__________
]11[]21[
]54[
]22[
]31[
]51[
]71[
]87[
]74[
CYTOKINE RECEPTOR
‫ פולינוקליוטיד‬,ZALPHA11 ‫קולטן ציטוקין‬
ZALPHA11, POLYNUCLEOTIDE
‫המקודד לקולטן הנ"ל ושיטות המשתמשות‬
ENCODING SAID RECEPTOR
‫בקולטן הנ"ל‬
AND METHODS USING SAID
RECEPTOR
23.09.1999
09/159254
]32[ 23.09.1998
]33[ US
09/265117
09.03.1999
US
09/347930
06.07.1999
US
Int. Cl.(2008.04) C07K 147/15, 16/28, C12N 15/12, 15/19
ZYMOGENETICS INC., U.S.A.
WO/2000/017235
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
[57] An isolated polynucleotide that
encodes a zalpha 11 (cytokine receptor)
polypeptide comprising a sequence of
amino acid residues that is at least 90%
identical to an amino acid sequence
selected from the group consisting of:
(a) the amino acid sequence as shown in
SEQ ID NO:2 from amino acid number 20
(Cys), to amino acid number 237 (His);
(b) the amino acid sequence as shown in
SEQ ID NO:2 from amino acid number 20
(Cys), to amino acid number 255 (Leu);
(c) the amino acid sequence as shown in
SEQ ID NO:2 from amino acid number
The applications for division
from this application have
not yet been published
218
142164
256 (Lys), to amino acid number 538
(Ser);
(d) the amino acid sequence as shown in
SEQ ID NO:2 from amino acid number 20
(Cys), to amino acid number 538 (Ser);
and
(e) the amino acid sequence as shown in
SEQ ID NO:2 from amino acid number 1
(Met) to amino acid number 538 (Ser),
wherein the amino acid percent identity is
determined using a FASTA program with
ktup=1, gap opening penalty=10, gap
extension penalty=1, and substation
matrix=BLOSUM62, with other
parameters set as default.
,185764
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
_________
]11[]21[
142225
‫תכשירים רפואיים המכילים אנלוגית גאבא‬
‫לטיפול במניה ובהפרעות ביפולאריות‬
]54[
PHARMACEUTICAL
COMPOSITIONS COMPRISING
GABA ANALOGS FOR THE
TREATMENT OF MANIA AND
BIPOLAR DISORDER
]22[
]31[
]51[
]71[
18.08.1999
60/104535
]32[ 16.10.1998
]33[ US
Int. Cl.(2008.04) A61K 311/97, A61P 25/18, C07C 229/08, 229/28
WARNER-LAMBERT COMPANY
LLC, U.S.A.
WO/2000/023067
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
[57] Pharmaceutical composition for the
treatment of the symptorns of mania in a
mammal comprising a therapeutically
effective amount of a compound of the
formula
or a pharmaceutically acceptable salt
thereof wherein R1 is a straight or
branched alkyl of from 1 to 6 carbons,
phenyl, or cycloalkyl of from 3 to 6
carbons; R2 is hydrogen or methyl; and R3
is hydrogen, methyl, or carboxyl.
__________
]11[]21[
September 22, 2009
–‫ד' בתשרי התש"ע‬
142566
219
‫אנטגוניסט לאסטרוגן‬/‫שימוש באגוניסט‬
‫בהכנת תרופות לטיפול בהפרעה בגירוי‬
‫מיני אצל נשים‬
]54[
USE OF AN ESTROGEN
AGONIST/ANTAGONIST IN THE
PREPARATION OF
MEDICAMENTS FOR TREATING
SEXUAL AROUSAL DISORDER IN
A FEMALE SUBJECT
]22[
]31[
]51[
]71[
]74[
12.04.2001
60/266387
]32[ 18.04.2000
]33[ US
Int. Cl.(2008.04) A61K 31/40, 31/55, 314/45, 314/985, A61P 15/12
PFIZER PRODUCTS, INC., U.S.A.
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
[57] The use of an effective amount of an
estrogen agonist/antagonist wherein the
estrogen agonist/antagonist is a compound
of the formula
wherein:
A is selected from CH2 and NR;
B, D and E are independently selected
from CH and N; Y is
(a) phenyl, optionally substituted with 1-3
substituents independently selected from
R4;
(b) naphthyl, optionally substituted with 13 substituents independently selected from
R4;
(c) C3-C6 cycloalkyl, optionally substituted
with 1-2 substituents independently
selected from R4;
(d) C3-C8 cycloalkenyl, optionally
substituted with 1-2 substituents
independently selected from R4;
(e) a five membered heterocycle
containing up to two heteroatoms selected
from the group consisting of –O-, -NR2and –S(O)n-, optionally substituted with 1 3 substituents independently selected from
R4;
(f) a six membered heterocycle containing
up to two heteroatoms selected from the
group consisting of –O-, -NR2- and –
S(O)n- optionally substituted with 1-3
substituents independently selected from
R4; or
(g) a bicyclic ring system consisting of a
five or six membered heterocyclic ring
fused to a phenyl ring, said heterocyclic
ring containing up to two heteroatoms
selected from the group consisting of –O-,NR2- and –S(O)n-, optionally substituted
with 1-3 substituents independently
selected from R4; Z1 is
220
September 22, 2009
–‫ד' בתשרי התש"ע‬
(a) –(CH2)p W(CH2)q-;
(b) –O(CH2)p CR5R8-;
(c) –O(CH2)pW(CH2)q-;
(d) –OCHR2CHR3-; or
(e) –SCHR2CHR3-;
G is
(a) –NR7R8;
(b)
wherein n is 0, 1 or 2; m is 1, 2 or 3; Z2 is
–NH-, -O-, -S-, or –CH2-; optionally fused
on adjacent carbon atoms with one or two
phenyl rings and, optionally independently
substituted on carbon with one to three
substituents and, optionally, independently
on nitrogen with a chemically suitable
substituent selected from R4; or
(c) a bicyclic amine containing five to
twelve carbon atoms, either bridged or
fused and optionally substituted with 1-3
substituents independently selected from
R4; or Z1 and G in combination may be
W is
(a) –CH2-;
(b) –CH=CH-;
(f)
(c) –O-;
(d) –NR2-;
(e) –S(O)n-;
(g) –CR2(OH)-;
(h) –CONR2-;
(i) –NR2CO-;
(j)
(k) -C≡C-;
R is hydrogen or C1-C6 alkyl;
R2 and R3 are independently
(a) hydrogen; or
(b) C1-C4 alkyl;
R4 is
September 22, 2009
–‫ד' בתשרי התש"ע‬
(a) hydrogen;
(b) halogen;
(c) C1-C6 alkyl;
(d) C1-C4 alkoxy;
(e) C1-C4 acyloxy;
(f) C1-C4 alkylthio;
221
(g) C1-C4 alkylsulfinyl;
(h) C1-C4 alkylsulfonyl;
(i) hydroxy (C1-C4) alkyl;
(j) aryl (C1-C4) alkyl;
(k) –CO2H;
(l) –CN;
(m) –CONHOR;
(n) –SO2NHR;
(o) –NH2;
(p) C1-C4 alkylamino;
(q) C1-C4 dialkylamino;
(r) –NHSO2R;
(s) –NO2;
(t) –aryl; or
(u) –OH;
R5 and R6 are independently C1-C8 alkyl or
together form a C3-C10 carbocyclic ring; R7
and R8 are independently
(a) phenyl;
(b) a C3-C10 carbocyclic ring, saturated or
unsaturated;
(c) a C3-C10 heterocyclic ring containing
up to two heteroatoms, selected from –O-,
-N- and –S-;
(d) H;
(e) C1-C6 alkyl; or
(f) form a 3 to 8 membered nitrogen
containing ring with R5 or R6; R7 and R8 in
either linear or ring form may optionally
be substituted with up to three substituents
independently selected from C1-C6 alkyl,
halogen, alkoxy, hydroxy and carboxy; a
ring formed by R7 and R8 may be
optionally fused to a phenyl ring;
e is 0, 1 or 2;
m is 1, 2 or 3;
n is 0, 1 or 2;
p is 0, 1, 2 or 3;
q is 0, 1, 2 or 3;
or an optical or geometric isomer thereof;
or a pharmaceutically acceptable salt, Noxide, ester, quaternary ammonium salt or
prodrug thereof, and a cyclic guanosine
3',5-monophosphate elevator, which is the
PDEv phosphodiesterase inhbitor 1-[[3(6,7-dihydro-1-methyl-7-oxo-3-propyl-1Hpyrazolo [4,3-d] pyrimidin-5-yl)-4-ethoxyphenyl] sufonyl]-4-methylpiperazine
citrate salt in preparing a medicament for
treating sexual arousal disorder in a female
subject in need of treatment thereof.
__________
]11[]21[
222
144739
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫תכשירים רוקחיים המכילים מלחים קשי‬
‫תמס של פפטידים בטיוניים ונשאים‬
‫ ושיטות‬,‫מקרומולקולריים יוניים נגדיים‬
‫להכנתם‬
]54[
PHARMACEUTICAL
COMPOSITION COMPRISING A
WATER-INSOLUBLE SALT OF A
CATIONIC PEPTIDIC
COMPOUND AND A
COUNTERIONIC CARRIER
MACROMOLECULE AND
METHODS FOR THE
PREPARATION THEREOF
]22[
]31[
]51[
]71[
29.01.2000
60/119076
]32[ 08.02.1999
]33[ US
Int. Cl.(2008.04) A61K 38/00, 38/09, 47/48, 9/10, 9/14, 9/19
AETERNA ZENTARIS GMBH,
GERMANY
WO/2000/047234
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
]87[
]74[
[57] A method for preparing a
pharmaceutical formulation, comprising a
peptidic compound and a carrier
macromolecule; characterized by the steps
of forming the free ions of both
compounds by removing the counter ions;
combining the ionic peptidic compound
and the ionic carrier macromolecule under
conditions such that a water-insoluble salt
of the peptidic compound and the carrier
macromolecule forms; and preparing a
pharmaceutical formulation comprising the
water insoluble salt.
__________
]11[]21[
]54[
HEMOCOMPATIBLE SURFACES
AND METHOD FOR PRODUCING
SAME
September 22, 2009
–‫ד' בתשרי התש"ע‬
144912
‫משטחים המוקומפטיבילים ושיטה לייצרם‬
223
]22[
]31[
]51[
]71[
24.02.2000
19908318.5
]32[ 26.02.1999
Int. Cl.(2008.04) A61L 33/00, 33/18
ROLAND HORRES, GERMANY
MICHAEL HOFFMANN, GERMANY
]87[
]74[
WO/2000/050106
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57] Hemocompatible surfaces,
characterized in that they contain as
materials artificial and/or natural organic
and/or inorganic compounds and/or
mixtures thereof and/or materials having
contact with blood and/or other body fluids
in invasive operations and/or animal
organs and/or organ parts, and constituents
]33[
DE
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
of the outer layers of blood cells and/or
mesothelial cells comprising
oligosaccharide, polysaccharide and/or
lipid portions of the glycoproteins,
glycolipids and/or proteoglycans are
applied and/or incorporated onto and/or
into the surfaces of said materials.
__________
]11[]21[
]54[
PROCESS FOR PARTITIONING
OF PROTEINS OR CELLS
145337
‫תהליך לחציית חלבונים או תאים‬
]22[
]31[
24.03.2000
990667
]32[ 25.03.1999
]33[ FI
19991782
20.08.1999
FI
]51[ Int. Cl.(2008.04) C07K 1/14, 14/37, 7/06, 7/08, C12N 1/15, 15/62, 15/63
]71[ VALTION TEKNILLINEN
TUTKIMUSKESKUS, FINLAND
]72[ MERJA PENTTILA, TIINA
NAKARI-SETALA, RICHARD
FAGERSTROM, KLAUS SELBER,
MARIA-REGINA KULA, MARKUS
LINDER, FOLKE TJERNELD
]87[ WO/2000/058342
]74[ EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
[57] A process for partitioning of proteins
(a) in order to obtain a fusion protein or
or cells in aqueous two-phase systems
cell, combining a protein or a cell of
(ATPS), comprising the steps of
interest to a targeting protein selected from
the group consisting of hydrophobins and
224
September 22, 2009
–‫ד' בתשרי התש"ע‬
hydrophobin-like proteins and parts
thereof, and
(b) subjecting said fusion protein or cell
carrying the targeting protein to an ATPS
separation.
__________
]11[]21[
145673
‫שרפי פלואורופולימר המכילים קבוצות‬
‫יוניות או קבוצות העוברות יוניזציה‬
‫ותוצרים המכילים אותם‬
]54[
FLUOROPOLYMER RESINS
CONTAINING IONIC OR
IONIZABLE GROUPS AND
PRODUCTS CONTAINING THE
SAME
]22[
]31[
15.02.2001
60/182732
]32[ 15.02.2000
]33[ US
774266
30.01.2001
US
Int. Cl.(2008.04) C08F 8/00, C08G 63/48, H01M 2/00
ATOFINA CHEMICALS, INC., U.S.A.
WO/2001/060872
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
[57] A composition comprising the
polymer product of blending:
(a) at least one polymer comprising acrylic
units, vinyl units or both, and at least one
ionic or ionizable group, wherein said
ionic or ionizable group is a sulfonated
group or a phosphonated group or both;
and
(b) at least one thermoplastic
fluoropolymer, wherein (a) and (b) are
different.
__________
]11[]21[
]54[
MANAGING OBJECT
RELATIONSHIPS USING AN
OBJECT REPOSITORY
September 22, 2009
–‫ד' בתשרי התש"ע‬
146161
‫ניהול יחסי יעדים תוך שימוש במאגר יעדים‬
225
]22[
]31[
]51[
]71[
]87[
]74[
28.04.2000
60/131970
]32[ 30.04.1999
Int. Cl.(2008.04) G06F 17/30
INTERGRAPH HARDWARE
TECHNOLOGIES COMPANY, U.S.A.
WO/2000/067156
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] A method for updating information
in a database, comprising a first relation
between a first entity and a second entity
and a second relation between a second
entity and a third entity, the method
comprising: changing a first object of the
first entity; identifying the first relation as
being associated with the first object; using
the first relation and repository metadata,
]33[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
identifying the second entity as an active
entity; identifying a semantic object
associated with the active entity, wherein
the semantic object comprises an action to
be performed in response to a change in
the first entity; using arguments of the
semantic object, identifying the third
entity; and evaluating the action to change
the third entity.
__________
]11[]21[
]54[
226
TIMED DUAL RELEASE DOSAGE
FORMS COMPRISING A SHORT
ACTING HYPNOTIC OR A SALT
146928
‫תצורת מינון בעלת שחרור כפיל מתוזמן‬
‫המכילות חומר היפנוטי קצר טווח או מלח‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫שלו‬
THEREOF
]22[
]31[
]51[
]71[
]87[
]74[
27.06.2000
99401605.3
]32[ 28.06.1999
Int. Cl.(2008.04) A61K 9/00, 9/50
SANOFI AVENTIS, FRANCE
WO/2001/000181
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]33[
EP
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
hydrochloric acid buffer at 37oC,
comprising two release pulses, the first
release pulse being immediate, having a
maximum duration of 30 minutes, and the
second release pulse being delayed by a
fixed time of between 50 and 200 minutes
after the administration, the delayed
second release pulse lasting between 30
and 200 minutes.
[57] A pharmaceutical composition
comprising a short acting hypnotic or a salt
thereof characterised in that it consists of a
timed dual release dosage form adapted to
release the short acting hypnotic over a
predetermined time period, according to an
in vitro profile of dissolution when
measured in a rotating paddle apparatus of
the European pharmacopeia in 0.01 M
__________
]11[]21[
146954
‫ מתאים לבני–אדם‬ERB 2 ‫נוגדנים נגד‬
ErB2 ‫וטיפול בנוגדנים נגד‬
]54[
HUMANIZED ANTI-ERBB2
ANTIBODIES AND TREATMENT
WITH ANTI-ERBB2 ANTIBODIES
]22[
]31[
]51[
]71[
]87[
]74[
23.06.2000
60/141316
]32[ 25.06.1999
]33[ US
Int. Cl.(2008.04) A61K 393/95, A61P 35/00, C07K 16/32, C12N 15/13
GENENTECH, INC., U.S.A.
WO/2001/000245
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
[57] A humanized antibody which binds
ErbB2 and blocks ligand activation of an
ErbB receptor, the humanized antibody
comprising a variable heavy (VH) domain
which comprises nonhuman hypervariable
The applications for division
from this application have
not yet been published
region residues incorporated into a human
VH domain and further comprises
framework region (FR) substitutions at
positions 69H, 71H and 73H.
,197359
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
_________
September 22, 2009
–‫ד' בתשרי התש"ע‬
227
]11[]21[
]54[
COMPOSITION COMPRISING IL 11 AND A CRYOPROTECTANT
HAVING REDUCED IL-11
AGGREGATION
]22[
]31[
]51[
]71[
]87[
]74[
14.07.2000
354390
]32[ 15.07.1999
Int. Cl.(2008.04) A61K 38/20, 47/00
GENETICS INSTITUTE, LLC, U.S.A.
WO/2001/005355
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57] A composition comprising about 1
μg/ml to about 20 mg/ml IL-11, 100 to
about 400 mM glycine and 0.5 to about
2.0% wt/wt cryoprotectant, wherein said
147599
‫ וחומר מגן בפני נזק‬IL – 11 ‫הרחב המכיל‬
IL – 11 ‫בהקפאה עם אגרציה מופחתת של‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
IL-11 in said composition shows reduced
aggregation as compared to IL-11 stored in
a composition with glycine and without
said cryoprotectant.
__________
]11[]21[
147639
‫תהליך להכנת ניטרוקסי אלקיל–אסטרים‬
‫של נפרוקסן וניטרוקסי אלקיל–אסטרים‬
‫ואסטרים חדשים שמתקבלים בתהליך זה‬
]54[
PROCESS FOR THE
PREPARATION OF NAPROXENE
NITROXYALKYLESTERS AND
NOVEL CORRESPONDING
ESTERS PREPARED THEREBY
]22[
]31[
]51[
]71[
]87[
]74[
27.07.2000
MI99A001753 ]32[ 04.08.1999
]33[ IT
Int. Cl.(2008.04) C07B 41/12, 53/00, C07C 201/02, 203/04
NICOX S.A., FRANCE
WO/2001/010814
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
[57] A process for obtaining
nitroxyalkylesters of the 2-(S)-(6-methoxy2-naphthyl)-propanoic acid having an
enantiomeric excess higher than or equal
to 97%, preferably higher than or equal to
228
98%, characterized in that a halide of the
2-(S)-(6-methoxy-2-naphthyl)-propanoic
acid of formula A-Hal, wherein A is the
acyl residue of acid, is reacted in an inert
organic solvent with an aliphatic
September 22, 2009
–‫ד' בתשרי התש"ע‬
nitroxyalkanol HO-Y-ONO2, wherein Y is
as defined in the specification in the
presence of an inorganic base.
__________
]11[]21[
]54[
UNIT DOSE CAPSULES AND DRY
POWDER INHALER
]22[
]31[
21.07.2000
60/145464
]32[ 23.07.1999
60/206123
22.05.2000
Int. Cl.(2008.04) A61M 15/00
MANNKIND CORPORATION, U.S.A.
WO/2001/007107
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]71[
]87[
]74[
[57] A dry powder inhaler comprising: an
intake section (10), mechanically
connected to a mixing section (30), the
mixing section mechanically connected to
a mouthpiece; wherein the intake section
and mouthpiece each have a longitudinal
147724
‫קופסיות יחידת מינון ומשאף אבקה יבשה‬
]33[
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
axis, and, in use, air flows through a
passage extending from the intake section
through the mixing section and through the
mouthpiece; the dry powder inhaler further
comprising means for regulating the flow
rate of the air.
,188519
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
________
]11[]21[
]54[
MICROELECTROMECHANICAL
OPTICAL SWITCH AND METHOD
OF MANUFACTURE THEREOF
]22[
01.08.2000
September 22, 2009
–‫ד' בתשרי התש"ע‬
148039
‫מתג אופטי מיקרואלקטרומכני ושיטה‬
‫ליצורו‬
229
]31[
]51[
]71[
]87[
]74[
09/372265
]32[ 11.08.1999
Int. Cl.(2008.04) B81B 7/00
ADC TELECOMMUNICATIONS,
INC., U.S.A.
WO/2001/011411
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[57] A method of forming a mirror on a
substrate, comprising: forming, over the
substrate, a patterned masking layer
covering a first region of the substrate and
two side regions of the substrate each
adjacent a side of the first region;
removing uncovered portions of the
substrate using the patterned masking layer
to leave a first raised structure in the first
]33[
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
substrate region and two sacrificial raised
structures on each side substrate region
adjacent the first raised structure;
selectively removing the sacrificial raised
structures while leaving the first raised
structure intact; and forming a reflective
surface on a sidewall of the first raised
structure.
__________
]11[]21[
]54[
230
THERAPEUTIC COMPOSITION
COMPRISING A BINDING AGENT
THAT BINDS MUC-1 ANTIGEN
AND USE OF SAID BINDING
AGENT
148165
‫תכשיר תרפיוטי הכולל גורם קושר אנטיגן‬
‫ ושימוש של גורם הקושר הנ''ל‬MUC– 1
September 22, 2009
–‫ד' בתשרי התש"ע‬
]22[
]31[
]51[
]71[
]87[
]74[
18.08.2000
60/149492
]32[ 18.08.1999
]33[ US
Int. Cl.(2008.04) A61K 39/00, 393/95, C07K 16/30
ALTAREX MEDICAL CORP.,
CANADA
WO/2001/012217
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
[57] A non-radiolabelled therapeutic
composition comprising a binding agent
that specifically binds to an epitope of
tumor-associated MUC-1 and to both
circulating and tumor-bound tumorassociated MUC-1 wherein the epitope
comprises an immunological determinant
that includes carbohydrate and peptide,
and wherein said binding agent is
therapeutically effective in treating a
mammal having a tumor that expresses a
tumor-associated MUC-1.
__________
]11[]21[
149173
‫מוטנטים רקומבינטים מוחלשים של נגיף‬
‫הכלבת ותרכיבי חיסון שהוכנו מהם‬
]54[
ATTENUATED RECOMBINANT
RABIES VIRUS MUTANTS AND
LIVE VACCINES THEREOF
]22[
]31[
16.04.2002
01201464.3
]32[ 23.04.2001
]33[ NL
01203773.5
05.10.2001
NL
Int. Cl.(2008.04) A61K 392/05, C12N 15/47, 7/01, 7/04
INTERVET INTERNATIONAL B.V.,
THE NETHERLANDS
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
]51[
]71[
]74[
[57] Recombinant rabies virus mutant
comprising a mutation in the G protein as
well as a mutation in the P protein,
wherein the mutation in the G protein is an
amino acid substitution of the arginine at
position 333 for another amino acid and
wherein the mutation in the P protein is a
deletion of amino acids 143 to 149 or 139
to 149.
__________
]11[]21[
]54[
GENE MINING SYSTEM AND
METHOD
September 22, 2009
–‫ד' בתשרי התש"ע‬
149294
‫מערכת ושיטה להכוונת גנים למטרה‬
231
]22[
]31[
]51[
]71[
]87[
]74[
25.10.2000
60/161495
]32[ 26.10.1999
]33[ US
Int. Cl.(2008.04) C12N 15/09, G06F 17/50, 19/00
BIOLOGICAL TARGETS, INC.,
U.S.A.
WO/2001/031011
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
[57] A method to design primers which
identify and target a first nucleotide
sequence wherein the expression of said
first nucleotide sequence results in at least
one phenotypic characteristic, the method
comprising the steps of: providing a
second nucleotide sequence that is known
to result in the phenotypic characteristics
wherein the first nucleotide sequence and
second nucleotide sequence are derived
from different species; comparing the
second nucleotide sequence to nucleotide
sequences catalogued in one or more
databases that annotate nucleotide
sequences with phenotypic characteristics;
extracting any catalogued nucleotide
sequences that contain a portion of the
second nucleotide sequence and which are
annotated with said phenotypic
characteristic; aligning the second
nucleotide sequence to each extracted
nucleotide sequence; prioritizing according
to statistical analysis the extracted
nucleotide sequences based on at least
percent similarity with sequences having
the highest percent similarity being highest
in priority to ensure alignment to the
second nucleotide sequence as determined
by said statistical analysis; and designing
one or more primers based on matching
portions of the aligned prioritized
sequences, which primers identify and
target said first nucleotide sequence.
__________
]11[]21[
]54[
BALLISTIC ARMOR
]22[
]51[
]71[
]72[
12.05.2002
Int. Cl.(2008.04) F41H 5/04
PLASAN SASA
MOSHE RAVID, YOAV
232
149591
‫שריון בליסטי‬
‫ מרום הגליל‬.‫נ‬.‫ ד‬,‫פלסן סאסא‬
‫ יואב הירשברג‬,‫משה רביד‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
]74[
HIRSCHBERG
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
[57] A composite armor unit for
providing ballistic protection from an
impacting projectile threat, the unit
comprising a ceramic body (32) having a
cylindrical body portion (34) with two end
faces, one of which is adapted to face said
threat, and a non-ceramic belt member (36)
preformed to have inner and outer
surfaces, and a hollow region defined by
the inner surface and adapted to receive
therein said ceramic body; said belt
member being mounted on said ceramic
body so that said member contiguously
surrounds said cylindrical body portion
without covering said one end face.
__________
]11[]21[
]54[
N-[5-[[[5-ALKYL-2 OXAZOLYL]
METHYL]THIO]-2-THIAZOLYL]
CARBOXAMIDE DERIVATIVES
AND PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM
]22[
07.12.2000
September 22, 2009
–‫ד' בתשרי התש"ע‬
149755
–2–‫–אלקיל‬N–]5–]]]–5 ‫תולדות‬
[‫–תיאזוליל‬2–[‫אוקסאזוליל[מתיל[תיו‬
‫קרבוקסאמיד ותכשירי רוקחות המכילים‬
‫אותן‬
233
]31[
]51[
]71[
]87[
]74[
[57]
09/464511
]32[ 15.12.1999
]33[ US
09/616627
26.07.2000
US
Int. Cl.(2008.04) A61K 314/27, 314/54, A61P 35/00, C07D 417/00, 417/10, 417/14
BRISTOL-MYERS SQUIBB
COMPANY, U.S.A.
WO/2001/044242
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A compound of the formula
and enantiomers, diastereomers and
pharmaceutically acceptable salts thereof
wherein
R is t-butyl;
R1 is hydrogen or alkyl;
X is NR2 or CHNR2R3;
R2 and R3 are each independently
hydrogen, alkyl, substituted alkyl,
cycloalkyl or substituted cycloalkyl; and n
is 0, 1, 2 or 3.
__________
]11[]21[
]54[
LOCK
]22[
]51[
]71[
27.05.2002
Int. Cl.(2008.04) E05B 47/06
MUL-T-LOCK TECHNOLOGIES
LTD.
DEKEL PATENT LTD.,
18 MENUHA VENAHALA ST.,
REHOVOT 76209
]74[
[57] A lock comprising:
a body (10); a locking assembly (12)
arranged for selectable locking
engagement with respect to said body; a
magnetic coupling assembly (54, 56) for
retaining said locking assembly in a locked
orientation notwithstanding at least one of
vibration thereof and application of
mechanical shocks thereto; wherein said
locking assembly comprises a plug (18),
defining a keyway (20), which is rotatably
mounted within a bore (22) formed in said
234
149876
‫מנעול‬
‫ יבנה‬,‫מולטילוק טכנולוגיות בע"מ‬
,‫דקל פטנט בע"מ‬
‫ רחובות‬,27 ‫חדר‬, 18 ‫מנוחה ונחלה‬
body, wherein said keyway communicates
with locking pins in the plug, which in turn
cooperate with locking pins in said body,
to provide conventional key-operated
locking of the plug relative to said body; a
lockable assembly (34) disposed in a
portion (24) of said plug, which is
operative for selectable looking of said
plug within said body, wherein said
locking assembly comprises a housing (36)
fixed within said plug and an actuator (38)
disposed within said housing, said locking
September 22, 2009
–‫ד' בתשרי התש"ע‬
assembly being operated by an electrical
circuit (26), and wherein said actuator
selectably rotatably positions a partially
cut away cylindrical locking element (40);
and a selectably positionable locking
element (42) mounted on said housing
which is normally urged into engagement
with a corresponding socket (46), and
wherein said selectably positionable
locking element is lockingly retained in
engagement with said socket by suitable
positioning of said cylindrical locking
element by said actuator.
__________
]11[]21[
150065
‫תאי גזע או עובריים המיוצרים באמצעות‬
‫השתלה גרעינית של מינים מוצלבים‬
]54[
EMBRYONIC OR STEM-LIKE
CELLS PRODUCED BY CROSS
SPECIES NUCLEAR
TRANSPLANTATION
]22[
]31[
]51[
]71[
10.05.2000
467076
]32[ 20.12.1999
]33[ US
Int. Cl.(2008.04) C12N 15/08, 15/09, 15/87, 5/02, 5/10
UNIVERSITY OF
MASSACHUSETTS, U.S.A.
WO/2001/046401
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
]87[
]74[
[57] A method of producing embryonic
or stem-like cells comprising the following
steps:
(i) inserting a donor differentiated human
or mammalian cell or cell nucleus into a
recipient animal oocyte, wherein such
oocyte is derived from a different animal
species than the human or mammalian cell
under conditions suitable for the formation
of a nuclear transfer (NT) unit, wherein the
endogenous oocyte nucleus is removed or
September 22, 2009
–‫ד' בתשרי התש"ע‬
inactivated before, concurrent, or after
introduction of donor cell or nucleus;
(ii) activating the resultant nuclear transfer
unit;
(iii) additionally inserting into said oocyte
cytoplasm derived from an oocyte or
blastomere of the same species as the
donor cell or nucleus ("compatible
cytoplasm");
(iv) culturing said activated nuclear
transfer unit until greater than the 2 cell
developmental stage; and
235
(v) culturing cells obtained from said
cultured NT units to obtain embryonic or
stem-like cells.
__________
]11[]21[
150222
‫תכשירי רוקחות המכילים מטבולית של‬
‫גיפירון‬
]54[
PHARMACEUTICAL
COMPOSITIONS CONTAINING A
GEPIRONE METABOLITE
]22[
]31[
18.12.2000
60/172684
]32[ 20.12.1999
]33[ US
09/709741
13.11.2000
US
Int. Cl.(2008.04) A61K 314/96, A61P 25/00, C07D 401/00
FABRE-KRAMER
PHARMACEUTICALS, INC., U.S.A.
EDWARD H. RUEDIGER, CANADA
JOSEPH P. YEVICH, U.S.A.
WO/2001/045687
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]51[
]71[
]87[
]74[
[57] The use of a gepirone metabolite, or
pharmaceutically acceptable salt or hydrate
thereof for the manufacture of a
medicament for administration to a
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
mammal, wherein the gepirone metabolite
is selected from the group consisting of 3OH gepirone and 3,5-dihydroxy gepirone.
__________
]11[]21[
]54[
236
AGRICULTURAL OR
HORTICULTURAL FUNGICIDAL
COMPOSITIONS CONTAINING
CYANOMETHYLENE
COMPOUNDS, SOME SUCH
NOVEL COMPOUNDS AND
PROCESS FOR PREPARING
THEM
150293
‫תכשירים קוטלי פטריות לחקלאות או‬
,‫לגננות המכילים תרכובות ציאנומתילן‬
‫מספר תרכובות ציאנומתילן כאלו ותהליך‬
‫להכנתן‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
]22[
]31[
]51[
]71[
]87[
]74[
05.09.2000
11/367615
]32[ 24.12.1999
]33[ JP
Int. Cl.(2008.04) A01N 43/72, C07D 277/10, 277/22, 279/06, 281/02, 281/18, 291/08,
417/04, 417/12, 417/14, 419/04, 419/12, 419/14
OTSUKA CHEMICAL CO., LTD.,
JAPAN
WO/2001/047902
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
[57] A fungicidal composition, for use in
agriculture and horticulture, comprising a
cyanomethylene compound of the formula
wherein: A, R1, and R are as defined in the
specification.
Claimed as novel are the compounds of
formula (1) wherein:
R is phenyl, optionally substituted with at
least one substituent selected from the
group consisting of a halogen atom, C1-4
alkyl, C1-4 haloalkyl, C1-4 alkoxy, C1-4
haloalkoxy, C1-4 alkylcarbonyl, C1-4
alkylthio and cyano; R1 is phenyl or
pyridyl, the phenyl and the pyridyl
optionally substituted with at least one
substituent selected from the group
consisting of a halogen atom, C1-4 alkyl,
C1-4 haloalkyl, C1-4 alkoxy, C1-4
haloalkoxy, C1-4 alkoxycarbonyl, C1-4
alkylamino, di-C1-4 alkylamino, C2-4
alkenyl, C1-4 alkylthio, C1-4 alkylsulfinyl,
C1-4 alkylsufonyl, phenyl, phenoxy, nitro
and cyano; A is C1-6 straight-chain or
branched-chain alkylene; and Y is a sulfur
atom.
__________
]11[]21[
150481
‫–אמינו– ניקוטינאמיד ושימושן‬2 ‫נגזרות של‬
‫ של טירוזין‬VEGF– ‫כמעכבים של רצפטור‬
‫קינאז‬
]54[
2-AMINO-NICOTINAMIDE
DERIVATIVES AND THEIR USE
AS VEGF-RECEPTOR TYROSINE
KINASE INHIBITORS
]22[
]31[
]51[
25.01.2001
0001930.7
]32[ 27.01.2000
]33[ GB
Int. Cl.(2008.04) A61K 314/35, A61P 35/00, C07D 213/78, 213/89, 401/12, 401/14,
417/12
NOVARTIS AG, SWITZERLAND
]71[
September 22, 2009
–‫ד' בתשרי התש"ע‬
237
]87[
]74[
WO/2001/055114
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
[57] Use of a compound of the formula
wherein
n is from 1 up to and including 6;
W is O or S;
R1 and R3 represent independently of each
other hydrogen, lower alkyl or lower acyl;
R2 represents cyclohexyl, phenyl,
indazolyl, thiazolyl, benzo[d]thiazolyl,
benzo[d] pyrazolyl or isoquinolinyl, which
in each case is unsubstituted or mono-or
disubstituted by C1-C7 alkyl, C1-C7 alkenyl
or C1-C7 alkynyl, wherein each radical R2
can be unsubstituted or mono-or
polysubstituted with halogen; R and R1 are
independently of each other hydrogen or
lower alkyl; X represents phenyl, pyridyl,
primidyl or quinolyl, which in each case is
unsubstituted or mono-or polysubstituted
by oxo, hydroxy, N-C1-C7 alkylcarbamoyl, C1-C7 alkyl or C1-C7 alkoxy; or
of a N-oxide or a possible tautomer
thereof; or of a pharmaceutically
acceptable salt of such a compound for the
preparation of a pharmaceutical
composition for the treatment of a disease
which responds to an inhibition of the
VEGF receptor tyrosine kinase activity.
__________
]11[]21[
150851
‫אבקה מתכתית המכילה חנקן ותהליך‬
‫להכנתה‬
]54[
NITROGEN CONTAINING
METALLIC POWDER AND
METHODS FOR THE
PRODUCTION THEREOF
]22[
]31[
]51[
]71[
22.07.2002
2000-31029
]32[ 08.02.2000
]33[ JP
Int. Cl.(2008.04) B22F 9/24, C22C 1/04, H01G 90/52
CABOT SUPER METALS K.K.,
238
September 22, 2009
–‫ד' בתשרי התש"ע‬
]74[
JAPAN
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] A nitrogen-containing metallic
powder consisting essentially of tantalum
containing 50-20,000 ppm nitrogen in a
form of solid solution, and optionally
containing phosphorus, boron, oxygen, or
combinations thereof, and wherein
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
substantially all of any nitrogen present in
said nitrogen-containing metallic powder
is in the form of solid solution, and said
nitrogen-containing metallic powder has a
mean particle size of 80 to 360 nm.
__________
]11[]21[
]54[
METHOD, APPARATUS AND
COMPUTER PROGRAM
PRODUCT FOR PROVIDING
SECURITY OF JAVA OBJECTS
]22[
]51[
]71[
]74[
28.07.2002
Int. Cl.(2008.04) G06F 21/22
YURY BENDERSKY
YURY BENDERSKY,
4 MATA ST.,
OFRA 90627
[57] A method for a secure authentication
of a Java object (as a client) via a Java
virtual machine and a web browser and a
web server or a local computer (as a
server), the method comprising the steps
of: loading a Java class file for the client
from the server (from the web site or from
the local file system) to a byte array;
defining the Java class from the loaded
byte array; starting the Java client object;
calculation of the secure authentication ID
(digest) of the said Java object, comprising
in its turn the calculation of: the digest of
September 22, 2009
–‫ד' בתשרי התש"ע‬
150933
‫ ומוצר תוכנת מחשב‬,‫ מכשיר‬,‫שיטה‬
‫לאספקת אבטחה של עצמים של ג'ווא‬
‫ עופרה‬,‫יורי בנדרסקי‬
,‫יורי בנדרסקי‬
‫ עופרה‬,4‫מטע‬
the said Java object itself via reflection of
the said Java object as well as the
serialization of the said Java object
(parsing and analysis of the Java class
file); the digests of the external objects,
including the system ClassLoader, the
JVM parameters, and the digests of the
calling Java objects (if any); and, finally,
the calculation of the general digest of the
aforementioned entities; creating the
secure connection between the Java client
and the server; and approving the secure
authentication ID by the server.
239
__________
]11[]21[
151695
‫בטא–קרבולינים מותמרים בעלי פעילות‬
‫–קינאז‬IKB ‫מעכבת‬
]54[
SUBSTITUTED BETACARBOLINES WITH IKB-KINASE
INHIBITING ACTIVITY
]22[
]31[
28.02.2001
00105514.4
]32[ 15.03.2000
]33[ EP
00125169.3
18.11.2000
EP
Int. Cl.(2008.04) A61K 31/44, A61P 29/00, C07D 471/04, 498/12
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2001/068648
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬
HERZLIYA 46733
]51[
]71[
]87[
]74[
[57] A compound of the formula
240
September 22, 2009
–‫ד' בתשרי התש"ע‬
or a stereoisomeric form of a compound of
the formula I or a physiologically tolerable
salt of a compound of the formula I, where
B6, B7, B8 and B9 are ring atoms
independently chosen from carbon atoms
and nitrogen atoms, where B6, B7, B8 and
B9 together comprise not more than two
nitrogen atoms; wherein in case (a) the
substituents R1, R2 and R3 may be
independently chosen from:
(1.1) hydrogen atom,
(1.2) halogen,
(1.3) –CN,
(1.4) –COOH,
(1.5) –NO2,
(1.6) –NH2,
(1.7) –O-(C1-C10)-alkyl, wherein alkyl is
unsubstituted or mono- to pentasubstituted by substituents independently
chosen from:
1.7.1 phenyl, which is unsubstituted or
mono-to penta-substituted by substituents
indepdenently chosen from halogen or –O(C1-C4)-alkyl,
1.7.2 halogen,
1.7.3 –NH2,
1.7.4 –OH,
1.7.5 –COOR16, wherein R16 is hydrogen
atom or –(C1-C10)-alkyl,
1.7.6 –NO2,
1.7.7 –S(O)y –R14, wherein y is zero, 1 or
2, R14 is –(C1-C10)-alkyl, phenyl, which
phenyl is unsubstituted or mono- to pentasubstituted by substituents independently
chosen from those defined under 1.7.1 to
1.7.11, amino or –N(R13)2, wherein R13 is
independently of one another chosen from
hydrogen atom, phenyl, -(C1-C10)-alkyl, C(O)-(C1-C7)-alkyl, -C(O)-phenyl, -C(O)NH-phenyl, -C(O)-O-(C1-C7)-alkyl, -S(O)y
–R14, wherein R14 and y are as defined in
1.7.7, and wherein the R13 alkyl or phenyl
groups in each case are unsubstituted or
mono-to penta-substituted by substituents
independently chosen from those as
defined under 1.7.1 to 1.7.11, or R13
together with the nitrogen atom to which it
is bonded may be independently chosen to
September 22, 2009
–‫ד' בתשרי התש"ע‬
form a heterocycle having 5 to 7 ring
atoms, 1.7.8 –O-phenyl, wherein phenyl is
unsubstituted or mono- to pentasubstituted independently of one another as
defined under 1.7.1 to 1.7.11, 1.7.9 a
radical selected from pyrrolidine,
tetrahydropyridine, piperidine, piperazine,
imidazoline, pyrazolidine, furan,
morpholine, pyridine, pyridazine, pyrazine,
oxolan, imidazoline, isoxazolidine, 2isoxazoline, isothiazolidine, 2isothiazoline, thiophene or thiomorpholine,
1.7.10 –(C3-C7) – cycloalkyl or 1.7.11=O,
(1.8) –N(R13)2, wherein R13 is as defined in
1.7.7 above,
(1.9) –NH-C(O)-R, wherein R15 is
1.9.1 a radical selected from pyrrolidine,
tetrahydropyridine, piperidine, piperazine,
imidazoline, pyrazolidine, furan,
morpholine, pyridine, pyridazine, pyrazine,
oxolan, imidazoline, isoxazolidine, 2isoxazoline, isothiazolidine, 2isothiazoline, thiophene or thiomorpholine,
wherein said radical is unsubstituted or
mono-to penta-substituted by substituents
independently chosen from as defined
under 1.7.1 to 1.7.11 above, by –CF3, by
benzyl or by –(C1-C10)-alkyl, wherein the –
(C1-C10) – alkyl is mono to tri-substituted
by substituents independently chosen from
those as defined under 1.7.1 to 1.7.11
above, 1.9.2 –(C1-C10)-alkyl, wherein alkyl
is unsubstituted or mono-to pentasubstituted by substituents independently
chosen from those as defined under 1.7.1
to 1.7.11 above or by –O-(C1-C10)-alkyl,
wherein alkyl is unsubstituted or mono-to
penta-substituted by substituents
independently chosen from those as
defined under 1.7.1 to 1.7.11 above,
1.9.3-(C3-C7)-cycloalkyl,
1.9.4-N(R13)2, wherein R13 is as defined in
1.7.7 above, or
1.9.5 phenyl, wherein phenyl is
unsubstituted or mono-to penta-substituted
by substituents independently chosen from
those as defined under 1.7.1 to 1.7.11
above, by –O-(C1-C10)-alkyl, by –CN, by –
241
CF3, by –(C1-C10)-alkyl, wherein alkyl is
mono to tri-substituted by substituents
independently chosen from those as
defined under 1.7.1 to 1.7.11 above, or by
two substituents of said phenyl which form
a dioxolan ring,
(1.10) –S(O)y-R14, wherein R14 and y are
as defined in 1.7.7 above,
(1.11) –O(O)-R12, wherein R12 is phenyl or
–(C1-C7)-alkyl, wherein alkyl or phenyl are
unsubstituted or mono-to penta-substituted
by substituents independently chosen from
those as defined under 1.7.1 to 1.7.11
above,
(1.12) –O(O)-O-R12, wherein R12 is as
defined in 1.11 above,
(1.13) –(C1-C10)-alkyl, wherein alkyl is
unsubstituted or mono- to pentasubstituted by substituents independently
chosen from those as defined under 1.7.1
to 1.7.11 above,
(1.14) –O-(C1-C6)-alkyl-O- (C1-C6)-alkyl,
(1.15)-O-(C0-C4)-alkyl-(C3-C7)-cycloalkyl,
(1.16)-(C1-C4)-alkyl-N(R13)2, wherein R13
is as defined in 1.7.7 above
(1.17)-CF3 or
(1.18) –CF2-CF3,
R4 is
(1) –(C1-C10)-alkyl, wherein alkyl is monoto penta-substituted by substituents
independently chosen from those as
defined under 1.7.1 to 1.7.10 above,
(2)-CF3,
(3)-CF2-CF3,
(4)-CN,
(5)-S(O)y-R14, wherein R14 and y are as
defined in 1.7.7 above,
(6)-NH2,
(7) –O-(C1-C10)-alkyl, wherein alkyl is
mono-to penta-substituted by substituents
independently chosen from 7.1 phenyl,
which is unsubstituted or mono-to pentasubstituted by substituents independently
chosen from halogen or –O-(C1-C4)-alkyl,
7.2 halogen,
7.3 –NH2,
7.4-OH,
242
7.5-COOR16, wherein R16 is hydrogen
atom or –(C1-C10)-alkyl,
7.6 –NO2,
7.7-S(O)y-R14, wherein y is zero, 1 or 2,
R14 is –(C1-C10)-alkyl, phenyl, which
phenyl is unsubstituted or mono- to pentasubstituted by substituents independently
chosen from those as defined under 1.7.1
to 1.7.11, amino or wherein R13 is
independently of one another chosen from
hydrogen atom, phenyl, -(C1-C10)-alkyl, C(O)-(C1-C7)-alkyl, -C(O)-phenyl, - C(O)NH-(C1-C7)-alkyl, -C(O)-O-phenyl, -C(O)NH-phenyl,-C(O)-O-(C1-C7)-alkyl, -S(O)yR14, wherein R14 and y are defined as in
7.7 above, and wherein the R13 alkyl or
phenyl groups in each case are
unsubstituted or mono-to penta-substituted
by substituents independently chosen from
those as defined under 1.7.1 to 1.7.11
above, or R13 together with the nitrogen
atom to which it is bonded form a
heterocycle having 5 to 7 ring atoms 7.8O-phenyol, wherein phenyl is unsubsituted
or mono-to penta-substituted by
substituents independently chosen from
those as defined under 1.7.1 to 1.7.11
above,
7.9 a radical selected from pyrrolidine,
tetrahydropyridine, piperidine, piperazine,
imidazoline, pyrazolidine, furan,
morpholine, pyridine, pyridazine, pyrazine,
oxolan, isoxazolidine, thiophene, 2isoxazoline, isothiazolidine, 2isothiazoline, or thiomorpholine, 7.10-(C3C7)-cycloalkyl or 7.11=O,
(8) –N(R17)2, wherein R17 is independently
of one another chosen from hydrogen
atom, phenyl, -(C1-C10)-alkyl, -C(O)phenyl, -C(O)-NH-(C1-C7)-alkyl, -C(O)(C1-C10)-alkyl, -C(O)-O-phenyl, -C(O)NH-phenyl, -C(O)-O-(C1-C7)-alkyl, S(O)y-R14, wherein R14 and y are as
defined as in 7.7 above, and wherein alkyl
or phenyl in each case are unsubstituted or
mono-to penta-substituted independently
of one another as defined under 1.7.1 to
September 22, 2009
–‫ד' בתשרי התש"ע‬
1.7.11 above, or R17 together with the
nitrogen atom to which it is bonded form a
heterocycle having 5 to 7 ring atoms,
(9)-NH-C(O)-R15, wherein R15 is
9.1 a radical selected from pyrrolidine,
tetrahydropyridine, piperidine, piperazine,
imidazoline, pyrazolidine, furan,
morpholine, pyridine, pyridazine, pyrazine,
oxolan, imidazoline, isoxazolidine, 2isoxazoline, isothiazolidine, 2isothiazoline, thiophene or thiomorpholine,
wherein said radical is unsubstituted or
mono-to penta-substituted by substituents
independently chosen from those as
defined under 1.7.1 to 1.7.11 above, -CF3,
benzyl or by –(C1-C10)-alkyl, wherein alkyl
is mono to tri-substituted by substituents
independently chosen from those as
defined under 1.7.1 to 1.7.11 above,
9.2 –(C1-C10)-alkyl, wherein alkyl is
mono- to penta-substituted by substituents
independently chosen from those as
defined under 1.7.1 to 1.7.11 above or by –
O-(C1-C10)-alkyl, wherein alkyl is
unsubstituted or mono-to penta-substituted
by substituents independently chosen from
those as defined under 1.7.1 to 1.7.11
above,
9.3-(C3-C7)-cycloalkyl,
9.4-N(R13)2, wherein R13 is as defined in
1.7.7 above provided that – N(R13)2 is not
–NH2, or
9.5 phenyl, wherein phenyl is
unsubstituted or mono- to pentasubstituted by substituents independently
chosen from those as defined under 1.7.1
to 1.7.11 above, by –O-(C1-C10)-alkyl, by –
CN, by –CF3, by –(C1-C10)-alkyl, wherein
alkyl is mono to tri-substituted by
substituents independently chosen from
those as defined under 1.7.1 to 1.7.11
above, or by two substituents of the phenyl
radical which form a dioxolan ring,
(10) –O(O)-R12, wherein R12 is phenyl or –
(C1-C7)-alkyl, wherein phenyl or alkyl are
mono-to penta-substituted by substituents
independently chosen from those as
defined under 1.7.1 to 1.7.11 above,
September 22, 2009
–‫ד' בתשרי התש"ע‬
(11)-O(O)-O-R12, wherein R12 is phenyl or
–(C1-C7)-alkyl, wherein phenyl or alkyl are
mono-to penta-substituted by substituents
independently chosen from those as
defined under 1.7.1 to 1.7.11 above,
(12) –O-(C1-C6)-alkyl-O-(C1-C6)-alkyl,
(13) –O-(C0-C4)-alkyl-(C3-C7)-cycloalkyl
or
(14) –(C1-C4)-alkyl-N(R13)2, wherein R13 is
as defined in 1.7.7 above, R5 is
(1) a hydrogen atom,
(2) –(C1-C10)-alkyl, wherein alkyl is
unsubstituted or mono-to penta-substituted
by substituents independently chosen from
those as defined under 1.7.1 to 1.7.4
above,
(3) –C(O)-R9, wherein R9 is
-NH2, -(C1-C10)-alkyl, wherein alkyl is
unsubsituted or mono-to penta-substituted
by substituents independently chosen from
those as defined under 7.1 to 7.4, or –
N(R13)2, wherein R13 is as defined in 1.7.7
above, or
(4) –S(O)2-R9, wherein R9 is as defined in
3 above, or
R4 and R5 together with the atom to which
they are bonded form a heterocycle, or R3
and R5 together with the atom to which
they are bonded form a heterocycle
containing an additional oxygen atom in
the ring and R6, R7 and R8 independently
of one another are chosen from hydrogen
atom or methyl, or in case (b) the
substituents R1, R2 and R4 may be
independently chosen as defined under 1.1
to 1.18 in case (a) above,
R3 is
(1)-CF3,
(2)-CF2-CF3,
(3)-CN,
(4)-COOH,
(5)-NO2,
(6)-NH2,
(7)-O-(C1-C10)-alkyl, wherein alkyl is
mono-to penta substituted by substituents
independently chosen from
7.1 phenyl, which is unsubstituted or
mono-to penta-substituted by substituents
243
independently chosen from halogen or –O(C1-C4)-alkyl,
7.2 halogen,
7.3 –NH2,
7.4 – OH,
7.5 – COOR16, wherein R16 is hydrogen
atom or –(C1-C10)-alkyl,
7.6 – NO2,
7.7 – S(O)y – R14, wherein y is zero, 1 or 2,
R14 is –(C1-C10)-alkyl, phenyl, which
phenyl is unsubstituted or mono-to pentasubstituted by substituents independently
chosen from those as defined under 1.7.1
to 1.7.11, amino or wherein R13 is
independently of one another chosen from
hydrogen atom, phenyl, -(C1-C10)-alkyl, C(O)-(C1-C7)-alkyl, -C(O)-phenyl, - C(O)NH-(C1-C7)-alkyl, -C(O)-O-phenyl, -C(O)NH-phenyl, - C(O)-O-(C1-C7)-alkyl, S(O)y –R14, wherein R14 and y are defined
as in 7.7 above, and wherein the R13 alkyl
or phenyl groups in each case are
unsubstituted or mono-to penta-substituted
by substituents independently chosen from
those as defined under 1.7.1 to 1.7.11
above, or R13 together with the nitrogen
atom to which it is bonded form a
heterocycle having 5 to 7 ring atoms, 7.8 –
O-phenyl, wherein phenyl is unsubsituted
or mono-to penta-by substituents
independently chosen from those as
defined under 1.7.1 to 1.7.11 above,
7.9 a radical selected from
tetrahydropyridine, piperidine, piperazine,
imidazoline, pyrazolidine, furan,
morpholine, pyridine, pyridazine, pyrazine,
oxolan, isoxazolidine, 2-isoxazoline,
isothiazolidine, 2-isothiazoline, thiophene
or thiomorpholine,
7.10 – (C3-C7)-cycloalkyl or
7.11=O,
(8)-N(R13)2, wherein R13 is as defined in
1.7.7 above,
(9)-NH-C(O)-R15, wherein R15 is
9.1 a radical selected from pyrrolidine,
tetrahydropyridine, piperidine, piperazine,
imidazoline, pyrazolidine, furan,
244
morpholine, pyridine, pyridazine, pyrazine,
oxolan, imidazoline, isoxazolidine, 2isoxazoline, isothiazolidine, 2isothiazoline, thiophene or thiomorpholine,
wherein said radical is unsubstituted or
mono-to penta-substituted by substituents
independently chosen from those as
defined under 1.7.1 to 1.7.11 above, -CF3,
benzyl or by –(C1-C10)-alkyl, wherein alkyl
is mono to tri-substituted by substituents
independently chosen from those as
defined under 1.7.1 to 1.7.11 above,
9.2 –(C1-C10)-alkyl, wherein alkyl is
unsubsituted or mono-to penta-substituted
by substituents independently chosen from
those as defined under 1.7.1 to 1.7.11
above or by –O-(C1-C10)-alkyl, wherein
alkyl is unsubstituted or mono-to pentasubstituted by substituents independently
chosen from those as defined under 1.7.1
to 1.7.11 above,
9.3-(C3-C7)-cycloalkyl,
9.4-N(R13)2, wherein R13 is as defined in
1.7.7 above, or
9.5 phenyl, wherein phenyl is
unsubstituted or mono-to penta-substituted
by substituents independently chosen from
those as defined under 1.7.1 to 1.7.11
above, by –O-(C1-C10)-alkyl, by –CN, by
CF3, by –(C1-C10)-alkyl, wherein alkyl is
mono to tri-substituted by substituents
independently chosen from those as
defined under 1.7.1 to 1.7.11 above, or by
two substituents of the phenyl radical
which form a dioxolan ring,
(10)-S(O)y-R14, wherein R14 and y are as
defined in 1.7.7 above,
(11)-C(O)-R12, wherein R12 is phenyl or –
(C1-C7)-alkyl, wherein phenyl or alkyl are
unsubstituted or mono-to penta-substituted
by substituents independently chosen from
those as defined under 1.7.1 to 1.7.11
above,
(12) –O(O)-O-R12, wherein R12 is phenyl
or –(C1-C7)-alkyl, wherein phenyl or alkyl
are unsubstituted or mono-to pentasubstituted by substituents independently
September 22, 2009
–‫ד' בתשרי התש"ע‬
chosen from those as defined under 1.7.1
to 1.7.11 above,
(13)-(C1-C10)-alkyl, wherein alkyl is
unsubsituted or mono-to penta-substituted
by substituents independently chosen from
those as defined under 1.7.1 to 1.7.11
above,
(14)-O-(C1-C6)-alkyl-O-(C1-C6)-alkyl,
(15)-O-(C0-C4)-alkyl-(C3-C4)-cycloalkyl or
(16)-(C1-C4)-alkyl-N(R13)2, wherein R13 is
as defined in 1.7.7 above, R5 is as defined
as R5 in a case (a) above,
R6, R7 and R8 independently of one another
are chosen from hydrogen atom or methyl,
with the following provisos for case (b):
when R6 is methyl, R3 is not an O-(C1C10)-alkyl monosubstituted by either an
unsubstituted phenyl or a –COO-(C1-C10)alkyl; and when R3 is an O-(C1-C10)-alkyl
monosubstituted by a –(C3-C7)-cycloalkyl,
R6 is hydrogen.
__________
]11[]21[
]54[
POLISHING AGENT AND
METHOD FOR PRODUCING
PLANAR LAYERS
]22[
]31[
19.03.2001
10016020.4
]32[ 31.03.2000
10063870.8
21.12.2000
Int. Cl.(2008.04) C09G 1/00
BAYER AKTIENGESELLSCHAFT,
GERMANY
WO/2001/074958
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
151794
‫גורם להברקה ושיטה ליצור שכבות‬
‫מישוריות‬
]33[
DE
DE
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
[57] A polishing abrasive containing
(b) 95 to 5% by weight silica particles of a
spherical, discrete silica particles which
size from 50 to 200 nm,
are not linked to one another via bonds,
with the proviso that the total set of
characterized in that the polishing abrasive
particles has a bimodal particle size
contains: (a) 5 to 95% by weight silica
distribution.
particles of a size from 5 to 50 nm, and
__________
]11[]21[ 152200
]54[
METHOD FOR IDENTIFYING A
PERSON AMONG A POPULATION
BY SENSING HIS FINGERPRINTS
]22[
]31[
]51[
13.06.2001
00/07707
]32[ 16.06.2000
Int. Cl.(2008.04) A61B 51/17
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫שיטה לזיהוי בן–אדם בקהל באמצעות‬
‫חישה של טביעת האצבעות שלו‬
]33[
FR
245
]71[
]87[
]74[
SAGEM SECURITE, FRANCE
WO/2001/095804
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57] A method for identifying a person
among a population, by sensing the
fingerprints of at least one finger of the
hand of said person and comparing said
sensed fingerprints with information of
fingerprints of said person previously
stored in a file, in which process: by a
previous registration step, the shape of the
least one hand and fingerprints of at least
one finger of the hand of all the persons of
the population are sensed, the hand shape
information is stored in said file in
correlation with at least the respective
fingerprint information, and in said file a
secondary file is created which includes
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
groups of substantially identical hand
shapes; then, by a later step of
identification of one person belonging to
the population; the shape of the hand of the
person is sensed at the same time as the
fingerprints of at least one of his/her
fingers are sensed; a group consisting of
the hand shapes substantially identical to
the sensed hand shape of the person to be
identified is selected from said secondary
file; and finally, the sensed fingerprints of
the finger of the person to be identified are
compared with the fingerprint information
stored in said secondary file of only the
persons of said selected group.
__________
]11[]21[
152269
‫מבנה טקסטיל לא ארוג הכולל מכלולי‬
‫סיבים מיוצבים‬
]54[
NON WOVEN TEXTILE
STRUCTURE INCORPORATING
STABILIZED FILAMENT
ASSEMBLIES
]22[
]51[
18.04.2000
Int. Cl.(2008.04) B32B 5/26, D02G 1/00, 3/00, D04H 13/00, 3/04, 3/07, 3/10, 3/14
246
September 22, 2009
–‫ד' בתשרי התש"ע‬
]71[
]72[
]87[
]74[
VLIESSTOFF-TECHNOLOGIE IN 3.
DIMENSION KG, GERMANY
GEORG MARTIN BARTH,
EDMUND HUGH CARUS
WO/2000/063479
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
[57] A method of producing a non-woven
textile structure comprising the steps of:
initial consolidation of a plurality of
substantially parallel continuous filaments
to provide a partially stabilized filament
assembly (10); further constraining said
,‫פרל כהן צדק לצר‬
,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬
filament assembly by a folding, bundling,
twisting or intertwining operation; and
bonding a spaced array of such resulting
constrained filament assemblies to a carrier
layer (12, 14).
__________
]11[]21[
152287
,‫תולדות של חומצת גרעין פוליאמידית‬
‫תכשירים ושיטות להכנתם‬
]54[
POLYAMIDE NUCLEIC ACID
DERIVATIVES AND AGENTS AND
METHODS FOR PRODUCING THE
SAME
]22[
]31[
]51[
07.04.2001
10019136.3
]32[ 18.04.2000
]33[ DE
Int. Cl.(2008.04) A61K 38/04, 48/00, A61P 31/04, 31/10, 35/00, 9/00, C07F 9/09,
9/24, 9/40, 95/47, C07H 21/00, C07K 14/00, C12Q 1/68, G01N 33/53
September 22, 2009
–‫ד' בתשרי התש"ע‬
247
]71[
]87[
]74[
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2001/079249
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
,‫פרל כהן צדק לצר‬
,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬
[57] Polyamide nucleic acid (PNA)
derivative of the formula
where
V is oxygen, sulfur, NR1, a group U(CR3R4)u'-CH2-C(O)-NH or a group U(CH2CH2O)u'-C(O)NH,
U is, independently of each other, oxygen,
sulfur or NH,
u' is, independently of each other, from 1
to 10, preferably from 1 to 4, particularly
preferably 1,
W is, independently of each other, oxygen,
sulfur or NR1,
Y is, independently of each other,
hydroxyl, mercapto, oxyanion, thioate or
NR1R2,
R1 and R2 are, independently of each other,
a radical consisting of hydrogen or C1-C6alkyl, preferably hydrogen,
R3 and R4 are, independently of each other,
a radical consisting of hydrogen or C1-C6alkyl, or the radical of an amino acid side
chain, preferably hydrogen,
X is, independently of each other, a group
U-(C2-C22-alkanediyl)-U or a group U(CH2CH2-O)u',
or X is a bifunctional labeling group,
preferably selected from the group
consisting of fluorescein, rhodamine,
TAMRA, biotin, pyrene, dinitrophenyl,
248
acridine, cyanine dye, Dabcyl,
digoxygenin or Edans derivative,
particularly preferably a biotin dertivative,
or X is a bifunctional group for
crosslinking with complementary nucleic
acids, preferably a psoralen derivative, or
X is a bifunctional group which promotes
intracellular uptake, preferably selected
from the group consisting of cholesteryl,
adamantyl and vitamin E derivatives, or X
is a bifunctional group which increases the
binding affinity of the PNA derivative for
a target nucleic acid, preferably acridine
and lexitropsin derivatives,
Z is hydroxyl, mercapto, oxyanion, thioate,
or NR1R2, C1-C22-alkyl, C1-C8-arylalkyl,
C1-C22-alkyl-U, C1-C8-arylalkyl-U,
hydroxy-C1-C18-U, aminoalkyl-U,
arylalkyl-U or mercaptoalkyl-U, or a group
of the formula R9(CH2CH2-O)m, where R9
is hydroxyl, amino or C1-C22-alkoxy, and
m is from 1 to 100, preferably from 2 to
10, or Z is a monofunctional or
bifunctional labeling group, preferably
selected from the group consisting of
fluorescein, rhodamine, TAMRA, biotin,
pyrene, dinitrophenyl, acridine, cyanine
dye, Dabcyl, digoxygenin or Edans
September 22, 2009
–‫ד' בתשרי התש"ע‬
derivatives, particularly preferably a biotin
derivative, or Z is a monofunctional or
bifunctional crosslinking group, preferably
a psoralen derivative, or Z is a
monofunctional or bifunctional group
which promotes intracellular uptake,
preferably selected from the group
consisting of cholesteryl, adamantyl and
vitamin E derivatives, or Z is a
monofunctional or bifunctional group
which promotes the binding affinity of the
PNA derivative for a target nucleic acid,
preferably a lexitropsin derivative, n is
from 0 to 10, preferably from 0 to 3, Q is
hydroxyl, amino, NHR7, NR7R8, an amino
acid derivative or a peptide radical, R7 and
R8 are, independently of each other, C1C18-alkyl or hydroxyl-C1-C18-alkyl, and
where {POLY} is described by the
formula
where {BLOCK} is, independently of each
other, either described by the formula
or the formula
or the formulae
September 22, 2009
–‫ד' בתשרי התש"ע‬
249
where each building block {BLOCK} can
be different,
and where it furthermore applies that
z' is from 0 to 100, preferably 1-20,
particularly preferably 4-15,
A is, independently of each other, a group
(CR1R2)s, where s is from 1 to 3,
preferably 1,
B is, independently of each other, either an
aromatic radical, which can also possess
heteroaromatic character, or hydrogen, or
hydroxyl or C1-C18-alkyl, or a nucleobase
which occurs naturally, and is customary
in nucleotide chemistry, or which does not
occur naturally, where at least one B
radical is a nucleobase, D is, independently
of each other, a group (CR3R4)t, where t is
from 2 to 10, preferably from 2 to 4,
particularly preferably 2, where two
adjacent R3 and R4 radicals can also form a
C5-C8-cycloalkyl ring, E is, independently
of each other, a group (CR5R6)u', where
two adjacent R5 and R6 radicals can also
form a C5-C8-cycloalkyl ring or a spiro
compound,
R5 and R6 are, independently of each other,
a radical consisting of hydrogen or C1-C6alkyl, preferably hydrogen, or an amino
acid side chain, and also physiologically
tolerated salts of the PNA derivative of the
formula l, with the proviso that at least one
Y or Z radical is hydroxyl, mercapto,
oxyanion or thioate.
__________
]11[]21[
152352
‫–אמינים ביציקלים‬3–‫מלחים של אימידזו‬
‫–אמינים ביציקלים שעברו‬5–‫ואימידזו‬
‫אצילציה בחנקן‬
]54[
SALTS OF BICYCLIC, NACYLATED IMIDAZO-3-AMINES
AND IMIDAZO-5-AMINES
]22[
]31[
]51[
]71[
]87[
]74[
03.04.2001
10019714.0
]32[ 20.04.2000
]33[ DE
Int. Cl.(2008.04) A61K 314/16, 314/353, 314/95, C07D 471/04, 487/04, 513/04
GRUNENTHAL GMBH, GERMANY
WO/2001/081344
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
250
September 22, 2009
–‫ד' בתשרי התש"ע‬
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
[57] A salt of a bicyclic, N-acylated
imidazo-3-amine or an imidazo-5-amine of
the formula
wherein
R1 is tert-butyl; 1,1,3,3-tetramethylbutyl;
(CH.2)nCN where n=4, 5 or 6; optionally
substituted phenyl; C4-C8 cycloalkyl;
CH2CH2R where R=4-morpholino; or
CH2Ra, wherein Ra represents hydrogen;
straight or branched C1-C8 alkyl;
optionally substituted phenyl; CO(OR')
where R'=straight or branched C1-C8 alkyl;
PO(OR")2 where R"=straight or branched
C1-C4 alkyl; or Si(RxRyRz) where Rx, Ry,
and Rz each independently is straight or
branched C1-C4 alkyl, C4-C8 cycloalkyl or
phenyl, R2 is hydrogen; CORb, wherein Rb
is straight or branched C1-C8 alkyl; straight
or branched C1-C8 alkoxy; C3-C8
cycloalkyl; CH2CH2CO(OR') where
R'=straight or branched C1-C4 alkyl;
adamantyl; optionally substituted phenyl;
benzyloxy; optionally substituted 1naphthyl or 2-naphthyl or respectively
September 22, 2009
–‫ד' בתשרי התש"ע‬
optionally substituted 2-pyridyl, 3-pyridyl,
4-pyridyl, thiazolyl or furyl; CH2Rc,
wherein Rc is hydrogen, straight or
branched C1-C8 alkyl or optionally
substituted phenyl; CH2CH2Rd, wherein Rd
is optionally substituted phenyl; or
CONHRe, wherein Re is branched or
straight C1-C8 alkyl; aryl; heteroaryl; C3-C8
cycloalkyl or an aryl bound via a C1-C3
alkylene group, heteroaryl or C3-C8
cycloalkyl radical, R3 is straight or
branched C1-C8 alkyl; C3-C8 cycloalkyl;
optionally substituted phenyl; optionally
substituted 1-naphthyl; 2-naphthyl;
quinoline; anthracene; phenanthrene;
benzothiophene; benzofurfuryl; optionally
substituted pyrrole; 2-, 3- or 4-pyridyl;
optionally substituted furfuryl; or
optionally substituted thiophene,
A is a four-membered ring fragment of the
formula:
251
wherein R4, R5, R6 and R7 each
independently is hydrogen; straight or
branched C1-C8 alkyl; fluorine; chlorine;
bromine; CF3; CN; NO2; NHRf, wherein Rf
represents hydrogen; straight or branched
C1-C8 alkyl; or COR'" wherein R'"=straight
or branched C1-C4 alkyl or optionally
substituted phenyl; SRg, wherein Rg
represents hydrogen, straight or branched
C1-C4 alkyl, optionally substituted phenyl,
optionally substituted pyridine, optionally
substituted benzyl, or optionally
substituted fluorenyl;
ORh, wherein Rh represnts hydrogen;
straight or branched C1-C8 alkyl; COR'"
where R'"=straight or branched C1-C4 alkyl
or optionally substituted phenyl; or
CO(OR') wherein R'=straight or branched
C1-C8 alkyl; CO(ORi) or CH2CO(ORi),
wherein Ri is branched or straight C1-C8
alkyl, or optionally substituted phenyl; or
R6 and R7 together represent a ring
fragment –CRi=CRj-CH=CH-, wherein Ri
and Rj each represents hydrogen, or one of
Ri and R1 is not hydrogen and represents F,
Cl, Br, I or straight or branched C1-C8
alkyl, whereas R4 and R5 independently
thereof have the meaning given above, R8
is branched or straight C1-C8 alkyl; aryl,
heteroaryl; C3-C8 cycloalkyl; or an aryl
bound by a C1-C3 alkylene group,
heteroaryl or C3-C8 cycloalkyl radical, and
X represents an anion of an inorganic or
organic acid.
__________
]11[]21[
152574
]54[
TRANSDERMAL DELIVERY
SYSTEM FOR DRIED
PARTICULATE OR
LYOPHILIZED MEDICATIONS
]22[
]51[
]71[
]74[
31.10.2002
Int. Cl.(2008.04) A61M 37/00, A61N 1/30
TRANSPHARMA MEDICAL LTD.
WEBB & ASSOCIATES,
2 PEKERIS ST., P.O.B. 2189,
REHOVOT 76121
[57] A system for transdermal delivery of
a dried pharmaceutical composition,
comprising: an apparatus for facilitating
transdermal delivery of a drug through
skin of a subject, said apparatus capable of
‫מערכת להולכה דרך העור של פריטים‬
‫יבשים או תרופות מיובשות‬
‫ לוד‬,‫טראנספארמה מדיקל בע"מ‬
,'‫ד"ר וב ושות‬
‫ רחובות‬,2189 .‫ד‬.‫ ת‬, 2 ‫רח' פקריס‬
generating at least one micro-channel in an
area on the skin of the subject, and a patch
comprising a therapeutically effective
amount of the dried pharmaceutical
composition.
__________
]11[]21[
]54[
252
MEDIUM CRACKING PRESSURE
VALVE ARRANGEMENT
152694
‫סידור ווסת בעל לחץ פתיחה בינוני‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
]22[
]31[
]51[
]71[
]87[
]74[
07.06.2001
00113777.7
]32[ 29.06.2000
Int. Cl.(2008.04) A61M 39/24
SOCIETE DES PRODUITS NESTLE
S.A., SWITZERLAND
WO/2002/000291
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
[57] A valve arrangement which is
suitable for use with a peristaltic pump and
which is capable of allowing flow of fluid
in a first direction and capable of
preventing flow of fluid in a second
direction, wherein the valve arrangement
comprises a valve having a cracking
pressure of about 0.10 to about 0.20 bar,
]33[
EP
,‫ד"ר יצחק הס ושותפיו‬
‫ תל אביב‬,6451 .‫ד‬.‫ ת‬, 279 ‫רחוב הירקון‬
characterized in that the valve comprises a
flexible membrane which is deformable
under pressure in a desired flow direction,
the flexible membrane including normally
closed perforations therethrough which are
configured to open at a selected extent of
deformation of the flexible membrane to
permit flow through said membrane.
__________
]11[]21[
]54[
]22[
]31[
]51[
]71[
152795
‫–קומארונים‬2 ‫–קומארון ו‬2 ‫שיטה ליצור‬
‫מותמרים‬
METHOD FOR THE
PRODUCTION OF 2COUMARONE AND
SUBSTITUTED 2-COUMARONES
09.05.2001
A983/2000
]32[ 06.06.2000
Int. Cl.(2008.04) C07D 307/00, 307/83
DSM FINE CHEMICALS AUSTRIA
NFG GMBH & CO. KG, AUSTRIA
]87[ WO/2001/094329
]74[ REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
September 22, 2009 –‫ד' בתשרי התש"ע‬
]33[
AT
,‫ריינהולד כהן ושותפיו‬
253
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
[57] A process for preparing 2coumarone or substituted 2-coumarones,
characterized in that cyclohexanone or
substituted cyclohexanones of the formula
where R is H or a C1-C3-alkyl or alkoxy
radical, are reacted with a carboxylic
acylating agent of the formula
where R1 and R2 are each independently
hydrogen or a C1-C3-alkyl radical and R3
is a C1-C3-alkyl radical,
(a) to give alkyl 2-(2-oxocyclohexyl)-2hydroxyacetate or substituted alkyl 2-(2oxocyclohexyl)-2-hydroxyacetates which
(a1) are either converted directly to 2coumarone or substituted 2-coumarones by
catalytic gas phase dehydrogenation, or
(a2) dehydrated by azeotropic distillation
using an acid or an acidic ion exchanger to
give a mixture of alkyl 2oxocyclohexylideneacetate and the enol
lactone of 2-oxocyclohexylideneacetic acid
or a mixture of substituted alkyl 2oxocyclohexylideneacetate and the enol
lactone of the substituted 2oxocyclohexylideeacetic acid which is
then in turn converted by catalytic gas
phase dehydrogenation into 2-coumarone
or substituted 2-coumarones, or
(b) reacted directly under acidic conditions
to give a mixture of alkyl 2oxocyclohexylideneacetate and the enol
lactone of 2-oxocyclohexylideneacetic acid
or a mixture of substituted alkyl 2oxocyclohexylideneacetate and the enol
lactone of the substituted 2oxocyclohexylideneacetic acid which is
then in turn converted by catalytic gas
phase dehydrogenation to 2-coumarone or
substituted 2-coumarones.
__________
]11[]21[
]54[
METHOD AND APPARATUS FOR
TREATING THE TEATS OF AN
ANIMAL
]22[
17.05.2001
254
152960
‫שיטה והתקן לטיפול בפטמות של בעלי‬
‫חיים‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
]31[
]51[
]71[
]87[
]74[
00305277.6
]32[ 22.06.2000
Int. Cl.(2008.04) A01J 7/04
DELAVAL HOLDING AB, SWEDEN
WO/2001/097603
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57] An apparatus for applying topical
composition to at least a part of an udder,
in particular a teat, of an animal,
comprising a robot arm and at least one
composition applying member positionable
by the robot arm for applying the topical
composition to the teat, characterised in
that different topical composition are
applicable by the at least one composition
]33[
EP
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
applying member, and a control device is
arranged to control the robot arm and the
at least one composition applying member
for one of the topical compositions
selected in accordance with information
relating the skin health condition of an
animal teat and/or climatic conditions of
the animal environment to be applied to
the teat.
__________
]11[]21[
153172
‫ התקן ונהלים לעיצוב לבקרה‬,‫שיטה‬
‫ מערכות מרובות‬LTI ‫באמצעות משוב‬
‫קלט מרובות פלט התלויות במשתנים‬
]54[
METHOD, APPARATUS AND
DESIGN PROCEDURE FOR
CONTROLLING MULTI-INPUT,
MULTI-OUTPUT (MIMO)
PARAMETER DEPENDENT
SYSTEMS USING FEEDBACK
LTI`ZATION
]22[
]31[
]51[
30.05.2001
09/580587
]32[ 30.05.2000
]33[ US
Int. Cl.(2008.04) B64C 13/00, 13/18, G05B 11/32, 13/02, 13/04, G05D 1/08, G06F
17/50
ATHENA TECHNOLOGIES, INC.,
]71[
September 22, 2009
–‫ד' בתשרי התש"ע‬
255
]87[
]74[
U.S.A.
WO/2001/092972
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57] A method of designing vehicle
control laws using multi-input, multioutput feedback LTIzation, said method
comprising the following steps:
determining co-ordinates for vehicle
equations of motion; transforming the coordinates for the vehicle equations of
motion into a multi-input linear time
The applications for division
from this application have
not yet been published
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
invariant system; establishing vehicle
control laws yielding the transformed
equations of motion linear time invariant;
adjusting the vehicle control laws to obtain
a desired closed loop behaviour for the
controlled system; and converting the
transformed co-ordinates vehicle control
laws to physical co-ordinates.
,190441
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
_______
]11[]21[
153420
‫שיטה והתקן להערכת הספק שידור‬
‫ליחידות קצה במערכת סלולארית‬
]54[
METHOD AND APPARATUS FOR
ESTIMATING TRANSMISSION
POWER TO SUBSCRIBER UNITS
IN A CELLULAR SYSTEM
]22[
]51[
]71[
12.12.2002
Int. Cl.(2008.04) H04B 17/07, H04Q 7/20, 7/28
FAZAN COMMUNICATIONS LLC,
U.S.A.
AHARON SHAPIRA
‫אהרון שפירא‬
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
‫ הרצליה‬,2081 .‫ד‬.‫ ת‬, 10 ‫שדרות אבא אבן‬
September 22, 2009 –‫ד' בתשרי התש"ע‬
]72[
]74[
256
HERZLIYA 46120
[57] In a cellular radio system that
transmits data from an IP-based network,
through a base station controller (BSC)
and any Base Station Transceiver (BTS)
controlled by the BSC, to a plurality of
active subscriber units, which are in radio
communication with the BTS and in a data
connection state, the data transmission
from the BTS to any active subscriber unit
at any time being at one of a plurality of
given transmission rates and at a defined
power level, relative to a maximum total
power transmittable by the corresponding
BTS; the power level is associated with
said transmission rate and is a product of a
specific power and a multiplier, the
specific power being the power level of
transmission to the subscriber unit at a
given fundamental data rate and said
multiplier having a fixed direct relation to
the associated transmission rate: a method
for estimating the specific power of
transmission from the BTS to each of the
active subscriber units at any given time,
the method comprising:
(i) defining in time a succession of
observation windows;
(ii) observing the data flowing into the
BSC and addressed to each of the active
subscribers and, for each subscriber,
measuring the amount of such data flowing
during each of a plurality of said
observation windows, obtaining measured
amounts; and
(iii) calculating from said measured
amounts an estimated specific power for
each of the subscribers.
__________
]11[]21[
]54[
METHOD OF REDUCING OR
ELIMINATING NEOPLASTIC
CELLS IN AN EX VIVO
SUSPENSION WITH NORMAL
HAEMATOPOIETIC CELLS BY
CONTACTING IT WITH
VESICULAR STOMATITIS VIRUS
(VSV), AND USE OF THIS VIRUS
IN THE MANUFACTURE OF A
September 22, 2009
–‫ד' בתשרי התש"ע‬
153570
‫שיטה להפחתתת או להסרת תאים‬
‫ניופלסטים בתרחיף חוץ –גופי עם תאים‬
‫הימאטופויאטים נורמלים באמצעות מגע‬
) VSV( ‫עם וירוס סטומאטיטיס משולחף‬
‫ושימוש בוירוס זה לייצור של תרופה‬
‫לטיפול בסרטן‬
257
MEDICAMENT FOR TREATING
CANCER
]22[
]31[
]51[
26.06.2001
60/214014
]32[ 26.06.2000
]33[ US
Int. Cl.(2008.04) A61K 35/12, 35/76, 39/42, 392/05, A61P 35/00, 37/00, C12N 15/06,
5/06, 5/08
]71[ WELLSTAT BIOLOGICS
CORPORATION, U.S.A.
UNIVERSITY OF OTTAWA,
CANADA
]72[ HAROLD L. ATKINS, JOHN C.
BELL, CONRAD J. HEILMAN JR.,
BRIAN D. LICHTY, ROBERT M.
LORENCE, MICHAEL S. ROBERTS,
DAVID F. STOJDL
]87[ WO/2002/000233
]74[ JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
,45087 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬
JERUSALEM 91450
[57] Method of reducing or eliminating
cells by contacting said mixture with
neoplastic cells in an ex vivo mixture of
vesicular stomatitis virus, wherein the
normal haematopoietic cells and neoplastic
mixture is a suspension.
__________
]11[]21[
]54[
WATERPROOFED
CEMENTITIOUS COMPOSITIONS
AND METHOD OF MAKING THE
SAME
]22[
]31[
]51[
]71[
03.05.2002
0111145.9
]32[ 08.05.2001
Int. Cl.(2008.04) C04B 24/42, 28/00
CONSTRUCTION RESEARCH &
TECHNOLOGY GMBH, GERMANY
WO/2002/090287
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
[57] A method of conferring water
impermeability on a hardened cementitious
composition which is formed from a fluid
258
153588
‫הרכבי מלט חסיני מים ושיטה לייצרם‬
]33[
GB
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
cementitious mix, by the addition to the
mix of an aqueous emulsion of
organosilicon material, which material
September 22, 2009
–‫ד' בתשרי התש"ע‬
comprises from 0.25-4.5% by weight of
the emulsion of an alkoxysilane and from
0.1-2.0% of an alkoxysiloxane.
__________
]11[]21[
]54[
METHOD OF SIMULTANEOUSLY
GENOTYPING MULTIPLE
SAMPLES IN A SINGLE ROUND
OF HYBRIDIZATION
]22[
]31[
]51[
]71[
03.07.2001
09/613006
]32[ 10.07.2000
Int. Cl.(2008.04) C12Q 1/68
TELECHEM INTERNATIONAL,
INC., U.S.A.
WO/2002/003849
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
[57] A method of simultaneously
genotyping multiple samples in a single
round of hybridization, the method
comprising:
(a) providing a microarray having on its
surface a plurality of amplified genomic
segments from a plurality of samples,
wherein said plurality of amplified
genomic segments are obtainable by
amplifying a plurality of genomic
segments from a plurality of samples using
a plurality of polymerase chain reaction
primers, each genomic segment
comprising a distinct genetic locus,
wherein each location on the surface
contains amplified material derived from a
single sample and consisting of essentially
a single genomic segment;
(b) incubating the microarray with a probe
mixture of synthetic oligonucleotides,
wherein the mixture comprises
oligonucleotides having sequences
specifically complementary to the genomic
153848
‫שיטה לאבחון בו זמנית של המבנה הגנטי‬
‫של מספר דוגמאות במעגל הכלאה יחיד‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
segments for each sample for which a
genotype is to be determined, wherein the
incubating forms hybrids of
polynucleotides of the microarray and
directly or indirectly labeled
complementary oligonucleotides of the
probe mixture, and allows discrimination
at single nucleotide resolution; and
(c) deriving genotyping information
simultaneously for the plurality of the
detecting signals from the hybridized
microarray wherein either the probe
mixture comprises oligonucleotides
specifically complementary to wild type
and mutant alleles and said
oligonucleotides are directly or indirectly
labeled with fluorescent tags that fluoresce
at different wavelengths or different color
tags and the detected signals are indicative
of a genotype of an individual or the
strength of the signal is detected and is
indicative of a genotype of an individual.
__________
]11[]21[
September 22, 2009
–‫ד' בתשרי התש"ע‬
153990
259
‫מטען פורק מחסנית‬
]54[
MAGAZINE LOADER AND
UNLOADER ACCESSORY
]22[
]31[
]51[
]71[
22.07.2001
60/221393
]32[ 23.07.2000
Int. Cl.(2008.04) F41A 9/83
RAN TAL
GUY TAL
]87[
]74[
WO/2002/008681
GUY TAL,
86/2 SHILO ST., ROSH HA'AIN
[57] A firearm magazine loader and
unloader accessory for magazines (70)
having an open side and containing
topmost and second-to-topmost rounds
which are exposed at and urged towards
said open side, comprising: thrusting
means for alternately (a) thrusting said
topmost round farther into said magazine
for creating space adjacent said open side
for enabling a new round to be loaded into
said space, and (b) thrusting said secondto-topmost round farther into said
magazine for releasing force on said
]33[
US
‫ תל אביב‬,‫רן טל‬
‫העין‬-‫ ראש‬,‫גיא טל‬
,‫גיא טל‬
‫העין‬-‫ ראש‬,86/2 ‫שילה‬
topmost round to enable said topmost
round to fall out of said magazine, and
mounting means (12) for operatively
positioning said thrusting means at said
open side of said magazine, whereby by
sequentially thrusting topmost rounds
farther into said magazine, said magazine
may be easily loaded with new rounds, and
alternatively, when sequentially thrusting
second-to-topmost rounds farther into said
magazine, topmost rounds may be easily
unloaded.
__________
]11[]21[
260
154170
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫תכשירים רפואים המכילים אריתרופואיטין‬
‫רקומביננטי בעל פעילות גבוהה ותופעות‬
‫לוואי מצומצמות‬
]54[
THERAPEUTIC COMPOSITIONS
COMPRISING A RECOMBINANT
ERYTHROPOIETIN HAVING
HIGH ACTIVITY AND REDUCED
SIDE EFFECTS
]22[
]31[
]51[
]71[
09.08.2001
09/637962
]32[ 11.08.2000
]33[
Int. Cl.(2008.04) A61K 38/18, A61P 7/06
BAXTER HEALTHCARE S.A.,
SWITZERLAND
WO/2002/014356
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
[57] Use of a recombinant erythropoietin
selected from the group consisting of:
Epoetin Omega, an erythropoietin
produced in baby hamster kidney cells,
erythropoietin expressed from an Apa I
restriction fragment of human genomic
erythropoietin DNA, an erythropoietin
having a glycosylation pattern
characterized by the presence of N-linked
glycosylated residue on at least three
asparagine residues, an erythropoietin
having an O-linked oligosaccharide
content of less than 1 mole per mole of
glycoprotein, an erythropoietin having one
or more isoforms at pI 4.3, or 4.5, or 4.6,
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
and a recombinant erythropoietin that
retains substantially all of its in vitro
biological activity after being subjected to
N-deglycosylation for the manufacture of a
medicament for treatment of anemia in a
subject adversely affected when treated
with a therapeutic amount of Epoetin
Alpha or Beta, the medicament having a
therapeutic amount of the recombinant
erythropoietin selected to provide a
therapeutic benefit within a treatment
period without producing or exacerbating
an adverse effect associated with treatment
by a therapeutic amount of Epoetin Alpha
or Beta.
,197584
The applications for division
from this application have
not yet been published
US
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
_________
]11[]21[
]54[
ARRANGEMENT FOR TYING A
PORTABLE OBJECT TO A
STATIONARY OBJECT BY A
CABLE
]22[
]51[
]71[
30.01.2003
Int. Cl.(2008.04) E05B 73/00
MEIR AVGANIM
September 22, 2009
–‫ד' בתשרי התש"ע‬
154194
‫סידור לקשירת חפץ נייד לחפץ נייח‬
‫באמצעות כבל‬
651 ‫ מושב גאליה‬,‫מאיר אבגנים‬
261
]74[
651 ‫ מושב גאליה‬,‫לי אבגנים‬-‫גבי‬
,'‫דניאל פריימן ושות‬
‫ תל אביב‬,10 ‫ בית כלל קומה‬5‫דרויאנוב‬
GABI-LEE AVGANIM
DANIEL FREIMANN & CO.,
5 DROYANOV ST., 10TH FLOOR ,
TEL AVIV 63143
[57] An arrangement for arresting a
portable object against a stationary object
by looping around the stationary object
one end of a cable (40) and releasably
coupling the other end thereof to the
portable object, the arrangement
comprising: a block-shaped body (44) to
which said other end of the cable is
affixed, the body having a planar side
surface; an oblong circular cavity formed
in the planar side surface with an undercut
portion extending along about 180o of one
side thereof; a a circular ribbed attachment
member (24) having a circular rib (28)
extending therearound configured to fit
into said cavity, said rib being at a width
less than said undercut portion so that after
fitting into the cavity it can be shifted into
engagement with the undercut portion
thereby preventing a head – on releasing
thereof from the cavity; the said body
being further provided with a key operated
locking device (50) having a locking pin
projectable into the said cavity to restrain
the shifting of the attachment member lock
from the first shifted position thereof; and
means for affixing the attachment member
to a side wall of the portable object.
__________
]11[]21[
]54[
]22[
]31[
]51[
]71[
]72[
]87[
]74[
262
154429
METHOD FOR THE DIAGNOSIS
‫שיטה לאבחון של סכיזופרניה‬
OF SCHIZOPHRENIA
15.08.2001
137865
]32[ 15.08.2000
]33[ IL
Int. Cl.(2008.04) C12N 15/12, C12Q 1/68
YEDA RESEARCH AND
‫ רחובות‬,‫ידע חברה למחקר ופיתוח בע"מ‬
DEVELOPMENT CO. LTD.
SARA FUCHS, TAL ILANI, ORLY
‫ אורלי פרל‬,‫ טל אילני‬,‫שרה פוקס‬
PERL
WO/2002/014547
BEN-AMI & ASSOCIATES,
,'‫בן עמי ושות‬
8 PLAUT ST.,
‫ רחובות‬,94 .‫ד‬.‫ ת‬, 8‫מנחם פלאוט‬
PARK TAMAR,
September 22, 2009
–‫ד' בתשרי התש"ע‬
P.O.B. 94,
REHOVOT 76100
[57] Method for the diagnosis of
schizophrenia in a tested individual,
comprising:
(i) measuring mRNA of D3 dopamine
receptor or of α7 nicotinic acetylcholine
receptor (α7 AChR) and of a control gene
in peripheral blood lymphocytes (PBLs) of
said tested individual and of at least one
healthy control individual or a pool of two
or more healthy individuals;
(ii) calculating the ratio between the D3
dopamine receptor mRNA and the control
gene mRNA or the ratio between the α7
AChR mRNA and the control gene mRNA
for the tested individual and the at least
one healthy control individual or pool of
two or more healthy individuals; and
(iii) evaluating the ratios obtained in (ii)
for the tested individual and for the at least
one healthy control indivudal or pool of
two or more healthy individuals, wherein
an increase of above 1.6 fold in the ratio of
D3 dopamine receptor mRNA/control gene
mRNA or a decrease of more than 20% in
the ratio of α7 AChR mRNA/control gene
mRNA in the tested individual in
comparision to that of the at least one
healthy control individual or pool of two or
more healthy individuals, indicates that
said tested individual has a high likelihood
of having schizophrenia.
__________
]11[]21[
]54[
SHIP HULL
]22[
]51[
]71[
]72[
]87[
]74[
12.04.2000
Int. Cl.(2008.04) B63B 1/00, 1/40
ALBERTO A. CALDERON, U.S.A.
ALBERTO A. CALDERON
WO/2001/079054
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
[57] A transonic hull portion having a
bow, a stern, and a length, a substantially
triangular waterplane, side surfaces
extending from said bow to outboard edges
of said stern with a deep draft forward and
a shallow draft to the rear, said hull portion
being immersed in a water body in a
displacement mode having a remote
reference water level and a supercritical
transonic three-dimensional hydrofield in
direct contact with and translating and
supporting by means of buoyant forces, the
submerged surfaces of said transonic hull
September 22, 2009
–‫ד' בתשרי התש"ע‬
154454
‫גוף של אוניה‬
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
,45087 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬
portion translating at high speed in said
water body in said displacement mode,
said hydrofield being further characterized
in having (a) a substantially triangular
planform at water level with substantially
rectilinear longitudinal sides with the base
of said triangular planform corresponding
to the stern of said hull portion and the
pointed end forward; (b) lateral
hydrodynamic rays of small elevation and
narrow width in cross-section extending
along said sides of said planform;
continuing downstream of said base of said
263
hydrofield as generally straight rearward
extensions of said rays; (d) with a
generally flat wake extending downstream
from said base of said planform, said
generally flat wake being contained
between the portion of said rays located to
the rear of said base, and having a water
level therebetween substantially equal to
that of said remote waterplane outboard of
said rays.
__________
]11[]21[
]54[
PROCESS TO PRODUCE HALO-4PHENOXYQUINOLINES
]22[
]31[
]51[
]71[
]72[
07.09.2001
60/231719
]32[ 08.09.2000
Int. Cl.(2008.04) C07D 215/20
DOW AGROSCIENCES LLC, U.S.A.
KARL LEOPOLD KRUMEL, RUTH
CEZAR REED, THOMAS A.
OLMSTEAD, GARY ALAN ROTH,
IAN ROBERT KING, DONALD NEIL
BRATTESANI, KENT DOUGLAS
CAMPBELL, JOHN DAVIES
WO/2002/020490
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]87[
]74[
154764
‫–פנוקסיקווינולינים‬4–‫תהליך להכנת הלו‬
]33[
US
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
‫ הרצליה‬,2081 .‫ד‬.‫ ת‬, 10 ‫שדרות אבא אבן‬
[57] Process comprising:
(1) reacting a compound of formula (I)
with a compound of formula (II)
to produce a compound of formula (III)
264
September 22, 2009
–‫ד' בתשרי התש"ע‬
wherein R1 and R3 are indepdnently halo
and R2 and R3 are independently halo and
R2 and R4 are H; or R3 is halo, R1 is halo or
H, and R2 and R4 are H; or R4 is halo and
R1 to R3 are H; R5 is a (C1-C4) alkyl and R6
and R7 are independently a (C1-C4) alkyl;
(2) reacting said compound of formula
(III) to produce a compound of formula
(IV);
wherein R8 is a (C1-C4) alkyl;
(3) reacting said compound of formula
four with water to produce a compound of
the formula
wherein H2O interacts with the –C(=O)-OR8 group on compound (IV) to produce a
compound of formula (VI)
(4) reacting said compound of formula VI
with SOCl2 to produce a compound of the
formula
September 22, 2009
–‫ד' בתשרי התש"ע‬
265
wherein SOCl2 interacts with the -OH
group on Compound (VI) to produce a
compound of formula VIII; wherein X is –
F, Cl, Br or I; and
(3) reacting said compound of formula
(VIII) with a compound of formula (IX) to
produce a compound of the formula
wherein R9 to R13 are independently H,
CN, NO2, OH, halo, (C1-C4) alkyl, (C2-C4)
alkanoyl, halo (C1-C7) alkyl, hydroxy (C1C7) alkyl, (C1-C7) alkoxy, halo (C1-C7)
alkoxy, (C1-C7) alkylthio, halo (C1-C7)
alkylthio, phenyl, substituted phenyl,
phenoxy, substituted phenoxy, phenylthio,
substituted phenylthio, phenyl (C1-C4)
alkyl, substituted phenyl (C1-C4) alkyl,
benzoyl, SiR20R21R22, or OSiR20R21R22
where R20, R21, and R22 are H, a (C1-C6)
alkyl group, phenyl, or substituted phenyl,
provided that at least one of R20, R21, and
R22 is other than H, or R11 and R12 or R12
and R13 combine to form a carbocyclic
ring, and provided that unless all of R9 to
R13 are H or F, then at least two of R9 to
R13 are H.
__________
]11[]21[
154840
‫נגזרות של טריאזולון‬
]54[
TRIAZOLONE DERIVATIVES
]22[
]31[
]51[
09.11.2001
60/247317
]32[ 10.11.2000
]33[ US
Int. Cl.(2008.04) A61K 314/196, 314/27, A61P 3/10, 9/02, C07C 281/06, C07D
249/12, 401/06, 405/06, 409/06, 413/06
ELI LILLY & CO., U.S.A.
WO/2002/038553
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
]71[
]87[
]74[
266
September 22, 2009
–‫ד' בתשרי התש"ע‬
BEER-SHEVA 84152
[57] A compound of the formula
and pharmaceutically acceptable salts,
solvates and hydrates thereof, wherein:
(a) R1 is selected from the group
consisting of hydrogen, substituted or
unsubstituted group selected from C1-C8
alkyl, aryl-C0-4-alkyl, heteroaryl-C0-4alkyl, C3-C6 cycloalkylaryl-C0-2-alkyl, and
–CH2-C (O)-R17-R18, wherein R17 is O
or NH and R18 is benzyl, wherein the R1
optional substituents are each
independently selected form the group
consisting of C1-C5 haloalkyl, C1-C5
haloalkoxy, nitro, cyano, CHO, hydroxyl,
C1-C4 alkanoic acid phenyl, aryloxy,
SO2R7, SR7, benzyloxy,
alkylcarboxamido and COOH;
(b) W is O or S;
(c) R2 is H or a substituted or
unsubstituted group selected from the
group consisting of C1-C6 alkyl, C1-C6
allyl, aryl-C0-4-alkyl, heteroaryl-C0-4-alkyl,
sulfonamide, amide, OR10 and C3-C6
cycloalkyl; and wherein the R2 optional
substituents are each independently
selected from the group consisting of: OH,
alkoxy, haloalkyl, amino, COOH,
heteroaryl-O-, heteroaryl-C(O)-, alkyl-O-,
alkyl-C(O)-, C3-C6 cycloalkyl, aryl-O-,
aryl-C(O)-, heteroaryl, aryl,
heterocycloalkyl, heterocycloalkyl-O-, and
heterocycloalkyl-C(O)wherein
September 22, 2009
–‫ד' בתשרי התש"ע‬
(d) X is an optionally substituted C2-C5
alkylene linker wherein one carbon atom
of the linker may be replaced with O, NH
or S and the optional alkylene linker
substituents are each independently
selected from the group consisting of C1C6 alkyl, oxo, substituted or unsubstituted
aryl C0-C3 alkyl, C1-C3 alkoxy, hydroxy,
C3-C6 cycloalkyl and halo;
(e) Y is C, O, S, NH or a single bond; and
(f) E is selected from the group consisting
of C(R3) (R4)A, (CH2)n COOR19 wherein
the (CH2)n COOR19 moiety is
unsubstituted or substituted with from one
to three substituents each independently
selected from the group consisting of C1C5 alkyl, C1-C5 alkoxy, C1-C5 haloalkyl,
C1-C5 haloalkoxy, nitro, cyano, CHO,
hydroxyl, C1-C4 alkanoic acid phenyl,
aryloxy, SO2R7, SR7, benzyloxy,
alkylcarboxamido, and COOH, and the
optional (CH2)n COOR19 moiety
substituents are each independently
selected from the group consisting of C1C5 alkyl, C1-C5 alkoxy, C1-C5
haloalkoxy, nitro, cyano, CHO, hydroxyl,
C1-C4 alkanoic acid phenyl, aryloxy,
SO2R7, SR7, benzyloxy,
alkylcarboxamido or COOH; wherein R7
is alkyl or haloalkyl,
267
(i) n is 0, 1, 2 or 3;
(ii) A is a moiety selected from the group
consisting of carboxyl;
(iii) R3 is H, saturated or unsaturated C1C5 alkyl, C1-C5 alkoxy;
(iv) R4 is H, halo, a substituted or
unsubstituted group selected from C1-C5
alkyl, C1-C5 alkoxy, C3-C6 cycloalkyl, aryl
C0-C4 alkyl and phenyl, or R3 and R4 are
combined to form a C3-C4 cycloalkyl;
(v) R19 is selected from the group
consisting of hydrogen, optionally
substituted arylmethyl and optionally
substituted C1-C4 alkyl;
wherein the optional substituents for R4,
R5, R9 and R19 are each independently
selected from the group consisting of C1C5 alkyl, C1-C5 alkoxy, C1-C5 haloalkyl,
C1-C5 haloalkoxy, nitro, cyano, CHO,
hydroxyl, C1-C4 alkanoic acid phenyl,
aryloxy, SO2R7, SR7, benzyloxy,
alkylcarboxamido and COOH;
(vi) R14 is selected from the group
consisting of CF3, phenyl, aryl-C0-4-alkyl,
and C1-C6 alkyl;
(g) R8 is independently selected from the
group consisting of hydrogen, C1-C4 alkyl,
C1-C4 alkylenyl, and halo;
(h) R9 is independently selected from the
group consisting of hydrogen, C1-C4 alkyl,
C1-C4 alkylenyl, halo, substituted or
unsubstituted aryl, substituted or
unsubstituted aryl -C1-C4 alkyl, substituted
or unsubstituted heteroaryl, C1-C6 allyl,
and OR10; and
(i) R10 is independently selected from the
group consisting of hydrogen and C1-C4
alkyl.
__________
]11[]21[
]54[
ANGULAR MOTION
MEASUREMENT
ARRANGEMENT
]22[
]51[
]71[
11.03.2003
Int. Cl.(2008.04) G01P 3/04
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
]72[
TZVI EFRATI, MICKY
NARODITSKY, MAKSIM
GOLDSHTEIN
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
]74[
268
154871
‫סידור למדידת תנועה סיבובית‬
,‫רפאל מערכות לחימה מתקדמות בע"מ‬
‫חיפה‬
‫ מקסים‬,‫ מיקי נרודיצקי‬,‫צבי אפרתי‬
‫גולדשטיין‬
,‫ד"ר מרק פרידמן בע"מ‬
,7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫ גן‬-‫רמת‬
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
[57] An angular motion measurement
system disposed on a movable platform
having a first section and a second section,
comprising;
(a) a first measurement arrangement (24)
configured to provide a first output
indicative of angular motion of the section,
said first measurement arrangement having
a bandwidth above 50 Hertz and at least
one of, a bias above 5 degrees per second
and a scale factor above 10%;
(b) a second measurement arrangement
(26) configured to provide a second output
indicative of angular motion of the second
section, said second measurement
arrangement having a bandwidth below 50
Hertz, a bias below 5 degrees per second
and a scale factor below 10%; and
(c) a processor arrangement (30)
responsive to a plurality of inputs, which
include said first output and said second
output, generating a corrected output
having a bandwidth above 50 Hertz, a bias
below 5 degrees per second and a scale
factor below 10%.
__________
]11[]21[
155029
–‫ – יל‬1 – ‫ – מתילפיפרזין‬4( – 4 –‫שימוש ב‬
– ‫ – פירידין‬4( – 3 – ‫ – מתיל‬N – [4 – )‫מתיל‬
– ]‫ – יל – אמינו) פניל‬2 – ‫ – יל)פירימידין‬3
‫בנזמיד להכנת תרופה לטיפול בסרטן של‬
‫משתית של מערכת העיכול‬
]54[
USE OF 4 - ( 4 METHYLPIPERAZIN - 1 - YLMETHYL) - N - [4 - METHYL - 3 - (4
- PYRIMIDIN - 3 - YL) PYRIMIDIN
- 2 - YL - AMINO) PHENYL] BENZAMIDE IN THE
PREPARATION OF A
MEDICAMENT FOR THE
TREATMENT OF
GASTROINTESTINAL STROMAL
TUMOR
]22[
]31[
]51[
]71[
]87[
26.10.2001
60/243810
]32[ 27.10.2000
]33[ US
Int. Cl.(2008.04) A61K 313/95, A61P 35/00, C07D 401/14
NOVARTIS AG, SWITZERLAND
WO/2002/034727
September 22, 2009
–‫ד' בתשרי התש"ע‬
269
]74[
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[57] The use of 4-(4-methylpiperazin-1ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)
pyrimidin-2-yl-amino) phenyl)-benzamide
of the formula
or a pharmaceutically acceptable salt
thereof for the manufacture of
pharmaceutical compositions for the
treatment of gastrointestinal stromal
tumours.
__________
]11[]21[
155217
‫שיטה והתקן לעיבוד מידע‬
]54[
METHOD AND APPARATUS FOR
DATA PROCESSING
]22[
]31[
]51[
]71[
01.10.2001
507386
]32[ 09.10.2000
]33[
Int. Cl.(2008.04) G06F 11/20, 12/00, 17/30
MAXIMUM AVAILABILITY
LIMITED, NEW ZEALAND
WO/2002/031696
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
[57] A method of replicating information
from a source system at a target system
comprising the steps of:
(i) receiving information strings from the
source system;
(ii) assigning the information strings to
serialization groups for processing,
(iii) arranging interdependent information
strings into groups, wherein information
270
NZ
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
strings having members that having a
database type relationship with other
members are grouped together to ensure
that they are updated in the correct
sequence, and wherein each group of
interdependent information strings is
processed in one of a plurality of
serialization groups, and
September 22, 2009
–‫ד' בתשרי התש"ע‬
(iv) processing the serialization groups in
parallel, to replicate the information from
the source system.
,192136
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
________
]11[]21[
]54[
PROCESS FOR PRODUCING
SUBSTITUTED ANILINE
COMPOUND
]22[
]31[
15.10.2001
2000-316345 ]32[ 17.10.2000
2001-034216
09.02.2001
Int. Cl.(2008.04) C07D 239/26, 239/74
IHARA CHEMICAL INDUSTRY CO.,
LTD., JAPAN
WO/2002/032882
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
]51[
]71[
]87[
]74[
155486
‫תהליך לייצור תרכובת אנילין מותמר‬
]33[
JP
JP
,'‫זליגסון גבריאלי ושות‬
‫ תל אביב‬,1426 .‫ד‬.‫ ת‬, 31 ‫רח' יבנה‬
[57] A process for producing a
substituted aniline compound of the
formula
September 22, 2009
–‫ד' בתשרי התש"ע‬
271
wherein R1, R2 and R3 are each
independently an alkyl group, an alkoxy
group, an alkoxyalkyl group, a haloalkyl
group, a carboxyl group, a nitro group, an
aryl group, an arylalkyl group, an aryloxy
group, a halogen atom or a hydrogen atom;
and X and Y are each independently a
hydrogen atom, an alkyl group, an alkoxy
group, an alkoxyalkyl group, a haloalkyl
group, a carboxyl group, or a halogen
atom, the process comprising: oxidizing a
substituted indole compound of the
formula
wherein, R1, R2, R3, X and Y have the
same definitions as given above to give
ring opening of the indole ring to produce
an acetanilide compound of the formula
wherein, R1, R2, R3, X and Y have the
same definitions as given above, and Ac is
an acetyl group; and subjecting compound
(4) to reduction and deacetylation to give
compound (6).
The applications for division
from this application have
not yet been published
,192827
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
________
272
September 22, 2009
–‫ד' בתשרי התש"ע‬
]11[]21[
155812
GLP–1 ‫חלבוני התכה‬
]54[
GLP-1 FUSION PROTEINS
]22[
]31[
]51[
]71[
]87[
]74[
29.11.2001
60/251954
]32[ 07.12.2000
Int. Cl.(2008.04) C07K 19/00
ELI LILLY & CO., U.S.A.
WO/2002/046227
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]33[
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
[57] A heterologous fusion protein
comprising a first polypeptide with a Nterminus and a C-terminus fused to a
second polypeptide with a N-terminus and
a C-terminus wherein the first polypeptide
is a Glucagon-Like Peptide 1 (GLP-1)
compound and the second polypeptide is
selected from
(a) the Fc portion of an immunoglobulin;
(b) an analog of the Fc portion of an
immunoglobulin; and
(c) fragments of the Fc portion of an
immunoglobulin,
and wherein the C-terminus of the first
polypeptide is fused to the N-terminus of
the second polypeptide.
,184429
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
_________
]11[]21[
155990
‫נגזרות של קרבפנם‬
]54[
CARBAPENEM DERIVATIVES
]22[
]31[
]51[
]71[
]87[
]74[
22.11.2001
2000-356997 ]32[ 24.11.2000
]33[ JP
Int. Cl.(2008.04) A61K 314/439, A61P 31/04, C07D 477/00, 477/14, 513/00, 519/00
MEIJI SEIKA KAISHA, LTD., JAPAN
WO/2002/042312
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57] A compound of the formula
September 22, 2009
–‫ד' בתשרי התש"ע‬
273
or a pharmaceutically acceptable salt
thereof wherein
R1 represents methyl,
R2 and R3, which may be the same or
different, each represent a hydrogen atom;
a halogen atom; lower alkyl optionally
substituted by a halogen atom, cyano,
hydroxyl, carbamoyl, amino, formylamino,
lower alkylcarbonylamino,
aminosulfonylamino, lower alkylthio,
lower alkoxy, lower cycloalkyl, N,N-dilower alkylamino, or N-carbamoyl lower
alkyl-N,N-di-lower alkylamino; lower
cycloalkyl; lower alkylcarbonyl;
carbamoyl; aryl; lower alkylthio is
optionally substituted by amino, hydroxyl,
azide, a halogen atom, cyano, carbamoyl,
formylamino, lower alkylcarbonylamino,
aminosulfonylamino, or lower alkylthio;
morpholinyl; lower alkylsulfonyl; or
formyl; n is 0 and Hy represents pyridine3-yl, pyridinium-3-yl or (2S)-pyrrolidin-2yl the heterocyclic group represented by
Hy is optionally substituted by a halogen
atom; cyano; lower alkyl wherein one or
more hydrogen atoms on the lower alkyl
group are optionally substituted by groups
selected from the group consisting of a
halogen atom; hydroxyl; carboxylamethylsubstituted carbamoyl; amino; N,N-dilower alkylamino; aryl optionally
substituted by amino; a monocyclic or
bicyclic heterocyclic group containing one
or more heteroatoms selected from the
group consisting of nitrogen, oxygen, and
sulfur atoms, optionally substituted by
aminosulfonyl or carboxyl; carboxyl;
imino; lower alkoxycarbonyl; lower
alkylcarbonyl; aminosulfonylamino; amino
lower alkylsulfonyl; (N,N-di-lower
alkylamino) sulfonylamino; N'-(N,N-dilower alkylamino) sulfonyl-N'-lower
alkylamino; halogenated lower Naminosulfonyl piperidinyl; and cyano;
lower alkylthio wherein one or more
hydrogen atoms on the alkyl group are
optionally substituted by a group selected
from the group consisting of a halogen
atom, hydroxyl, carbamoyl, amino, and
aryl; lower alkylsulfonyl wherein one or
more hydrogen atoms on the alkyl group
are optionally substituted by a group
selected from the group consisting of a
halogen atom, hydroxyl, carbamoyl,
amino,1-iminoethylamino, and aryl;
hydroxyl; lower alkoxy; halogenated lower
alkoxy; aminophenyl-substituted lower
alkoxy; formyl; lower alkylcarbonyl;
arylcarbonyl; carboxyl; lower
alkoxycarbonyl; carbamoyl; N-lower
alkylcarbamoyl; N,N-di-lower
alkylaminocarbonyl; amino; N-lower
alkylamino; N,N-di-lower alkylamino;
formylamino; lower alkylcarbonylamino;
aminosulfonylamino; (N-lower
alkylamino) sulfonylamino; (N,N-di-lower
alkylamino) sulfonylamino; aryl; or a
monocyclic or bicyclic heterocyclic group
containing one or more heteroatoms
selected from the group consisting of
nitrogen, oxygen, and sulfur atoms,
optionally substituted by aminosulfonyl or
carboxyl.
__________
274
September 22, 2009
–‫ד' בתשרי התש"ע‬
]11[]21[
]54[
SEMICONDUCTOR DEVICE
FABRICATED ON SURFACE OF
SILICON HAVING <110>
DIRECTION OF CRYSTAL PLANE
AND ITS PRODUCTION METHOD
]22[
]31[
]51[
]71[
]87[
]74[
02.10.2002
2001-307899 ]32[ 03.10.2001
Int. Cl.(2008.04) H01L 29/78
TADAHIRO OHMI, JAPAN
WO/2003/032399
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] A semiconductor device comprising:
a plurality of field effect transistors formed
on an unstrained silicon surface having
substantially a ‹110› orientation, the
plurality of field effect transistors each
having a gate insulator film containing
krypton atoms with a surface density of up
to 5x1011 cm-2, wherein the field effect
transistors are disposed on the silicon
surface such that a direction connecting a
156116
‫התקן מוליך למחצה המיוצר על שטח‬
‫< של מישור גביש‬011> ‫סיליקון בעל כיוון‬
‫ושיטת הייצור‬
]33[
JP
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
source region and a drain region of said
field effect transistor is coincident to a
substantially ‹110› direction, and wherein
the field effect transistors have an electron
mobility at least about 1.4 times greater
than an electron mobility of a field effect
transistor formed in the same manner on a
silicon surface having substantially a ‹100›
orientation.
__________
September 22, 2009
–‫ד' בתשרי התש"ע‬
275
]11[]21[
]54[
METHOD FOR IN-SITU FOCUSFUSION MULTI-LAYER
SPECTRAL IMAGING AND
ANALYSIS OF PARTICULATE
SAMPLES
]22[
]31[
]51[
]71[
]72[
02.12.2001
09/727753
]32[ 04.12.2000
Int. Cl.(2008.04) G06K 9/00
GREEN VISION SYSTEMS LTD.
DANNY S. MOSHE, MICHAEL
KHAZANSKI
WO/2002/047017
APPELFELD ZER FISHER,
B.S.R TOWER 1, FLOOR 16
2 BEN GURION ST.
RAMAT GAN 52573
]87[
]74[
[57] A method for in-situ focus-fusion
multi-layer spectral imaging and analysis
of a particulate sample, particles of the
particulate sample exhibiting layer or
depth dependent features and
characteristics, the method comprising the
steps of:
(a) preparing the sample for the in-situ
focus-fusion multi-layer spectral imaging
and analysis;
(b) providing a spectroscopic imaging
system, including a light illumination
source and a sample holder moveable by a
three dimensional translation stage, for insitu spectral imaging of the sample;
(c) selecting and defining imaging scenario
parameters for acquiring and analyzing insitu spectral images of the sample, said
imaging scenario parameters are particle
physicochemical information and
parameters relating to particle chemical
composition and particle morphology, and,
particle spectral information and
parameters relating to pixel energy level or
intensity, signal-to-noise ratio, image
sharpness, and, spectral fingerprints
associated with distinct spectral emission
276
156325
‫שיטה לאיחוי–פוקוס בהדמיה ספקטרלית‬
‫רב–ממדית באתר ובחינה של דגימות‬
‫חלקיקיות‬
]33[
US
‫ תל אביב‬,‫גרין ויז'ן מערכות בע"מ‬
‫ מיכאל חזנסקי‬,‫דני משה‬
,‫ עו"ד עורכי פטנטים‬,‫אפלפלד זר פישר‬
‫ גן‬- ‫ רמת‬,16 ‫ קומה‬.‫ר‬.‫ס‬.‫ מגדל ב‬2 ‫בן גוריון‬
patterns of the particles of the sample, each
said spectral emission pattern featuring
emission intensity as a function of
wavelength of light emitted by the sample;
(d) adjusting and setting said spectroscopic
imaging system for said in-situ spectral
imaging of the sample at a selected i-th
field of view, having central (x, y) position
coordinates relative to said translation
stage;
(e) acquiring a spectral plane image of the
sample in said selected i-th field of view,
at a selected j-th differential
imaging/focusing distance, in a selected
range of imaging distance defined along zdirection between the sample and said light
illumination source of said spectroscopic
imaging system, by focusing said imaging
system in said z-direction until receiving a
sharp gray level image of the sample;
(f) constructing and analyzing a focused
spectral plane imageij of the sample for
said selected i-th field of view, at said
selected j-th differential imaging/focusing
distance, from said acquired spectral plane
image of the sample, whereby said
constructing and analyzing features
September 22, 2009
–‫ד' בתשרי התש"ע‬
identifying target in said sharp gray level
image of the sample by using said selected
and said defined particle physicohemical
imaging scenario parameters and said
selected and said defined particle spectral
imaging scenario parameters;
(g) repeating step (e) and step (f) in said
selected i-th field of view, for a plurality of
said selected j-th differential
imaging/focusing distances, in said
selected range of imaging distance, for
forming a plurality of said focused spectral
plane imagesij of the sample for said
selected i-th field of view;
(h) constructing a fused focused spectral
image, for said selected i-th field of view,
using a plurality of said identified targets
having high content selected from said
plurality of said focused spectral plane
imagesij, and, using spectral background
parameters, empirically determined from
said plurality of said focused spectral plane
imagesij;
(i) acquiring and constructing a plurality of
said fused focused spectral imagesi of the
sample in other said selected i-th fields of
view, having corresponding said central (x,
y) position coordinates relative to said
translation stage, for a plurality of said
selected j-th differential imaging/focusing
distances, by repeating step (d) through
step (h), until selected sample
viewing/imaging range is imaged and
analyzed; and
(j) applying at least one image analysis
algorithm to data of said plurality of said
fused focused spectral imagesi for
correlating said particle spectral
information and parameters to said particle
physicochemical information and
parameters, thereby characterizing the
particulate sample.
__________
September 22, 2009
–‫ד' בתשרי התש"ע‬
277
]11[]21[
156341
,‫ תהליכים ליצורם‬,‫נגזרות בנזותיאזפין‬
‫תכשירי רוקחות המכילים אותם והשימוש‬
‫בהם ליצור תרופות וכתרופות ליצירת‬
‫ בבעל חיים בעל דם‬IBAT ‫אפקט מעכב‬
‫חם‬
]54[
BENZOTHIAZEPINE
DERIVATIVES, PROCESSES FOR
THEIR MANUFACTURE,
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM AND THEIR USE IN THE
MANUFACTURE OF
MEDICAMENTS AND AS
MEDICAMENTS FOR THE
PRODUCTION OF AN IBAT
INHIBITORY EFFECT IN A
WARM-BLOODED ANIMAL
]22[
]31[
17.12.2001
0004811-6
]32[ 21.12.2000
]33[ SE
0112592.1
24.05.2001
GB
Int. Cl.(2008.04) A61K 315/54, 316/75, 38/05, 38/06, A61P 3/06, C07D 281/10,
417/12, C07F 96/536, C07K 50/65, 50/87
ALBIREO AB, SWEDEN
INGEMAR STARKE, MIKAEL ULF
JOHAN DAHLSTROM, DAVID
BLOMBERG
WO/2002/050051
S. HOROWITZ & CO.,
,'‫ הורוביץ ושות‬.‫ש‬
ZION HOUSE,
‫ תל‬,41-45 ‫ שדרות רוטשילד‬,‫בית ציון‬
41-45 ROTHSCHILD BLVD.,
‫אביב‬
TEL AVIV 65784
]51[
]71[
]72[
]87[
]74[
[57] A compound of the formula
wherein:
Rv and Rw are independently selected from
hydrogen or C1-6 alkyl;
278
R1 and R2 are independently selected from
C1-6 alkyl;
September 22, 2009
–‫ד' בתשרי התש"ע‬
Rx and Ry are independently selected from
hydrogen or C1-6 alkyl, or one of Rx and Ry
is hydrogen or C1-6 alkyl and the other is
hydroxy or C1-6 alkoxy;
Rz is selected from halo, nitro, cyano,
hydroxy, amino, carboxy, carbamoyl,
mercapto, sulphamoyl, C1-6 alkyl, C2-6alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6
alkoxy, C1-6 alkanoyl, C1-6 alkanoyloxy, N(C1-6 alkyl) amino, N,N-(C1-6 alkyl)2
amino, C1-6 alkanoylamino, N-( C1-6 alkyl)
carbamoyl, N,N-( C1-6 alkyl)2 carbamoyl,
C1-6 alkylS(O)a wherein a is 0 to 2, C1-6
alkoxycarbonyl, C1-6
alkoxycarbonylamino, ureido, N', N'-(C1-6
alkyl)2 ureido, N'-(C1-6 alkyl)-N-(C1-6
alkyl) ureido, N-(C1-6 alkyl) sulphamoyl
and N,N-(C1-6 alkyl)2 sulphamoyl; v is 0-5;
R3, R4, R5 and R6 are as defined in the
specification or a pharmaceutically
acceptable salt or an in vivo hydrolysable
ester or amide thereof.
__________
]11[]21[
156435
IGF–1 ‫גיבוש של‬
]54[
CRYSTALLIZATION OF IGF-1
]22[
]31[
01.02.2002
60/267977
]32[ 09.02.2001
]33[ US
60/287072
27.04.2001
US
Int. Cl.(2008.04) C07K 14/65, C30B 29/58, G01N 23/20
GENENTECH, INC., U.S.A.
WO/2002/064627
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
[57] A crystal of IGF-1 having
approximately the following cell constants
a=31.831Å, b=71.055Å, c=65.995Å, and a
space group of C2221 to allow the
determination of the three-dimensional
structure of IGF-1 by X-ray diffraction
studies.
__________
September 22, 2009
–‫ד' בתשרי התש"ע‬
279
]11[]21[
156440
‫מערכת נקודה לרב נקודות ותהליך‬
‫להעברת נתונים דיגיטליים דרך רשת‬
‫החשמל‬
]54[
POINT TO MULTIPOINT SYSTEM
AND PROCESS FOR THE
TRANSMISSION OF DIGITAL
DATA OVER THE ELECTRICITY
NETWORK
]22[
]31[
]51[
]71[
18.12.2001
P200003024
]32[ 18.12.2000
]33[ ES
Int. Cl.(2008.04) H04B 3/54, H04J 11/00, H04L 27/26, 5/02
DISENO DE SISTEMAS EN SILICIO,
S.A., SPAIN
WO/2002/051024
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]87[
]74[
[57] System for the digital transmission
of data, point to multipoint over the
electricity network, that comprises a
communication in the downstream
channel, determined by a link from the
head-end to various different users, and a
communication in the upstream channel,
determined by a link from each of the
users to the head-end, where the
communication medium is the electricity
network (5) and communication is
achieved by means of an OFDM
modulation (orthogonal frequency division
multiplexing) to obtain OFDM symbols,
where both the head-end and the users
contain a transmitter/receiver that includes
a medium access control module (MAC) to
provide a master-slave communication, as
well as means to add/extract a cyclic prefix
in the OFDM symbols and means of
converting the OFDM symbols from
frequency to time and from time to
frequency, and digital-to-analog and
analog-to-digital converters; characterized
in that the transmitter (1) / receiver (2) of
the head-end and the users comprises:
means to adapt the digital signal to the
electricity network that provide: an OFDM
modulation with a carrier width reduced to
280
at least 1,5 KHz and with the number of
carriers increased to at least 500 carriers
for each 10MHz to strengthen against
selective frequency fadings arising from
the varying cable lengths in the electricity
network between each user and the headend and to strengthen against interferences
in the electricity network; a cyclic prefix of
long duration, at least 7 microseconds, to
recover the signal; where the transmitter
(1) includes means of sharing the medium
in time TDMA (Time Division Multiple
Access), in frequency FDMA (Frequency
Division Multiple Access), and/or in
Orthogonal Frequency Division Multiple
Access (OFDMA), of the data transmitted
in both the upstream and downstream
channels for multiple users; where the
receivers (2) include means to process the
information corresponding to the data
transmitted in the communication in the
time and frequency domains, to reach
maximum throughput; means to calculate
without interruption the SNR (signal to
noise ratio) for each of the carriers in the
OFDM modulation in both the upstream
and downstream, so that different users
located at differing distances from the
head-end use dynamically different
September 22, 2009
–‫ד' בתשרי התש"ע‬
carriers in the same OFDM symbol, with a
variable number of bits per carrier,
maximizing the throughput of the channel
in time; where the transmitter includes
means to assign without interruption the
carriers and a particular number of bits per
carrier to each of the carriers in the OFDM
modulation from the result of the SNR
calculation, and means to associate the
number of the bits to be transmitted to
each designated carrier to achieve the
transmission taking into consideration the
changes suffered by the electricity line (5)
response at different distances between the
users and the head-end in each frequency,
and to adapt transmission speed in function
of the SNR calculation and the quality of
transmission required for each user; means
to translate the frequency to user
bandwidths higher than base band, so as to
be adapted to the electricity network and to
allow the use of spectral zones superior to
base band.
__________
]11[]21[
]54[
DEVICE FOR ELLIPSOMETRIC
TWO-DIMENSIONAL DISPLAY
OF SAMPLE, DISPLAY METHOD
AND ELLIPSOMETRIC
MEASUREMENT METHOD WITH
SPATIAL RESOLUTION
]22[
]31[
]51[
]71[
18.12.2001
00/16529
]32[ 18.12.2000
Int. Cl.(2008.04) G01N 21/21
CENTRE NATIONAL DE LA
RECHERCHE SCIENTIFIQUE
(C.N.R.S), FRANCE
UNIVERSITE PIERRE ET MARIE
CURIE, FRANCE
WO/2002/050513
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
September 22, 2009
–‫ד' בתשרי התש"ע‬
156480
‫התקן לתצוגה אליפסומטרית דו–מימדית‬
‫ שיטת תצוגה ומדידה‬,‫של דגימה‬
‫אליפסומטרית עם הפרדה מרחבית‬
]33[
FR
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
281
[57] A device for ellipsometric twodimensional display of a sample (1),
comprising an object (4), placed in an
incident medium (32), observed between a
convergent light cross-reflected analyzer
and polarizer, wherein the ellipsometric
parameters of the set composed of the
object and a substrate (8) whereon it is
placed, are processed, characterised in that:
the substrate comprises a base (7) and a
stack (5) of layers and that its ellipsometric
properties are known, the ellipsometric
properties of the substrate being such that
the variations of the ellipsometric
parameters of the sample due to the object
are displayed with a contrast greater than
the contrast produced in the absence of
such substrate.
,193361
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
_________
]11[]21[
156505
‫נגזרות של דהידרו–נפתלן ותרופות‬
‫המכילות תרכובות אלו כמרכיב הפעיל‬
]54[
DIHYDRONAPHTHALENE
DERIVATIVES AND AGENTS
COMPRISING THE DERIVATIVES
AS ACTIVE INGREDIENT
]22[
]31[
]51[
21.12.2001
2000-392723 ]32[ 25.12.2000
]33[ JP
Int. Cl.(2008.04) A61K 314/21, 314/26, A61P 3/00, 43/00, 9/00, C07D 263/32,
413/04, 413/10, 413/12, 413/14, 417/04
ONO PHARMACEUTICAL CO.,
LTD., JAPAN
WO/2002/051820
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
]71[
]87[
]74[
[57] Dihydronaphthalene derivatives of
the formula
282
September 22, 2009
–‫ד' בתשרי התש"ע‬
(wherein X represents a bond, or C1-4
alkylene,
Y represents –O-, or –S-,
Z represents C1-4 alkylene,
A represents –O-, or –S-,
R1 represents COOR5, CONH2, CONHOH,
CH2OH, CHO, 1H-tetrazol-5-yl, or 3,5dioxoisooxazolin-4-yl, R5 represents
hydrogen, or C1-8 alkyl, R2 and R3 each
independently represents hydrogen, C1-8
alkyl, C1-8 alkoxy, or C1-8 alkoxy
substituted by a phenyl, R4 represents
hydrogen, or C1-8 alkyl, D represents D1,
D2, or D3,
D1 represents
ring l represents benzene
D2 represents
ring2 represents pyridine, dioxaindan,
morpholine, piperidine, thiomorpholine,
pyrazole, pyrazine, dihydropiperidine,
piperazine, D3 represents C1-8 alkyl,
R6 represents hydrogen, C1 -8 alkyl, nitro,
NR7R8, halogen, C1-8 alkoxy, C1-8
The applications for division
from this application have
not yet been published
alkylthio, CF3, CF3O, cyclohexane,
morpholine or piperidine, R7 and R8 each
independently represents hydrogen atom,
or C1-alkyl, m represents 1-3), or nontoxic
salts thereof.
,197407
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
_______
September 22, 2009
–‫ד' בתשרי התש"ע‬
283
]11[]21[
156646
‫ תכשירים‬,‫תרכובות איזואינדול–אמיד‬
‫רפואיים המכילים אותן והשימוש בהן‬
‫להכנת תרופות‬
]54[
ISOINDOLE-IMIDE COMPOUNDS,
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM AND USES THEREOF FOR
PREPARING MEDICAMENTS
]22[
]31[
21.12.2001
60/258372
]32[ 27.12.2000
]33[ US
09/972487
05.10.2001
US
Int. Cl.(2008.04) A61K 314/45, A61P 29/00, 35/00, 43/00, C07D 401/04, 401/14,
405/14, 409/14
CELGENE CORPORATION, U.S.A.
WO/2002/059106
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
[57] A compound of the formula
or a pharmaceutically acceptable salt,
hydrate, solvate, clathrate, enantiomer,
diastereomer, racemate, or mixture thereof,
wherein:
one of X and Y is C=O and the other is
CH2 or C=O; R1 is H, (C1-C8) alkyl, (C3C7) cycloalkyl, (C2-C8) alkynyl, benzyl,
aryl, (C0-C4) alkyl-(C1-C6)
heterocycloalkyl, (C0-C4) alkyl-(C2-C5)
heteroaryl, C(O)R3, C(S)R3, C(O)OR4,
(C1-C8) alkyl-N(R6)2, (C1-C8) alkyl-OR5,
(C1-C8) alkyl-C(O)OR5, C(O)NHR3,
C(S)NHR3, C(O)NR3R3', C(S)NR3R3', or
(C1-C8) alkyl-O(CO)R5; R2 is H, or (C1-C8)
alkyl; R3 and R3' are independently (C1-C8)
alkyl, (C3-C7) cycloalkyl, (C2-C8) alkenyl,
(C2-C8) alkynyl, benzyl, aryl, (C0-C4)
alkyl-(C1-C6) heterocycloalkyl, (C0-C4)
alkyl-(C2-C5) heteroaryl, (C0-C8) alkylN(R6)2, (C1-C8) alkyl-OR5, (C1-C8) alkylC(O)OR5, (C1-C8) alkyl-O(CO)5, or
C(O)OR5; R4 is (C1-C8) alkyl, (C2-C8)
alkenyl, (C2-C8) alkynyl, (C1-C4) alkylOR5, benzyl, aryl, (C0-C4) alkyl-(C1-C6)
heterocycloalkyl, or (C0-C4) alkyl- (C2-C5)
heteroaryl; R5 is (C1-C8) alkyl, (C2-C8)
alkenyl, (C2-C8) alkynyl, benzyl, aryl, or
(C2-C5) heteroaryl; each occurrence of R6
is independently H, (C1-C8) alkyl, (C2-C8)
alkenyl, (C2-C8) alknyl, benzyl, aryl, (C2C5) heteroaryl, or (C0-C8) alkyl-C(O)OR5,
or the R6 group can join to form a
heterocycloalkyl group; and the*
represents a chiral-carbon center.
__________
284
September 22, 2009
–‫ד' בתשרי התש"ע‬
]11[]21[
156801
‫מעקב זמן בסביבת רווח רבת–נתיבים‬
‫שאינה זניחה‬
]54[
TIME TRACKING IN A NONNEGLIGIBLE MULTIPATHSPACING ENVIRONMENT
]22[
]31[
11.01.2002
60/261402
]32[ 11.01.2001
]33[ US
09/964589
25.09.2001
US
Int. Cl.(2008.04) H04B 17/07, 7/06, 7/08
QUALCOMM INCORPORATED,
U.S.A.
WO/2002/061963
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]51[
]71[
]87[
]74[
[57] A method for offset time tracking in
a non-negligible multipath spacing
environment encompassing an antenna
diversity system, the antenna diversity
system comprising a plurality of antennas
each transmitting a modulated signal, the
method comprising: demodulating each of
the plurality of modulated signals based on
a time offset, a plurality of data
despreading sequences, and a plurality of
pilot estimates, each signal having a
different data despreading sequence of the
plurality of data despreading sequences
and a different pilot estimate of the
plurality of pilot estimates; generating a
plurality of time tracking error signals, one
for each of the plurality of demodulated
signals, in response to a pilot despreading
sequence for each of the plurality of
demodulated signals; generating an
average time tracking error signal in
response to the plurality of time tracking
error signals; and generating an updated
offset in response to the average time
tracking error signal.
__________
]11[]21[
September 22, 2009
–‫ד' בתשרי התש"ע‬
156862
285
‫אריג שאינו ארוג בלול באמצעות מים‬
‫ושיטות והתקנים להכנתו‬
]54[
NONWOVEN
HYDROENTANGLED FABRIC
AND METHODS AND
APPARATUS FOR PRODUCING
THE SAME
]22[
]51[
]71[
]87[
]74[
12.01.2001
Int. Cl.(2008.04) D04H 1/46, 1/56, 3/10, 3/16, 5/02
POLYMER GROUP, INC., U.S.A.
WO/2002/055778
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] A nonwoven fabric formed on a
three-dimensional image transfer device,
said fabric consisting of a continuous web
(8) of substantially endless thermoplastic
melt extruded filaments (2) comprised of
polyolefins, or polyesters, said filaments
having a denier of about 0.5 to 3, wherein
said filaments are collected and thereafter
hydroentangled in the form of
interengaged packed loops, with the
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
substantially endless filaments being
substantially free of breaking, wrapping
and knotting, said fabric exhibiting crossdirection elongation of at least about 90%,
and machine direction elongation of at
least about 75%, while exhibiting tensile
strength generally proportional to crossdirection and machine-direction elongation
values.
__________
]11[]21[
]54[
286
SYSTEM FOR DETECTION AND
156868
‫מערכת לזיהוי והערכה של מבנים מחזוריים‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫באות רועש‬
ESTIMATION OF PERIODIC
PATTERNS IN A NOISY SIGNAL
]22[
]51[
]71[
10.07.2003
Int. Cl.(2008.04) A61B 5/05
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
]72[
LIDROR TROYANSKY, ARNON
BREUER
YORAM TSIVION,
2 HATOCHEN ST.
P.O.B. 3148,
CAESAREA 38900
]74[
[57] A method for discerning
periodicities in signals, comprising the
succession of steps of: sampling and preprocessing of the raw-signal in discrete
succession of equally spaced slices of
time; generating short-term characteristics
vectors for each such slice of time;
,‫רפאל מערכות לחימה מתקדמות בע"מ‬
‫חיפה‬
‫ ארנון ברויאר‬,‫לידרור טרוינסקי‬
,‫יורם צביון‬
,3148 .‫ד‬.‫ ת‬, ‫ פארק התעשיה‬,2 ‫רח' הטוחן‬
‫קיסריה‬
grouping said short-term characteristics
vectors into sets; obtaining at least one
representative vector for each of said sets
of short-term characteristics vectors, and
estimation of periodic structures using said
representative vectors.
__________
September 22, 2009
–‫ד' בתשרי התש"ע‬
287
]11[]21[
]54[
FREQUENCY SEARCHER AND
FREQUENCY-LOCKED DATA
DEMODULATOR USING A
PROGRAMMABLE ROTATOR
156947
‫מחפש תדר ודימודולטור מידע נעול תדר‬
‫המשתמש ברוטטור הנתון לתיכנות‬
]22[
]31[
18.01.2002
60/262691
]32[ 19.01.2001
]33[ US
10/017073
07.12.2001
US
]51[ Int. Cl.(2008.04) H04B 17/07, H04L 27/22, 272/27
]71[ QUALCOMM INCORPORATED,
U.S.A.
]87[ WO/2002/069594
]74[ SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
[57] A searcher method for finding a
increments to generate a total phase
signal having a frequency deviation from
increment; and when the total phase
an expected frequency, the method
increment has reached a predetermined
comprising the steps of: initializing the
total phase increment threshold,
searcher on predetermined frequency bins;
performing a phase rotation function that is
determining a phase error in the signal;
substantially equivalent to the total phase
generating a phase increment in response
increment.
to the phase error; accumulating the phase
__________
]11[]21[
]54[
288
157030
‫חומר סופג חבטה‬
IMPACT ABSORBING MATERIAL
September 22, 2009
–‫ד' בתשרי התש"ע‬
]22[
]31[
]51[
]71[
]87[
]74[
23.01.2002
60/263644
]32[ 24.01.2001
]33[
Int. Cl.(2008.04) B32B 3/02, D04H 1/46
AUBURN UNIVERSITY, U.S.A.
WO/2002/059412
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] An impact resistant material (10)
comprising: a plurality of in-plane fibers
defining a fabric plane, and a plurality of
upright fibers, wherein at least a portion of
each upright fiber is oriented generally
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
perpendicular to the fabric plane, said
upright fibers comprising a ballistic fiber
material (34), wherein said upright fibers
comprise at least about 25% of said
material.
__________
]11[]21[
157208
‫–אילבנזאמיד‬2–‫–אינדן‬N– ‫–פלואורו‬4
‫והשימוש בו לייצור תרופות‬
]54[
USE OF 4-FLUORO-N-INDAN-2-YL
BENZAMIDE FOR THE
MANUFACTURE OF
MEDICAMENTS
]22[
]31[
]51[
]71[
12.02.2002
01102852.9
]32[ 13.02.2001
]33[ EP
Int. Cl.(2008.04) A61K 311/66, A61P 9/00, C07C 233/65
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2002/064146
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬
HERZLIYA 46733
]87[
]74[
[57] The use of 4-fluoro-N-indan-2-yl
benzamide of the formula
September 22, 2009
–‫ד' בתשרי התש"ע‬
289
for the manufacture of a medicament for
the treatment of stable or unstable angina
pectoris, coronary heart disease,
Prinzmetal angina, acute coronary
syndrome, heart failure, myocardial
infarction, thrombosis, peripheral artery
occlusive disease, atherosclerosis,
restenosis, endothelial damage after
PTCA, hypertension, essential
hypertension, pulmonary hypertension,
secondary hypertension, renovascular
hypertension, chronic glomerulonephritis,
erectile dysfunction, ventricular
arrhythmia, diabetes, nephropathy,
retinopathy, angiogenesis, asthma
bronchiale, chronic renal failure, cirrhosis
of the liver or osteoporosis or for the
lowering of cardiovascular risk of
postmenopausal women or after intake of
contraceptiva.
__________
]11[]21[
]54[
PROCESS FOR THE
PREPARATION OF (E)-5-(2 BROMOVINYL)- 2'DEOXYURIDINE
]22[
]31[
]51[
]71[
21.02.2002
10109657.7
]32[ 28.02.2001
Int. Cl.(2008.04) C07H 190/73
MENARINI RICERCHE S.P.A.,
ITALY
BERLIN-CHEMIE AG, GERMANY
WO/2002/068443
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
157573
– )‫ – ברומוויניל‬E) – 5 – (2( ‫תהליך להכנת‬
‫' – דאוקסיורידין‬2
]33[
DE
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
[57] Process for the preparation of (E)-5(2-bromovinyl)-2'-deoxyuridine of the
formula
290
September 22, 2009
–‫ד' בתשרי התש"ע‬
comprising:
(a) reaction of a compound of
the formula
in which R is an alkanoyl C1-C8 group, a
benzyol group or a benzoyl group
substituted at the para position with a C1C4 alkyl group or with a halogen atom,
with a brominating agent in the presence of
a radical initiator, in a halogen-free solvent
selected from an alkyl ester or a cyclic
ether;
(b) dehydrobromination of the resulting
compound of the formula
wherein R has the above defined meaning,
with or without bases, in a halogen-free
solvent to give an intermediate of the
formula
September 22, 2009
–‫ד' בתשרי התש"ע‬
291
wherein R has the above defined meaning;
(c) deprotection of the intermediate of formula (IV).
__________
]11[]21[
157589
‫תרכובות קרבמט לשימוש במניעה ובטיפול‬
‫בהפרעת ביפולאר‬
]54[
CARBAMATE COMPOUNDS FOR
USE IN PREVENTING OR
TREATING BIPOLAR DISORDER
]22[
]31[
21.02.2002
60/271680
]32[ 27.02.2001
]33[ US
10/081606
21.02.2002
US
Int. Cl.(2008.04) A61K 31/27, A61P 25/18, 25/24, C07C 271/10
ORTHO-MCNEIL
PHARMACEUTICAL, INC., U.S.A.
WO/2002/067924
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
‫ תל אביב‬,11490 .‫ד‬.‫ ת‬, 124 ‫אבן גבירול‬
P.O.B. 11490,
TEL AVIV 62038
]51[
]71[
]87[
]74[
[57] A medicament comprising a
therapeutically effective amount of an
enantiomer of the formula
or enantiomeric mixture, wherein one
enantiomer predominates, for use in
preventing or treating bipolar disorder in a
subject in need thereof,
wherein
phenyl is substituted at X with one to five
halogen atoms selected from the group
consisting of fluorine, chlorine, bromine
and iodine; and, R1, R2, R3 and R4 are
independently selected from the group
consisting of hydrogen and C1-C4 alkyl;
wherein C1-C4 alkyl is optionally
substituted with phenyl (wherein phenyl is
optionally substituted with substituents
independently selected from the group
consisting of halogen, C1-C4 alkyl, C1-C4
alkoxy, amino, nitro and cyano).
__________
292
September 22, 2009
–‫ד' בתשרי התש"ע‬
]11[]21[
157610
‫שיטות לייצור תחמוצת מתכתית של‬
‫ניוביום‬
]54[
METHODS OF MAKING A
NIOBIUM METAL OXIDE
]22[
]31[
]51[
]71[
]87[
]74[
27.02.2002
60/271983
]32[ 28.02.2001
Int. Cl.(2008.04) C01G 33/00
CABOT CORPORATION, U.S.A.
WO/2002/068333
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
]33[
US
,'‫זליגסון גבריאלי ושות‬
‫ תל אביב‬,1426 .‫ד‬.‫ ת‬, 31 ‫רח' יבנה‬
[57] A method of milling material
comprising milling said material with a
first milling media having a first size and
then milling said material with a second
milling media having a size smaller than
said first size, wherein said material
comprises a getter material, a starting
metal oxide, an oxygen reduced metal
oxide, or combinations thereof.
__________
]11[]21[
]54[
SKIN SUBSTITUTES AND USES
THEREOF
]22[
]31[
01.03.2002
60/273034
]32[ 02.03.2001
60/287898
01.05.2001
Int. Cl.(2008.04) C12N 5/00, 5/02
STRATATECH CORPORATION,
U.S.A.
WO/2002/070729
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]51[
]71[
]87[
]74[
[57] A composition comprising a pregraft human skin equivalent, said pre-graft
skin equivalent having a surface electrical
capacitance of from about 40 to about 240
The applications for division
September 22, 2009
–‫ד' בתשרי התש"ע‬
157667
‫תחליפי עור ושימושיהם‬
]33[
US
US
,‫פרל כהן צדק לצר‬
,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬
pF measured as the difference in reading
over a 10 second interval, wherein said
pre-graft skin equivalent comprises Near
Diploid Immortalized Keratinocyte cells.
,195076
‫בקשות חלוקה מבקשה זו‬
293
.‫שטרם פורסמו‬
from this application have
not yet been published
________
]11[]21[
157695
‫פולימרים אניונים המורכבים מחומצות‬
‫דיקרבוקסיליות ומוצרי דשן המכילים אותם‬
]54[
ANIONIC POLYMERS
COMPOSED OF DICARBOXYLIC
ACIDS AND FERTILIZER
PRODUCTS CONTAINING THEM
]22[
]31[
]51[
]71[
27.02.2002
09/799210
]32[ 05.03.2001
]33[
Int. Cl.(2008.04) C05G 3/10, C08F 222/04
SPECIALTY FERTILIZER
PRODUCTS, LLC, U.S.A.
JOHN LARRY SANDERS, U.S.A.
WO/2002/071086
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]87[
]74[
[57] A polymer consisting of recurring
polymeric subunits each made up of at
least two different moieties individually
and respectively taken from the group
US
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
consisting of B and C moieties, or
recurring C moieties, where moiety B is of
the formula
and moiety C is of the formula
294
September 22, 2009
–‫ד' בתשרי התש"ע‬
wherein each R7 is individually and
respectively selected from the group
consisting of H, OH, C1-C30 straight,
branched chain and cyclic alkyl or aryl
groups, C1-C30 straight, branched chain
and cyclic alkyl or aryl based ester groups,
R'CO2 groups, OR' groups and COOX
groups, wherein R' is selected from the
group consisting of C1-C30 straight,
branched chain and cyclic alkyl or aryl
groups and X is selected from the group
consisting of H, the alkali metals, NH4 and
the C1-C4 alkyl ammonium groups, R3 and
R4 are individually and respectively
selected from the group consisting of H,
C1-C30 straight, branched chain and cyclic
alkyl or aryl groups, R5, R6, R10 and R11
are indivudally and respectively selected
from the group consisting of H, the alkali
metals, NH4 and the C1-C4 alkyl
ammonium groups, Y is selected from the
group consisting of Fe, Mn, Mg, Zn, Cu,
Ni, Co, Mo, V and Ca, and R8 and R9 are
individually and respectively selected from
the group consisting of nothing (i.e., the
groups are non-existent), CH2, C2H4, and
C3H6, each of said moieties having or
being modified to have a total of two COO
groups therein.
__________
]11[]21[
]54[
INJECTION NEEDLE ASSEMBLY
]22[
15.03.2002
September 22, 2009
–‫ד' בתשרי התש"ע‬
157945
‫התקן מחט להזרקה‬
295
]31[
]51[
]71[
PA200100483 ]32[ 23.03.2001
Int. Cl.(2008.04) A61B 532/
NOVO NORDISK A/S, DENMARK
NIPRO CORPORATION, JAPAN
]87[
]74[
WO/2002/076540
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57] An injection needle assembly
comprising: a needle cannula with a lumen
extending through said needle cannula
from a skin piercing distal end (4) to an
opposite proximal end along a longitudinal
axis of the needle cannula, which
longitudinal lumen is cylindrical and has
approximately the same uniform inside
diameter through the needle cannula from
the skin piercing distal end to the opposite
proximal end, wherein a first elongated
portion (6) of the needle cannula has a
conical tapered outside over at least a part
of the length which conical taper
terminates at the skin piercing distal end,
and a second elongated portion (7) of the
]33[
DK
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
needle cannula has an outside diameter
equal to or larger than the largest diameter
of the first elongated portion, characterized
by a needle hub (14) comprising a base
and an annular sleeve (16) extending from
the base, the annular sleeve having means
for removably mounting the hub onto a
syringe, wherein the needle cannula is
fastened in the base such that the first
elongated portion extends from the base in
a direction away from the sleeve and the
second elongated portion extends in the
opposite direction, the second portion
being at least partly surrounded by the
sleeve.
__________
]11[]21[
]54[
296
DEVELOPMENT AND TESTING
SYSTEM AND METHOD
158007
‫מערכת לפיתוח ובדיקה ושיטה‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
]22[
]31[
]51[
]71[
]87[
]74[
22.03.2002
60/278212
]32[ 23.03.2001
60/299555
19.06.2001
60/363436
11.03.2002
Int. Cl.(2008.04) G06F 11/28, 9/46
S2 TECHNOLOGIES, INC., U.S.A.
WO/2002/077813
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
[57] A system for providing
communication between a host computer
and an embedded computer comprising: an
embedded computer executing a plurality
of threads that provide a communication
interface, each communication interface
having a plurality of data fields; a script
engine for executing script instructions; a
communication database identifying each
of the communication interfaces, wherein
the communication database is
automatically generated, at least in part,
from information comprising: an interface
description file that defines the
communications interfaces; machine
characteristics of the embedded device;
and machine characteristics of a platform
that is executing the script engine; a
]33[
US
US
US
,'‫ד"ר שלמה כהן ושות‬
‫ תל אביב‬,11490 .‫ד‬.‫ ת‬, 124 ‫אבן גבירול‬
communication module for providing an
application programming interface for the
script instructions to access the
communication interface, wherein the
communication module is automatically
generated based upon information from
information from the communication
database; and wherein the script
instructions identify at least one of the
communication interfaces in the
communication database and invoke a
function with respect to at least one field in
the identified communication interface via
the application programming interface,
wherein the function is selected from the
group comprising: storing data in one of
the data fields, reading data from one of
the data fields, and testing a data field.
__________
]11[]21[
September 22, 2009
–‫ד' בתשרי התש"ע‬
158102
297
]54[
SCALABLE AUDIO/CODING
METHOD AND APPARATUS
]22[
]31[
24.09.2003
97-12232
]32[ 02.04.1997
97-61298
19.11.1997
Int. Cl.(2008.04) G10L 21/00
SAMSUNG ELECTRONICS CO.,
LTD., REPUBLIC OF KOREA
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]71[
]74[
[57] A computer usable medium having
computer readable program code means
embodied therein for coding audio signals
into a layered datastream having a base
layer and enhancement layers of a
predetermined number, the computer
readable program code means in said
computer usable medium comprising:
(a) computer readable program code means
for causing a computer to effect signalprocessing input audio signals and
quantizing the same for each
predetermined coding band;
(b) computer readable program code
means for causing a computer to effect
coding the quantized data corresponding to
the base layer within a predetermined layer
size;
(c) computer readable program code means
for causing a computer to effect coding the
quantized data corresponding to the next
‫פענוח של צננים‬/‫מתקן ושיטה להצפנה‬
‫שמעיים שניתן לייצגו‬
]33[
KR
KR
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
enhancement layer of the coded base layer
and the remaining quantized data uncoded
and belonging to the enhancement layer,
within a predetermined layer size; and
(d) computer readable program code
means for causing a computer to effect
sequentially performing the layer coding
steps for all layers, wherein the computer
readable program code means (b), (c) and
(d) each comprise;
(e) computer readable program code means
for causing a computer to effect
representing the quantized data
corresponding to a layer to be coded by
digits of a predetermined number; and
(f) computer readable program code means
for causing a computer to effect coding the
most significant digit sequences of most
significant digits of the magnitude data of
said quantized signal-processing input
audio signals.
__________
298
September 22, 2009
–‫ד' בתשרי התש"ע‬
]11[]21[
]54[
METHOD FOR PREPARING (E) -7[2 - CYCLOPROPYL - 4 - (4 FLUOROPHENYL)- QUINOLIN- 3 YL] - 3, 5 - DIHYDROXYHEPT-6ENOATES
]22[
]31[
]51[
]71[
22.03.2002
2001-106820 ]32[ 05.04.2001
Int. Cl.(2008.04) C07D 215/14
NISSAN CHEMICAL INDUSTRIES
LTD., JAPAN
KENICHI TOKUNAGA, MASAMI
KOZAWA, KENJI SUZUKI
WO/2002/081451
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]72[
]87[
]74[
158151
‫ – ציקלופרופיל‬E) – 7 – [2( ‫שיטות להכנת‬
]‫ – יל‬3 – ‫ – פלואורופניל) – קווינולין‬4( – 4 –
‫ אנואטים‬6 – ‫ – דיהידרוקסיהפט‬5 ,3 –
]33[
JP
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
‫ הרצליה‬,2081 .‫ד‬.‫ ת‬, 10 ‫שדרות אבא אבן‬
[57] Method for preparing a 7-quinolinyl3,5-dihydroxyhept-6-enoate of the formula
(wherein R represents an alkyl group or a
an aryl group), characterized in that a
compound of the formula
(wherein R is as defined above), or a
compound of the formula
September 22, 2009
–‫ד' בתשרי התש"ע‬
299
(wherein R is as defined above), is reduced
by sodium borohydride in a reaction
solvent in the presence of a boron
compound of the formula R'OBR" 2
(wherein R' and R" represent
independently an alkyl group), the reaction
solvent is removed, and then the resultant
reaction mixture is treated with an aqueous
solution of hydrogen peroxide in the
presence of an inorganic base in a two
phase system with an organic solvent
which separates from water.
__________
]11[]21[
]54[
USE OF FATTY ALCOHOL
ETHOXYLATES AS
PENETRATION PROMOTERS
]22[
]31[
]51[
]71[
02.04.2002
10118076.4
]32[ 11.04.2001
Int. Cl.(2008.04) A01N 43/40, 47/40
BAYER CROPSCIENCE AG,
GERMANY
WO/2002/098230
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
158180
‫שימוש בכהלים אתוקסילטוטים שומניים‬
‫כמסייעים להחדרה‬
]33[
DE
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
[57] Use of fatty alcohol ethoxylates of
the formula
in which
300
September 22, 2009
–‫ד' בתשרי התש"ע‬
m represents average values from 8.0 to
13.0 and
n represents average values from 6.0 to
17.0
for the preparation of penetrating plant
treatment compositions containing
insecticidally active compounds from the
group of the neonicotinyls, where said
fatty alcohol ethoxylates are employed in
such amounts that, in commercial
formulations, they are present in
concentrations from 0.1 to 30% by weight,
and the weight ratio of insecticidally active
compound from the group of the
neonicotinyls to said fatty alcohol
ethoxylate is from 1:0∙1 to 1:2.0.
__________
]11[]21[
158185
–‫–הלו–בתא‬2' ‫תהליך להכנת נוקליאוצידים‬
‫–אראבינופואנוציל‬L
]54[
PROCESS FOR THE
PREPARATION OF 2'-HALOBETA-L-ARABINOFURANOSYL
NUCLEOSIDES
]22[
]31[
]51[
]71[
29.03.2002
60/280307
]32[ 30.03.2001
]33[
Int. Cl.(2008.04) C07H 15/04, 19/04, 190/73
BUKWANG PHARMACEUTICAL
CO., LTD., REPUBLIC OF KOREA
WO/2002/079213
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
[57] A process for the preparation of a 2'deoxy-2'-halo-β-L-arabinofuranosyl
nucleoside of the formula
September 22, 2009
–‫ד' בתשרי התש"ע‬
301
wherein X is a halogen (F, Cl, Br or I); and
B is a pyrimidine, purine, heterocylic or
heteroaromatic base; by preparing a 2-
deoxy-2-halo-L-arabinofuranose
comprising the steps of:
(a) obtaining a 2-dexoy-2-halo-Larabinopyranose of the formula
wherein each of R1 and R2 is independently
hydrogen, alkyl, acyl or silyl; and
(b) converting the 2-deoxy-2-halo-Larabinopyranose to the 2-deoxy-2-halo-Larabinofuranose.
__________
]11[]21[
]54[
CYLINDRICAL WING TIP WITH
HELICAL SLOT
]22[
]31[
]51[
]71[
]87[
]74[
09.04.2002
01/04998
]32[ 11.04.2001
Int. Cl.(2008.04) B64C 23/06
CHRISTIAN HUGUES, FRANCE
WO/2002/083497
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57] Wingtip device integrated with or
articulated on said wingtip, the object of
which is to increase lift, reduce induced
drag and marginal swirl (vortex) to
increase lift/drag ratio, characterized by
the fact that it resembles a goose feather or
302
158327
‫קצה כנף צילינדרית עם חריץ סלילי‬
]33[
FR
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
small tongue (18) with an ovoid bevel cut
(15) on the opposite side to the device
attachment (24) and towards leading edge
(1), the body of which represents a
cylindrical or approximately cylindrical
cavity, approximately spiral in form and/or
September 22, 2009
–‫ד' בתשרי התש"ע‬
approximately spiral with a helical or
approximately helical slot, with the tip of
said small tongue always or approximately
always having the same diameter, said
device commencing at leading edge on
upper surface (10), then broadening to
form an approximately semi-cylindrical
shape up to the approximately cylindrical
inlet approximately at the point of
maximum wing thickness, where starts a
rolled up envelope surface part in
seemingly helical form (29) between
approximately 180o and 360o; showing, on
an approximately helical slot round axis
(9) arranged approximately along and
parallel to wingtip airfoil chord (6) this
approximately helical slot at helix angle
and with thickness that can be
approximately adapted to the airfoil and
wing aspect-ratio, wing taper, wing sweep,
speed and angle of attack in the medium
considered, whether gaseous or liquid, in
which the wing moves, and on the flow
path along this approximately helical slot,
the trailing edge of the wingtip runs
approximately the mid-point of thickness
of said approximately helical slot always
in continuity, so that the depth of said
device extends beyong trailing edge of the
wingtip to about one third of the depth of
the chord and terminating in a
approximately annular form, said device
making it possible to thus increase lift/drag
ratio by decreasing resistance to the vortex
effect induced by relative wind (16)
penetrating frontally, and lateral induced
flow (26) from overpressure (13) on
undersurface (11), to direct and merge the
flows in a cylindrical duct to the point of
ejection; said device being applicable to
airplanes, gliders, all types of blade, tractor
and pusher propellers, wind-powered
generator blades, also underwater devices
for surface vessels or submarines using
standard or symmetrical profiles to move
in one, two or three axes, thus providing
for the use of lower power drive systems,
longer distance travel at higher speeds and
with reduced energy consumption, or
increased energy production in the case of
wind-powered generators, and even
transport of heavier loads and increased
safety for transit, incoming and outgoing
airport traffic.
__________
]11[]21[
]54[
THERAPEUTIC COMPOSITIONS
FOR TARGETING LYSOSOMES
]22[
30.04.2002
September 22, 2009
–‫ד' בתשרי התש"ע‬
158623
‫תכשירים רפואיים להכוונה לליזוזומים‬
303
]31[
]51[
]71[
]87[
]74[
60/287531
]32[ 30.04.2001
]33[ US
60/304609
10.07.2001
US
60/329461
15.10.2001
US
60/351276
23.01.2002
US
Int. Cl.(2008.04) A61K 45/00, 47/00, 47/48, A61P 3/00, C07K 19/00
ZYSTOR THERAPEUTICS, INC.,
U.S.A.
WO/2002/087510
BOROCHOV, KORAKH & CO.,
,'‫בורוכוב קורח ושות‬
15TH FLOOR, ATIDIM TOWER,
‫אביב‬-‫ תל‬,58100 .‫ד‬.‫ ת‬, ‫מגדל כלל עתידים‬
KIRYAT ATIDIM,
P.O.B. 58100,
TEL AVIV 61580
[57] A targeted therapeutic comprising a
lysosomal enzyme and a peptide that binds
an extracellular domain of human cationindependent mannose-6-phosphate
receptor in a mannose-6-phosphateindependent manner, wherein the peptide:
(a) has sufficient amino acid sequence
identity to human IGF-II such that the
peptide binds the human cationindependent mannose-6-phosphate
receptor; or
The applications for division
from this application have
not yet been published
(b) comprises IGF-II or an antibody
variable domain that recognizes the
receptor; or
(c) comprises the amino acid sequence of
IGF-I or of a mutein of IGF-I which: (i)
amino acids 55 and 56 are changed; or (ii)
amino acids 1-4 are deleted or changed; or
(iii) amino acids 55 and 56 are changed
and amino acids 1-4 are deleted or
changed.
,197348
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
_________
]11[]21[
158728
‫תולדות פיפראזין אוקסים בעלות פעילות‬
NK–1 ‫מעכבת לקולטן‬
]54[
PIPERAZINE OXIME
DERIVATIVES HAVING NK-1
RECEPTOR ANTAGONISTIC
ACITIVITY
]22[
]31[
]51[
]71[
03.07.2002
01202631.6
]32[ 09.07.2001
]33[ EP
Int. Cl.(2008.04) A61K 314/95, A61P 25/00, C07D 403/06, 403/14, 405/06, 413/12
SOLVAY PHARMACEUTICALS
B.V., THE NETHERLANDS
WO/2003/006459
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
]87[
]74[
304
September 22, 2009
–‫ד' בתשרי התש"ע‬
[57] Compounds of the formula:
wherein:
X represents phenyl or pyridyl substituted
with 1 to 2 substituents from the group
CH3, CF3, OCH3, halogen, cyano and 5CF3-tetrazol-1-yl;
Y represents 2- or 3-indolyl, phenyl, 7-azaindol-3-yl or 3-indazolyl, 2-naphthyl, 3benzo[b] thiophenyl or 2-benzofuranyl,
which groups may be substituted with one
or more halogen or alkyl (1-3C); n has the
value 0-3; m has the value 0-2; R1
represents NH2, NH-alkyl (1-3C), dialkyl
(1-3C)N, morpholino or morpholino
substituted with one or two methyl and/or
methoxymethyl groups, thiomorpholino,
1,1-dioxothiomorpholino, 2-, 3- or 4pyridyl or 4-CH3-piperazinyl; R2 is
hydrogen, alkyl (1-4C) or phenyl, or R2
together with (CH2)m wherein m is 1, and
the intermediate carbon, nitrogen and
oxygen atoms forms an isoxazolyl or a 4,5dihydroisoxazolyl group; R3 and R4
independently represent hydrogen or
methyl, or R3 and R4 together are oxygen;
and physiologically acceptable salts
thereof.
__________
]11[]21[
158884
‫פרוצדורה עבור מדידת איכות דינמית של‬
‫ערוץ עבור אפנון מוסגל ושיטות הצפנה‬
]54[
DYNAMIC CHANNEL QUALITY
MEASUREMENT PROCEDURE
FOR ADAPTIVE MODULATION
AND CODING TECHNIQUES
]22[
]31[
15.04.2002
60/290877
]32[ 14.05.2001
]33[ US
029569
21.12.2001
US
Int. Cl.(2008.04) H04B 17/00, 7/26, H04J 13/00, H04L 1/00, 12/56, H04Q 7/38
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2002/093951
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
[57] A user equipment mobile terminal
(UE) comprising: a receiver configured to
receive a request to begin channel quality
(CQ) measurements; a transmitter
September 22, 2009
–‫ד' בתשרי התש"ע‬
configured to transmit CQ measurement
results in response to the request; and the
receiver being further configured to
receive an allocation of radio resources,
305
the allocation of radio resources being
based on the CQ measurement results, and
to receive downlink data in accordance
with the allocation of radio resources.
__________
]11[]21[
158915
‫חומצת שומן גראם חיובית לפירוק ושיטה‬
‫לפרק חומצת שומן או שומן‬
]54[
GRAM-POSITIVE FATTY ACID
DEGRADER AND A METHOD
FOR DEGRADING FATTY ACID
OR GREASE
]22[
]31[
]51[
]71[
]87[
]74[
26.04.2002
09/861142
]32[ 18.05.2001
]33[ US
Int. Cl.(2008.04) C02F 3/34, C12N 1/20, 1/38, C12R 1/11
NOVOZYMES A/S, DENMARK
WO/2002/094181
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬
HERZLIYA 46733
[57] A composition comprising Bacillus
megaterium having all of the
characteristics of strain SB-3112, ATCC
PTA-3142, and a component selected from
the group consisting of a non-toxic nutrient
formulation, surfactant, activator,
preservative, filler, stabilizer, fragrance,
viscosifier, enzymes, and a combination
thereof.
__________
306
September 22, 2009
–‫ד' בתשרי התש"ע‬
]11[]21[
]54[
METHOD AND SYSTEM FOR
DETERMINING THE RANGE
AND VELOCITY OF A MOVING
OBJECT
]22[
]51[
]71[
18.11.2003
Int. Cl.(2008.04) G01S 13/58, 72/92
EL-OP ELECTRO-OPTICS
INDUSTRIES LTD.
]72[
]74[
YAIR SHIMONI
BOROCHOV, KORAKH & CO.,
15TH FLOOR, ATIDIM TOWER,
KIRYAT ATIDIM,
P.O.B. 58100,
TEL AVIV 61580
[57] Device for determining a range of a
moving object, when a received signal
respective of a sequence of pulses,
transmitted toward said moving object, is
of the order of ambient noise, the device
comprising: at least one sampler for
producing a plurality of sampled signals,
by sampling said received signal; a multiprocess array running a plurality of
processes, said multi-process array being
coupled with said at least one sampler,
wherein each of said processes is
associated with one of said at least one
sampler, each of said processes being
158937
‫שיטה ומערכת לקביעת טווח ומהירות של‬
‫גוף בתנועה‬
,‫אופטיקה בע"מ‬-‫אופ תעשיות אלקטרו‬-‫אל‬
‫רחובות‬
‫יאיר שמעוני‬
,'‫בורוכוב קורח ושות‬
‫אביב‬-‫ תל‬,58100 .‫ד‬.‫ ת‬, ‫מגדל כלל עתידים‬
associated with a respective time shift
which is determined according to a
respective radial velocity assumption of
said moving object with respect to said
device, and with the pulse rate of said
sequence of pulses, each of said processes
producing a signal summation by
sequentially shifting said sampled signals
by said respective time shift, and adding
together said sampled signals; and a
selector coupled with said multi-process
array, said selector determining said range
according to at least one signal summation
which includes a summed pulse event.
__________
September 22, 2009
–‫ד' בתשרי התש"ע‬
307
]11[]21[
158986
‫אמצעי תקשורת עם אנטנה חכמה‬
‫המשתמשת באות כיוון איכותי‬
]54[
COMMUNICATION DEVICE
WITH SMART ANTENNA USING
A QUALITY-INDICATION
SIGNAL
]22[
]31[
]51[
]71[
09.05.2002
60/294290
]32[ 31.05.2001
]33[ US
Int. Cl.(2008.04) H04B 17/07, 7/06, 7/10, 7/26, 70/05
MAGNOLIA BROADBAND, INC.,
U.S.A.
WO/2002/099999
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬
HERZLIYA 46733
]87[
]74[
[57] A method for a first communication
device to communicate with a second
communication device over a
communication link, the first
communication device having a plurality
of antenna elements, the method
comprising: receiving a quality-indication
signal from the second communication
device, the communication link configured
according to at least one Code-DivisionMultiple-Access (CDMA) protocol from
the group of CDMA-IS-95 A/B, CDMA
2000 IX/RTT, CDMA 2000 3X, CDMA
EV-DO, WCDMA, 3G Universal Mobile
Telecommunications System (UMTS) and
4G UMTS, the quality-indication signal
being a power-control bit according to the
CDMA protocol, the power-control bit
having a value of one or zero for each time
period from a plurality of time periods, the
power-control bit being generated by the
second communication device and
indicating an adjustment to a power of a
transmitted signal at the first
communication device so that a
predetermined threshold requirement for
the second communication device can be
satisfied; calculating a complex weighting
based on the quality-indication signal, the
308
complex weighting being associated with a
total power of the transmitted signal and at
least one from a phase rotation and a
power ratio associated with each antenna
element from the plurality of antenna
elements, the complex weighting
associated with the total power of the
transmitted signal and the phase rotation
associated with each antenna element from
the plurality of antenna elements, the
calculating of the complex weighting being
performed for each antenna element from
the plurality of antenna elements and
wherein said calculating includes:
adjusting the total power of the transmitted
signal while maintaining the phase rotation
associated with an antenna element from
the plurality of antenna elements until a
steady state is obtained at a first time;
adjusting the phase rotation associated
with each antenna element from the
plurality of antenna elements while
maintaining the total power of the
transmitted signal to produce an optimal
phase rotation for each antenna element;
and adjusting the total power of the
transmitted signal while maintaining the
optimal phase rotation for each antenna
element until a second steady state is
September 22, 2009
–‫ד' בתשרי התש"ע‬
obtained at a second time subsequent to the
first time; modifying a pre-transmission
signal based on the complex weighting to
produce a plurality of modified pretransmission signals, each modified pretransmission signal from the plurality of
modified pre-transmission signals being
uniquely associated with an antenna
element from a plurality of antenna
elements; and sending the plurality of
modified pre-transmission signals from the
plurality of antenna elements to produce
the effective combined transmitted signal.
__________
]11[]21[
159151
‫ תהליך‬,‫פולימורף יציב של פליבאנסרין‬
‫טכני להכנתו והשימוש בו להכנת תרופות‬
]54[
STABLE POLYMORPH OF
FLIBANSERIN, TECHNICAL
PROCESS FOR ITS
PREPARATION AND THE USE
THEREOF FOR PREPARING
MEDICAMENTS
]22[
]31[
30.07.2002
01118593.1
]32[ 02.08.2001
]33[ EP
01130180.1
19.12.2001
EP
Int. Cl.(2008.04) A61K 314/95, A61P 25/00, C07D 403/06
BIDACHEM S.P.A., ITALY
WO/2003/014079
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
[57] Crystalline polymorph A (form A) of
flibanserin
September 22, 2009
–‫ד' בתשרי התש"ע‬
309
having an endothermic maximum at 161oC
which occurs during thermal analysis using
DSC and process for its preparation,
characterized in that in a first reaction step
a benzimidazolone derivatire:
wherein R denotes a suitable aminoprotecting group, is reacted with a
piperazine derivative:
wherein X is a leaving group selected from
chlorine, bromine, iodine,
methanesulphonate,
trifluoromethanesulphonate and paratoluenesulphonate in a suitable solvent
selected from water, alcohols, mixtures of
water with alcohols, polar aprotic solvents
and mixtures thereof with water in
presence of a suitable base and that in a
second reaction step the amino protecting
group R is cleaved under suitable cleaving
conditions.
__________
]11[]21[
159260
‫ ערכות ומחסניות‬,‫ תרכובות‬,‫תהליכים‬
‫ של‬18 ‫להכנת סמנים המסומנים באיזוטופ‬
‫פלואור ושימושם בטופוגרפיה של פליטת‬
‫פוזיטרונים‬
]54[
PROCESSES, COMPOUNDS, KITS
AND CARTRIDGES FOR THE
PRODUCTION OF TRACERS
LABELED WITH F18 AND USES
THEREOF IN POSITRON
EMMISION TOMOGRAPHY
]22[
]31[
]51[
18.06.2002
0115927.6
]32[ 29.06.2001
]33[ GB
Int. Cl.(2008.04) A61K 101/02, 51/04, C07B 59/00, C07C 229/36, 309/69, C07D
239/54, C07H 11/00, C07M 5/00
GE HEALTHCARE LIMITED,
UNITED KINGDOM
]71[
310
September 22, 2009
–‫ד' בתשרי התש"ע‬
]87[
]74[
HAMMERSMITH IMANET
LIMITED, UNITED KINGDOM
WO/2003/002157
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57] A process for the production of an
18
F-labeled tracer which comprises
treatment of a resin-bound precursor of the
formula solid support – linker – x- tracer
precursor wherein X is a group which
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
promotes nucleophilic substitution at a
specific site on the attached tracer
precursor; with 18F to produce the labeled
tracer of the formula 18F-TRACER.
__________
]11[]21[
159298
‫התקן ושיטה לסימון מים של תמונה‬
‫דיגיטלית‬
]54[
APPARATUS AND METHOD FOR
WATERMARKING A DIGITAL
IMAGE
]22[
]31[
]51[
]71[
13.06.2002
09/881017
]32[ 13.06.2001
]33[ US
Int. Cl.(2008.04) G06T 1/00, H04N 7/08, 70/81, 71/67
QUALCOMM INCORPORATED,
U.S.A.
WO/2002/101648
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]87[
]74[
[57] An apparatus for adding a watermark
to a moving image as it is displayed, the
apparatus comprising: a watermark
generator in which data representing a
watermark is generated containing first
information pertaining to the displaying of
the moving image and protected by
forward error encoding and second
information pertaining to the displaying of
September 22, 2009
–‫ד' בתשרי התש"ע‬
the moving image and protected by
scrambling; and a watermark applicator for
applying the watermark data to image data
representing substantially all of the moving
image depending on a characteristic of the
data, wherein the watermark generator is
connected to receive at least one of
program data identifying the moving
image and frame data unique in identifying
311
a predetermined number of frames of the
moving image as said second information
pertaining to the displaying of the image.
__________
]11[]21[
159323
‫ארכיטקטורה סף מסתגל בעלת שני‬
‫מצבים עבור מערך מוקדי מישורי של‬
‫מגלה טווח לייזר תלת מימדי‬
]54[
DUAL MODE ADAPTIVE
THRESHOLD ARCHITECTURE
FOR 3-D LADAR FOCAL PLANE
ARRAY
]22[
]31[
]51[
]71[
]87[
]74[
08.01.2003
10/040214
]32[ 08.01.2002
]33[ US
Int. Cl.(2008.04) G01S 17/00, 17/10, 17/89, 7/48, 74/81, 74/87
RAYTHEON COMPANY, U.S.A.
WO/2003/058274
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
[57] An integrated detector and signal
processor (31) for ladar focal plane arrays
(30) comprising:
a first circuit (42) for receiving an input
signal, wherein said first circuit is located
in an interior of said array; a second circuit
(72) for generating an adaptive threshold
setting based on a characteristic of said
input signal; and a third circuit (74) for
312
detecting when said input signal is above
said threshold, characterized in that said
second and third circuits are located on a
periphery of said array, and said second
circuit is comprised in a threshold
generation and detection unit (52) which
continuously monitors said input signal
and estimates the noise level to set said
threshold.
September 22, 2009
–‫ד' בתשרי התש"ע‬
__________
]11[]21[
]54[
METHOD AND DEVICES FOR
DATA TRANSFER
]22[
]51[
]71[
28.06.2001
Int. Cl.(2008.04) G06F 13/00, 13/36
TREK 2000 INTERNATIONAL
LTD., SINGAPORE
WO/2003/003141
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
September 22, 2009
–‫ד' בתשרי התש"ע‬
159391
‫שיטה והתקן להעברת מידע‬
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
313
[57] A method of transferring data
between a plurality of electronic devices
including a computer device, a portable
transfer apparatus and one or more
secondary devices external to the computer
device, each of the computer device and
the secondary devices including wireless
communication means, and the transfer
apparatus comprising a processor, a nonvolatile memory having a capacity of at
least 1 GB and wireless transceiver means,
the method including the steps of: a first
one of the devices transmitting a wireless
signal to the transceiver means including
data for transmission to the computer
device, the processor storing the data as at
least one file in a directory, in the nonvolatile memory of the transfer apparatus,
the computer device reading the directory
on the transfer apparatus and selecting
some or all of the files stored therein; and
the processor using the transceiver means
to transmit the selected files to the
computer device.
__________
]11[]21[
159412
‫תצריף רוקוחות סינרגיסטי למניעה או‬
‫טיפול בסכרת‬
]54[
SYNERGISTIC
PHARMACEUTICAL
COMBINATION FOR THE
PREVENTION OR TREATMENT
OF DIABETES
]22[
]31[
10.07.2002
P0102982
]32[ 17.07.2001
]33[ HU
P0202204
05.07.2002
HU
Int. Cl.(2008.04) A61K 314/55, 45/06, A61P 3/10, C07D 401/00
N-GENE RESEARCH
LABORATORIES INC., U.S.A.
WO/2003/007951
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
314
September 22, 2009
–‫ד' בתשרי התש"ע‬
[57] A synergistic pharmaceutical
combination for the prevention or
treatment of a prediabetic state, metabolic
X-syndrome or diabetes mellitus as well as
disorders which are associated with the
states listed above, namely endogenic
metabolic disorders, insulin resistance,
dislipidemia, alopecia and/or diffuse
effluvium comprising
(a) a first pharmaceutical composition
containing an antidiabetic active agent
selected from the group consisting of
insulin, peroxisome proliferator-activated
receptor γ-agonists, sulfonylurea
derivatives and biguanidine derivatives or
an anti-hyperlipidemic active agent,
namely a HMG coenzyme reductase
inhibitor or, if desired and chemically
possible, a pharmaceutically suitable acid
addition salt or a salt formed with a
pharmaceutically suitable base thereof and
one or more conventional carrier(s), and
(b) a second pharmaceutical composition
containing O-(3-piperidino-2-hydroxy-lpropyl) nicotinic amidoxime or a
pharmaceutically suitable acid addition salt
thereof, and one or more conventional
carrier(s).
__________
]11[]21[
]54[
IN VIVO SENSING DEVICE WITH
A CIRCUIT BOARD HAVING
RIGID SECTIONS AND FLEXIBLE
SECTIONS
]22[
]31[
]51[
]71[
]72[
]87[
]74[
18.06.2002
60/298387
]32[ 18.06.2001
Int. Cl.(2008.04) A61B 5/07
GIVEN IMAGING LTD.
DOV AVNI
WO/2002/102224
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
[57] A swallowable in vivo sensing
capsule (10) comprising: a circuit board
that comprises at least two rigid sections
(33, 35) and a flexible section (32')
September 22, 2009
–‫ד' בתשרי התש"ע‬
159450
‫מכשיר לחישה תוך גופית עם לוח מעגלים‬
‫שיש בו מקטעים קשיחים ומקטעים‬
‫גמישים‬
]33[
US
‫ יקנעם‬,‫גיוון אימג'ינג בע"מ‬
‫דב אבני‬
,‫פרל כהן צדק לצר‬
,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬
connecting said two rigid sections, and one
or more batteries (25) positioned between
the two rigid sections.
315
__________
]11[]21[
159510
‫שיטה ומתקן לבקרת רמת ההגברה בערוץ‬
CDMA ‫נוסף במערכת תקשורת‬
]54[
METHOD AND APPARATUS FOR
CONTROLLING GAIN LEVEL OF
A SUPPLEMENTAL CHANNEL IN
A CDMA COMMUNICATION
SYSTEM
]22[
]31[
]51[
]71[
17.06.2002
09/895375
]32[ 29.06.2001
]33[ US
Int. Cl.(2008.04) H04B 17/07, H04Q 7/22
QUALCOMM INCORPORATED,
U.S.A.
WO/2003/003593
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]87[
]74[
[57] In a code division multiple access
communication system, a method for
controlling gain of a forward supplemental
channel comprising: determining gain
level of a forward fundamental channel
(Gfch), wherein said forward fundamental
channel is associated with said forward
supplemental channel for being targeted
for a common mobile station; determining
316
an adaptive margin (Ma) for said forward
supplemental channel; determining a
forward supplemental channel gain (Gsch)
based on said Gfch and said Ma;
successively descreasing said Gsch for
subsequent data frames targeted for said
common mobile station on said forward
supplemental channel.
September 22, 2009
–‫ד' בתשרי התש"ע‬
__________
]11[]21[
]54[
BALLNOSE END MILL
]22[
]51[
]71[
]74[
29.12.2003
Int. Cl.(2008.04) B23C 5/00
HANITA METAL WORKS LTD.
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
[57] A ballnose end mill having a
diameter and a central rotational axis about
which the end mill is to be rotated, said
end mill comprising: a shank portion being
configured to be held by a tool; a fluted
portion connected to said shank portion;
said fluted portion comprising a rounded,
semispherical tip portion disposed opposite
said shank portion; and said fluted portion
comprising: a first chip flute and a
corresponding first cutting tooth; a second
slip flute and a corresponding second
cutting tooth; said first cutting tooth
comprising a first flank surface; said
second cutting tooth comprising a second
flank surface; said first chip flute being
September 22, 2009
–‫ד' בתשרי התש"ע‬
159639
‫כרסום קצה–כדורי‬
‫חניתה מפעלי מתכת בע"מ‬
,‫פרל כהן צדק לצר‬
,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬
disposed to intersect with said first flank
surface to form a first cutting edge; said
second chip flute being disposed to
intersect with said second flank surface to
form a second cutting edge; said first
cutting edge being disposed to extend
along the length of said first chip flute and
across a portion of said rounded,
semispherical tip portion; said second
cutting edge being disposed to extend
along the length of said first chip flute and
across a portion of said rounded,
semispherical tip portion; said first flank
surface merging with said second flank
surface on said rounded, semispherical tip
portion to form a continuous flank surface
317
extending continuously along the length of
said first cutting tooth, across said
rounded, semispherical tip portion, and
along the length of said second cutting
tooth; said first cutting edge comprises a
first cutting edge end section and said
second cutting edge comprises a second
cutting edge end section; said first cutting
edge end section is disposed to run on one
side of the central rotational axis and said
second cutting edge end section is
disposed to run on another side of the
central rotational axis; said first cutting
edge end section and said second cutting
edge end section are each disposed on said
tip portion at a distance from the central
rotational axis; said first cutting edge end
section is disposed opposite said second
cutting edge end section about the central
rotational axis and at least substantially
parallel to said second cutting edge end
section; and said continuous flank surface
comprises a smooth uninterruptedly
curved, rounded surface portion disposed
between said first cutting edge end section
and said second cutting edge end section
and which said rounded surface portion
passes through the central rotational axis.
__________
]11[]21[
159698
‫מלחים של נגזרות נוגדות פירכוסים‬
]54[
ANTICONVULSANT DERIVATIVE
SALTS
]22[
]31[
]51[
]71[
03.07.2002
60/303962
]32[ 09.07.2001
]33[ US
Int. Cl.(2008.04) A61K 31/34, A61P 25/08, C07D 493/14
ORTHO-MCNEIL
PHARMACEUTICAL, INC., U.S.A.
WO/2003/006467
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
‫ תל אביב‬,11490 .‫ד‬.‫ ת‬, 124 ‫אבן גבירול‬
P.O.B. 11490,
TEL AVIV 62038
]87[
]74[
[57] A crystalline sodium or potassium
salt of a compound of the formula:
318
September 22, 2009
–‫ד' בתשרי התש"ע‬
wherein the salt of said compound is
formed at the sulfamate group, and has a
structure selected from the group
consisting of
__________
]11[]21[
159770
‫תכשירי רוקחות המכילים‬
‫טריפלורואצטט הסידן עם פעילות‬
‫ציטוטוקסית‬
]54[
PHARMACEUTICAL
COMPOSITIONS CONTAINING
CALCIUM TRIFLUOROACETATE
HAVING CYTOTOXIC ACTIVITY
]22[
]31[
]51[
]71[
]87[
]74[
01.07.2002
MI2001A001495 ]32[ 12.07.2001
]33[ IT
Int. Cl.(2008.04) A61K 33/00, 33/06, 33/16, A61P 35/00
EUREON AG, GERMANY
WO/2003/006031
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
September 22, 2009
–‫ד' בתשרי התש"ע‬
319
[57] The use of calcium trifluoroacetate
for the preparation of cytotoxic
medicaments for the treatment of tumours
substantially as described in the
specification.
__________
]11[]21[
]54[
MULTILAYER COMPOSITE ARMOUR
]22[
]31[
]51[
]71[
12.07.2002
01/09261
]32[
12.07.2001
Int. Cl.(2008.04) F41H 5/04
ETAT FRANCAIS REPRESENTE PAR LE
DELEGUE GENERAL POUR
L'ARMEMENT, FRANCE
ARC
LEICHTMETALLKOMPETENZZENTRUM
RANSHOFEN GMBH, AUSTRIA
WO/2003/012363
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
[57] Multilayer armour (1), comprising: a
first material comprising a metal or a metal
alloy; a second material where the second
material is porous; and a cage made of
plates having openings, wherein the
second material is mounted in the cage and
320
159805
‫שיריון מורכב משכבות‬
]33[
FR
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
the first material passes through the
openings to infiltrate some or all of the
pores of the second material and coats the
cage, at least partly, with the first material,
the melting point of the cage being higher
than that of the first material.
September 22, 2009
–‫ד' בתשרי התש"ע‬
________
]11[]21[
]54[
APPARATUS, METHOD AND
SYSTEM OF TRANSFERRING
CORRECTION INFORMATION
]22[
]31[
]51[
]71[
19.07.2002
09/910365
]32[ 20.07.2001
Int. Cl.(2008.04) G01S 1/00, 5/14
QUALCOMM INCORPORATED,
U.S.A.
WO/2003/008994
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
[57] A method comprising: calculating a
plurality of correction factors, each
correction factor relating to a position of at
least a corresponding one among a set of
physical objects; and transmitting said
plurality of correction factors in a
predetermined order, wherein said
correspondence of each among said
plurality of correction factors with at least
one among the set of physical objects is
indicated at least in part by said
September 22, 2009
–‫ד' בתשרי התש"ע‬
159806
‫ שיטה ומערכת להעברת מידע‬,‫התקן‬
‫תיקוני‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
predetermined order; wherein said
calculating a plurality of correction factors
comprises: computing a reference position
of each among the set of physical objects;
and computing a supplemental position of
each among the set of physical objects,
wherein each among said correction
factors is based at least in part on a
difference between said corresponding
reference and supplemental positions.
321
__________
]11[]21[
]54[
FUEL CELL WITH PROTON
CONDUCTING MEMBRANE AND
WITH IMPROVED WATER AND
FUEL MANAGEMENT
]22[
]31[
18.07.2002
60/305865
]32[ 18.07.2001
60/305866
18.07.2001
Int. Cl.(2008.04) H01M 8/04
TEL-AVIV UNIVERSITY FUTURE
TECHNOLOGY DEVELOPMENT
L.P.
WO/2003/009410
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
[57] A cathode suitable for use in a fuel
cell having a proton conducting
membrane, the cathode comprising a
plurality of layers including a catalyst
layer and a hydrophobic porous support
layer, wherein at least one of said plurality
of layers is a liquid-water leak-proof layer
322
159878
‫תא דלק בעל ממברנה מוליכת פרוטונים‬
‫וניהול משופר של משק המים והדלק‬
]33[
US
US
‫אביב פיתוח טכנולוגיות‬-‫אוניברסיטת תל‬
‫ תל אביב‬,‫ שותפות מוגבלת‬,‫עתידיות‬
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
capable of allowing passage of gas and
preventing passage of liquid water and/or
aqueous fuel solution, from the cathode
catalyst layer to the airside of the cathode
and outside the fuel cell, wherein said fuel
cell is a direct oxidation fuel cell fed by
water soluble fuels.
September 22, 2009
–‫ד' בתשרי התש"ע‬
__________
]11[]21[
]54[
TAMPON APPLICATOR WITH
PETALS
]22[
]31[
]51[
]71[
06.08.2002
923201
]32[ 06.08.2001
Int. Cl.(2008.04) A61F 13/26
THE PROCTER & GAMBLE
COMPANY, U.S.A.
WO/2003/013407
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
[57] An applicator (10) capable of
receiving a tampon, having a tube (21)
with a first end portion and a second end
portion, the first end portion having an end
portion edge (15), which is connected to or
integral with a dome shaped insertion tip
(20), said insertion tip extending from said
end portion edge and having at least 3
petals (23); each petal having a first edge
and a second edge, wherein the first edge
and the second edge of each petal extends
September 22, 2009
–‫ד' בתשרי התש"ע‬
159924
‫ממקם טמפון בעל שוליים‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
from said end portion edge; wherein for
each petal, at least a portion of the first
edge of the petal is positioned on top of at
least a portion of one directly neighbouring
petal and at least a portion of the second
edge of said petal is positioned under
another directly neighbouring petal to
form, for each petal, a region of overlap;
and wherein said tampon is expelled
through said petals of said applicator.
323
__________
]11[]21[
]54[
METHOD AND APPARATUS FOR
PRODUCING UNIFORM PROCESS
RATES
]22[
]31[
18.07.2002
60/308469
]32[ 27.07.2001
10/033807
18.12.2001
Int. Cl.(2008.04) H01J 37/00
LAM RESEARCH CORPORATION,
U.S.A.
WO/2003/012821
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]51[
]71[
]87[
]74[
[57] An antenna arrangement for
generating an electric field inside a process
chamber, said antenna arrangement
comprising: a first loop disposed around an
antenna axis, comprising: a first turn with
a first turn gap wherein a first end of the
first turn is on a first side of the first turn
gap and a second end of the first turn is on
a second side of the first turn gap; a second
turn with a second turn gap wherein a first
end of the second turn is on a first side of
the second turn gap and a second end of
324
159935
‫שיטה והתקן לייצור שעורי עיבוד אחידים‬
]33[
US
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
the second turn is on a second side of the
second turn gap, wherein the second turn is
concentric and coplanar with the first and
spaced apart from the first turn, and where
the antenna axis passes through the centre
of the first turn and second turn, and a first
current path connector electrically
connected to the first turn and the second
turn comprising a spanning section
between and coplanar with the first turn
and the second turn and which spans the
first turn gap, wherein the first current path
September 22, 2009
–‫ד' בתשרי התש"ע‬
connector is connected between the first
turn and the second turn and comprises: a
spanning section with a first end and a
second end, wherein the spanning section
is substantially parallel to a circumference
of the first turn; a first turn connector leg
connected between the first end of the
spanning section and the second end of the
first turn, wherein the first turn connector
leg is substantially radial to the first turn,
and a second turn connector leg connected
between the second end of the spanning
section and the first end of the second turn,
wherein the second turn connector leg is
substantially radial to the second turn.
__________
]11[]21[
]54[
METHOD AND DEVICE FOR
ACTIVE RADIAL CONTROL OF
WHEEL PAIRS OR WHEEL SETS
ON VEHICLES
]22[
]31[
29.07.2002
10137443.7]32[ 27.07.2001
21
Int. Cl.(2008.04) B61F 5/38
BOMBARDIER TRANSPORTATION
GMBH, GERMANY
WO/2003/010039
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]51[
]71[
]87[
]74[
[57] A method for active radial control of
the wheels (11) of at least one wheel unit
(8, 9, 10) of a running gear, in particular a
running gear of a rail vehicle, wherein
September 22, 2009
–‫ד' בתשרי התש"ע‬
160014
‫מתקן ושיטה לבקרה רדיאלית פעילה של‬
‫זוגות גלגלים או מערכי גלגלים בכלי רכב‬
]33[
DE
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
control movements are applied to said
wheel unit characterised in that an
integrated control with control movements
in at least two non-identical frequency
325
ranges is carried out, wherein first control
movements in a first frequency range, and
second control movements in a second
frequency range, different from said first
frequency range, are superimposed and
applied to said wheel unit.
__________
]11[]21[
]54[
FROZEN CONFECTIONERY
]22[
]51[
]71[
17.08.2001
Int. Cl.(2008.04) A23G 9/00
SOCIETE DES PRODUITS NESTLE
S.A., SWITZERLAND
WO/2003/015530
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
]87[
]74[
[57] Frozen confectionery, comprising
fat, sweetener, milk solids-not-fat, water
and starch, characterized in that the sum of
the quantities of starch and milk solids-
160054
‫ממתק מוקפא‬
,‫ד"ר יצחק הס ושותפיו‬
‫ תל אביב‬,6451 .‫ד‬.‫ ת‬, 279 ‫רחוב הירקון‬
not-fat is between 2.5 and 18% by weight
and in that the starch/milk solids-not-fat
weight ratio is between 0.03 and 1.5.
__________
326
September 22, 2009
–‫ד' בתשרי התש"ע‬
]11[]21[
160140
‫שיטה ומתקן לתקשורת מועברת בשידור‬
‫המשתמשים בסיגנלים עוברי–פס עבור‬
‫ביטול הפרעה–עצמית‬
]54[
METHOD AND APPARATUS FOR
RELAYED COMMUNICATION
USING BAND-PASS SIGNALS FOR
SELF-INTERFERENCE
CANCELLATION
]22[
]31[
]51[
]71[
]87[
]74[
24.09.2001
09/925410
]32[ 08.08.2001
]33[ US
Int. Cl.(2008.04) H04B 1/50, 1/52, H04L 25/38, 25/52
VIASAT, INC., U.S.A.
WO/2003/015295
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
[57] A method for providing selfinterference cancellation in two-way
relayed electromagnetic communication
between a first device and a second device
through a relay station comprising the
steps of: generating at said first device a
modulated near signal; transmitting said
modulated near signal from said first
device to said relay station; receiving at
said first device a composite signal from
said relay station, said composite signal
containing a relayed version of said
modulated near signal and a relayed
version of a modulated far signal
transmitted from said second device;
providing said composite signal in a
representation as a first interface signal to
a canceler module of said first device;
providing a representation of said
modulated near signal as a second
interface signal to said canceler module,
said second interface signal being of a
frequency centered at a or near a second
interface frequency not at baseband;
September 22, 2009
–‫ד' בתשרי התש"ע‬
canceling at said canceler module a portion
of said relayed version of said modulated
near signal from said representation of said
composite signal using said second
interface signal to a produce a
cancellation-processed signal; outputting
said cancellation-processed signal as a
third interface signal from said canceler
module; and wherein said canceling step
includes; applying a time delay and phase
rotation to a representation of said second
interface signal to obtain a time-delayed
and phase-rotated local near signal;
correlating said time-delayed and phaserotated local near signal with at least a
representation of said first interface signal
to obtain correction signals for said timedelayed and phase-rotated local near
signal; adaptively filtering said timedelayed and phase-rotated local near signal
to produce a filtered signal; and applying
said filtered signal with said at least said
representation of said composite signal to
yield said cancellation-processed signal.
327
__________
]11[]21[
160232
‫תכשירים למתן דרך הפה לטיפול‬
‫בהפרעות בקרקפת‬
]54[
ORAL COMPOSITIONS FOR THE
TREATMENT OF SCALP
DISORDERS
]22[
]31[
]51[
]71[
]87[
]74[
14.11.2001
MI2001A001732 ]32[ 07.08.2001
]33[ IT
Int. Cl.(2008.04) A61K 35/00, 36/20, 36/87, A61P 17/14
INDENA S.P.A., ITALY
WO/2003/013561
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
[57] The use of
(a) extract of Serenoa repens and
(b) extract of Vitis vinifera in the free form
and/or as phospholipid complexes for the
preparation of oral pharmaceutical
compositions for the treatment and the
prevention of scalp disorders.
__________
328
September 22, 2009
–‫ד' בתשרי התש"ע‬
]11[]21[
160235
‫שיטה לנתינת כתובת ואיתות של יחידות‬
‫משתמש רבגוניות בחריץ אחד‬
]54[
METHODS OF ADDRESSING AND
SIGNALING A PLURALITY OF
SUBSCRIBER UNITS IN A SINGLE
SLOT
]22[
]31[
]51[
]71[
]87[
]74[
07.05.2003
09/910365
]32[ 11.06.2002
]33[ US
Int. Cl.(2008.04) H04B 72/12, H04L 12/28, H04Q 7/22
MOTOROLA, INC., U.S.A.
WO/2003/105378
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
[57] In a system having at least a first
slot, a method comprising the steps of:
configuring the first slot into at least a first
segment and a second segment, wherein
the first slot comprises a fixed number of
symbols; appropriating a first set of
symbols to the first segment; and
appropriating a second set of symbols to
the second segment, wherein the sum of at
least the first set of symbols and the
second set of symbols equals the fixed
number of symbols, wherein the first
segment is addressed to a first subscriber
unit and the second segment is addressed
to a second subscriber unit, and wherein
the first segment is modulated at a first
modulation rate and the second segment is
modulated at a second modulation rate.
__________
]11[]21[
September 22, 2009
–‫ד' בתשרי התש"ע‬
160251
329
‫שיטה עבור בקשה לשידור חוזר אוטומטית‬
‫בשכבה פיסית עבור תחנת בסיס‬
]54[
METHOD FOR PHYSICAL LAYER
AUTOMATIC REPEAT REQUEST
FOR A BASE STATION
]22[
]31[
21.08.2002
939410
]32[ 24.08.2001
]33[ US
084043
27.02.2002
US
Int. Cl.(2008.04) H04B 72/16, H04J 11/00, 13/00, H04L 1/16
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2003/019838
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
[57] A method for adjusting data
modulation at a base station comprising:
receiving data in data blocks from a higher
layer ARQ mechanism at a physical layer
transmitter for transmission; formatting the
received data blocks into packets for
transmission, the packets being smaller in
size than the data blocks, and each packet
having a forward error correction (FEC)
type of encoding/data modulation;
appending an error check sequence for
each packet; providing a physical layer
ARQ mechanism performing steps
including: transmitting the packets; storing
the packets for retransmission in a buffer
memory incorporated into the physical
layer transmitter; monitoring a return
channel for receipt of an acknowledgment
for each packet that the packet has been
received; limiting the number of
retransmissions to an operator-defined
integer value; clearing the buffer memory
after the integer value is reached; and
retransmitting an original or selectively
modified packet at the physical layer
transmitter in response to failure to receive
330
a corresponding acknowledgement for a
given packet; wherein the physical layer
ARQ mechanism and physical layer
transmitter operate transparently with
respect to the higher layer ARQ
mechanism; receiving and demodulating
received packets at a physical layer
receiver; receiving a corresponding
acknowledgement for a given packet at the
physical layer receiver, wherein a
mechanism configured to receive the
corresponding acknowledgment for the
given packet operates transparently with
respect to the higher layer ARQ
mechanism; collecting retransmission
statistics and adjusting the particular
encoding/data modulation using the
collected statistics at an adaptive
modulation and coding controller;
buffering, decoding, and detecting packet
errors at a combiner/decoder; and
generating an acknowledgement for each
received packet in an acknowledgment
generator if that packet has an acceptable
error rate.
September 22, 2009
–‫ד' בתשרי התש"ע‬
__________
]11[]21[
160305
‫תכשירים ושיטות למודולציה של‬
DARPP–32 ‫פוספורילציה של‬
]54[
COMPOSITIONS AND METHODS
FOR MODULATION OF DARPP-32
PHOSPHORYLATION
]22[
]31[
]51[
]71[
12.08.2002
60/311641
]32[ 10.08.2001
]33[ US
Int. Cl.(2008.04) A61K 49/00, G01N 33/15, 33/53, 335/67
THE ROCKEFELLER UNIVERSITY,
U.S.A.
WO/2003/014321
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
]87[
]74[
[57] A method for identifying an agent
for use in treating depression in a patient in
need thereof, comprising: (a) contacting an
agent with phosphatase 2C ("PP2C") and
Ser137-phosphorylated Dopamine-and
cyclic-AMP-Regulated PhosphoProtein of
molecular weight 32,000 Dalton
("DARPP-32"); (b) detecting the amount
of dephosphorylation of Ser137-
phosphorylated DARPP-32; and (c) testing
the agent in an animal model of
depression, wherein the agent is identified
as an agent for use in treating depression if
a decrease in the dephosphorylation of
Ser137-phosphorylated DARPP-32 is
detected in the presence of the agent in
step (b) and if the agent is effective in the
animal model tested in step (c).
__________
September 22, 2009
–‫ד' בתשרי התש"ע‬
331
]11[]21[
160331
‫שיטה לביצוע בקשת שידור חוזר‬
‫אוטומטית על שכבה פיסית עבור יחידת‬
‫מנוי‬
]54[
METHOD FOR PHYSICAL LAYER
AUTOMATIC REPEAT REQUEST
FOR A SUBSCRIBER UNIT
]22[
]31[
23.08.2002
939410
]32[ 24.08.2001
]33[ US
085187
27.02.2002
US
Int. Cl.(2008.04) H04B 72/12, H04L 1/16, 1/18, 1/20, H04Q 7/22
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2003/019812
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
[57] A method for adjusting data
modulation at a subscriber unit,
comprising: receiving data at a transmitter
for transmission, wherein the received data
is received in data blocks from a higher
layer ARQ mechanism; formatting the
received data into packets for transmission,
wherein the packets are smaller in size
than the data blocks, and each packet
having a forward error correction (FEC)
encoding/data modulation, and wherein the
packets are transmitted using an
orthogonal frequency division multiple
access (OFDMA) air interface; appending
an error check sequence for each packet;
transmitting the packets; storing the
packets for retransmission in a buffer
memory incorporated into the transmitter;
monitoring a return channel for receipt of
an acknowledgment for each packet that
that packet has been received; limiting the
number of retransmissions to an operatordefined integer value; clearing the buffer
memory after the integer value is reached;
retransmitting an original or selectively
modified packet at the transmitter, if an
acknowledgment for that packet has not
332
been received within a predetermined
period of time; collecting retransmission
statistics; adjusting the particular
encoding/data modulation of each packet
using the collected retransmission
statistics; wherein if the collected
retransmission statistics indicate a low
number of retransmissions, a higher
capacity encoding/data modulation scheme
is selected as the particular encoding/data
modulation and if the collected
retransmission statistics indicate a high
number of retransmissions, a lower
capacity encoding/data modulation scheme
is selected as the particular encoding/data
modulation;
combining the retransmitted original or
selectively modified packet with the
transmitted packets; and selectively nulling
subchannels from an OFDM frequency set
wherein the use of a poor quality
subchannel is precluded for a
predetermined period and adding a
previously nulled subchannel back into the
OFDM frequency set where a
retransmission rate or retransmission rate
September 22, 2009
–‫ד' בתשרי התש"ע‬
or link quality indicates a high quality for
the previously nulled subchannel.
__________
]11[]21[
160352
‫תת–רישום של שרת זכויות ניהול‬/‫רישום‬
DRM ‫דיגיטליות לתוך ארכיטקטורת‬
]54[
ENROLLING/SUB-ENROLLING A
DIGITAL RIGHTS
MANAGEMENT (DRM) SERVER
INTO A DRM ARCHITECTURE
]22[
]31[
]51[
]71[
12.02.2004
373458
]32[ 25.02.2003
]33[ US
Int. Cl.(2008.04) G06F 21/24, G06Q 30/00, 50/00, H04L 9/32, H04N 71/67
MICROSOFT CORPORATION,
U.S.A.
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
[57] A method in combination with a
Digital Rights Management (DRM) system
having a plurality of DRM servers
performing DRM functionality, the method
of an entering DRM-E server to be
enrolled into the system by an enrolling
DRM-R server such that the entering
DRM-E server is to be trusted within the
system and comprising: the DRM-E server
procuring a public/private key pair (PU-E,
PR-E) for identifying such DRM-E server
within the DRM system; the DRM-E
server procuring a proffering identification
September 22, 2009
–‫ד' בתשרי התש"ע‬
thereof; the DRM-E server sending an
enrollment request to the DRMR server,
the request including the proffering
identification and (PU-E); the DRM-R
server validating the proffering
identification; the DRM-R server, if the
request is to be honored, generating a
digital enrollment certificate for the DRME server to enroll such DRM-E server into
the DRM system; the DRM-R server
returning the generated enrollment
certificate to the requesting DRM-E server;
and the now-enrolled DRM-E server
333
storing the returned enrollment certificate
in an appropriate location for future use,
the DRM-E server with the enrollment
certificate able to employ same to issue
DRM documents within the DRM system,
the enrollment certificate employable to
issue the DRM documents being based at
least in part on (PU-E).
__________
]11[]21[
]54[
TRANSDERMAL THERAPEUTIC
SYSTEM (TTS) WITH FENTANYL
AS ACTIVE INGREDIENT
]22[
]31[
]51[
]71[
10.07.2002
10141651.2
]32[ 24.08.2001
Int. Cl.(2008.04) A61K 9/70
LTS-LOHMANN THERAPIESYSTEME AG, GERMANY
WALTER MULLER
WO/2003/018071
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]72[
]87[
]74[
[57] A transdermal therapeutic system
(TTS) containing an active substance
having increased security against overdose
of the active substance comprising an
active substance impermeable backing
layer (1); an active substance layer (2), the
active substance being fentanyl and/or a
fentanyl analog derivative and/or a salt of
fentanyl and/or a salt of a fentanyl analog
334
160515
‫מערכת להעברה תוך עורית של פנטניל‬
‫כחומר הפעיל‬
]33[
DE
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
‫ הרצליה‬,2081 .‫ד‬.‫ ת‬, 10 ‫שדרות אבא אבן‬
derivative, where said active substance
layer comprises a polymer or a polymer
mixture with microreservoirs (3) dispersed
therein, wherein the active substance is
dissolved in the microresrvoirs and a
membrane layer (4) following the skin side
comprises of an ethylene-vinyl acetate
copolymer or a polyethylene or
polypropylene microporous film;
September 22, 2009
–‫ד' בתשרי התש"ע‬
optionally a subsequent adhesive layer (5)
and a protective layer (6), which is
removed before use.
__________
]11[]21[
]54[
SYSTEM AND METHOD FOR
FAST DYNAMIC LINK
ADAPTATION
]22[
]31[
]51[
]71[
18.10.2002
60/344693
]32[ 19.10.2001
Int. Cl.(2008.04) H04B 7/26, 70/05
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2003/041317
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
[57] A method for selecting a transport
format combination (TFC) out of a
transport format combination set (TFCS)
for use in wirelessly transferring a coded
composite transport channel (CCTrCh), the
method comprising: selecting a TFC out of
the TFCS; eliminating the selected TFC
September 22, 2009
–‫ד' בתשרי התש"ע‬
160526
‫מערכת ושיטה לסיגנל קישור דינמי מהיר‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
for future selection and repeating the step
of selecting a TFC, if a determined
transmission power level for the selected
TFC exceeds a maximum allowed power
level; and transmitting the CCTrCh using
the selected TFC, if the selected TFC was
not eliminated.
335
The applications for division
from this application have
not yet been published
,194767
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
________
]11[]21[
160700
‫–פירימידון ותרופות‬4–‫–מותמרות‬3 ‫תולדות‬
‫המכילות אותן לטיפול במחלת עצב ניוונית‬
]54[
3-SUBSTITUTED-4-PYRIMIDONE
DERIVATIVES AND
MEDICAMENTS COMPRISING
THEM FOR THE TREATMENT OF
NEURODEGENERATIVE DISEASE
]22[
]31[
20.09.2002
2001-331677 ]32[ 21.09.2001
]33[ JP
2001-331678
21.09.2001
JP
2001-331674
21.09.2001
JP
2001-331675
21.09.2001
JP
Int. Cl.(2008.04) A61K 315/13, 315/386, A61P 25/28, 3/10, C07D 401/04, 401/14,
405/14, 409/14, 413/14, 417/14, 498/10
SANOFI AVENTIS, FRANCE
MITSUBISHI TANABE PHARMA
CORPORATION, JAPAN
WO/2003/037888
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
336
September 22, 2009
–‫ד' בתשרי התש"ע‬
[57] A pyrimidone derivative of the
formula
or a salt thereof, or a solvate thereof or a
hydrate thereof wherein R1 represents a
C1-C12 alkyl group; R represents any one
of groups of the formulas
wherein R2 and R3 independently
represent a hydrogen atom or a C1-C8 alkyl
group and R4, R5, R6, R7, R8, R9, R10 and X
are as defined in the specification.
__________
]11[]21[
]54[
FAST DURABLE MAGAZINE
LOADER
]22[
]31[
]51[
]71[
09.09.2002
145348
]32[ 10.09.2001
Int. Cl.(2008.04) F41A 9/83
RAN TAL
GUY TAL
]87[
]74[
WO/2003/023308
GUY TAL,
86/2 SHILOH ST. , ROSH HA'AYIN
[57] A loading device for loading a
plurality of ammunition rounds (50) or
cartridges into a firearm magazine (60),
said magazine comprising a substantially
hollow body having a predetermined size
and shape with a case end having a rim or
September 22, 2009
–‫ד' בתשרי התש"ע‬
160729
‫מטען מהיר ועמיד של מחסנית‬
]33[
IL
‫ תל אביב‬,‫רן טל‬
‫ ראש העין‬,‫גיא טל‬
,‫גיא טל‬
‫ ראש העין‬,86/2 ‫רח' שילה‬
flange, and an opposite bullet or slug end,
said loading device comprising:
(a) an elongated body (2) having an upper
surface with a magazine recess or
compartment at one end of said body
337
which extends into said body from said
upper surface,
(b) said magazine recess having a
predetermined shape and size for receiving
and holding said firearm magazine,
(c) said body having an elongated rounds
recess or slideway at another end of said
body extending into said body from said
upper surface,
(d) said elongated rounds recess
communicating with said magazine recess,
(e) said elongated rounds recess having a
bottom and a pair of opposing sidewalls,
(f) each of said sidewalls having at its tip a
protruding elongated projection, ledge, or
rib so as to provide and partially define an
elongated groove or recess on each
sidewall under said elongated projection,
(g) the groove on one sidewall being a
case-holding groove and having a
predetermined shape and size so that it can
hold and slidingly guide said case ends of
said plurality of said rounds when said
case ends are stacked in said case-holding
groove,
(h) the groove on the opposite sidewall
being a bullet-holding groove and having a
predetermined shape and size so that it can
338
hold and slidingly guide said bullet ends of
said plurality of said rounds when said
bullet ends are stacked in said bulletholding groove,
(i) said case-holding and bullet-holding
grooves thus enabling said rounds to slide
in and be captured by said elongated
rounds recess with said case and bullet
ends in said case-holding and bulletholding grooves, respectively, and
(j) a slider (40) or pusher having a plunger
positioned in and extending between said
case-holding and bullet-holding grooves,
said plunger being shaped to fit in said
case-holding and said bullet-holding
grooves, such that said plunger can slide in
said rounds recess, whereby when said
magazine is placed in said magazine
recess, a user can load it with said
ammunition rounds quickly, easily, and
safely by inserting said rounds in said
rounds recess and moving said slider
toward said magazine to force said rounds
sequentially into said magazine, and said
loading device has few parts, lighter
weight, requires less handling time, and is
more durable.
September 22, 2009
–‫ד' בתשרי התש"ע‬
__________
]11[]21[
160734
‫תכשיר רוקחות המכיל גמא–בוטירובטאין‬
‫ושימוש שלו‬
]54[
PHARMACEUTICAL
COMPOSITION COMPRISING
GAMMA-BUTYROBETAINE AND
USE THEREOF
]22[
]31[
]51[
]71[
04.03.2002
P-01-00134
]32[ 07.09.2001
]33[ LV
Int. Cl.(2008.04) A61K 311/95, 312/05, 45/00, A61P 15/10, C07C 229/10, 243/14
IVARS KALVINSH, LATVIA
MARIS VEVERIS, LATVIA
ANATOLIJS BIRMANS, LATVIA
]87[
]74[
WO/2003/022262
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
[57] Use of gamma-butyrobetaine as free
base or its pharmaceutically acceptable salt
,‫פרל כהן צדק לצר‬
,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬
for producing a medicament for treatment
of impotence in male mammals.
__________
]11[]21[
]54[
CUTTING TOOL AND CUTTING
INSERT THEREFOR
]22[
]51[
]71[
]72[
]74[
18.03.2004
Int. Cl.(2008.04) B23B 27/04
ISCAR LTD.
GIL HECHT
ISCAR LTD.,
P.O.B. 11,TEFEN 24959
[57] A cutting tool comprising an insert
holder and a cutting insert, the insert
holder comprising a body portion and a
clamping portion, the clamping portion
comprising a base jaw, a clamping jaw and
an insert pocket therebetween, the insert
pocket extending from a pocket opening at
a forward end of the pocket to a rear end
September 22, 2009
–‫ד' בתשרי התש"ע‬
160935
‫כלי חיתוך ושימת חיתוך עבורו‬
‫ תפן‬,‫ישקר בע"מ‬
‫גיל הכט‬
,‫ישקר בע"מ‬
‫ תפן‬,11 .‫ד‬.‫ ת‬,
thereof, the clamping jaw comprising two
elongated sub-clamping jaws separated by
an elongated forward recess, wherein the
cutting insert is resiliently clamped in the
insert pocket between the two elongated
sub-clamping jaws and the base jaw and
wherein the two elongated sub-clamping
jaws are independently resilient.
339
__________
]11[]21[
]54[
METHOD AND KIT FOR
DETECTING EXPLOSIVE
SUBSTANCES CONTAINING
CERTAIN OXIDANTS
]22[
]51[
]71[
]74[
21.03.2004
Int. Cl.(2008.04) G01N 31/22
MISTRAL DETECTION LTD.
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
[57] A method for detecting an explosive
substance which contains an oxidant
selected from chlorate, bromate and
organic peroxide, which method comprises
the sequential steps of: providing a sample
of suspect explosive substance; contacting
the sample of said substance with a first
reagent, which is a strongly acid solution
of at least one primary or secondary
aromatic amine, whereby the presence of a
chlorate or bromate type explosive affords
160989
‫שיטה וערכה לגילוי חומרי נפץ המכילים‬
‫מחמצים מסוימים‬
‫ הרצליה פיתוח‬,‫מיסטרל דטקשון בע"מ‬
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
,45087 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬
a distinct coloration; and in the absence of
such coloration, contacting the same
sample, which is already in contact with
the first reagent, with a second reagent,
which is a solution comprising cations of
at least one transition metal, whereby the
presence of organic peroxides in the
sample, which has been hydrolyzed at least
partly to hydrogen peroxide by the strong
acid of the first reagent, affords a distinct
coloration.
__________
340
September 22, 2009
–‫ד' בתשרי התש"ע‬
]11[]21[
161079
‫זן של סטרפטומיזיה פלווידווירנס ותהליך‬
‫להכנת פראבסטאטין המשתמש בו‬
]54[
STRAIN OF STREPTOMYCES
FLAVIDOVIRENS AND PROCESS
FOR THE MANUFACTURE OF
PRAVASTATIN UTILIZING THE
SAME
]22[
]51[
]71[
]87[
]74[
27.09.2001
Int. Cl.(2008.04) C12N 1/20, C12P 7/62, C12R 14/65
BIOCON LIMITED, INDIA
WO/2003/027302
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] A new strain Streptomyces
flaviodovirens DSM 14455 and a
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
microbial process for the preparation of the
compound of the formula
from a substrate compound of the formula
wherein R represents an alkali metal or
ammonium ion, comprising steps of
(i) preparing seed inoculum of a strain of
Streptomyces flavidovirens DSM 14455
able to 6β-hydroxylate a compound of
formula II,
September 22, 2009
–‫ד' בתשרי התש"ע‬
(ii) transferring the said seed inoculum to a
production medium,
(iii) subjecting the said production medium
to fermentation,
341
(iv) feeding the substrate to be transformed
in the said production medium at different
intervals,
(v) controlling the pH during fermentation
by feeding carbon sources,
(vi) fermenting the substrate until the end
of bioconversion,
(vii) extracting the whole cell broth and
separating the compound of formula I, and
(viii) isolating the compound of formula I.
__________
]11[]21[
]54[
RECORD CARRIER AND
APPARATUS FOR SCANNING
THE RECORD CARRIER
]22[
]31[
]51[
]71[
23.09.2002
01203881.6
]32[ 15.10.2001
Int. Cl.(2008.04) G11B 7/00
KONINKLIJKE PHILIPS
ELECTRONICS N.V., THE
NETHERLANDS
WO/2003/034434
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
[57] Record carrier comprising a servo
track indicating an information track
intended for recording information blocks
represented by marks, which servo track
has a periodic variation of a physical
parameter at a predetermined frequency
and modulated parts for encoding position
information at regular intervals, a first type
of modulated parts starting with a bit sync
element and being of a data type having a
data bit element, and a second type of
modulated parts starting with a bit sync
element and being of a word sync type
having a word sync element, the word sync
element and the data bit element being
342
161350
‫נשא להקלטה והתקן לסריקת נשא‬
‫ההקלטה‬
]33[
EP
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
modulated according to a same
predetermined type of modulation of the
periodic variation, characterized in that the
word sync element comprises two equal,
modulated partial elements separated by an
interval of not modulated periodic
variations and the effective strength of the
partial elements of the word sync element
and the effective strength of the data bit
element are equal, the effective strength
being the number of periodic variations
that are substantially different and
available for detection of the
corresponding element.
September 22, 2009
–‫ד' בתשרי התש"ע‬
__________
]11[]21[
161750
‫מטרות התזה מסגסוגת אלומניום בעלות‬
‫מרקם בלתי יציב‬
]54[
TEXTURED-METASTABLE
ALUMINUM ALLOY SPUTTER
TARGETS
]22[
]31[
]51[
]71[
23.10.2002
09/991851
]32[ 14.11.2001
]33[ US
Int. Cl.(2008.04) C22C 21/00, C23C 14/34
PRAXAIR S.T. TECHNOLOGY, INC.,
U.S.A.
WO/2003/066929
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
[57] An aluminum alloy sputter target,
the sputter target having a sputter target
face for sputtering the sputter target, the
sputter target face having a texturedmetastable grain structure, the texturedmetastable grain structure having a grain
orientation ratio of at least about 35
percent (200) orientation, the texturedmetastable grain structure being stable
during sputtering of the sputter target, the
textured-metastable grain structure having
a grain size of less than about 5 μm.
__________
]11[]21[
September 22, 2009
–‫ד' בתשרי התש"ע‬
161769
343
–‫פוליפפטידים נוגדי חיידקים המופקים מ‬
NIGRELLA PSEUDOPLECTANIA
]54[
ANTIMICROBIAL
POLYPEPTIDES FROM
PSEUDOPLECTANIA NIGRELLA
]22[
]31[
20.11.2002
PA200101732 ]32[ 20.11.2001
]33[ DK
PA200201243
23.08.2002
DK
Int. Cl.(2008.04) A23K 1/16, 1/17, A61K 38/16, C07K 14/37, C12N 15/31
NOVOZYMES A/S, DENMARK
WO/2003/044049
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
[57] A polypeptide having antimicrobial
activity, selected from the group consisting
of:
(a) a polypeptide comprising an amino
acid sequence which has at least 65%
identity with amino acids 1 to 40 of SEQ
ID NO:2;
(b) a polypeptide which is encoded by a
nucleotide sequence which hybridizes
under medium stringency conditions, using
0.2xSSC at 42oC for washing, with a
polynucleotide probe selected from the
group consisting of:
(i) the complementary strand of
nucleotides 166 to 285 of SEQ ID NO:1,
(ii) the complementary strand of
nucleotides 70 to 285 of SEQ ID NO:1,
and
(iii) the complementary strand of
nucleotides 1 to 285 of SEQ ID NO:1; and
(e) a fragment of (a) or (b) that has
antimicrobial activity.
__________
]11[]21[
344
161773
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫שיטה לבחירת תאים מותמרים גנטית‬
]54[
METHOD FOR SELECTING
GENETICALLY TRANSFORMED
CELLS
]22[
]31[
]51[
]71[
06.11.2002
1019308
]32[ 06.11.2001
]33[ NL
Int. Cl.(2008.04) A01H 5/00, C12N 15/82, 5/04
EXPRESSIVE RESEARCH B.V., THE
NETHERLANDS
JOSEPHUS CHRISTIANUS MARIA
SMEEKENS, HENRIETTE
SCHLUPMANN
WO/2003/040377
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬
HERZLIYA 46733
]72[
]87[
]74[
[57] Method for selecting genetically
transformed cells from a population of
cells, comprising the steps of
(a) introducing into a cell at least one
desired nucleotide sequence and at least
one selection-nucleotide sequence to
obtain a genetically transformed cell,
wherein the selection-nucleotide sequence
comprises a region which codes for a
protein involved in the metabolizing of
trehalose;
(b) placing a population with transformed
and non-transformed cells into contact
with trehalose and/or derivative thereof;
and
(c) selecting the transformed cells from the
population on the basis of the capacity of
the transformed cells to metabolize the
trehalose and/or derivative.
__________
]11[]21[
]54[
REVERSE LINK POWER
CONTROLLED REPEATER
161882
‫משחזר בעל בקרת כוח מקושרת במהופך‬
]22[
]31[
]51[
]71[
20.11.2002
60/331943
]32[ 20.11.2001
]33[ US
Int. Cl.(2008.04) H04B 1/00, 70/05, 71/55
QUALCOMM INCORPORATED,
U.S.A.
]87[ WO/2003/044970
]74[ SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
[57] A method of controlling output
coupling a pre-selected portion of a donor
power for a repeater communicating with
base station communication signal
one or more base stations in a wireless
intended for remote stations to an
communication system, comprising:
embedded wireless communication device
September 22, 2009
–‫ד' בתשרי התש"ע‬
345
within said repeater establishing a reverse
communication link between said wireless
communication device and said donor base
station in response to said pre-selected
portion using a reverse link signal path in
common with remote station
communication signals being transferred to
said base station; and receiving power
adjustment information for said wireless
communication device from said donor
base station and generating at least one
power control signal for adjusting the
return link gain of said repeater.
__________
]11[]21[
]54[
346
REVERSE PULSE CLEANING OF
162015
‫ניקוי רכיבי מסנן באמצעות פולס הפיך‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
FILTER ELEMENTS
]22[
]31[
]51[
]71[
]87[
]74[
18.12.2002
PR9668
]32[ 20.12.2001
Int. Cl.(2008.04) B01D 19/00, 46/04
GOYEN CONTROLS CO. PTY. LTD.,
AUSTRALIA
WO/2003/053539
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57] An air supply system adapted to
provide a reverse pulse of air for cleaning
a filter element located in a filter housing,
said system comprising: a pressure vessel
adapted to contain a volume of compressed
air to be used for supplying said reverse
pulse, said pressure vessel having a wall
with at least one outlet aperture therein:
valve means (16) mounted to said wall
around said aperture to control the flow of
air from said pressure vessel, said valve
means comprising a valve body having an
inlet, an outlet and a flow passage
connecting the inlet and outlet, a portion of
said valve body located within said vessel,
said inlet, said outlet and said flow passage
generally extending axially through said
valve body defining a relatively straight
flow passage, a valve seat surrounding said
September 22, 2009
–‫ד' בתשרי התש"ע‬
]33[
AU
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
flow passage, and a valve closure member
movable towards and away from said
valve seat into closed and open positions to
thereby close or open said flow passage,
and operating means for moving said valve
closure member between said closed and
open positions, said relatively straight flow
passage providing minimal pressure drop
across said valve when said valve is in an
open position to allow substantially all of
the air from said pressure vessel to
discharge rapidly; and a conduit (18)
mounted to said valve body around said
outlet and adapted to extend into said filter
housing in use so as to direct a pulse of air
towards a filter element to be cleaned
when said valve closure member is in said
open position.
347
__________
]11[]21[
162047
‫התקן נשתל להספקת תרופה באמצעות‬
‫מנגנון פתחים המסוגל להזרים נוזל בקצב‬
‫נמוך‬
]54[
IMPLANTABLE DEVICE FOR
DELIVERING DRUGS USING
ORIFICE MECHANISM CAPABLE
OF LOW FLUID FLOW RATES
]22[
]31[
]51[
]71[
]74[
19.05.2004
459969
]32[ 12.06.2003
]33[ US
Int. Cl.(2008.04) A61F 2611/00, A61M 1/12, 37/00, 51/42
CORDIS CORPORATION, U.S.A.
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57] An implantable device (100) for
delivering a drug comprising: a housing
(105); a source of drug (108) contained
within the housing; an orifice mechanism
(200) at the housing and communicating
with the source of drug, the orifice
mechanism comprising:
348
(i) an inner member (210) having a
proximal end (234) and a distal end (236);
(ii) a winding helically wound around the
inner member;
(iii) the winding and the inner member
defining a first channel for carrying the
September 22, 2009
–‫ד' בתשרי התש"ע‬
drug therethrough and an inlet at the
proximal end of the winding and an outlet
at the distal end of the winding; and
the drug being carried by the orifice
mechanism and dispensed outside of the
housing.
__________
]11[]21[
162053
‫ערכות לשימוש בטיפול באי סדרים של‬
‫עצם‬
]54[
KITS FOR USE IN THE
TREATMENT OF BONE
DISORDERS
]22[
]31[
]51[
]71[
16.12.2002
60/344875
]32[ 21.12.2001
]33[ US
Int. Cl.(2008.04) A61K 31/66, 316/63, 316/75, A61P 19/00, 19/10, C07F 9/00, 9/38
THE PROCTER & GAMBLE
COMPANY, U.S.A.
WO/2003/055496
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
]87[
]74[
[57] A kit for use in the treatment for
increasing bone mass comprising unitary
doses of bisphosphonate for a loading
period and unitary doses of a
bisphosphonate for a maintenance period
wherein the unitary loading period dose is
from 2 to 20 times greater that the unitary
dose for the maintenance period.
__________
September 22, 2009
–‫ד' בתשרי התש"ע‬
349
]11[]21[
]54[
METHOD AND APPARATUS FOR
MEASURING STRESS IN
SEMICONDUCTOR WAFERS
]22[
]31[
]51[
]71[
]72[
26.11.2002
09/991709
]32[ 26.11.2001
Int. Cl.(2008.04) G01B 9/02
NANOMETRICS- ISRAEL LTD.
YARON ISH-SHALOM, OFER DUNOUR
WO/2003/046474
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
]87[
]74[
[57] Apparatus for measuring properties
of a wafer (54), the apparatus comprising:
at least one monochromatic light source
(52), for producing monochromatic light
for directing at said wafer, at least a first
(62) and a second beam director (64), each
optically associated with said
monochromatic light source for directing
said monochromatic light from said source
to provide respective substantially parallel
light beams towards said wafer, said beam
directors being configured to cause said
respective beams to strike at respective
places on a planar surface of said wafer,
said first beam director (62) being
arranged to direct a first of said respective
162102
‫שיטה ומכשיר למדידת מתח ברכיבים‬
‫מוליכים למחצה‬
]33[
US
‫ יוקנעם‬,‫ישראל בע"מ‬-‫נאנומטריקס‬
‫נור‬-‫ עופר די‬,‫שלום‬-‫ירון איש‬
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
,11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל אילון‬
‫רמת גן‬
beams substantially centrally onto said
planar surface and said second beam
director (66) being alignable to direct a
second of said respective beams
substantially outwardly of said center to a
point at a selected distance (xh) from said
first beam, an optical processor (58)
arranged to receive reflections of each
beam and further comprising an
interferometer unit to process said
reflections together, thereby to detect any
optical difference between said reflections,
said optical difference being indicative of
bow (Y) in said wafer, said bow being
usable with said selected distance to
calculate a stress within said wafer.
__________
350
September 22, 2009
–‫ד' בתשרי התש"ע‬
]11[]21[
162277
‫מחסנית הכוללת מדית הדפסה מצופה‬
‫בדבק ואספקת דיו‬
]54[
CARTRIDGE INCLUDING
ADHESIVE COATED PRINT
MEDIA AND AN INK SUPPLY
]22[
]31[
09.11.1999
PP7019
]32[ 09.11.1998
]33[ AU
PP7017
09.11.1998
AU
PP7026
09.11.1998
AU
PP7020
09.11.1998
AU
PP7021
09.11.1998
AU
PP7027
09.11.1998
AU
Int. Cl.(2008.04) A63F 13/00, B41J 2/01, 21/75, G03B 17/02, 19/02, 27/52, 29/00,
G06C 11/04, G06F 3/12, 30/33, H04M 1/03, H04N 57/65
DIVISION FROM 142715
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2000/028379
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]51[
]62[
]71[
]87[
]74[
[57] A cartridge assembly (19) for a
printhead assembly (30), said cartridge
including: a cartridge assembly casing
defining a first container portion for
September 22, 2009
–‫ד' בתשרי התש"ע‬
housing therein a supply of a sticker roll
(18) and a second container portion for
storing an ink supply (7).
351
________
]11[]21[
162354
‫יהלום מסומם בבורון‬
]54[
BORON DOPED DIAMOND
]22[
]31[
]51[
]71[
13.12.2002
0130005.2
]32[ 14.12.2001
]33[ GB
Int. Cl.(2008.04) C23C 16/26, C30B 25/10, 29/04
ELEMENT SIX LIMITED, UNITED
KINGDOM
WO/2003/052174
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
]87[
]74[
352
September 22, 2009
–‫ד' בתשרי התש"ע‬
[57] A layer of single crystal boron doped
diamond produced by CVD wherein the
total boron concentration is uniform, with
a variation over the majority volume which
is less than 50%, measured with a lateral
resolution at each measurement point of
less than 50μm, wherein the majority
volume represents at least 70% of the total
volume of the layer, and wherein the layer
has at least one of the following
characteristics:
(i) the layer is formed from a single growth
sector,
(ii) the layer thickness exceeds 100 μm,
and
(iii) the volume of the layer exceeds 1
mm3.
__________
]11[]21[
‫חומר קולט אנרגיה‬
]54[
ENERGY ABSORBING
MATERIAL
]22[
]31[
]51[
]71[
23.12.2002
0130834.5
]32[ 22.12.2001
Int. Cl.(2008.04) A41D 13/00
DESIGN BLUE LTD., UNITED
KINGDOM
WO/2003/055339
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]87[
]74[
162679
[57] A self-supporting energy absorbing
composite comprising:
(i) a solid foamed synthetic polymer
matrix;
(ii) a polymer-based dilatant, different
from (i) distributed through the matrix and
]33[
GB
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
incorporated therein during manufacture of
(i); and
(iii) a fluid distributed through the matrix,
the combination of matrix, dilatant and
fluid being such that the composite is
resiliently compressible.
__________
September 22, 2009
–‫ד' בתשרי התש"ע‬
353
]11[]21[
162809
‫שיטה והתקן לבחירה יעילה ולרכישה‬
‫יעילה של מערכת תקשורת אלחוטית‬
]54[
METHOD AND APPARATUS FOR
EFFICIENT SELECTION AND
ACQUISITION OF A WIRELESS
COMMUNICATIONS SYSTEM
]22[
]31[
]51[
]71[
10.01.2003
10/043695
]32[ 10.01.2002
]33[ US
Int. Cl.(2008.04) H04L 12/56, H04Q 7/38
QUALCOMM INCORPORATED,
U.S.A.
WO/2003/061327
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]87[
]74[
[57] In a mobile station including a
preferred roaming list, a system acquisition
procedure comprising the steps of:
maintaining a list of unusable wireless
communications systems, each entry in the
list of unusable wireless communications
systems including a system identifier and
corresponding avoidance criterion;
selecting a wireless communication system
from the preferred roaming list in
accordance with a predetermined system
acquisition sequence and repeating the step
of selecting until a usable system is
selected; and attempting to acquire and
register with the selected wireless
communications system, wherein the
selected wireless communications system
is unusable if the list of unusable wireless
communications systems includes a
corresponding system identifier and the
corresponding avoidance criterion is
satisfied.
__________
354
September 22, 2009
–‫ד' בתשרי התש"ע‬
]11[]21[
]54[
APPARATUS FOR SEARCHING
AND DETECTING DEFECTS IN
PARTS BY ENDOSCOPY
]22[
]31[
]51[
]71[
01.07.2004
03/08156
]32[ 04.07.2003
Int. Cl.(2008.04) A61B 1/00
SNECMA SERVICES, FRANCE
SNECMA, FRANCE
]72[
ISABELLE BONNINGUE, JOHN
LEQUELLEC, JEAN-CLAUDE
LEMOAL, MICHEL BACCELLA
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]74[
[57] Apparatus for searching for and
detecting defects on parts by penetration
testing and endoscopy, the apparatus
comprising: a rigid tubular cylindrical rod
(16) of small diameter, pipes received in
the rod for feeding air and penetration test
substances on a portion of the part (12)
under examination, and light guide and
image transmission means received in the
rod to illuminate and observe said portion
of the part under examination,
characterized in that the light guide and
image transmission means are constituted
by a first endoscope (22) that operates with
162830
‫מכשיר לחיפוש ואבחון פגמים בחלקים על‬
‫ידי אנדוסקופיה‬
]33[
FR
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
visible light mounted axially in the rod and
surrounded by pipes for air and penetration
test substances, said endoscope having a
rectilinear tube in which the visible light
guide means and the image transmission
means are mounted in parallel, and in that
the apparatus further comprises a second
endoscope that operates with ultraviolet
light, independent of the first endoscope
and of the above-mentioned rod for
observing the portions of the part that has
been treated by the penetration test
substances.
__________
]11[]21[
September 22, 2009
–‫ד' בתשרי התש"ע‬
162882
355
‫מיכל עם מיכסה בעל קפיץ גמיש‬
]54[
CONTAINER WITH
ELASTOMERIC LID SPRING
]22[
]31[
]51[
]71[
]74[
06.07.2004
633422
]32[ 01.08.2003
]33[
Int. Cl.(2008.04) B65D 1/12, 43/16, 43/24
DART INDUSTRIES INC., U.S.A.
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57] A spring (40) fur use in resiliently
biasing a container lid from a closed
position to an open position about a pivot
axis relative to a container body (12), said
spring comprising a block of elastomeric
material, characterized by a central
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
foldable area of maximum thickness and
tapering to opposed ends of minimal
thickness which are adapted to selectively
engage with the container body and lid
with the area of maximum thickness
alignable with the pivot axis.
__________
]11[]21[
356
163031
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫שיטה לבקרת חיובים של שרות שידור‬
‫באמצעות יחידות זמן‬
]54[
METHOD FOR CONTROLLING
THE BILLING OF A BROADCAST
SERVICE BY UNITS OF TIME
]22[
]31[
]51[
07.02.2003
0265/02
]32[ 15.02.2002
]33[ CH
Int. Cl.(2008.04) G06F 21/00, 21/24, G06Q 30/00, 50/00, G09C 1/00, H04N 1/00,
1/16, 71/67
NAGRACARD S.A., SWITZERLAND
WO/2003/069910
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]71[
]87[
]74[
[57] A time accounting method of access
to a stream of data encrypted by control
words (CW) modified at intervals
representing a crypto-period (CP), said
stream being received by a user unit (UU)
connected to a security module (SC) in
charge of verifying the rights of a user and
of decrypting messages (ECM) comprising
the control words, said accounting being
based on accounting units (CT) authorizing
the use of the service for an assigned time
(AT), said method comprising the
following stages:
(a) commutation by the user on an
encrypted stream constituting an access
service per time unit,
(b) reception by the security module of
encrypted messages containing the control
words and data specific to said service
allowing to determine the assigned time
and its cost of the accounting unit,
(c) reading of a time variable (Rdate)
representative of the time during which the
use of said service is authorized,
(c) determination, on the basis of the timecurrent if it is placed during the
authorization time defined by the time
variable (Rdate), and if this is the case, to
authorize the service by resending the
control words to the user unit,
(e) if this is not the case, to order the debit
of an accounting unit and to determine if
the time-current is comprised in an
assigned time adjacent to the time interval
defined by the time variable, if this is the
case to determine the new value of the
time variable in order to move the latter
from an assigned time, and to authorize the
service by resending the control words in
plaintext to the user unit,
(f) if this is not the case, to load the time
variable (Rdate) of an assigned time (AT)
starting from the time-current and to
authorize the service by resending the
control words in plaintext to the user unit.
__________
September 22, 2009
–‫ד' בתשרי התש"ע‬
357
]11[]21[
163252
‫העברת נתונים עם פיזור בלתי אחיד של‬
‫קצבי נתונים ממערכת (מימו) רב–קלטי‬
‫ורב–פלטי‬
]54[
DATA TRANSMISSION WITH
NON-UNIFORM DISTRIBUTION
OF DATA RATES FOR
MULTIPLE-INPUT MULTIPLEOUTPUT (MIMO) SYSTEM
]22[
]31[
]51[
]71[
27.02.2003
10/087503
]32[ 01.03.2002
]33[ US
Int. Cl.(2008.04) H04B 7/04, 7/26, H04J 11/00, 15/00, H04L 1/00, 1/06
QUALCOMM INCORPORATED,
U.S.A.
WO/2003/075479
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]87[
]74[
[57] A method for determining data rates
for a plurality of data streams to be
transmitted via a plurality of transmission
channels in a multi-channel
communication system, comprising:
determining a required signal-to-noiseand-interference ratio (SNR) for each of a
plurality of data rates to be used for the
plurality of data streams, wherein at least
two of the data rates are unequal;
358
determining an effective SNR for each of
the plurality of data streams based in part
on successive interference cancellation
processing at a receiver to recover the
plurality of data streams; comparing the
required SNR for each data stream against
the effective SNR for the data stream; and
determining whether or not the plurality of
data rates are supported based on results of
the comparing.
September 22, 2009
–‫ד' בתשרי התש"ע‬
__________
]11[]21[
163671
‫שיטה והתקן לטעון אשראי מחדש‬
‫לכרטיסי שבב‬
]54[
METHOD AND DEVICE FOR
RECHARGING A CREDIT TO
CHIP CARDS
]22[
]31[
]51[
]71[
]87[
]74[
17.03.2003
PV2002-1130 ]32[ 29.03.2002
]33[ CZ
Int. Cl.(2008.04) G07F 7/08, H04M 17/00
SAZKA, A.S., CZECH REPUBLIC
WO/2003/083791
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
[57] A method for recharging of chip
cards, in which method the recharging is
executed from a terminal (1), which
terminal is connected with a service center
for chip card (5) recharging, and in which
method input data are loaded into the
terminal, which input data comprise at
least the identification number of the
recharged chip and the amount to be
recharged to the credit of the chip card;
and loaded input data are checked (4) with
regard to their correctness, and when the
terminal is connected with the service
September 22, 2009
–‫ד' בתשרי התש"ע‬
center an assessment of meaningfulness of
the requirement to recharge the chip card is
carried out, and in the case of a positive
evaluation of said check, the value
corresponding to the amount loaded into
the chip card is transferred, and eventually,
the account associated with the card by
means of an identification number is
increased by this amount, wherein the
input data are loaded by incremental
crossing of frames in the respective part of
a fill-in coupon, which part corresponds to
the respective input datum; the terminal is
359
connected with the first service center (2),
where detection of a requirement for
recharging of a chip card is carried out and
the requirement is registered, whereupon,
the first service center is connected with a
second service center (3), in which second
service center meaningful assessment of
the requirement for recharging of a chip
card is carried out, whereby after a positive
meaningful assessment of the requirement
for recharging, a unique code is allocated
to the requirement and a report is sent from
the second service center to the first
service center, by which report it is
confirmed that the requirement is
realizable, whereupon, the requirement is
queued into a queue (6) of waiting
requirements in the first service center for
a preset time period, during which time
period the first service center determines
whether a cancellation of the requirement
has not been sent from the terminal,
whereupon, after elapse of said preset time
period, if there was not a cancellation sent
via the terminal, the second service center
issues an instruction to transfer the value
into the chip card and sends a text message
about recharging to the identification
number of the chip card, whereby, the
length of the waiting queue is set by
characteristics, while in the case of
negative meaningful assessment of the
requirement for recharging, the second
service center issues an instruction to
cancel the whole transaction.
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
‫ לתקנות‬35 ‫פירוט זה נבחן בהתאם לתקנה‬
1968 – ‫ תשכ"ח‬,‫הפטנטים‬
________
]11[]21[
360
163833
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫מעקב לאחר מהירות ביחס לזמן‬
]54[
VELOCITY RESPONSIVE TIME
TRACKING
]22[
]31[
]51[
]71[
12.03.2003
10/097043
]32[ 12.03.2002
]33[ US
Int. Cl.(2008.04) H04B 17/07, H04Q 7/38
QUALCOMM INCORPORATED,
U.S.A.
WO/2003/079570
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]87[
]74[
[57] A system for providing velocity
responsive tracking of a timing reference
in a signal received by a wireless
communications device (WCD),
comprising: a velocity estimator that
estimates the velocity of the WCD; and a
filter having a tracking speed that
corresponds to the estimated velocity,
wherein said filter filters a timing error
signal to produce a control signal that
controls the timing of a synchronization
clock.
__________
]11[]21[
]54[
SECURE METHOD OF STORING
ENCRYPTED DATA ON A
September 22, 2009
–‫ד' בתשרי התש"ע‬
163890
‫שיטה מאובטחת לאיחסון נתונים מקודדים‬
‫על רשם ספרתי אישי‬
361
PERSONAL DIGITAL RECORDER
]22[
]31[
]51[
]71[
]87[
]74[
13.03.2003
0456/02
]32[ 15.03.2002
]33[
Int. Cl.(2008.04) H04L 9/14, H04N 59/13
NAGRAVISION S.A.,
SWITZERLAND
WO/2003/079683
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] A recording method of a content
encrypted by control words in a
receiver/decoder unit connected to a
security unit, said control words as well as
the necessary rights for the access of this
content being transmitted in entitlement
messages encrypted by system keys that
are shared by a plurality of
CH
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
receiver/decoder units, characterized in
that it consists in storing the encrypted
content as well as the entitlement messages
in the storage unit, in locally encrypting
the system keys by a predefined local key
contained in the security unit, and storing
in the storage unit the system keys in
encrypted form by a predefined local key.
__________
]11[]21[
]54[
BROADBAND DIPOLE ANTENNA
TO BE WORN BY A USER AND
ASSOCIATED METHODS
]22[
]31[
]51[
]71[
]74[
06.09.2004
665004
]32[ 19.09.2003
Int. Cl.(2008.04) H01Q 1/27
HARRIS CORPORATION, U.S.A.
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57] An antenna assembly (21) to be
worn by a user and comprising: an antenna
(25) comprising a dipole feed (40)
comprising a broadband matching
network, a first dipole element (42)
connected to and extending outwardly
from said dipole feed in a first direction, a
transmission line (44) extending from said
dipole feed in a second direction opposite
362
163915
‫אנטנה לפס רחב שניתנת לנשיאה על ידי‬
‫משתמש ושיטות הקשורות בכך‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
the first direction, and a flexible
electrically conductive sleeve (45)
surrounding said transmission line and
connected to and extending outwardly
from said dipole feed to serve as a second
dipole element and as a balun; and at least
one fastener (26a, 26b) to removably
fasten the antenna to a garment of the user;
wherein said broadband matching network
September 22, 2009
–‫ד' בתשרי התש"ע‬
comprises: a three Winding transformer
(T1) connected across pair of dipole
elements, a first capacitor (C1), a first
inductor (L1), and a third inductor (L3)
connected in series between an inner
conductor of an input and the transformer,
and a second capacitor (C2) and second
inductor (L2) connected in parallel with
each other and across transformer between
the first and third inductors.
__________
]11[]21[
]54[
PROCESS FOR IMPROVING
MEMBRANES
]22[
]51[
]71[
19.09.2004
Int. Cl.(2008.04) B01D 67/00, 71/56
BEN GURION UNIVERSITY OF
THE NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
CHARLES LINDER, SOPHIA
BELFER, ROSALIA FAINSTEIN,
LUBA KESSELMAN
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]72[
]74[
[57] A process for improving the
antifouling properties and for increasing
the selectivity of composite polyamide
nanofiltration (NF) and reverse osmosis
(RO) membranes comprising circulating
from 0.01% to 5% of water soluble
monomers and an initiating redox couple
September 22, 2009
–‫ד' בתשרי התש"ע‬
164122
‫תהליך לשיפור ממברנות‬
‫ הרשות למחקר‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬
‫ באר שבע‬,‫ופיתוח‬
,‫ רוזליה פיינשטיין‬,‫ סופיה בלפר‬,‫צ'רלס לינדר‬
‫לובה קסלמן‬
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
in an aqueous solvent without transverse
pressure over the surface of the membrane
thereby effecting a free-radical graft
polymerization on the surface of the
membrane, characterised in that the
process comprises grafting between 1 and
5 additional layers in sequence, wherein a
363
second graft layer is grafted onto a first
grafted layer, and wherein the flow rate at
which the monomer and initiator are
circulated over the surface of the
membranes is between 0.1 l/min and 2
l/min.
__________
]11[]21[
164231
‫אבקות רסס ה מכילות כרומיה–אלומינה‬
‫ותהליך להכנתן‬
]54[
CHROMIA-ALUMINA SPRAY
POWDERS AND A PROCESS FOR
MAKING THE SAME
]22[
]31[
04.04.2003
10/118133
]32[ 08.04.2002
]33[ US
10/234422
03.09.2002
US
Int. Cl.(2008.04) C01G 370/33, C04B 35/12, C23C 4/10
SAINT-GOBAIN CERAMICS &
PLASTICS, INC., U.S.A.
WO/2003/086974
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬
HERZLIYA 46733
]51[
]71[
]87[
]74[
[57] A thermosprayable powder
comprising from 45 to 100% chromia and
correspondingly from 0 to 55% of alpha
alumina, all proportions being by weight,
and less than 50 ppm of each of any alkali
metals and alkaline earth metals that
stabilize chromium in the hexavalent state,
wherein the thermosprayable powder is
essentially single-phase such that alumina
in phases other than alpha phase does not
exceed 10 wt% of the total alumina
content.
__________
]11[]21[
]54[
364
GEO-INTELLIGENT TRAFFIC
164237
‫מדווח תנועה גיואוגרראפי חכם‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
REPORTER
]22[
]31[
]51[
]71[
]72[
]87[
]74[
22.09.2004
10/106523
]32[ 25.03.2002
]33[ US
Int. Cl.(2008.04) H04L 12/24, 12/26, 12/56, 29/08
DIGITAL ENVOY INC., U.S.A.
ROBERT FRIEDMAN, SANJAY
PAREKH
WO/2003/084159
SOROKER-AGMON,
,‫אגמון‬-‫סורוקר‬
14 SHENKAR ST.,
‫ הרצליה פיתוח‬,14 ‫ רחוב שנקר‬,‫בית נולטון‬
HERZLIYA PITUAH 46725
[57] A method for routing network traffic
based on geographic information in a
network (7) having a plurality of traffic
managers which route traffic in the
network based on information stored in a
database reflecting the normal network
traffic conditions; the method comprises:
(1) obtaining local real-time information
on traffic traveling through a network by
monitoring local traffic network;
(2) maintaining a database of historical
data on historical network traffic at an
entity named traffic reporter;
(3) comparing the historical data on the
historical network traffic to the real-time
information on the traffic;
(4) determining significant changes
between the historical data and the realtime information on the traffic; wherein
determining if changes are significant
comprises concluding the changes to be
significant based on a magnitude of change
from the historical data or comprise
concluding the changes to be significant if
the change exceeds a predetermined
percentage;
(5) generating traffic reports by the traffic
reporter, wherein the reports contain the
significant changes in the network traffic
derived from the real-time information and
which are tailored to the geographical
regions in which the traffic managers are
located;
(6) transmitting each report to the traffic
manager to which the report is matched,
enabling the traffic manager to derive
routing directions through the network in
response to changes to the real-time
information on network traffic by using the
information given in the report.
__________
September 22, 2009
–‫ד' בתשרי התש"ע‬
365
]11[]21[
164378
MIMO ‫מדידות תדירות פנימית עם מסופי‬
]54[
INTER-FREQUENCY
MEASUREMENTS WITH MIMO
TERMINALS
]22[
]31[
]51[
]71[
20.03.2003
113690
]32[ 02.04.2003
]33[ US
Int. Cl.(2008.04) H04B 7/26, H04J 13/00, 15/00, H04Q 7/22, 7/38
NOKIA CORPORATION, FINLAND
NOKIA, INC., U.S.A.
]87[
]74[
WO/2003/084253
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57] In a data transmission system
including a station which transmits M
encoded data streams using M antennas to
a terminal and a station controller which
controls the station, wherein M is an
integer at least equal to 2, the terminal
comprising: at least one radio transceiver
including P radio receivers and at least one
transmitter with P being an integer at least
equal to 2, each radio receiver including an
antenna which receives the M encoded
data streams and a detecting function
which decodes the M encoded data streams
into decoded data; and a terminal
controller which controls the at least one
radio transceiver, and wherein in response
366
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
to a transmission from the station that the
terminal is to operate at least one of the
radio receivers in at least one frequency
band not used to receive the M encoded
data streams during at least one identified
data frame therein to measure a radio
indicator of the at least one frequency band
not used to receive the M encoded data
streams, the terminal controller causes at
least one of the radio receivers to be tuned
to the at least one frequency band during
the at least one identified data frame and to
make measurements therein and to
transmit the measurements with the at least
one transmitter of the at least one radio
transceiver to the station.
September 22, 2009
–‫ד' בתשרי התש"ע‬
__________
]11[]21[
164434
‫תכשירי רוקחות מקומיים המכילים‬
‫פרואנתוציאנידינים לטיפול בדלקת עור‬
]54[
TOPICAL PHARMACEUTICAL
COMPOSITIONS COMPRISING
PROANTHOCYANIDINS FOR THE
TREATMENT OF DERMATITIS
]22[
]31[
]51[
]71[
31.03.2003
MI2002A000756 ]32[ 09.04.2002
]33[ IT
Int. Cl.(2008.04) A61K 314/25, 36/00, 9/00, 9/06, 9/10, A61P 17/00
SINCLAIR PHARMACEUTICALS
LIMITED, UNITED KINGDOM
WO/2003/084553
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
]87[
]74[
[57] A pharmaceutical composition for
topical administration, comprising as
active ingredients proanthocyanidins,
September 22, 2009
–‫ד' בתשרי התש"ע‬
glycyrrhetinic acid and telmesteine in
admixture with a suitable carrier.
367
__________
]11[]21[
]54[
RADIO INTERFACE
SYNCHRONIZATION
]22[
]31[
11.04.2003
60/372,296
]32[ 11.04.2002
60/388,705
13.06.2002
Int. Cl.(2008.04) H04B 17/07, 7/26
QUALCOMM INCORPORATED,
U.S.A.
WO/2003/088527
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]71[
]87[
]74[
[57] A method in a wireless device of
determining a timing offset of a channel
relative to reference channel, the method
comprising: determining an integer
number of full frames offsetting the
channel from the reference channel;
determining a fractional number, less than
one, of full frames offsetting the channel
from the reference channel such that the
368
164481
‫סינכרון ממשק רדיו‬
]33[
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
timing offset may be determined from the
sum of the integer number of full frames
with the fractional number of full frames;
re-determining the fractional number of
full frames; and updating to a memory the
integer number of full frames based, at
least in part, on the fractional number of
full frames.
September 22, 2009
–‫ד' בתשרי התש"ע‬
__________
]11[]21[
164519
‫צורת מתן רוקחית של דסמופרסין‬
‫ תהליך להכנתה‬,‫המתפרקת בפה‬
‫והשימושים בה‬
]54[
ORODISPERSIBLE
PHARMACEUTICAL DOSAGE
FORM OF DESMOPRESSIN, A
PROCESS FOR ITS PREPARATION
AND ITS USE
]22[
]31[
07.05.2003
0210397.6
]32[ 07.05.2002
]33[
PCT/IB02/04036
10.01.2005
Int. Cl.(2008.04) A61K 38/11, 47/42, 9/00, 9/20
FERRING B.V., THE NETHERLANDS
WO/2003/094886
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
[57] An orodispersible pharmaceutical
dosage form of desmopressin acetate
GB
WO
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
which disintegrates in the mouth within 10
seconds.
__________
September 22, 2009
–‫ד' בתשרי התש"ע‬
369
]11[]21[
]54[
PACIFIER, SYSTEM AND
METHOD FOR MAINTAINING
PROPER DENTITIONS
]22[
]31[
19.09.2003
60/412454
]32[ 20.09.2002
10/665458
18.09.2003
Int. Cl.(2008.04) A61J 17/00
ORTHO-TAIN, INC., U.S.A.
WO/2004/026219
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]71[
]87[
]74[
[57] A pacifier (90) sized to be worn in
the mouth of a user, the pacifier
comprising: a shield (92) having a
substantially planar body; a shelf (94)
attached to the shield wherein the shelf has
a first end, a second end located opposite
to the first end and a midline located in the
middle of the first end of the shelf and the
second end of the shelf wherein the
midline of the shelf is adjacent to the
shield wherein the first end of the shelf and
the second end of the shelf extend
rearward with respect to the mouth of the
164886
‫ מערכת ושיטה לאחזקת מערכת‬,‫מוצץ‬
‫שיניים‬
]33[
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
user when the shelf is worn in the mouth of
the user wherein the shelf is substantially
U-shaped and wherein the shelf has a
width defined between an upper side of the
shelf and a lower side of the shelf wherein
the width at the first end of the shelf and
the second end of the shelf is thicker than
the width at the midline of the shelf; and a
depression (97) within the top side of the
shelf and the bottom side of the shelf
wherein the depression is substantially Ushaped.
__________
370
September 22, 2009
–‫ד' בתשרי התש"ע‬
]11[]21[
165081
‫הרכבים יעילים לטיפול באין אונות‬
‫גברית ונשית‬
]54[
FORMULATIONS USEFUL IN THE
TREATMENT OF MALE AND
FEMALE IMPOTENCE
]22[
]31[
]51[
]71[
]87[
]74[
30.04.2003
MI2002A000990 ]32[ 10.05.2002
]33[ IT
Int. Cl.(2008.04) A61K 35/00, 36/16, 36/54, A61P 15/00, 15/10
INDENA S.P.A., ITALY
WO/2003/094943
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
[57] Pharmaceutical compositions
containing: Tribulus terrestris, Turnera
diffusa and Cinnamon cassia extracts in
the weight ratio of 1.5-3.5 : 1-2:0.1-0.4
respectively; extract of Ginkgo biloba, and
optionally arginine or a physiologically
equivalent ester, salt or precursor thereof
in admixture with a suitable carrier or
excipient.
,192138
The applications for division
from this application have not
yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
________
]11[]21[
165122
‫תכשיר המשמש לטיפול באין–אונות‬
‫אצל גברים ונשים‬
]54[
FORMULATIONS USEFUL IN THE
TREATMENT OF MALE AND
FEMALE IMPOTENCE
]22[
]31[
]51[
]71[
]87[
]74[
02.05.2003
MI2002A000994 ]32[ 10.05.2002
]33[ IT
Int. Cl.(2008.04) A61K 35/00, 36/00, 36/54, A61P 15/00, 15/10
INDENA S.P.A., ITALY
WO/2003/094944
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
[57] Pharmaceutical compositions
comprising: extracts of Tribulus terrestris,
Epimedium koreanum, Cinnamon cassia in
the weight ratio of 1.5-3.5 : 1-2; 0.1-0.4,
respectively;
The applications for division
September 22, 2009 –‫ד' בתשרי התש"ע‬
and optionally arginine or a
physiologically equivalent ester, salt or
precursor thereof and a suitable carrier or
excipient.
,192137
‫בקשות חלוקה מבקשה זו‬
371
.‫שטרם פורסמו‬
from this application have not
yet been published
________
]11[]21[
165132
‫אטם למשאבה‬
]54[
PUMP BOOT SEAL
]22[
]51[
]71[
]74[
10.11.2004
Int. Cl.(2008.04) F04D 29/08, 29/12, F16J 15/34
CARMELI ADAHAN
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57] A boot seal (28) for a rotary pump
(10) comprising a drive unit (14) including
an eccentric drive member, and a pump
unit (12) including an eccentrically driven
member (20) disposed within a pump
housing (16) and being engaged to said
eccentric drive member so as to impart an
orbital motion to the eccentrically driven
member, the boot seal being compliant,
and configured for being affixed on one of
its ends to the eccentrically driven member
and on its other end to the pump housing,
such that the eccentric drive member can
freely drive the eccentrically driven
member, by a crank (21) orbiting within
the boot seal, transmitting drive torque to
‫ ירושלים‬,‫ רמות‬,‫כרמלי אדהאן‬
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
the eccentrically driven member, without
any rotary movement between said boot
seal and the eccentrically driven member
or the pump housing when affixed thereto,
wherein said boot seal is prevented from
moving inward or collapsing, when outside
pressure is applied on it, by means of rigid
support members which are placed within
it, yet providing for free orbital movement
of the eccentric crank within the booth seal
and rendering the boot seal equally
effective in sealing when pressure is
applied inwards or outwards, and wherein
said boot is made of compliant material
such as rubber.
__________
372
September 22, 2009
–‫ד' בתשרי התש"ע‬
]11[]21[
]54[
DEVICE FOR THE HEATING OF A
LIQUID
]22[
]31[
]51[
]71[
]87[
]74[
03.07.2003
02015461.3
]32[ 12.07.2002
Int. Cl.(2008.04) A47J 31/54
NESTEC S.A., SWITZERLAND
WO/2004/006742
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
[57] A device (5) for the heating of a
liquid in a beverage machine comprising: a
tube or flat base arranged so that liquid can
traverse it for being heated, a first
individual resistor (R1) placed on a portion
of the tube or flat base to heat liquid at a
first temperature, a set of at least two
resistors (R2, R3) is placed on a portion of
the tube or flat base to heat the liquid from
said first temperature to a final desired
temperature, wherein said set of at least
165297
‫מתקן עבור החימום של נוזל‬
]33[
EP
,‫ד"ר יצחק הס ושותפיו‬
‫ תל אביב‬,6451 .‫ד‬.‫ ת‬, 279 ‫רחוב הירקון‬
two resistors is electrically linked together
so that one resistor can be empowered
either individually or in serial mounting
with one or more of the resistors (R3) of
the same set, and wherein the first
individual resistor can be empowered
either individually or in parallel mounting
with one resistor of said set of resistors or
in parallel mounting with a serial mounting
of said set of resistors.
__________
]11[]21[
September 22, 2009
–‫ד' בתשרי התש"ע‬
165667
373
]54[
AIRCRAFT DE-ICING SYSTEM
]22[
]51[
]62[
]71[
30.07.1999
Int. Cl.(2008.04) B64D 15/12
DIVISION FROM 146852
NORTHCOAST TECHNOLOGIES,
U.S.A.
WO/2001/008463
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
[57] A heat-conducting tape having a
length and comprising at least two layers
laminated to each other under heat and
pressure, the layers comprising (i) an outer
heat-conducting layer (130) that is an
electrical insulator, and (ii) a non-metallic
electrical and heat-conducting layer (120),
the non-metallic electrical and heatconducting layer consisting of a
continuous flexible expanded graphite foil
‫מערכת הפשרה למטוס‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
sheet and having a first area (122) along
the length of the tape comprising a first
thickness, and a second area (123, 124)
disposed on a side of the first area along
the length of the tape comprising a second
thickness, wherein the thickness of the
flexible expanded graphite foil sheet in the
first area is greater than the thickness of
the foil sheet in the second area.
__________
]11[]21[
374
165981
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫התקן לבדיקת נגישה ושיטת שימושה‬
]54[
ACCESSIBLE ASSAY DEVICE
AND METHOD OF USE
]22[
]31[
09.06.2003
60/398758
]32[ 26.07.2002
10/422336
24.08.2003
Int. Cl.(2008.04) G01N 335/58
QUANTUM DESIGN, INC., U.S.A.
WO/2004/001194
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]71[
]87[
]74[
]33[
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
[57] A lateral flow assay test device for
detection of target analytes in a sample,
said device comprising: a housing member
(30) shaped and configured to have two
arms connected by a spanning portion,
thereby generally forming an open space
between the two arms, the housing also
having an interior space exposed on one
side of the housing; a cover element (39)
shaped and configured to enclose the
interior space of the housing member; at
least one analytical test strip (10) having
first and second ends and being positioned
between the two arms, the strip also being
at least partially sandwiched between the
housing member and the cover element,
the strip comprising: a base member (24);
an analytical membrane (18) having a first
end and a second end; a conjugate pad (11)
at the first end of the analytical membrane;
and at least one capture region (15) in the
analytical membrane intermediate said first
and second ends thereof, said capture
region being configured to capture labeled
analytes moving from said first end of said
analytical membrane toward said second
end of said analytical membrane; the open
space in the housing member being shaped
and configured to provide lateral access to
the test strip and to enable the
determination of the presence of target
analytes in the capture region of the test
strip while the test strip remains mounted
to the housing.
__________
]11[]21[
]54[
METHOD FOR THE PREPARATION
OF AEROGELS
September 22, 2009
–‫ד' בתשרי התש"ע‬
166212
‫שיטה להכנת אירוג'לים‬
375
]22[
]31[
]51[
]71[
]87[
]74[
24.06.2003
NO2002A000010 ]32[ 12.07.2002
]33[
Int. Cl.(2008.04) B01J 13/00, C01B 331/58
NOVARA TECHNOLOGY S.R.L.,
ITALY
WO/2004/007368
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57] A process for the preparation of
aerogels comprising,
(a) exchanging the liquid phase of an
aquagel with xenon liquid to form a
xenongel; and
IT
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
(b) extracting xenon from the xenongel of
step (a) under hypercritical or supercritical
drying conditions of xenon; and
(c) optionally, recovering xenon from step
(b).
__________
]11[]21[
]54[
INDEX TAB SYSTEM
]22[
]31[
]51[
]71[
]72[
18.01.2005
10/231926
]32[ 29.08.2002
Int. Cl.(2008.04) B42F 13/00
ESSELTE CORPORATION, U.S.A.
MICHAEL SLATTERY, JAMES
LYNCH, ROCHELLE NARUP
WO/2004/020219
WEBB & ASSOCIATES,
2 PEKERIS ST., P.O.B. 2189,
REHOVOT 76121
]87[
]74[
[57] An index tab system comprising a
strip of resilient plastic film providing a
plurality of tab-forming structures each of
which is capable of providing an index tab
member, wherein said strip of plastic film
is attachable to an object that is in need of
such index tabs wherein each said tab
376
166369
‫מערכת תוויות לקטלוג‬
]33[
US
,'‫ד"ר וב ושות‬
‫ רחובות‬,2189 .‫ד‬.‫ ת‬, 2 ‫רח' פקריס‬
forming tab structure includes first
interlocking means for forming the index
tab member, and second interlocking
means for forming a tab cavity that is
capable of receiving an informational
insert.
September 22, 2009
–‫ד' בתשרי התש"ע‬
__________
]11[]21[
166739
‫פורמולציות של פוליתיאופן לשיפור‬
‫דיודות אורגניות הפולטות אור‬
]54[
POLYTHIOPHENE
FORMULATIONS FOR IMPROVING
ORGANIC LIGHT-EMITTING
DIODES
]22[
]31[
08.02.2005
102004006583.7 ]32[ 10.02.2004
]33[
102004010811.0
05.03.2004
Int. Cl.(2008.04) C08L 65/00, H01L 51/30
H.C. STARCK GMBH, GERMANY
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]74[
DE
DE
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
[57] Formulation comprising
(A) at least one polythiophene containing
recurring units of the formula
wherein
A represents an optionally substituted C1C5-alkylene radical, in particular an
optionally substituted ethylene or
propylene radical, R represents a linear or
branched C1-C18-alkyl radical, a C5-C12cycloalkyl radical, a C6-C14-aryl radical, a
C7-C18-aralkyl radical, a C1-C4hydroxyalkyl radical or a hydroxyl radical,
x represents an integer from 0 to 8 and in
the case where several radicals R are
bonded to A, these can be identical or
different,
(B) at least one polymer containing SO3M+ or COO-M+ groups, wherein M+
represents H+, Li+, Na+ K+, Rb+, Cs+ or
NH4+, in particular H+, Na+ or K+ and
September 22, 2009
–‫ד' בתשרי התש"ע‬
377
(C) at lest one partly fluorinated or
perfluorinated polymer containing SO3-M+
groups, wherein M+ represents H+, Li+,
Na+ K+, Rb+, Cs+ or NH4+, in particular H+,
Na+ or K+.
__________
]11[]21[
]54[
FLUID CONTROL DEVICE
]22[
]31[
]51[
]71[
]87[
]74[
22.08.2003
2002-256617 ]32[ 02.09.2002
Int. Cl.(2008.04) F16K 311/22
FUJIKIN INCORPORATED, JAPAN
WO/2004/023011
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] A fluid control device (1)
comprising a valve case (2) having a fluid
inlet (2a) and outlet (2b) channels, a valve
element holder (5) upwardly or
downwardly movable for opening or
closing the fluid channel, a lower casing
(7) provided on an upper portion of the
valve case, an upper casing (8) joined to
the lower casing, a valve stem (9) disposed
in a space defined by the upper and lower
casings and having a lower end in bearing
contact with the valve element holder and
a piston (10) secured to the valve stem, an
upper space being formed between and
378
166866
‫התקן לבקרת ניגרים‬
]33[
JP
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
defined by an upper surface of the piston
and a lower surface of a top wall (8a) of
the upper casing, a lower space (S2) being
formed between and defined by a lower
surface of the piston and an upper surface
of a bottom wall (7a) of the lower casing,
the fluid control device being characterized
in that a compression coil spring (11) is
provided in one of the upper space and the
lower space for biasing the piston, a
compressed air admitting passageway
being in communication with the other of
the upper and lower spaces.
September 22, 2009
–‫ד' בתשרי התש"ע‬
__________
]11[]21[
]54[
PROCESS OF SCREENING
LIBRARIES OF SMALL ORGANIC
COMPOUNDS
]22[
]31[
]51[
]71[
15.02.2005
105372
]32[ 26.06.1998
Int. Cl.(2008.04) G01N 33/53
SUNESIS PHARMACEUTICALS,
INC., U.S.A.
WO/2000/000823
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
[57] A process comprising:
(a) screening a library of small organic
compounds, less than about 2000 daltons
in size, with a target protein-ligand
conjugate formed by the covalent bonding
of a target protein comprising a first
reactive functionality with a ligand that (1)
comprises less than about 20 carbon
atoms; (2) has affinity for interacting with
a particular site on the target protein, (3)
comprises a second reactive functionality
September 22, 2009
–‫ד' בתשרי התש"ע‬
166892
‫תהליך לסריקת ספריות של מולקולות‬
‫אורגניות קטנות‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
and (4) comprises a free chemically
reactive group, wherein the second
reactive functionally of the ligand reacts
with the first reactive functionality of the
target protein to form a first covalent bond
such that the ligand in the target proteinligand conjugate contains a free chemically
reactive group, in aqueous solution, under
conditions wherein at least one member of
the library forms a second covalent bond
379
with said free chemically reactive group in
the target protein-ligand conjugate, and
(b) determining the identity of a small
organic compound that binds covalently to
the free chemically reactive group of the
target protein-ligand conjugate.
__________
]11[]21[
]54[
FLUID CONDITION MONITOR
]22[
]31[
]51[
]71[
]87[
]74[
22.09.2003
10/260754
]32[ 30.09.2002
Int. Cl.(2008.04) G01N 33/28
UNIVERSITY OF DAYTON, U.S.A.
WO/2004/031764
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] A sensor device (10) for monitoring
the condition of a fluid comprising: a
member (12); a plurality of liquid sensors
(20) provided at various lengths along said
member and each comprising at least two
wires or wire rods (22, 23, 24, 26) for
measuring liquid parameters of the fluid,
said at least two wires or wire rods are
adapted to be electrically connected to one
another by the fluid when said at least two
wires or wire rods are immersed in and in
contact with the fluid to complete an
electrical circuit such that in use current
passes between said at least two wires or
wire rods through the fluid in order to
380
167479
‫משגוח מצב ניגרים‬
]33[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
monitor the condition of the fluid, and a
plurality of vapor sensors (30) in contact
with vapors of the fluid for measuring
vapor parameters of the fluid coupled to
said member, at least one of said plurality
of vapor sensors comprising conductive
surfaces (27) adapted to be electrically
connected to one another by vapor of the
fluid such that in use current passes
between said conductive surfaces through
the vapor, wherein said plurality of liquid
sensors and plurality of vapor sensors are
positioned a distance from one another so
that said plurality of vapor sensors do not
contact a liquid of the fluid.
September 22, 2009
–‫ד' בתשרי התש"ע‬
__________
]11[]21[
]54[
METHOD AND SYSTEM FOR
DETERMINING THE RATE OF
NON UNIFORMITY OF
BOLOMETER BASED SYSTEMS
]22[
]51[
]71[
24.03.2005
Int. Cl.(2008.04) G01J 5/20
SEMI-CONDUCTOR DEVICES - AN
ELBIT SYSTEMS - RAFAEL
PARTNERSHIP
UDI MIZRAHI, AVRAHAM
FRAENKEL, ZVI KOPOLOVICH,
AMNON ADIN, LEONID BIKOV
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]72[
]74[
[57] A focal plan array system of the
bolometer type having means for
determining the rate of non uniformity,
which comprises:
(a) an array of i x j pixel detectors of the
bolometer type for sensing scenery
radiation;
September 22, 2009
–‫ד' בתשרי התש"ע‬
167637
‫שיטה ומערכת לקביעת שיעור אי האחידות‬
‫של מערכות המבוססות על בלומטר‬
‫ שותפות אלביט‬- ‫התקני מצב מוצק‬
‫ חיפה‬,‫ רפא"ל‬- ‫מערכות‬
,‫ צבי קופולוביץ‬,‫ אברהם פרנקל‬,‫אודי מזרחי‬
‫ לאוניד ביקוב‬,‫אמנון עדין‬
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
(b) a case which accommodates said array
of detectors, said case (13) having a front
window (15) that provides exposure to the
sensing element of all the i x j pixel
detectors to radiation coming from the
scenery;
(c) at least a portion of column j + 1 of
blind detectors (Rr) that are shielded from
381
the scenery by a homogeneous reference
surface (14);
(d) reading circuitry for reading indication
for the scenery radiation as sensed by each
of i x j detectors of the array, and for
reading indication for the non uniformity
as sensed by said detectors in column
(j+1);
(e) a register (16) for recording the
radiation values as read from all the
detectors within column (j+1); and
(f) a processing unit for finding the
standard deviation б of all the values in
said register, and for comparing the same
to a predetermined threshold Q, wherein a
standard deviation above Q being an
indication for a non uniformity above the
allowed level.
__________
]11[]21[
]54[
COMMUNICATION INTERFACE
FOR DIAGNOSTIC CIRCUITS OF
AN INTEGRATED CIRCUIT
]22[
]31[
]51[
]71[
]87[
]74[
17.09.2003
10/417330
]32[ 17.04.2003
Int. Cl.(2008.04) G01R 313/185
ARM LIMITED, UNITED KINGDOM
WO/2004/095041
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
382
167671
‫ממשק תקשורת למעגלים דיאגונוסטיים‬
‫של מעגל משולב‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
[57] An integrated circuit (2) for
processing data, said integrated circuit
comprising: a functional circuit (10, 12,
14, 16) operable to perform data
processing operations; a diagnostic circuit
(8) operable to perform diagnostic
operations upon said functional circuit; and
an interface circuit (16) operable to
provide communication between said
diagnostic circuit and an external
diagnostic device (4); wherein said
interface circuit is configured to use a bidirectional line carrying a bi-directional
serial signal to transfer:
(i) control signals from said external
diagnostic device to said diagnostic circuit
to control said diagnostic operations of
said diagnostic circuit; and
(ii) diagnostic data between said external
diagnostic device and said diagnostic
circuit.
__________
]11[]21[
]54[
METHOD FOR THE
MANUFACTURE OF A BABY
FEEDING BOTTLE BEING
PROVIDED WITH A ONE-WAY
VALVE
]22[
]51[
]71[
]74[
29.03.2005
Int. Cl.(2008.04) A61J 9/04
HISENSE LIMITED
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
[57] A method for the manufacture of a
baby feeding bottle (1) being provided
with a one-way valve (hereinafter: "valve")
which valve carries at its end a tail (11)
said bottle having an opening at the top
through which said valve is inserted by any
suitable inserting means, which valve is
inserted up to the end through a small
round opening having a suitable size
September 22, 2009
–‫ד' בתשרי התש"ע‬
167726
‫שיטה עבור הייצור של בקבוק האכלה‬
‫לתינוק המצוייד בשסתום חד–כיווני‬
‫לציון‬-‫ ראשון‬,‫היסנס בע"מ‬
,‫ד"ר יצחק הס ושותפיו‬
‫ תל אביב‬,6451 .‫ד‬.‫ ת‬, 279 ‫רחוב הירקון‬
corresponding to the groove of the valve
being located at the bottom of said bottle,
through which round opening the valve is
pulled by any suitable pulling means inside
the bottle until the bottom of the bottle is
closed hermetically by the valve, finally
the tail of the valve being cut off by any
cutting means (13).
383
__________
]11[]21[
167781
11 ‫נגזרות הידרוקסי–פניל–אלקאן בעל‬
‫ תהליך לייצורן ותכשירים‬,‫פחמנים‬
‫רפואיים המכילים אותן‬
]54[
HYDROXYPHENYLUNDECANE
DERIVATIVES, A PROCESS FOR
THEIR PRODUCTION AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM
]22[
]31[
]51[
]71[
18.09.2003
02022095.0
]32[ 02.10.2002
]33[ EP
Int. Cl.(2008.04) A61K 312/35, A61P 25/00, C07C 305/24, 69/00, 69/88
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2004/031123
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬
HERZLIYA 46733
]87[
]74[
[57] A compound of the formula
wherein
R1 and R2 are independently H or SO3H,
and/or a physiologically tolerated salt
thereof.
__________
384
September 22, 2009
–‫ד' בתשרי התש"ע‬
]11[]21[
]54[
FUEL NOZZLE FOR A FOSSIL
FUEL FIRED COMBUSTION
ARRANGEMENT
]22[
]31[
]51[
]71[
20.04.2005
829878
]32[ 22.04.2004
Int. Cl.(2008.04) F23D 1/00
ALSTOM TECHNOLOGY LTD.,
SWITZERLAND
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
[57] An apparatus (210) for pivotally
mounting one side of a coal nozzle tip
(212) of a coal nozzle (208) operable in a
pulverized solid fuel-fired furnace to a coal
nozzle body (214) of the coal nozzle, the
one side of the coal nozzle tip having a
through hole (216) therethrough and the
coal nozzle tip and the coal nozzle body
being mounted relative to one another such
that the one side of the coal nozzle tip is
outward of the coal nozzle body, the
apparatus comprising: a latch
interconnecting assembly (220) including:
a pin (222) for insertion in a traversing
movement along an insertion axis (IAX)
through both the through hole of the coal
nozzle tip and a correspondingly aligned
pivot support hole (218) of the coal nozzle
body, the pin having a traverse end (226)
and an inside end (228) with the traverse
end of the pin being inserted during the
traversing movement initially through the
pivot support hole of the coal nozzle body
and thereafter through the through hole of
the one side of the coal nozzle tip,
whereupon, in the fully inserted position of
the pin, the traverse end of the pin is
September 22, 2009
–‫ד' בתשרי התש"ע‬
168162
‫פי צינור דלק עבור התקן לשריפת דלק‬
‫מאובנים‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
outward of the one side of the coal nozzle
body and the inside end of the pin is
inward of the coal nozzle body; and an
engagement element (232) for resisting a
withdrawal movement of the pin in a
direction opposite to its traversing
movement, the engagement element being
reversibly movable between a deployed
position in which the engagement element
engages the pin to resist withdrawal
movement of the pin in a direction
opposite to its traversing movement and a
non-deployed position in which resistance
of withdrawal movement of the pin by the
engagement element is insufficient to
prevent withdrawal of the pin from the
through hole of the coal nozzle tip, the
path of movement of the engagement
element between its deployed position and
its non-deployed position being such that,
throughout such movement of the
engagement element, the path of
movement of the engagement element can
be intersected by a radial plane passing
through the pin perpendicular to the
insertion axis.
385
__________
]11[]21[
]54[
METHOD AND DEVICE FOR
MANUFACTURING A DRILL
BLANK OR A MILL BLANK
]22[
]31[
]51[
]71[
21.04.2005
0401150-8
]32[ 04.05.2004
Int. Cl.(2008.04) B21C 23/14
SANDVIK INTELLECTUAL
PROPERTY AB, SWEDEN
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]74[
[57] Method for manufacturing a drill
blank or a mill blank by extrusion, said
method comprising the forming of a first
blank portion (B1) having external, axially
extending external flutes and the forming
of a further blank portion (B3) in the shape
of a shaft, characterized in the following
steps:
(1) extruding a first blank portion having a
free end and external flutes;
(2) allowing the extrusion to continue in
order to enter the free end and an adjacent
portion of the first blank portion into a
cavity and sealing said cavity in the area of
the free end of the first blank portion;
(3) allowing the extrusion to continue to
supply further extruding mass to the
386
168169
‫שיטה והתקן לייצור גולם למקדח וגולם‬
‫לכרסום‬
]33[
SE
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
cavity, said supply of extruding mass
completely filling out the external flutes of
the first blank portion to produce a second
blank portion integral with the first blank
portion;
(4) allowing the extrusion to continue and
the sealing to terminate in order to allow
the second blank portion to be pushed out
of the cavity;
(5) allowing the extrusion to continue to
produce a desired length of the first blank
portion; and
(6) cutting off the first blank portion at the
end facing away from the second blank
portion.
September 22, 2009
–‫ד' בתשרי התש"ע‬
__________
]11[]21[
168238
‫ תהליך לייצורו וחומר‬,‫מוצר ביולוגי משופר‬
‫ביניים‬
]54[
MODIFLED BIOLOGICAL
SUBSTANCE, PROCESS FOR
PRODUCING THE SAME AND
INTERMEDIATE
]22[
]31[
]51[
]71[
]87[
]74[
20.11.2003
2002-337113 ]32[ 20.11.2002
]33[ JP
Int. Cl.(2008.04) A61K 38/43, 47/48, C08G 2/00, 65/32
NOF CORPORATION, JAPAN
WO/2004/046222
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57] A compound of the formula
wherein R is a hydrocarbon group having 1
to 24 carbon atoms, the different R groups
in the compound being the same or
different from each other; OA2 is an
oxyalkylene group having 2 to 4 carbon
atoms, the different OA2 groups in the
compound being the same or different
from each other, m, which is the average
number of moles of oxyalkylene groups, is
10 to 1000; and X is a moiety selected
from Group (l) or Group (ll):
group (I)
September 22, 2009
–‫ד' בתשרי התש"ע‬
387
Group (ll) –Z-NH2(g)-NH2 (j)-Z-COOH
(k)
wherein Y represents a hydrocarbon group
having 1 to 10 carbon atoms which may
contain fluorine atom(s), and Z is selected
from the following (zl)-(z6):
,194501
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
_________
]11[]21[
]54[
PLASMA TORCH FOR USE IN A
WASTE PROCESSING
CHAMBER
]22[
]51[
]71[
28.04.2005
Int. Cl.(2008.04) F23G 5/00, 7/00
E.E.R. ENVIRONMENTAL
ENERGY RESOURCES (ISRAEL)
LTD.
VALERI G. GNEDENKO, DAVID
PEGAZ, ALEXANDER L. SURIS
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]72[
]74[
388
168286
‫לפיד פלזמה לשימוש במערכת לעיבוד‬
‫פסולת‬
‫אר החברה למשאבי סביבה ואנרגיה‬.‫אי‬.‫אי‬
‫ גן‬- ‫ רמת‬,‫(ישראל) בע"מ‬
‫ סוריס‬.‫ אלקסנדר ל‬,‫ דוד פגץ‬,‫ גנדנקו‬.‫ולרי ג‬
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
[57] A plasma torch (140) for insertion
through an opening (11) in a wall of a
waste processing chamber (10), said
processing chamber having at least one
liquid outlet (20) at a lower part thereof,
for removing molten material, said plasma
torch comprising a body having a front end
(143), a rear end (145), a longitudinal outer
surface (141), an outlet through which the
high temperature plasma jet (39) exits and
a heat protecting ring (21), both located at
said front end; said plasma torch
characterized by comprising a coaxial
sleeve (52), said sleeve surrounding at
least a portion (56) of said outer surface of
said torch that is located in said opening in
said wall, thereby forming an insulating
chamber (54) between said outer surface of
said torch and the inner surface of said
sleeve; wherein at least a part of said
portion of said coaxial sleeve that
surrounds at least said portion of said outer
surface of said torch that is located in said
opening in said wall is porous or
permeable to a heat exchanging fluid, said
torch comprising an inlet for introducing
said heat exchanging fluid into said
insulating chamber.
__________
]11[]21[
168345
‫שימוש בבנזופיראנים בהכנת תרופה‬
‫להמרצת גידול שיער‬
]54[
USE OF BONZOPYRANS IN THE
MANUFACTURE OF
MEDICAMENTS FOR
STIMULATING HAIR GROWTH
]22[
]31[
]51[
]71[
03.11.2003
60/425686
]32[ 12.11.2002
]33[ US
Int. Cl.(2008.04) A61K 313/53, 315/01, A61P 17/14, C07D 311/00, 405/12
WARNER-LAMBERT COMPANY
LLC, U.S.A.
WO/2004/043424
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
[57] Use of (3S, 4R)-3,4-dihydro-4-(2,3dihydro-2-methyl -3-oxopyridazin-6-yl)
September 22, 2009
–‫ד' בתשרי התש"ע‬
oxy-3-hydroxy-6-(3-hydroxyphenyl)
sulphonyl 1-2,2,3-trimethyl-2H-benzo[b]
389
pyran, or pharmaceutically acceptable salt
thereof, in the manufacture of a
medicament for an alopecia selected from
the group consisting of alopecia areata,
hair loss secondary to chemotherapy or
radiation treatment, stress-related hair loss,
self-induced hair loss, and scarring
alopecia.
__________
]11[]21[
]54[
COMPOSITE SACRIFICIAL
ANODES
]22[
]31[
14.11.2003
0226706.0
]32[ 15.11.2002
0310021.1
01.05.2003
Int. Cl.(2008.04) C23F 13/10
MAGNESIUM ELEKTRON
LIMITED, UNITED KINGDOM
WO/2004/046422
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]71[
]87[
]74[
[57] A composite sacrificial anode (10)
for immersion in a corrosive environment
comprising a plurality of castings of a
sacrificial material each disposed around a
corresponding electrical connector for
attachment to a structure to be protected, a
part of the surface of each casting being
protected from corrosion by the
168557
‫אנודות של הקרבה מחומר מורכב‬
]33[
GB
GB
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
environment by being adjacent to at least
one other casting, wherein the castings are
connected electrically together only via
their respective electrical connectors,
wherein the composite anode has a weight
greater than 10 kg and wherein the castings
are joined together by a waterproof mastic
or resin.
__________
390
September 22, 2009
–‫ד' בתשרי התש"ע‬
]11[]21[
]54[
THERMAL INK JET PRINTHEAD
WITH SYMMETRIC BUBBLE
FORMATION
]22[
]31[
]51[
]71[
17.11.2003
10/303433
]32[ 23.11.2003
Int. Cl.(2008.04) B41J 2/05
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2004/048109
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
[57] An ink jet printhead comprising: a
plurality of nozzles (3); and at least one
respective heater element (10)
corresponding to each nozzle, wherein
each heater element is arranged for being
in thermal contact with a bubble forming
liquid, each heater element is configured to
heat at least part of the bubble forming
liquid to a temperature above its boiling
168609
‫ראש מדפסת הזרקת דיו תרמי עם תבנית‬
‫בועה סימטרית‬
]33[
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
point to form a gas bubble therein thereby
to cause the ejection of a drop of an
ejectable liquid through the nozzle
corresponding to that heater element, and
each heater element has two opposite sides
and is configured such that a gas bubble
formed by that heater element is formed at
both of said sides.
__________
]11[]21[
September 22, 2009
–‫ד' בתשרי התש"ע‬
168657
391
]54[
SENSOR SYSTEM AND METHOD
FOR SENSING IN AN ELEVATEDTEMPERATURE ENVIRONMENT,
WITH PROTECTION AGAINST
EXTERNAL HEATING
]22[
]31[
]51[
]71[
]87[
]74[
30.04.2004
10/427408
]32[ 30.04.2003
Int. Cl.(2008.04) G01J 5/04, G01K 1/08
RAYTHEON COMPANY, U.S.A.
WO/2004/099743
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57] A sensor system (22) comprising a
structure affixed to an aircraft (20) in a
forward facing orientation, wherein the
structure affixed to the aircraft includes: a
sensor housing (30) having an exterior
wall (32) with a window-support region
(34) having an outwardly facing external
face (36), wherein the window-support
region of the exterior wall comprises a
segment of a mounting flange (42) adapted
to attach the remainder of the sensor unit
(44) to the aircraft, and a window (40)
through the window-support region of the
exterior wall and affixed to the exterior
392
‫מערכת חיישן ושיטות חישה של סביבה‬
‫עם טמפרטורות גבוהות והגנה כנגד חימום‬
‫חיצוני‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
wall; a sensor unit contained within the
sensor housing and receiving an input
signal (26) through the window, wherein
the sensor unit comprises an infrared
sensor (46), and a cryocooler (48) that
cools the sensor; and a thermal-insulation
layer (50) affixed to the external face of
the window-support region of the exterior
wall at a location immediately adjacent to
the window, wherein the thermalinsulation layer is a stand-alone piece of an
insulating material affixed to the external
face of the window-support region with an
adhesive layer.
September 22, 2009
–‫ד' בתשרי התש"ע‬
__________
]11[]21[
‫וורה‬-‫כפפה שטופלה עם קמומיל או אלו‬
]54[
CAMOMILE/ALOE VERA
TREATED GLOVE
]22[
]31[
]51[
]71[
08.12.2003
10/321897
]32[ 17.11.2002
Int. Cl.(2008.04) A01N 25/34
ANSELL HEALTHCARE PRODUCTS
LLC, U.S.A.
WO/2004/060064
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
168841
[57] A treated glove comprising cured
material and a moist film on the interior
surface of the cured material, the film
comprising water, glycerol, and a botanical
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
extract; wherein the water is present in an
amount ranging from about 30 mg to about
90 mg per glove.
__________
September 22, 2009
–‫ד' בתשרי התש"ע‬
393
]11[]21[
]54[
AREAL METAL ELEMENT AND
PROFILE ELEMENT
]22[
]31[
]51[
]71[
25.11.2003
10259307.8
]32[ 18.12.2002
Int. Cl.(2008.04) E04C 2/08, 2/42, 3/08
PROTEKTORWERK FLORENZ
MAISCH GMBH & CO. KG,
GERMANY
WO/2004/055289
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]87[
]74[
[57] An areal metal element having a
surface (13) which extends from a first
outside edge (8) to a second outside edge
(9) lying opposite the first outside edge,
with the region of the metal element
adjoining the first outside edge forming a
first side region (26) and the region of the
metal element adjoining the second outer
edge forming a second side region (27),
both said side regions being connected to
one another by a central region (28) lying
between them, and with at least one
completely bordered aperture (22, 23)
being formed in at least one of the side
regions with its border being formed in one
part by said side region and in the other
part by the central region, with the central
region including at least two sections (29,
30) which each consist of two outwardly
disposed part sections (31, 33, 34, 36) and
a central part section (32, 35) lying
between them, with the outwardly
394
168923
‫אלמנט מתכת איזורי ופרופיל אלמנט‬
]33[
DE
,‫פרל כהן צדק לצר‬
,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬
disposed part sections being folded over
with respect to the central part section for
the production of the aperture, with the
sections forming part of the border of the
aperture, and with the central region,
including the sections, being made in one
piece with the two side regions of the
metal element, characterized in that, in the
central region, at least one further section
is formed for each section and is associated
with and of the same type as this section,
with the sections associated with one
another being arranged sequentially in a
direction from the first side region to the
second side region and with each of the
two outwardly disposed part sections of
one of these sections being directly
connected to the respective corresponding
outwardly disposed part section of the
other section by an areal region (24, 25) of
the metal element.
September 22, 2009
–‫ד' בתשרי התש"ע‬
__________
]11[]21[
]54[
HIP PROSTHESIS COMPRISING A
SHAFT TO BE FIXED IN THE
MEDULLARY CANAL OF THE
FEMUR
]22[
]31[
14.01.2004
03001040.9
]32[ 17.01.2003
03016156.6
16.07.2003
Int. Cl.(2008.04) A61F 2/36
WALDEMAR LINK GMBH & CO.
KG, GERMANY
WO/2004/064688
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
[57] A hip prosthesis with a shaft (1) to
be anchored in the medullary canal of the
femur, of which the distal portion (7)
configured to be anchored in a diaphysis
has a core cross-section which tapers
toward a distal end (11) and which has
longitudinal ribs (16) at least on a lateral
side and a medial side whose height
increases from a proximal portion of the
shaft to a distal end portion of the shaft,
characterized in that the shaft core cross-
September 22, 2009
–‫ד' בתשרי התש"ע‬
169353
‫ירך תותבת המכילה מוט לקיבוע בתעלה‬
‫לשדית של עצם הירך‬
]33[
EP
EP
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
section at a distance of 1 cm from the
distal end portion has substantially
rectangular boundary with an axis ratio of
at least 1.5 to 1 and, at least near a distal
end thereof has a rib on each of its two
lateral edges, the height of which is on
average under 2 mm, the boundary of the
shaft core cross-section between the two
ribs located on the lateral edges not
protruding further laterally than the ribs.
395
__________
]11[]21[
]54[
SLANTED KEY COMBINATION
ELEMENT IN KEY BLANK AND
KEY
]22[
]51[
]71[
23.06.2005
Int. Cl.(2008.04) E05B 19/08, 35/00
MUL-T-LOCK TECHNOLOGIES
LTD.
SHLOMO AVITAL
DEKEL PATENT LTD.,
18 MENUHA VENAHALA ST.,
REHOVOT 76209
]72[
]74[
[57] A key blank (10) comprising: a
generally elongate shaft portion (12)
defining first and second generally flat
oppositely directed side surfaces (14, 16)
joined by edge surfaces (18), at least one
of said first and second side surfaces
cuttable to form key cuts (20) that define a
key combination surface, said shaft portion
having a longitudinal axis (13) that extends
along a length thereof and a transverse axis
396
169371
‫אלמנט צירוף מפתח באלכסון בגלם מפתח‬
‫ובמפתח‬
‫ יבנה‬,‫מולטילוק טכנולוגיות בע"מ‬
‫שלמה אביטל‬
,‫דקל פטנט בע"מ‬
‫ רחובות‬,27 ‫חדר‬, 18 ‫מנוחה ונחלה‬
(15) that extends along a width thereof;
and at least one key combination element
(26) movably disposed in the elongate
shaft portion and adapted for touching a
lock combination element (54) disposed in
a cylinder lock plug (46), characterized by
said at least one key combination element
comprising a resilient arm (28) disposed in
a recess (30) formed in said elongate shaft
portion, said resilient arm and recess being
September 22, 2009
–‫ד' בתשרי התש"ע‬
slanted at a non-zero angle with respect to
both longitudinal and transverse axes of
said shaft portion.
__________
]11[]21[
]54[
TOOL GUIDING DEVICE
]22[
]31[
]51[
]71[
]87[
]74[
05.01.2004
10300722.9
]32[ 11.01.2003
Int. Cl.(2008.04) B30B 15/06
JOHANN ANDERL, GERMANY
WO/2004/062901
HENRY SINAI,
P.O.B. 669, RAANANA
[57] A tool guiding device with a base
frame (1) and guide rails (2) which are
parallel relative to each other arranged on
the base frame and at least one carriage (3,
4) having a processing tool (13, 14)
displaceably linearly guided via a carriage
connector (10, 11) by a drive mechanism,
the tool guiding device comprising: the
carriage coupled to the carriage connectors
via at least one compensating device
having at least one angle compensation
element and at least one lateral
compensation element; the angle
compensation element comprising a ball
element or a ball section element rigidly
September 22, 2009
–‫ד' בתשרי התש"ע‬
169432
‫מכשיר לכיוונון כלי עבודה‬
]33[
DE
,‫הנרי סיני עו"פ‬
‫ רעננה‬,669 .‫ד‬.‫ת‬
connected with the carriage connector; the
at least one lateral compensation element
including an intermediate piece forming a
ball socket, wherein the angle
compensation element is seated in the ball
socket of the intermediate piece; the
intermediate piece either forming a further
ball socket on a side facing away from the
ball socket in which one of a further ball
element and a further ball section element
connected with the carriage is seated in an
articulated manner, or on the side facing
away from the ball socket the intermediate
piece is seated on a bearing that is
397
moveable transversely to a displacement
direction of the carriage.
__________
]11[]21[
]54[
CONVERSION OF SPECTRAL
COMPONENTS FOR ENCODING
AND LOW-COMPLEXITY
TRANSCODING
]22[
]31[
30.01.2004
60/445931
]32[ 06.02.2003
10/458798
09.06.2003
Int. Cl.(2008.04) G10L 19/14
DOLBY LABORATORIES
LICENSING CORPORATION, U.S.A.
WO/2004/072957
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]71[
]87[
]74[
[57] A method of processing an audio
signal comprising: receiving a signal
conveying initial scaled values and initial
scale factors representing spectral
components of the audio signal, wherein
each initial scale factor is associated with
398
169442
‫המרה של מרכיבים ספקטרליים מסונתזים‬
‫לקידוד וקידוד–טרנס ברמת סיבוך נמוכה‬
]33[
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
one or more initial scaled values, each
initial scaled value is scaled according to
its associated initial scale factor, and each
initial scaled value and associated initial
scale factor represent the value of a
respective spectral component; generating
September 22, 2009
–‫ד' בתשרי התש"ע‬
coded spectral information by performing
a coding process that is responsive to
initial spectral information that comprises
at least some of the initial scale factors;
deriving one or more first control
parameters in response to the initial scale
factors and a first bit-rate requirement;
allocating bits according to a first bit
allocation process in response to the one or
more first control parameters; obtaining
quantized scaled values by quantizing at
least some of the initial scaled values using
quantizing resolutions based on numbers
of bits allocated by the first bit allocation
process; deriving one or more second
control parameters in response to at least
some of the initial scale factors, one or
more modified scale factors and a second
bit-rate requirement, wherein the one or
more modified scale factors are obtained
by: analyzing the initial spectral
information with respect to a synthesis
process to be applied to the coded spectral
information in a decoding method that
generates synthesized spectral components
represented by synthesized scaled values
and associated synthesized scale factors to
identify one or more potentially
unnormalized synthesized scaled values,
wherein the synthesis process is quasiinverse to the coding process, and
generating the one or more modified scale
factors to represent modified values of
initial scale factors in the initial spectral
information corresponding to synthesized
scale factors that are associated with at
least some of the one or more potentially
unnormalized synthesized scaled values to
compensate for loss of normalization of
the identified potentially unnormalized
synthesized scaled values to compensate
for loss of normalization of the identified
potentially unnormalized synthesized
scaled values; and assembling encoded
information into an encoded signal,
wherein the encoded information
represents the quantized scaled values, at
least some of the initial scale factors, the
coded spectral information, the one or
more first control parameters and the one
or more second control parameters.
__________
September 22, 2009
–‫ד' בתשרי התש"ע‬
399
]11[]21[
169611
‫שסתום עבור מערכת ריקון בריק‬
]54[
VALVE FOR VACUUM
DISCHARGE SYSTEM
]22[
]31[
]51[
]71[
09.02.2004
2003-034762 ]32[ 13.02.2003
]33[
Int. Cl.(2008.04) F16K 27/00, 51/02, 7/12
TADAHIRO OHMI, JAPAN
FUJIKIN INCORPORATED, JAPAN
]87[
]74[
WO/2004/072519
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] A valve (1) in a vacuum exhaustion
system which comprises a body (2) having
a valve seat (8) formed on the bottom face
of a valve chamber (7) being in
communication with a flow-in passage (3)
and a flow-out passage (6), a valve body
permitted to rest on or move away from
the afore-mentioned valve seat, and a
driving means (4) operating to allow the
JP
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
afore-mentioned valve body to rest on or
move away from the valve seat such that
the fluid passage is closed or opened for
controlling the fluid by allowing the valve
body to rest on and move away from the
valve seat wherein aluminum passivation
is applied at least on the surfaces of the
body which come in contact with fluids.
__________
400
September 22, 2009
–‫ד' בתשרי התש"ע‬
]11[]21[
]54[
REWINDING MACHINE TO
PRODUCE LOGS OF WEB
MATERIAL AND RELATIVE
WINDING METHOD
]22[
]31[
]51[
]71[
]87[
]74[
09.02.2004
FI2003A000036 ]32[ 12.02.2003
Int. Cl.(2008.04) B65H 19/22, 35/08
FABIO PERINI S.P.A., ITALY
WO/2004/071914
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
[57] Rewinding machine (1) to produce
logs of web material comprising: a
winding cradle (7), an insertion member
(29) to insert a winding core (A) into said
winding cradle; an ejector to eject a log
formed in said winding cradle by causing
the log to roll on an unloading chute (41),
a severing device (53) to sever the web
material after the log is ejected from said
winding cradle; wherein disposed along
the unloading chute is an aperture (43)
elongated in a direction transverse to a
direction in which the log is unloaded
169898
‫מכונת גלילה ליצור גליל חומר ארוג‬
‫ושיטת גלילה בהתאם‬
]33[
IT
,‫פרל כהן צדק לצר‬
,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬
along said unloading chute; said severing
device comprises a movable element (55)
that is inserted into said aperture to cause
severing of the web material between the
winding cradle and the log of wound web
material, and a first glue container (45) is
disposed underneath said unloading chute
and wherein a first movable dispensing
member that collects glue from said first
glue container to apply the glue to the log
of wound web material is associated with
said first glue container.
__________
September 22, 2009
–‫ד' בתשרי התש"ע‬
401
]11[]21[
]54[
DISPENSER
]22[
]31[
]51[
]71[
20.02.2004
0304000.3
]32[ 21.02.2003
Int. Cl.(2008.04) A61M 15/00
CLINICAL DESIGNS LIMITED,
UNITED KINGDOM
WO/2004/073776
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
[57] A dispenser for dose dispensing of a
gaseous, gas borne or droplet substance
from a source (c) thereof, the dispenser
comprising: a body (1) with a mouthpiece;
a junction member in the body and having:
a socket for receiving a spout of the
substance source; a breath actuatable valve
(48) incorporated with the junction
member, for controlling the release of the
gas and/or liquid containing or comprising
the substance, the valve comprising: a
flexible tube for receiving a dose of the
said substance gas or liquid, the tube
extending from a valve inlet connected to
the junction member spout and having; a
portion which is kinkable for closure of the
valve and movable to a release position in
which the tube is un-kinked for opening of
the valve and an outlet end movable for
kinking/unkinking of the tube; and an
outlet member carrying the outlet end of
the flexible tube and pivotally connected to
the junction member for control of
kinking/un-kinking movement of the
flexible tube; the tube being kinked to an
402
169921
‫מכשיר לחלוקה‬
]33[
GB
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
obturating extent when the pivoted outlet
member is in a ready position and unkinked when the pivoted outlet member is
moved to its release position; and a sear on
the outlet member to hold it in the ready
position prior to inhalation, a breath
actuatable flap (61) carried on the junction
member and arranged for action of
inhalation breath on it, the flap having: a
latch complementary to the sear and the
flap being arranged: to latch the pivoted
outlet member for kinked closure of the
flexible tube via action of the latch and the
sear and to release the pivoted outlet
member for unkinking of the tube, and
substance release, on inhalation by release
of the sear by the latch and movement to
its release position of the outlet member,
characterised in that the source is a
pressurized medicament container with a
metered dose valve held in the body and in
that the junction member is slidably
mounted in the body for movement
towards the container and dispensing of a
dose to the valve via the junction member.
September 22, 2009
–‫ד' בתשרי התש"ע‬
__________
]11[]21[
]54[
SAFETY RAZORS
]22[
]31[
]51[
]71[
]87[
]74[
19.02.2004
0303865
]32[ 19.02.2003
Int. Cl.(2008.04) B26B 19/38, 21/40
THE GILLETTE COMPANY, U.S.A.
WO/2004/073936
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57] A safety razor comprising a blade
unit (2) carried on a handle (1), an
electrical arrangement including an
electrically operated device, and an
indicator (28), wherein the electrically
operated device is actuable by the
September 22, 2009
–‫ד' בתשרי התש"ע‬
169961
‫סכיני גילוח בטיחותיים‬
]33[
GB
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
electrical arrangement during shaving, and
the indicator produces a signal for
indicating to a razor user that the electrical
arrangement is connected to a source of
electrical power and ready for actuation of
the device.
403
__________
]11[]21[
170025
‫תולדות גואדין פולימרי בתצורת תרופה‬
‫סיטוסטתית‬
]54[
POLYMERIC GUANIDINE
DERIVATIVES AS A
CYTOSTATIC MEDICAMENT
]22[
]31[
]51[
]71[
22.01.2004
A 174/2003
]32[ 04.02.2003
]33[ AT
Int. Cl.(2008.04) A61K 311/55, A61P 35/00, C08G 73/02
GEOPHARMA
PRODUCKTIONSGMBH, AUSTRIA
WO/2004/069898
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬
HERZLIYA 46733
]87[
]74[
[57] The use of a polymeric guanidine
derivative based on a diamine containing
oxyalkylene chains between two amino
groups, with the guanidine derivative
representing a product of polycondensation
between a guanidine acid addition salt and
a diamine containing polyoxyalkylene
chains between two amino groups, as well
as the pharmaceutically acceptable salts
thereof, for the preparation of a
cytostatically active drug composition.
__________
404
September 22, 2009
–‫ד' בתשרי התש"ע‬
]11[]21[
170095
‫שיטה לשינוי מזהם הנמצא בתוך נוזל‬
]54[
METHOD OF ALTERING A
FLUID-BORNE CONTAMINANT
]22[
]31[
27.01.2004
60/445979
]32[ 07.02.2003
]33[ US
60/486507
11.07.2003
US
Int. Cl.(2008.04) A61L 2/00, 9/16, A62D 3/00
THE RESEARCH FOUNDATION OF
THE STATE UNIVERSITY OF NEW
YORK, U.S.A.
WO/2005/038428
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
‫ תל אביב‬,11490 .‫ד‬.‫ ת‬, 124 ‫אבן גבירול‬
P.O.B. 11490,
TEL AVIV 62038
]51[
]71[
]87[
]74[
[57] A method for killing at least 99.9%
of the anthrax spores in a fluid, comprising
the steps of:
(a) passing fluid containing anthrax spores
through one positive-displacement pump
or through multiple positive-displacement
pumps connected in series; and,
(b) operating the one positivedisplacement pump or multiple positive-
displacement pumps connected in series at
a pressure ratio or pressure ratios such that
the passage of the fluid containing anthrax
spores through the one positivedisplacement pump or through the multiple
positive-displacement pumps connected in
series kills at least 99.9% of the anthrax
spores in the fluid.
,197052
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
_________
September 22, 2009
–‫ד' בתשרי התש"ע‬
405
]11[]21[
170215
‫שיטה ומבנה למסננים וקדם מסננים‬
‫להארכת מחזור החיים של גופי המסננים‬
‫בתוכו‬
]54[
METHOD AND CONSTRUCTION
OF FILTERS AND PRE-FILTERS
FOR EXTENDING THE LIFE
CYCLE OF THE FILTER BODIES
THEREIN
]22[
]31[
]51[
]71[
04.02.2004
60/446440
]32[ 12.02.2003
]33[ US
Int. Cl.(2008.04) B01D 35/06, 43/00, B03C 3/12
GIDEON ROSENBERG
‫ קרית טבעון‬,‫גדעון רוזנברג‬
INNOVATIVE DEFENSE
TECHNOLOGIES LTD., U.S.A.
GIDEON ROSENBERG
‫גדעון רוזנברג‬
WO/2004/071613
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
,11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל אילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
]72[
]87[
]74[
[57] A method of operating a filter (10) to
remove solid particles from a fluid by
passing the fluid through a filter body (11)
having an upstream side and a downstream
side, characterized in applying to the fluid,
solely at the upstream side of the filter
body, an AC electrical field (15) of a
frequency and intensity to agglomerate
solid particles in the fluid before reaching
the upstream side of the filter body, such
as to reduce the number of small particles
in the fluid tending to clog the filter body
and thereby to extend the life cycle of the
filter body before cleaning or replacement
thereof is required.
__________
406
September 22, 2009
–‫ד' בתשרי התש"ע‬
]11[]21[
]54[
AUTOMATED COVERING FOR
AN AUTOMOBILE
]22[
]31[
]51[
]71[
]87[
]74[
30.01.2004
10/386914
]32[ 12.03.2003
Int. Cl.(2008.04) B60J 7/20
THOMAS C. RHEA, U.S.A.
WO/2004/080741
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] An automated device (10) for
covering the windows of a vehicle (14),
comprising: a collection container; a
plurality of extensions attached to the
collection container and positioned to be
substantially retained within and extended
from the collection container; a motor
attached to the collection container to
rotate the collection container, whereby
170346
‫כיסוי אוטומטי עבור כלי רכב‬
]33[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
rotation of the collection container extends
and retracts the plurality of extensions; a
covering (16) attached to the plurality of
extensions and sized to cover the windows
of the automobile; and a top (28) attached
to the collection container and positioned
to retain the covering when the plurality of
extensions are retracted.
__________
]11[]21[
September 22, 2009
–‫ד' בתשרי התש"ע‬
170493
407
‫תוית‬
]54[
LABEL
]22[
]31[
]51[
]71[
27.02.2004
2003900886
]32[ 27.02.2003
Int. Cl.(2009.01) G09F 03//10
GLOBAL APEEL LIMITED, UNITED
KINGDOM
WO/2004/077385
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
]87[
]74[
[57] A label for affixing to a container of
produce, the label including:- a front
portion (16) for carrying labeling indicia;
an adhesive backing (18) substantially
covering one side of the front portion; a
non-stick backing sheet (17, 19) affixed to
the adhesive backing, and a token (14); a
portion of the front portion constituting the
token and being readily severable from the
front portion when the label is affixed to
the container, a portion (24) of the backing
sheet being removable from the adhesive
]33[
AU
,‫ד"ר מרק פרידמן בע"מ‬
,7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
backing such that another portion (22) of
the backing sheet remains attached to the
token; wherein perforations (20) in the
front portion defining the token do not
extend into the backing sheet, and wherein
the backing sheet is cut through such that
the other portion of the backing sheet
which remains attached to the token is
smaller than the token, the adhesive
extending beyond the smaller other portion
of the backing sheet.
__________
]11[]21[
408
170497
September 22, 2009
–‫ד' בתשרי התש"ע‬
]54[
AIRPORT NAVIGATION LIGHT
UNIT AND SYSTEM
]22[
]31[
]51[
]71[
19.03.2004
03006362.2
]32[ 20.03.2003
Int. Cl.(2008.04) G08G 5/06
ADB AIRFIELD SOLUTIONS GMBH
& CO. KG, GERMANY
WO/2004/084154
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
[57] Airport navigation light unit (2)
comprising a base body in which
connection elements (8) are arranged for
connecting supply lines (3), a lighting
device (9), a sensor device (10), a
switching device (11) and a
communication device (12), wherein the
switching device and the communication
device are connected to the connection
elements, wherein the switching device
can be switched by the communication
device according to control signals (S)
which are transmitted via the supply lines
to the communication device so that the
‫מערכת ויחידת תאורה לניווט בשדה‬
‫תעופה‬
]33[
EP
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
lighting device can be switched on to the
connection elements by means of the
switching device, wherein a state
prevailing outside the airport navigation
light unit can be detected by means of the
sensor device and transmitted as a raw
signal (R) to the communication device,
wherein the raw signal (R) can be
evaluated by the communication device
and a useful signal (N) determined
therefrom fed to the supply lines, wherein
the control signals (S) and the useful signal
(N) can be transmitted as OFDM signals
via the supply lines.
__________
September 22, 2009
–‫ד' בתשרי התש"ע‬
409
]11[]21[
170575
‫שיטה להפסקת פעולת וחידוש פעולת‬
‫מודולות אבטחה‬
]54[
METHOD FOR DEACTIVATING
AND REACTIVATING SECURITY
MODULES
]22[
]31[
]51[
]71[
]87[
]74[
02.03.2004
00325/03
]32[ 03.03.2003
]33[
Int. Cl.(2008.04) G07F 7/10, H04N 7/16
NAGRACARD S.A., SWITZERLAND
WO/2004/079672
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] Method for deactivating and
reactivating security modules particularly
intended for access control to conditional
access data, the security module including
a plurality of registers containing values,
this process including a step of sending, by
an operator, at least one management
message (RUN-EMM) containing an
CH
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
executable code, said executable code
being loaded into a memory of the security
module and then executed, this method
being characterized in that its execution
modifies in a reversible way said values
contained in the registers, the content of
the registers after modification rendering
the module unusable.
__________
]11[]21[
]54[
PROCESS FOR THE
PRODUCTION OF AN
ELECTROLYTIC ELECTRODE
WITH A PLATINUM GROUP
METAL OXIDE COATING AND
ELECTRODES MADE
THEREFROM
]22[
]31[
]51[
]71[
10.12.2003
10/395939
]32[ 24.03.2003
Int. Cl.(2008.04) C25B 11/06
ELTECH SYSTEMS CORPORATION,
U.S.A.
WO/2004/094698
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
]87[
]74[
410
170874
‫תהליך להכנת אלקטרודה אלקטרוליטית‬
‫עם צפוי אקסיד מתכתי של קבוצת פלטינה‬
‫ואלקטרודים המיוצרים המנו‬
]33[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
September 22, 2009
–‫ד' בתשרי התש"ע‬
JERUSALEM 91013
[57] A process for the production of an
electrolytic electrode having an
electrocatalytic coating thereon, said
electrocatalytic coating having reduced
amounts of platinum group metal oxides
while maintaining coating durability, said
process comprising the steps of: providing
a valve metal electrode base; coating said
valve metal electrode base with a coating
layer of an electrochemically active
coating on said valve metal base, said
coating comprising a uniform mixture of
platinum group metal oxides, and
optionally, a valve metal oxide in an
amount not greater than 25 mole percent,
basis 100 mole percent of the metal
content of the coating, said mixture of
platinum group metal oxides consisting
essentially of ruthenium oxide and iridium
oxide in a proportion providing from at
least about 5 mole percent up to about 50
mole percent ruthenium, and at least about
50 mole percent up to about 95 mole
percent iridium, basis 100 mole percent of
these metals present in the coating,
wherein said ruthenium oxide and iridium
oxide are present in a molar proportion
from about 1:1 to about 1:4 and, wherein
said electrochemically active coating is
applied in an amount from about 0.2 g/m2
to about 1.0 g/m2, basis said iridium, as
metal, per a side of said electrode base.
__________
]11[]21[
171287
‫שיטות ומערכות להצפנת אודיו‬
‫המשתמשות במרכיב מצמד ספקטרלי‬
‫ובמרכיב רגנרציה ספקטרלי‬
]54[
AUDIO CODING SYSTEMS AND
METHODS USING SPECTRAL
COMPONENT COUPLING AND
SPECTRAL COMPONENT
REGENERATION
]22[
]31[
]51[
]71[
30.04.2004
10/434449
]32[ 08.05.2003
]33[ US
Int. Cl.(2008.04) G10L 21/02, H03M 1/00
DOLBY LABORATORIES
LICENSING CORPORATION, U.S.A.
WO/2004/102532
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]87[
]74[
[57] A method for encoding a plurality of
input audio signals, wherein the method
comprises: receiving the plurality of input
September 22, 2009
–‫ד' בתשרי התש"ע‬
audio signals and obtaining therefrom one
or more baseband signals and one or more
residual signals, wherein spectral
411
components of a baseband signal represent
spectral components of a respective input
audio signal in a first set of frequency
subbands and spectral components in an
associated residual signal in a second set of
frequency subbands that are not
represented by the baseband signal;
obtaining energy measures of at least some
spectral components of one or more
synthesized signals to be generated during
decoding, wherein the one or more
synthesized signals have spectral
components within the second set of
frequency subbands; obtaining energy
measures of at least some spectral
components of each residual signal;
obtaining from the plurality of input audio
signals a coupled-channel signal having
spectral components representing a
composite of spectral components of two
or more of the input audio signals in a third
set of frequency subbands; obtaining
energy measures of at least some spectral
components of the coupled-channel signal;
obtaining energy measures of at least some
of the spectral components of the two or
more input audio signals represented by
the coupled-channel signal in the third set
of frequency subbands; calculating
coupling scale factors by obtaining square
roots of ratios of the energy measures of
spectral components in the two or more
input audio signals to the energy in the
coupled-channel signal, square roots of
ratios of the energy measures of spectral
energy in the coupled-channel signal to the
energy measures of spectral components in
the two or more input audio signals, ratios
of square roots of the energy measures of
spectral components in the two or more
input audio signals to square roots of the
energy measures of spectral energy in the
coupled-channel signal, or ratios of square
roots of the energy measures of spectral
energy in the coupled-channel signal to
square roots of the energy measures of
spectral components in the two or more
input audio signals; calculating scale
factors by obtaining square roots of ratios
of the energy measures of spectral
components in the residual signals to the
energy measures of spectral energy in the
coupled-channel signal to square roots of
the energy measures of spectral
components in the two or more input audio
signals; calculating scale factors by
obtaining square roots of ratios of the
energy measures of spectral components in
the residual signals to the energy measures
of spectral components in the one or more
synthesized signals, square roots of ratios
of the energy measures of spectral
components in the one or more synthesized
signals to the energy measures of spectral
components in the residual signals, ratios
of square roots of the energy measures of
spectral components in the residual signals
to square roots of the energy measures of
spectral components in the one or more
synthesized signals, or ratios of square
roots of the energy measures of spectral
components in the one or more synthesized
signals to square roots of the energy
measures of spectral components in the
residual signals; and assembling signal
information and scaling information into
an encoded signal, wherein the signal
information represents the spectral
components in the one or more baseband
signals and the spectral components in the
coupled-channel signal, and wherein the
scaling information represents the scale
factors and the coupling scale factors.
__________
]11[]21[
]54[
412
PROCESS TO PREPARE A SKIN
SOFTENING COMPOSITION
171317
‫תהליך להכנת תכשיר לריכוך העור‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
]22[
]31[
]51[
]71[
]87[
]74[
14.04.2004
60/468302
]32[ 14.04.2003
]33[ US
Int. Cl.(2008.04) A61K 08/31, 08/34, 08/368, 6/00
TARO PHARMACEUTICALS U.S.A.,
INC., U.S.A.
WO/2004/091554
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬
HERZLIYA 46733
[57] A method of making a skin softening
ointment, comprising the steps of:
(a) heating and mixing a humectant and a
non-aqueous thickener under vacuum in a
first vessel;
(b) introducing urea under vacuum into the
mixture of step (a);
(c) heating and mixing the contents of step
(b) under vacuum, at a temperature
sufficient to dissolve the urea;
(d) heating and mixing a non-aqueous base
and at least one emulsifier in a second
vessel, whereby the non-aqueous base
liquefies;
(e) drawing by vacuum the mixture from
step (d) into the mixture in the first vessel;
(f) mixing, heating and homogenizing the
contents of step (e) under vacuum;
(g) cooling, mixing and homogenizing the
mixture of step (f) to a congealing
temperature under vacuum;
(h) cooling the mixture of step (g);
(i) drawing by vacuum salicylic acid into
the mixture of step (h);
(j) recirculating the mixture of step (i)
under vacuum; and,
(k) cooling the mixture of step (j) under
vacuum.
__________
]11[]21[
]54[
FLUID CONTROLLER
]22[
]31[
]51[
]71[
]87[
]74[
07.12.2005
2003-408975 ]32[ 08.12.2003
Int. Cl.(2008.04) F16K 7/16
FUJIKIN INCORPORATED, JAPAN
WO/2005/054729
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] A fluid controller (21) comprising: a
block-like main body (22) having a fluid
inflow passage (23), a fluid outflow
passage (24) and a concave portion (25)
open upward; and diaphragm (28) pressed
against or moved apart from an annular
valve seat (27) arranged within the
September 22, 2009
–‫ד' בתשרי התש"ע‬
171506
‫בקר ניגרים‬
]33[
JP
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
concave portion of the main body so as to
open and close the fluid passages, wherein
the concave portion is formed into a shape
including a large-diameter portion (25a)
close to the opening and a small-diameter
portion (25c) connected to a lower side of
the large-diameter portion via a step
413
portion (25b), and the fluid controller is
further provided with a flow path forming
disk (26) fitted to the concave portion, the
flow path forming disk includes a largediameter cylinder portion (31) fitted to the
large-diameter portion of the concave
portion in a fluid tight manner, a smalldiameter cylinder portion (33) having an
outer diameter smaller than an inner
diameter of the small-diameter portion of
the concave portion and having a lower
end received by a bottom surface of the
concave portion, and a coupling portion
(32) coupling a lower end portion of the
large-diameter cylinder portion and an
upper end portion of the small-diameter
cylinder portion and received by the step
portion of the concave portion, and a
peripheral edge portion of the diaphragm is
fixed to an upper end portion of the largediameter cylinder portion of the flow path
forming disk, a valve seat is provided in
the upper end portion of the smalldiameter cylinder portion of the flow path
forming disk, an inner annular space (52)
of the large-diameter cylinder portion is
formed by an inner periphery of the largediameter cylinder portion of the flow path
forming disk, the diaphragm, the valve seat
and a top surface of the coupling portion of
the flow path forming disk, a plurality of
through holes communicating an outer
annular space (51) of the small-diameter
cylinder portion formed between the smalldiameter cylinder portion of the flow path
forming disk and a peripheral surface of
the small-diameter portion of the concave
portion with an inner annular space of the
large-diameter cylinder portion are formed
in a coupling portion of the flow path
forming disk, any one of the fluid inflow
passage and the fluid outflow passage is
communicated with a lower end of the
small-diameter cylinder portion of the flow
path forming disk, and the other is formed
so as to be communicated with the outer
annular space of the small-diameter
cylinder portion.
__________
]11[]21[
]54[
CERVICAL DILATION MONITOR
]22[
]31[
]51[
]71[
04.05.2004
10/430297
]32[ 07.05.2003
Int. Cl.(2008.04) A61B 51/03
ILAN HALEVI
414
171571
‫מכשיר ניטור התרחבות צוואר הרחם‬
]33[
US
‫ פתח תקוה‬,‫אילן הלוי‬
September 22, 2009 –‫ד' בתשרי התש"ע‬
MIKI BEN-CNAAN
BARAK HALEVI
]87[
]74[
WO/2004/098375
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
[57] A system (10) for measuring dilation
of a cervix of a uterus of a female during
the first stage of labor, comprising:
(a) an expandable gripping arrangement
(12) having two oppositely facing gripping
members (14) each resiliently biased to
gripping configuration for non-penetrating
engagement of the cervix and an outwardly
biased restoring member (16), said
gripping arrangement being configured,
such that, said restoring member pushes
said gripping members apart to that said
gripping arrangement grips the cervix
while the cervix dilates;
(b) a first elongated element (20) having a
calibrated scale (22) disposed thereon;
(c) a second elongated element (30), a part
of said second elongated element being
disposed along said calibrated scale, said
part of said second elongated element
having an indicator (32) disposed thereon,
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫ תל אביב‬,‫כנען‬-‫מיקי בן‬
‫ציונה‬-‫ נס‬,‫ברק הלוי‬
,‫ד"ר מרק פרידמן בע"מ‬
,7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
said first elongated element and said
second elongated element being
mechanically connected to said gripping
arrangement, in a manner such that, as said
gripping arrangement expands with the
dilating cervix, relative linear movement is
generated between said first elongated
element and said part of said second
elongated element, thereby moving said
indicator with respect to said calibrated
scale so as to give a measurement of
dilation of the cervix; and
(d) an insertion arrangement (40)
configured to temporarily retain said
gripping members in an open configuration
during fitting of said gripping arrangement
on the cervix and to simultaneously release
said gripping members so as to allow said
gripping members to return to said
gripping configuration for non-penetrating
engagement of the cervix.
415
__________
]11[]21[
]54[
]22[
]31[
]51[
]71[
‫מזרק סיבובי‬
ROTARY INJECTOR
21.05.2004
10/249967
]32[ 22.05.2003
Int. Cl.(2008.04) F02C 7/22
WILLIAMS INTERNATIONAL CO.,
L.L.C., U.S.A.
]87[ WO/2005/028843
]74[ WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] A rotary injector, comprising:
(a) at least one arm (48) adapted to rotate
about an axis of rotation, wherein said at
least one arm extends in a radial direction
with respect to said axis of rotation, said at
least one arm is adapted to rotate within a
stream of a first fluid adapted to flow
416
171935
]33[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
across said at least one arm, and at least
one said arm comprises a plurality of lands
(52), wherein said plurality of lands are
adapted so that said stream of first fluid
can flow across said plurality of lands and
at least two of said plurality of lands are
located at different radial distances from
September 22, 2009
–‫ד' בתשרי התש"ע‬
said plurality of lands are located at
different radial distances from said axis of
rotation; and
(b) at least one port (58) located on each of
said plurality of lands, wherein said at least
one port is operatively coupled by an
associated fluid passage to a source of a
second fluid.
__________
]11[]21[
]54[
METHOD FOR FORMING A
SUPERHARD AMORPHOUS
CARBON COATING IN VACUUM
]22[
]31[
]51[
]71[
]72[
21.04.2004
2003115309
]32[ 22.05.2003
Int. Cl.(2008.04) C23C 14/22
ARGOR ALJBA AG, SWITZERLAND
ALEXANDER YAKOVLEVICH
KOLPAKOV, VITALY
NIKOLAEVICH INKIN, SERGEI
IVANOVICH UKHANOV
]87[ WO/2004/104263
]74[ DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
[57] A method for forming a superhard
wear-resistant carbon coating in vacuum,
comprising the steps of: placing an article
into a vacuum chamber that is
subsequently vacuumed; treating a surface
of the article with accelerated ions;
applying a layer of a material to the
September 22, 2009
–‫ד' בתשרי התש"ע‬
172000
–‫שיטה ליצירת ציפוי פחמן אמורפי קשה‬
‫ביותר בתוך ריק‬
]33[
RU
,‫ד"ר מרק פרידמן בע"מ‬
,7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
surface, said material providing adhesion
of subsequent layers; and initializing a
pulse electric arc discharge at a graphite
cathode, and producing a pulse stream of
carbon plasma from a plurality of cathode
spots that move along a cathode surface;
condensing the cathode plasma within a
417
predetermined area on the surface of the
article to produce a superhard amorphous
carbon coating, wherein a temperature of
the article is maintained within the range
of from 200 to 450 K by adjusting a pulse
repetition rate of the electric arc discharge,
the method characterized by using a pulse
stream of the carbon plasma having an
average energy of ions 25 to 35 eV and an
ion concentration of 1012 to 1013 cm-3,
wherein an axis of said carbon plasma
stream is positioned at an angle of from
15o to 45o to a predetermined surface of
the article, and an article temperature
variation ∆ t is maintained in a range of
from 50 to 100 K during application of the
coating.
__________
]11[]21[
172717
‫ ושיטה לאבטחת כלי טיס‬,‫ מערכת‬, ‫מתקן‬
]54[
APPARATUS, SYSTEM AND
METHOD FOR AIRCRAFT
SECURITY
]22[
]31[
30.12.2003
60/482807
]32[ 26.06.2003
]33[ US
10/643101
18.08.2003
US
Int. Cl.(2008.04) B64D 45/00, G08B 29/00
MICHAEL ARNOUSE, U.S.A.
WO/2005/016747
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
‫ הרצליה‬,2081 .‫ד‬.‫ ת‬, 10 ‫שדרות אבא אבן‬
HERZLIYA 46120
]51[
]71[
]87[
]74[
[57] A security mechanism for
identifying authorized users and reacting to
detection of unauthorized users during all
phases of an aircraft flight, the system
comprising: a controller (112) operable by
a user, a security device (114) to read
information associated with the user
attempting to operate the controller, the
security device being located so as to be
able to read the information at any time
while the user is attempting to operate the
controller; and one or more monitoring
devices (116) storing information as to all
users authorized to operate the controller
and comparing the information of the user
attempting to operate the controller against
418
the stored information as to all authorized
users to determine whether the user is
authorized to operate the controller, the
stored information having been loaded into
the monitoring device prior to flight; the
one or more monitoring devices being
operable to disable the controller and
engage an autopilot if an unauthorized user
is detected at the controller at any time
during all phases of an aircraft flight,
comprising starting up of the aircraft,
movement of the aircraft from a fixed
position, take-off or landing of the aircraft,
taxiing of the aircraft as well as in the air
flight.
September 22, 2009
–‫ד' בתשרי התש"ע‬
__________
]11[]21[
]54[
HIGH STRENGTH FABRIC
STRUCTURE AND SEAM
THEREFOR WITH UNIFORM
THICKNESS AND A METHOD OF
MAKING SAME
]22[
]31[
]51[
]71[
]72[
08.06.2004
10/620888
]32[ 16.07.2003
Int. Cl.(2008.04) B32B 3/00, 5/12
RAYTHEON COMPANY, U.S.A.
WILLIAM H. FOSSEY, SHARON A.
ELSWORTH
WO/2005/014905
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
]87[
]74[
[57] A high strength flexible fabric
structure comprising: a plurality of flexible
fabric sections (42, 44), each section
including a plurality of plies (46, 48, 50,
52, 54, 56) of alternating fiber orientation;
September 22, 2009
–‫ד' בתשרי התש"ע‬
173118
‫מבנה בד בעל חוזק גבוה ותפר עבורו בעל‬
‫עובי אחיד ושיטה לייצורו‬
]33[
US
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
,45087 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬
and a joint between adjacent sections
wherein the plies of each section are offset
to form a uniform thickness seam between
the two sections without any overlap of
plies of like fiber orientation.
419
__________
]11[]21[
]54[
PORTABLE TELEPHONE AND
TERMINAL EQUIPMENT
]22[
]31[
]51[
]62[
]71[
]72[
07.12.2000
349460/99
]32[ 08.12.1999
Int. Cl.(2008.04) H04M 12/47, 17/25
DIVISION FROM 144790
NTT DOCOMO, INC., JAPAN
MASAAKI YAMAMOTO,
MASAHARU NAKATSUCHI
WO/2001/043403
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
]87[
]74[
[57] A method for automatically
switching a mode for a wireless
communication terminal, the wireless
communication terminal having a
communication terminal control and a
browser, the wireless communication
terminal being configurable to a telephone
mode, a video play mode and a music play
mode, the method comprising: configuring
the communication terminal control to the
telephone mode; using the communication
420
174055
‫טלפון נייד וציוד למסוף‬
]33[
JP
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
,45087 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬
terminal control to activate the browser;
using functionality of the browser to
selectively access a content comprising at
least one of audio data and visual data; and
automatically switching, based on the
accessed content, the wireless
communication terminal from the
telephone mode to at least one of the video
play mode or music play mode for play
functionality on the output device.
September 22, 2009
–‫ד' בתשרי התש"ע‬
__________
]11[]21[
174322
‫קולר תומך‬
]54[
SUPPORTING COLLAR
]22[
]31[
]51[
]71[
]74[
15.03.2006
05/02695
]32[ 18.03.2005
Int. Cl.(2008.04) F16L 3/00
HISPANO-SUIZA, FRANCE
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
[57] Supporting collar (10) for an element
(8) such as a cable or a pipe, comprising a
strap (18) capable of being fixed to a
support (12), said collar being
characterized in that it comprises an outer
sleeve (16) encircled by this strap, an inner
sleeve (14) through which said element
]33[
FR
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
‫ הרצליה‬,2081 .‫ד‬.‫ ת‬, 10 ‫שדרות אבא אבן‬
can pass, and a deformable web (15)
connecting said sleeves and allowing the
inner sleeve to move relative to the outer
sleeve, and in that the web is formed by
two annular membranes that come together
at the outer sleeve and diverge with
distance from the latter.
__________
]11[]21[
September 22, 2009
–‫ד' בתשרי התש"ע‬
174394
421
]54[
LOCK AND KEY SYSTEM WITH
EXTRA CODE COMBINATIONS
]22[
]31[
13.09.2004
60/504202
]32[ 22.09.2003
10/913519
09.08.2004
Int. Cl.(2008.04) E05B 27/00
WINLOC AG, SWITZERLAND
BO WIDEN
WO/2005/028789
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]51[
]71[
]72[
]87[
]74[
[57] A lock and key system including
locks of the kind comprising: a housing
(204) having a cylindrical bore, a
cylindrical key plug (202) being rotatably
journalled in said cylindrical bore, said key
plug having a longitudinal key slot (201)
and, at a side of said key slot, a number of
side locking tumblers (206) in a row
cooperating with a side locking means
(213) for locking the key plug against
rotation in the cylindrical bore, at least one
of said side locking tumblers having a
transversely projecting finger and being
mounted in an associated chamber for
elevational and rotational movement
therein, said elevational movement being
performed against the action of a force
exerted along said chamber, and said
rotational movement of the side locking
tumbler corresponding to the associated
finger performing a pivotal motion, the
rotational movement of the side locking
tumbler being limited between two angular
positions corresponding to a respective
pivotal end position of the finger, and
including keys (100) of the kind
comprising: a longitudinally extending key
blade (102), which is insertable into said
key slot of the key plug of an associated
lock, said key blade having a side material
region at one side of said key blade
422
‫מערכת של מנעול ומפתח עם תוספת‬
‫צירופי קוד‬
]33[
US
US
,‫פרל כהן צדק לצר‬
,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬
defined upwardly by a longitudinally
extending shelf surface, which is at least
partially interrupted by a side code pattern
cut into said material region so as to form a
wave-like guiding surface (105) including
a ramp surface portion (106) at the free
end portion (107) of the key blade, said
wave-like guiding surface engaging with
said finger of said at least one side locking
tumbler and making the latter follow said
wave-like guiding surface, while the side
locking tumbler is moved elevationally
against the action of said force and the
finger being caused to pivot sideways
between said pivotal end positions, when
the key blade is inserted into the key slot,
said wave-like guiding surface including at
least one side code portion associated with
said side locking tumbler and guiding the
finger thereof, upon fully inserting the key
blade into the key slot, into a specific
position causing the locking tumbler to
allow said side locking means to
rotationally release the key plug relative to
said housing, said at least one side code
portion being located at a selected one of a
predetermined number of vertical code
levels and at a selected one of a
predetermined number of longitudinal
positions corresponding to a specific
pivotal position of said finger,
September 22, 2009
–‫ד' בתשרי התש"ע‬
characterized in that in addition to said
number of vertical code levels for said at
least one side code portion, there is an
extra top code level located at said shelf
surface, any side code top segment located
at this extra top code level representing an
extra code for the corresponding side
locking tumbler of the associated lock,
whereby the number of possible code
combinations is increased.
__________
]11[]21[
]54[
CONSTRUCTIONAL PANELS
]22[
]31[
]51[
]71[
04.10.2004
0323314.5
]32[ 04.10.2003
Int. Cl.(2008.04) E01C 5/20, 5/22, 9/08
FERGUS JONATHAN ARDERN,
UNITED KINGDOM
WO/2005/035874
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]87[
]74[
[57] A constructional panel (10)
comprising: a central section (13) and two
opposed end sections (14, 15), said central
section being of generally rectangular form
with two parallel external side edges and
two parallel end edges, each said end
section having an isosceles trapezoid part
(16, 17) conjoined to a rectangular part
(18, 19), said trapezoid part having parallel
long (28) and short (27) edges and a pair of
external oblique edges (29, 30) and said
rectangular part having a pair of parallel
first edges (33, 34) and a pair of external
second edges (35, 36), the short edge of
September 22, 2009
–‫ד' בתשרי התש"ע‬
174754
‫לוחות מבניים‬
]33[
GB
,‫פרל כהן צדק לצר‬
,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬
the trapezoid part conjoining an end edge
of the central section and the long edge
conjoining a first edge of the rectangular
part, the other first edge of the rectangular
part being external, and the length of the
external side edges of the central part
being substantially twice the length of the
each second edge of the rectangular parts,
whereby one said panel (50) may be
interengaged with other like panels (51) by
an oblique edge of an end section of said
one panel being engageable with an
oblique edge of an end section of a second
panel, a second edge of the rectangular
423
part of the interenchangeable end sections
of each of the two panels being engageable
with the respective side edge of the central
section of the other panel, and a third panel
way be interengaged with said two panels
in a similar manner whereby an end
section thereof is engageable with an end
section of said one panel and the external
first edge of said end section of the third
panel (52) is engageable with the
corresponding external first edge of said
second panel, characterized by the feature
that at least some of the external edges of
the one panel are configured for
connection to the corresponding edges of
the second like panel by providing on one
of the edges which interengages the other
edge, one or more projections (31), and on
that other edge corresponding one or more
recesses (30) for receiving each projection.
__________
]11[]21[
]54[
BORON CARBIDE COMPOSITE
BODIES AND METHODS FOR
MAKING SAME
]22[
]31[
20.11.2001
60/252489
]32[ 21.11.2000
60/329358
15.10.2001
Int. Cl.(2008.04) C04B 355/63
DIVISION FROM 155729
M CUBED TECHNOLOGIES, INC.,
U.S.A.
WO/2002/068373
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]62[
]71[
]87[
]74[
[57] A composite material, comprising: a
matrix comprising silicon carbide;
an at least partially interconnected material
distributed throughout said matrix, said
424
174808
‫ ושיטות להכנתם‬,‫גופי קרביד–בורון מרוכב‬
]33[
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
material consisting essentially of elemental
silicon and at least one substance
comprising boron; and at least one
reinforcement material comprising boron
carbide, said reinforcement material also
September 22, 2009
–‫ד' בתשרי התש"ע‬
distributed throughout said matrix, said
reinforcement material comprising at least
one morphology selected from the group
consisting of particulate, flakes,
microspheres and aggregate, said boron
carbide being substantially unaffected by
said silicon.
__________
]11[]21[
]54[
CAPSULE LOADING DEVICE FOR
FEEDING A CAPSULE
DISPENSING MACHINE
]22[
]31[
]51[
]71[
]87[
]74[
22.04.2005
04010644.5
]32[ 05.05.2004
Int. Cl.(2008.04) A47F 1/08
NESTEC S.A., SWITZERLAND
WO/2005/104910
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
[57] Capsule loading device to form a
reserve of stacked capsules (8) comprising:
a detachable tube (2) containing stacked
capsules furnished with an opening (24)
for the capsules to pass through the tube,
means of aligning the tube allowing the
tube to be aligned with a capsule receiving
zone for the capsules to descend by gravity
178260
‫מתקן הטענת כמוסה עבור הזנת מכונת‬
‫חלקות כמוסות‬
]33[
EP
,‫ד"ר יצחק הס ושותפיו‬
‫ תל אביב‬,6451 .‫ד‬.‫ ת‬, 279 ‫רחוב הירקון‬
into this zone, characterized in that the
alignment means comprise means for
retaining the capsules in their stack when
the tube is moved with its opening oriented
downwards, in the direction of the position
in which the tube is aligned with the
reception zone.
__________
]11[]21[
]54[
KEY COMBINATION ELEMENT
September 22, 2009
–‫ד' בתשרי התש"ע‬
178364
‫אלמנט צירוף מפתח בתוך גלם מפתח‬
425
‫ומפתח‬
IN KEY BLANK AND KEY
]22[
]31[
]51[
]71[
]72[
]87[
]74[
28.03.2005
0407196.5
]32[ 30.03.2004
]33[
Int. Cl.(2008.04) E05B 19/08, 27/00, 35/00
MUL-T-LOCK TECHNOLOGIES
LTD.
DANI MARKBREIT, EFFI BENAHARON
WO/2005/095738
DEKEL PATENT LTD.,
18 MENUHA VENAHALA ST.,
REHOVOT 76209
[57] A key blank comprising: a generally
elongate shaft portion (12) defining first
and second generally flat oppositely
directed side surfaces (14, 16) joined by
edge surfaces (18), at least one of said first
and second side surfaces cuttable to form
key cuts (20) that define a key combination
surface; and at least one key combination
element (26) movably disposed in the
elongate shaft portion and adapted for
touching a lock combination element (54)
disposed in a cylinder lock plug (46)
426
GB
‫ יבנה‬,‫מולטילוק טכנולוגיות בע"מ‬
‫ אפי בן אהרון‬,‫דני מרקברייט‬
,‫דקל פטנט בע"מ‬
‫ רחובות‬,27 ‫חדר‬, 18 ‫מנוחה ונחלה‬
wherein said at least one key combination
element has inherent energy for applying
an urging force against the lock
combination element, and wherein said at
least one key combination element
comprises a resilient arm (28) disposed in
a recess (34) formed in said elongate shaft
portion and capable of resiliently
protruding outwards from the recess
beyond both of said first and second side
surfaces.
September 22, 2009
–‫ד' בתשרי התש"ע‬
__________
]11[]21[
]54[
METHOD, DEVICE AND
CARRIER FOR ENCODING
MULTIWORD INFORMATION
]22[
]31[
]51[
]62[
]71[
22.04.1999
98201395.5
]32[ 29.04.1998
Int. Cl.(2008.04) H03M 1/22
DIVISION FROM 133735
KONINKLIJKE PHILIPS
ELECTRONICS N.V., THE
NETHERLANDS
WO/1999/060706
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
September 22, 2009
–‫ד' בתשרי התש"ע‬
183567
‫ התקן ונשא להצפנת מידע רב‬,‫שיטה‬
‫מילים‬
]33[
EP
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
427
[57] A method for encoding multiword
information that is based on multibit
symbols disposed between synchronizing
bit groups and in relative contiguity with
respect to a medium, whilst providing
wordwise interleaving and wordwise error
protection code facilities and
synchronizing bit groups and furthermore
error locative clues in clue words arranged
in columns of clue words, across words of
a multiword group, characterized in that
the clue columns are locally scarcer
disposed around columns of synchronizing
bit groups.
__________
]11[]21[
185867
‫בנזופיראנים מותמרים כאגוניסטים לקולטן‬
‫ביתא סלקטיבי לאסטרוגן‬
]54[
SUBSTITUTED BENZOPYRANS
AS SELECTIVE ESTROGEN
RECEPTOR-BETA AGONISTS
]22[
]31[
07.11.2002
60/332766
]32[ 19.11.2001
]33[ US
60/363622
11.03.2002
US
Int. Cl.(2008.04) A61K 313/53, A61P 1/04, 11/00, 13/00, 19/00, 25/00, 35/00, 43/00,
9/00, C07D 311/00, 311/94
DIVISION FROM 161325
ELI LILLY AND COMPANY, U.S.A.
WO/2003/044006
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]51[
]62[
]71[
]87[
]74[
[57] A compound of the formula
wherein
R1b is amido or hydroxy;
R2b is –H, or C1-C6 alkyl;
R3b is –H or C1-C6 alkyl;
R4b is amido or hydroxy;
G is –CH2-, -CH2CH2-, -CH2CH2CH2-; and
with the proviso that at least one of R1b and
R4b is amido;
or a pharmaceutically acceptable salt
thereof.
__________
428
September 22, 2009
–‫ד' בתשרי התש"ע‬
]11[]21[
186305
‫מלואה שעוצב בצד הנגדי‬
]54[
REVERSE MOLDED PANEL
]22[
]31[
09.01.2001
60/198709
]32[ 20.04.2000
]33[ US
09/742840
21.12.2000
US
Int. Cl.(2008.04) B27N 3/08, 5/00, E04F 13/10
DIVISION FROM 152283
MASONITE CORPORATION, U.S.A.
WO/2001/081055
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
‫ תל אביב‬,11490 .‫ד‬.‫ ת‬, 124 ‫אבן גבירול‬
P.O.B. 11490,
TEL AVIV 62038
]51[
]62[
]71[
]87[
]74[
[57] A wood composite article (10)
reverse molded from a mat of refined
cellulosic fibers and sufficient binder to
adhere the cellulosic fibers together into a
structurally sound article having a specific
gravity in the range of about 0.96 to about
1.08, said article formed from at least 80%
by weight fibrillated cellulosic fibers
refined from wood chips, based on the
total dry weight of the fibers in the article
and including planar surface portions (13)
surrounding an outwardly protruding
contoured panel (14), having a plurality of
exterior corners (15), that simulates natural
wood millwork, back surface portions of
said article being coplanar for adhering
said back surface to a planar surface of a
substrate, said contoured panel extending
outwardly from said planar substrate
surface.
152283
The parent application from which
this application has been divided has
not yet been published
‫בקשת הורה לבקשה זו שטרם‬
‫פורסמה‬
________
]11[]21[
September 22, 2009
–‫ד' בתשרי התש"ע‬
187834
429
]54[
SYSTEM AND METHOD FOR
DISPLAYING A DRIVING
PROFILE
]22[
]31[
]51[
]71[
08.06.2006
60/688696
]32[ 09.06.2005
Int. Cl.(2008.04) G09B 19/16
GREENROAD DRIVING
TECHNOLOGIES LTD.
]87[
]74[
WO/2006/131926
ALEF GIMEL - INTELLECTUAL
PROPERTY CONSULTING LTD.,
P.O.B. 2079,
REHOVOT 76120
[57] A system for displaying real time
evaluations of driving sessions to a driver,
the system comprising: a vehicle sensor
utility operative to monitor the state of the
vehicle and to output a raw data stream
corresponding thereto; a driving event
handler operative to receive the raw data
stream detect driving events based thereon
and to output a driving event string
containing at least one driving event
representation corresponding thereto; a
maneuver detector operative to receive
said at least one driving event
representation, recognize patterns of
430
‫מערכת ושיטה להצגת פרופיל נהיגה‬
]33[
US
‫ אור‬,‫גרינרואד טכנולוגיות נהיגה בע"מ‬
‫יהודה‬
,‫ ייעוץ לקניין רוחני בע"מ‬- .‫ג‬.‫א‬
‫ רחובות‬,2079 .‫ד‬.‫ ת‬,
driving maneuvers and to construct and
output a driving maneuver representation
corresponding thereto, said driving
maneuver representation containing a
representation of at least one driving
maneuver; and a processor configured to
evaluate a driving session based upon
rating each of a plurality of driving
maneuvers comprised in said driving
session and to display the evaluation of
said driving session and/or the rating of
said plurality of driving maneuvers on a
display; and the display.
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫ לתקנות‬35 ‫פירוט זה נבחן בהתאם לתקנה‬
1968 – ‫ תשכ"ח‬,‫הפטנטים‬
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
________
]11[]21[
]54[
AREAL METAL ELEMENT AND
PROFILE ELEMENT
]22[
]31[
]51[
]62[
]71[
25.11.2003
10259307.8
]32[ 18.12.2002
Int. Cl.(2008.04) E04C 2/08, 2/42, 3/08
DIVISION FROM 168923
PROTEKTORWERK FLORENZ
MAISCH GMBH & CO. KG,
GERMANY
WO/2004/055289
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]87[
]74[
[57] An areal metal element having a
surface (13) which extends from a first
outside edge (8) to a second outside edge
(9) lying opposite the first outside edge,
with the region of the metal element
adjoining the first outside edge forming a
first side region (26) and the region of the
September 22, 2009
–‫ד' בתשרי התש"ע‬
187854
‫אלמנט מתכת אזורי ופרופיל אלמנט‬
]33[
DE
,‫פרל כהן צדק לצר‬
,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬
metal element adjoining the second outer
edge forming a second side region (27),
both said side regions being connected to
one another by a central region (28) lying
between them, and with at least one
completely bordered aperture (22, 23)
being formed in at least one of the side
431
regions, with its border being formed in
one part by said side region and in the
other part by the central region, with the
central region including at least two
sections (29, 30) which each consist of two
outwardly disposed part sections (31, 33,
34, 36) and a central part section (32, 35)
lying between them, with the outwardly
disposed part sections being folded over
with respect to the central part section for
the production of the aperture, with the
sections forming part of the border of the
aperture, and with the central region,
including the sections being made in one
piece with the two side regions of the
metal element, characterized in that two
folding edges (16, 17; 18, 19) are provided
which are formed by the folding over of
the outwardly disposed part sections with
respect to the central part section and of
which the folding edge (17; 19) disposed
more closely to the first outer edge of the
metal element faces in the direction of the
first outer edge (8) and the folding edge,
disposed more closely to the second outer
edge of the metal element faces in the
opposite way thereto in the direction of the
second outer edge.
________
432
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫פטנטים‬
PATENTS
‫פטנטים שניתנו‬
PATENTS GRANTED
115880
152327
153085
154120
154551
155047
155705
156123
156661
163438
164768
166908
138818
141920
147506
148595
149636
151343
172412
143160
144852
146544
137053
158196
159262
160347
161916
117422
152364
153128
154134
154572
155150
155709
156212
156948
163881
165045
167053
139364
142088
147651
148685
149843
151397
174376
143591
144891
180435
157254
158446
159593
160704
161987
September 22, 2009
130829
152431
153163
154236
154652
155165
155734
156226
157021
163897
165830
168225
139569
142170
147735
148796
149956
151399
175296
143604
145412
184144
157559
158816
159672
160977
162435
130954
152704
153221
154238
154731
155224
155792
156239
157070
164025
166229
168684
140001
142179
148134
148907
150215
151573
178782
143862
145866
134202
157637
158892
159753
161008
162450
–‫ד' בתשרי התש"ע‬
132661
152783
153503
154256
154755
155226
155883
156337
157150
164123
166509
168861
140721
142328
148154
149291
150371
151644
110669
143900
145908
134796
157817
158928
159893
161319
162561
133311
152834
153655
154332
154866
155477
155923
156474
157169
164134
166567
169680
140732
142366
148246
149358
150461
151903
127216
144518
146208
135587
157873
158940
160103
161396
162579
152120
152844
153699
154450
154896
155513
156086
156560
163124
164393
166697
169715
141769
142596
148371
149582
150866
151954
142699
144675
146255
135983
158068
159113
160223
161548
162753
152172
153049
153883
154480
154905
155538
156091
156615
163373
164486
166744
108276
141775
147416
148484
149592
150934
171405
142766
144681
146421
136127
158183
159261
160309
161870
433
‫פטנטים שחודשו‬
PATENTS RENEWED
97585
97646
97720
97779
110943
112969
113061
113137
113177
113239
113298
113412
128838
129084
129225
129297
133141
133706
137648
138080
138221
138289
138353
138424
138527
138599
138645
138717
138805
138935
139017
139364
141373
143862
148079
150215
152172
153085
154238
154755
155095
155477
156474
158183
434
97592
97658
97723
97800
112842
112995
113062
113138
113179
113245
113316
113448
128876
129097
129230
129310
133247
133707
137872
138090
138247
138291
138369
138438
138533
138605
138647
138719
138818
138953
139027
139569
141766
143900
148134
150371
152431
153221
154256
154773
155165
155538
156615
158196
97620
97674
97727
97837
112851
113010
113104
113143
113193
113248
113343
113449
128883
129119
129244
129317
133260
134796
137896
138092
138249
138306
138378
138439
138547
138606
138657
138723
138830
138961
139113
139725
141769
144852
148154
151168
152497
153503
154332
154808
155197
155705
156723
158226
97631
97690
97730
97892
112873
113021
113108
113153
113194
113255
113344
113465
128885
129120
129257
129375
133374
135344
138018
138118
138263
138333
138392
138458
138548
138613
138660
138733
138835
138970
139119
139834
141775
145126
148907
151321
152703
153655
154551
154835
155226
155709
157021
158816
97632
97693
97740
97904
112916
113023
113121
113156
113195
113259
113367
115560
128890
129163
129273
130829
133469
135721
138019
138127
138284
138337
138399
138466
138549
138614
138669
138745
138841
139005
139127
139857
141920
145838
149358
151732
152704
153834
154572
154866
155286
155734
157150
158928
97633
97695
97741
97910
112921
113034
113122
113162
113209
113271
113388
122675
128966
129172
129274
130954
133700
135893
138034
138137
138285
138345
138406
138467
138555
138620
138670
138746
138845
139008
139159
140258
142088
145866
149582
151903
152783
154109
154606
154894
155290
155792
157169
159113
September 22, 2009
97635
97701
97744
97915
112930
113036
113131
113165
113221
113278
113403
127216
129003
129218
129278
132750
133704
137138
138060
138142
138286
138346
138414
138476
138556
138623
138711
138765
138863
139009
139315
140711
142170
147506
149843
151954
152834
154120
154630
155012
155314
155883
157817
159201
97644
97709
97746
97935
112963
113037
113134
113172
113230
113289
113409
128837
129071
129223
129281
132835
133705
137549
138078
138153
138288
138352
138416
138497
138559
138640
138712
138767
138934
139013
139348
140721
142596
147735
149956
152089
153003
154236
154731
155025
155323
156337
158068
159261
–‫ד' בתשרי התש"ע‬
‫‪161319‬‬
‫‪163373‬‬
‫‪164123‬‬
‫‪164412‬‬
‫‪165045‬‬
‫‪166744‬‬
‫‪168861‬‬
‫‪174376‬‬
‫‪435‬‬
‫‪160943‬‬
‫‪163227‬‬
‫‪164113‬‬
‫‪164393‬‬
‫‪164997‬‬
‫‪166567‬‬
‫‪168684‬‬
‫‪174357‬‬
‫‪184144‬‬
‫‪160704‬‬
‫‪162915‬‬
‫‪164084‬‬
‫‪164303‬‬
‫‪164969‬‬
‫‪166509‬‬
‫‪167838‬‬
‫‪172465‬‬
‫‪180435‬‬
‫‪160347‬‬
‫‪162858‬‬
‫‪164076‬‬
‫‪164253‬‬
‫‪164768‬‬
‫‪166384‬‬
‫‪167294‬‬
‫‪172412‬‬
‫‪179036‬‬
‫‪160309‬‬
‫‪162579‬‬
‫‪163936‬‬
‫‪164206‬‬
‫‪164561‬‬
‫‪166223‬‬
‫‪167053‬‬
‫‪171814‬‬
‫‪178910‬‬
‫‪159672‬‬
‫‪162450‬‬
‫‪163881‬‬
‫‪164175‬‬
‫‪164486‬‬
‫‪165201‬‬
‫‪167034‬‬
‫‪169803‬‬
‫‪178782‬‬
‫‪159335‬‬
‫‪161870‬‬
‫‪163871‬‬
‫‪164170‬‬
‫‪164475‬‬
‫‪165135‬‬
‫‪166828‬‬
‫‪169715‬‬
‫‪176365‬‬
‫ד' בתשרי התש"ע–‬
‫‪159262‬‬
‫‪161813‬‬
‫‪163438‬‬
‫‪164134‬‬
‫‪164456‬‬
‫‪165071‬‬
‫‪166775‬‬
‫‪169680‬‬
‫‪175296‬‬
‫‪September 22, 2009‬‬
‫פטנטים שתוקפם פקעו בגלל אי תשלום אגרת חידוש‬
PATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL
FEES
110468
110553
110657
110748
110831
125791
125946
126066
171559
119415
95262
95429
95559
134538
134846
436
110470
110577
110683
110753
110832
125809
125965
147787
108276
129812
95267
95433
95576
134613
134894
110471
110588
110684
110759
110845
125854
125972
150640
138450
132882
95268
95472
95578
134688
135006
110475
110591
110704
110767
111688
125885
126017
151090
138451
133172
95296
95473
95582
134698
135735
110493
110602
110708
110769
125681
125906
126034
151307
138689
145491
95297
95507
133962
134716
136622
110506
110606
110721
110777
125698
125908
126035
151504
155578
95208
95298
95508
134377
134718
157339
September 22, 2009
110522
110617
110722
110784
125713
125913
126049
151511
179842
95243
95334
95525
134413
134733
159557
110549
110632
110740
110808
125731
125922
126051
151582
119162
95251
95425
95542
134491
134837
159655
–‫ד' בתשרי התש"ע‬
‫פטנטים שחודשו לעשרים שנה‬
PATENTS RENEWED FOR 20 YEARS
151754
159663
September 22, 2009
166310
–‫ד' בתשרי התש"ע‬
437
Patents for which applications have
been filed for extension of the patent
term under chapter 4, part B1 of the
Patents Law
105048
438
112081
‫פטנטים שלגביהם הוגשו בקשות‬
‫להארכת תקופת ההגנה על פי פרק‬
‫ לחוק הפטנטים‬1'‫ד' סימן ב‬
143091
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫הודעה‬
NOTICE
‫ לחוק‬60 ‫לפי סעיף‬
1967-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר‬
‫תוקפו של הפטנט המפורט‬
‫ שתוקפו פקע מחמת‬,‫מטה‬
‫אי תשלום אגרות החידוש‬
:‫הקבועות‬
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
101460
8/1995
‫מס' הפטנט‬
:'‫קיבול פורסם ביומן מס‬
:‫שם בעל הפטנט‬
‫נ התקנים בע"מ‬.‫מ‬.‫ת‬
T.M.N. DEVICES LTD.
Title of invention:
:‫שם האמצאה‬
‫מכונית והתקן להכנסה והוצאה של כסא גלגלים מתא המטען‬
CAR AND DEVICE FOR INSERTING AND REMOVING A WHEELCHAIR FROM A
LUGGAGE COMPARTMENT
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫שנקבע‬
‫ כפי‬,‫יומן פטנטים זה‬
prescribed by section 61 of
92
‫ובתקנה‬
‫ לחוק‬61 ‫בסעיף‬
the law and by regulation 92
-‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
5728-1968
1968
September 22, 2009
–‫ד' בתשרי התש"ע‬
439
‫הודעה‬
NOTICE
Under section 66 of the Patents
Law, 5727-1967
This is to notify that permission
has been granted to the owner of
Patent Application No.
Acceptance published in journal
To amend the specification of the
said Patent Application.
Any person may oppose such
grant of permission within three
months from the date of this
Patents Journal, as prescribed by
section 67 of the Law and by
regulation 99 of the Patent
Regulations, 5728-1968.
440
164768
7/2008
,‫ לחוק הפטנטים‬66 ‫לפי סעיף‬
1967-‫תשכ"ז‬
‫מודע בזאת כי ניתנה רשות‬
'‫לבעלת בקשת הפטנט מס‬
‫דבר הקיבול פורסם ביומן‬
‫לתקן את הפירוט של בקשת‬
‫הפטנט האמורה‬
‫כל אדם רשאי להתנגד למתן‬
‫הרשות תוך שלושה חודשים‬
‫ כפי‬,‫מתאריך יומן פטנטים זה‬
‫ לחוק ובתקנה‬67 ‫שנקבע בסעיף‬
-‫ התשכ"ח‬,‫ לתקנות הפטנטים‬99
.1968
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫הודעה‬
NOTICE
Under section 66 of the Patents
Law, 5727-1967
This is to notify that permission
has been granted to the owner of
Patent Application No.
Acceptance published in journal
To amend the specification of the
said Patent Application.
Any person may oppose such
grant of permission within three
months from the date of this
Patents Journal, as prescribed by
section 67 of the Law and by
regulation 99 of the Patent
Regulations, 5728-1968.
September 22, 2009
–‫ד' בתשרי התש"ע‬
167402
3/2007
,‫ לחוק הפטנטים‬66 ‫לפי סעיף‬
1967-‫תשכ"ז‬
‫מודע בזאת כי ניתנה רשות‬
'‫לבעלת בקשת הפטנט מס‬
‫דבר הקיבול פורסם ביומן‬
‫לתקן את הפירוט של בקשת‬
‫הפטנט האמורה‬
‫כל אדם רשאי להתנגד למתן‬
‫הרשות תוך שלושה חודשים‬
‫ כפי‬,‫מתאריך יומן פטנטים זה‬
‫ לחוק ובתקנה‬67 ‫שנקבע בסעיף‬
-‫ התשכ"ח‬,‫ לתקנות הפטנטים‬99
.1968
441
‫שינויים בפרטים רשומים בפנקס‬
CHANGES IN PARTICULARS ENTERED IN REGISTER
‫שינוי בעלות‬
CHANGES IN PROPRIETORSHIP
No. of Patent:
Previous Proprietors:
:‫מס' פטנט‬
:‫הבעלים הקודמים‬
127907
NOVARTIS AG
:‫הבעלים החדשים‬
New Proprietors:
NESTEC S.A.
No. of Patent:
Previous Proprietors:
:‫מס' פטנט‬
:‫הבעלים הקודמים‬
137103
NOVARTIS AG
:‫הבעלים החדשים‬
New Proprietors:
NESTEC S.A.
No. of Patent:
Previous Proprietors:
:‫מס' פטנט‬
:‫הבעלים הקודמים‬
139170
NOVARTIS AG
:‫הבעלים החדשים‬
New Proprietors:
NESTEC S.A.
No. of Patent:
Previous Proprietors:
:‫מס' פטנט‬
:‫הבעלים הקודמים‬
167389
NOVARTIS AG
:‫הבעלים החדשים‬
New Proprietors:
NESTEC S.A.
442
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫תיקון טעות‬
CORRIGENDUM
Journal
P. 4270 Patent application No. 144324
Correct name of applicant to -
10/2008
‫יומן‬
144324 '‫ בקשת פטנט מס‬4270 '‫ע‬
-‫תקן שם המבקשת ל‬
OVESCO ENDOSCOPY GMBH
September 22, 2009
–‫ד' בתשרי התש"ע‬
443
‫קודים למדינת המופיעים ביומן‬
COUNTRY CODES APPEARING IN THIS JOURNAL
Code
AR
AT
AU
BA
BE
BR
CA
CH
CN
CU
CZ
DE
DK
EC
EP
ES
FI
FR
GB
GE
GR
GT
HR
HU
IE
IL
IN
IT
JP
KR
LK
LU
LV
MX
Country or Organization
Argentina
Austria
Australia
Herzegovina
Belgium
Brazil
Canada
Switzerland
China
Cuba
Czech Republic
Germany
Denmark
Ecuador
European Patent Office
Spain
Finland
France
United Kingdom
Georgia
Greece
Guatemala
Croatia
Hungary
Ireland
Israel
India
Italy
Japan
Republic of Korea
Sri Lanka
Luxembourg
Latvia
Mexico
MY
Malaysia
444
September 22, 2009
–‫ד' בתשרי התש"ע‬
NL
NO
NZ
PL
PT
RU
SE
SG
SI
SK
TH
TR
TW
UA
US
UY
UZ
WO
ZA
The Netherlands
Norway
New Zealand
Poland
Portugal
Russian Federation
Sweden
Singapore
Slovenia
Slovakia
Thailand
Turkey
Taiwan
Ukraine
United States of America
Uruguay
Uzbekistan
World Intellectual Property Organization (W.I.P.O.)
South Africa
September 22, 2009
–‫ד' בתשרי התש"ע‬
445
‫מדגמים‬
DESIGNS
‫מדגמים שנרשמו‬
DESIGNS REGISTERED
Class
43335
6(01)
19. 11.2006
‫סוג‬
‫ אריכא ובניו בע"מ‬.‫שחם י‬
SHAHAM Y. ARICHA AND SONS
LTD.
‫ספסל‬
Bench
43611
3(01)
9. 1.2007
Class
‫סוג‬
‫שוגון מוצרי עור בע"מ‬
SHUGON LEATHER GOODS LTD.
‫תיק גב‬
Bagpack
43935
9(03)
11. 3.2007
Class
‫סוג‬
‫פק תעשיות בע"מ‬-‫ואקו‬
VACO PAK INDUSTRIES LTD.
‫קופסא‬
Box
Class
44000
4(02)
27. 3.2007
‫סוג‬
UNILEVER PLC
Cleansing implement
Convention date (U.S.A.)
Class
10.10.2006
44159
7(07)
9. 5.2007
‫כלי ניקוי‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
MARLA WOLFSON
Paper roll dispenser
Convention date (U.S.A.)
446
27.3.2007
‫מתקן לגלילי נייר‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
Class
44202
1(04)
17. 5.2007
‫סוג‬
‫אורלי הרוני‬
ORLY HARONI
‫פריט מזון‬
Food article
Class
44229, 47251
12(16)
27. 5.2007
‫סוג‬
‫אספיר בע"מ‬
ASFIR LTD.
‫מערכת מיגוני סף‬
Set of side protectors
Class
44230
12(16)
27. 5.2007
‫סוג‬
‫אספיר בע"מ‬
ASFIR LTD.
‫מערכת מיגונים תחתיים‬
Set of skid plates
Class
44259
2(03)
30. 5.2007
‫סוג‬
‫מרדכי פרוש‬
MORDECHAI PORUSH
‫כיפה‬
Kipa
Class
44462
3(01)
5. 7.2007
‫סוג‬
‫ידור פרוייקטים בע"מ‬
YIDOR PROJECTS LTD.
‫תיק למוצרי בישול‬
Bag for cooking goods
Class
44666
11(01)
20. 8.2007
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫תכשיט‬
Jewel
September 22, 2009
–‫ד' בתשרי התש"ע‬
447
44768
11(01)
9. 9.2007
Class
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫תכשיט‬
Jewel
44789
6(09)
16. 9.2007
Class
‫סוג‬
ORIT EZRACH AND MEIR ASSA
‫משטח פעילות שהפך לקופסת‬
‫צעצועים‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
Play mat converting into bag
30.3.2007
Convention date (U.S.A.)
44858
11(01)
8. 10.2007
Class
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫תכשיט‬
Jewel
Class
44888
21(03)
15. 10.2007
‫סוג‬
‫חמוטל וייס ועופר זיק‬
HAMUTAL WEISZ AND OFER
ZICK
‫סייע מין לנשים‬
Female sex aid
Class
45000
26(04)
7. 11.2007
‫סוג‬
‫יגאל און‬
YIGAL ONN
‫נורה‬
Lamp
Class
PASCALE BENCHIMOL AND
MURIEL BENICHOU
45024, 45026
2 (03)
12. 11.2007
‫סוג‬
‫פסקל בן שימול ומוריאל בנישו‬
‫בסיס למטפחת‬
Basis for kerchief
448
September 22, 2009
–‫ד' בתשרי התש"ע‬
Class
45044, 46169, 46170
11(01)
13. 11.2007
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫תכשיט‬
Jewel
Class
45072, 45073
25(01)
15. 11.2007
ALUMA ALUMINUM SOLUTIONS
LTD.
‫סוג‬
‫אלומה פתרונות באלומיניום‬
‫בע"מ‬
‫פרופיל‬
Profile
Class
45121
11(01)
2. 12.2007
‫סוג‬
‫יהלומי לילי‬
LILI DIAMONDS
‫אבן חן‬
Gemstone
Class
45179
9(01)
11. 12.2007
‫סוג‬
MICRO FINANCE INVESTMENT AG
‫בקבוק‬
Bottle
Class
45309
12(16)
27. 5.2007
‫סוג‬
‫אספיר בע"מ‬
ASFIR LTD.
‫פגוש‬
Bumper
Class
‫סוג‬
‫אספיר בע"מ‬
ASFIR LTD.
‫התקן גרירה לרכב‬
Towing device
September 22, 2009
45310
12(16)
27. 5.2007
–‫ד' בתשרי התש"ע‬
449
Class
45477
14(02)
7. 2.2008
‫סוג‬
SKYCROSS, INC.
Antenna
Convention date (U.S.A.)
Class
‫אנטנה‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
17.8.2007
45760
9(03)
31. 3.2008
‫סוג‬
‫דרפק בע"מ‬
DARPACK LTD.
‫מיכל‬
Container
Class
45766
11(01)
31. 3.2008
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫תכשיט‬
Jewel
Class
45828, 45833
11(01)
14. 4.2008
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫תכשיט‬
Jewel
Class
45882
11(01)
27. 4.2008
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫תכשיט‬
Jewel
Class
45994
11(01)
22. 5.2008
‫סוג‬
‫ראובן גרש‬
RUVEN GERSH
‫יהלום‬
Diamond
450
September 22, 2009
–‫ד' בתשרי התש"ע‬
46002, 46003
9(03)
26. 5.2008
Class
‫סוג‬
‫מנשה רוגוטנר‬
MENASHE ROGOTNER
‫מגש‬
Tray
46022, 46023
11(01)
29. 5.2008
Class
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫תכשיט‬
Jewel
Class
46030, 46031, 46032
11(01)
2. 6.2008
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫תכשיט‬
Jewel
46051
24(02)
12. 6.2008
Class
‫סוג‬
SCALPAL LLC
‫איזמל‬
Scalpel
Class
46120, 46121
25(02)
24. 6.2008
‫סוג‬
‫) בע"מ‬1986 ‫פלסטוקיט (ייצור‬
PLASTOKIT (MANUFACTURING
1986) LTD.
‫מחסום‬
Barrier
Class
46135
9(03)
25. 6.2008
PLASGAD PLASTIC PRODUCTS
AGSHACH LTD.
‫פלסגד מוצרים פלסטיים אגש"ח‬
‫בע"מ‬
‫ארגז מתקפל‬
Foldable box
September 22, 2009
‫סוג‬
–‫ד' בתשרי התש"ע‬
451
Class
46142
11(01)
29. 6.2008
‫סוג‬
‫ראובן גרש‬
RUVEN GERSH
‫יהלום‬
Diamond
Class
46228
23(04)
9. 7.2008
‫סוג‬
‫טוויטופלסט בע"מ‬
TWITOPLAST LTD.
‫תעלה למערכת מיזוג אוויר‬
Air conditioning system duct
Class
46229
23(04)
9. 7.2008
‫סוג‬
‫טוויטופלסט בע"מ‬
TWITOPLAST LTD.
‫יחידה למערכת מיזוג‬
Air conditioning system unit
Class
46235
11(01)
10. 7.2008
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫תכשיט‬
Jewel
Class
46292, 46293, 46294,
46295
20(03)
‫סוג‬
JCDECAUX SA
‫לוח פרסום‬
Advertising panel
Class
46302
14(03)
24. 7.2008
LOOL INDUSTRIAL DESIGN LTD.
Identification tag holder
452
‫סוג‬
‫לול עיצוב תעשייתי בע"מ‬
‫מחזיק לדיסקית זיהוי‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
Class
46313
6(04)
27. 7.2008
‫סוג‬
‫טקסטורה רהיטים בע"מ‬
TEXTURA FURNITURE LTD.
‫שידה‬
Chest
Class
46493
28(03)
14. 8.2008
‫סוג‬
HENKEL AG & CO.KGAA
Deodorant dispenser
Convention date (OHIM)
Class
27.3.2008
46500
11(01)
14. 8.2008
‫מנפק דאודורנט‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
‫ראובן גרש‬
RUVEN GERSH
‫יהלום‬
Diamond
Class
46527
11(01)
21. 8.2008
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫תכשיט‬
Jewel
Class
46582
6(01)
3. 9.2008
‫סוג‬
‫קיט אגודה שיתופית בע"מ‬-‫קידס‬
KIDS-KIT COOPERATIVE
SOCIETY LTD.
‫מושב לתינוק‬
Baby seat
Class
46619
6(01)
10. 9.2008
SHAHAM Y. ARICHA AND SONS
LTD.
‫אריכא ובניו בע"מ‬.‫שחם י‬
‫ספסל‬
Bench
September 22, 2009
‫סוג‬
–‫ד' בתשרי התש"ע‬
453
Class
46642, 46643
14(03)
15. 9.2008
‫סוג‬
ZEM CO LTD.
‫צמח זם בע"מ‬
Remote control for air conditioner
‫שלט למיזוג אוויר‬
Class
46687
10(06)
25. 9.2008
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫התקן לאיתות‬
)‫(ברזיל)הברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
Signaling device
Convention date (Brazil)
Class
4.7.2008
46703, 46704
25(01)
2. 10.2008
‫סוג‬
‫שוקת אלומיניום בע"מ‬
SHOKET ALUMINIUM LTD.
‫פרופיל‬
Profile
Class
46726, 47276
11(01)
12. 10.2008
‫סוג‬
‫יעקב דהאן‬
YAACOV DAHAN
‫תליון‬
Pendant
Class
46736, 46737
12(16)
12. 10.2008
‫סוג‬
‫שלמה שמול‬
SHLOMO SHMUL
‫כיסוי רכב‬
Car cover
454
September 22, 2009
–‫ד' בתשרי התש"ע‬
Class
46745, 46746, 46747,
46748, 46750, 46751,
46752, 46753, 46754,
46755, 46756, 46757,
46758, 46760, 46761,
46762, 46763, 46764
11(01)
22. 10.2008
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫תכשיט‬
Jewel
46796
6(04)
29. 10.2008
Class
ALUMA ALUMINUM SOLUTIONS
LTD.
‫סוג‬
‫אלומה פתרונות באלומיניום‬
‫בע"מ‬
‫פרופיל מעמד לבקבוקי יין‬
Profile for bottle stand
Class
46800, 46801, 46802,
46803, 46804, 46806,
46807, 46808, 46809,
46810, 46811
11(01)
29. 10.2008
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫תכשיט‬
Jewel
Class
46826
9(03)
11. 11.2008
I.M.A. 1990 – ITZUR MUTZAREI
ARIZA
‫סוג‬
‫ – ייצור מוצרי אריזה‬1990 .‫א‬.‫מ‬.‫י‬
‫מגש‬
Tray
Class
‫סוג‬
‫אספיר בע"מ‬
ASFIR LTD.
‫התקן גרירה‬
Towing device
September 22, 2009
47249
12(16)
27. 5.2007
–‫ד' בתשרי התש"ע‬
455
Class
47250
12(16)
27. 5.2007
‫סוג‬
ASFIR LTD.
‫אספיר בע"מ‬
Fuel tank skid plate
‫מיגון מיכל דלק‬
Class
47251
12(16)
27. 5.2007
‫סוג‬
‫אספיר בע"מ‬
ASFIR LTD.
‫מערכת מיגוני סף‬
Set of side protectors
456
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫מדגמים שחודשו‬
DESIGNS RENEWED
29939
35228
39095
39225
31194
37349
39099
39240
September 22, 2009
31224
38495
39168
39246
31242
39003
39169
39247
–‫ד' בתשרי התש"ע‬
31293
39047
39170
39385
31338
39073
39171
39410
31514
39083
39203
42119
35227
39086
39217
457
‫מדגמים שבוטלו‬
DESIGNS VOID
22256
30399
30454
38373
38403
38433
22307
30400
30485
38375
38404
38435
30355
30410
38354
38385
38420
38436
Dr. Meir Noam
Commissioner of Patents,
Designs and Trade Marks
458
30356
30420
38359
38395
38421
38439
30359
30423
38364
38396
38425
38443
30395
30424
38370
38399
38426
38444
30396
30433
38371
38401
38427
38454
30398
30434
38372
38402
38428
‫ד"ר מאיר נועם‬
‫ המדגמים‬,‫רשם הפטנטים‬
‫וסימני מסחר‬
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫מפתחות לבקשות שקובלו‬
‫‪INDICES OF APPLICATIONS ACCEPTED‬‬
‫מפתח שמי‬
‫אברהם כהן ‪120066‬‬
‫אוניברסיטת בן‪-‬גוריון בנגב‪ ,‬הרשות למחקר‬
‫ופיתוח ‪164122‬‬
‫אוניברסיטת תל‪-‬אביב פיתוח טכנולוגיות‬
‫עתידיות‪ ,‬שותפות מוגבלת ‪159878‬‬
‫אי‪.‬אי‪.‬אר החברה למשאבי סביבה ואנרגיה‬
‫(ישראל) בע"מ ‪168286‬‬
‫איל רובוטיקה והנדסה בע"מ ‪164709‬‬
‫אילן הלוי ‪171571‬‬
‫איתן‪ ,‬פרל‪ ,‬לצר וכהן צדק ‪164231‬‬
‫אל‪-‬אופ תעשיות אלקטרו‪-‬אופטיקה בע"מ‬
‫‪158937‬‬
‫אפרת ביופולימריים בע"מ ‪140017‬‬
‫בוריס ורשיצקי ‪134127‬‬
‫ברק הלוי ‪171571‬‬
‫גבי‪-‬לי אבגנים ‪154194‬‬
‫גדעון רוזנברג ‪170215‬‬
‫גיא טל ‪153990‬‬
‫גיא טל ‪160729‬‬
‫גיוון אימג'ינג בע"מ ‪159450‬‬
‫גרין ויז'ן מערכות בע"מ ‪156325‬‬
‫גרינרואד טכנולוגיות נהיגה בע"מ ‪187834‬‬
‫היסנס בע"מ ‪167726‬‬
‫התקני מצב מוצק ‪ -‬שותפות אלביט מערכות ‪-‬‬
‫רפא"ל ‪167637‬‬
‫חיים שטלריד ‪167726‬‬
‫חניתה מפעלי מתכת בע"מ ‪159639‬‬
‫טבת טכנולוגיות לבקרת תהליך בע"מ ‪162102‬‬
‫טראנספארמה מדיקל בע"מ ‪152574‬‬
‫ידע חברה למחקר ופיתוח בע"מ ‪154429‬‬
‫‪i‬‬
‫‪NAME INDEX‬‬
‫יורי בנדרסקי ‪150933‬‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים ‪133540‬‬
‫ישקר בע"מ ‪160935‬‬
‫ישקר בע"מ ‪160935‬‬
‫כרמלי אדהאן ‪165132‬‬
‫מאיר אבגנים ‪154194‬‬
‫מולטילוק טכנולוגיות בע"מ ‪149876‬‬
‫מולטילוק טכנולוגיות בע"מ ‪169371‬‬
‫מולטילוק טכנולוגיות בע"מ ‪178364‬‬
‫מיסטרל דטקשון בע"מ ‪160989‬‬
‫מיקי בן‪-‬כנען ‪171571‬‬
‫מירבל מדיקל סיסטמס בע"מ ‪115525‬‬
‫נאנומטריקס‪-‬ישראל בע"מ ‪162102‬‬
‫נומד אקסס בע"מ (בפירוק) ‪153420‬‬
‫נחום בוריבקר ‪134127‬‬
‫סידרום אקס בע"מ ‪133540‬‬
‫פלסן סאסא ‪149591‬‬
‫רן טל ‪160729 ,153990‬‬
‫רפאל מערכות לחימה מתקדמות בע"מ‬
‫‪154871‬‬
‫רפאל מערכות לחימה מתקדמות בע"מ‬
‫‪156868‬‬
‫& ‪ADB AIRFIELD SOLUTIONS GMBH‬‬
‫‪CO. KG 170497‬‬
‫‪ADC TELECOMMUNICATIONS, INC.‬‬
‫‪148039‬‬
‫‪AERO-HYDRO ASSOCIATES 154454‬‬
‫‪AETERNA ZENTARIS GMBH 144739‬‬
‫‪AKZO NOBEL N.V. 149173‬‬
‫‪ALBERTO A. CALDERON 154454‬‬
‫ד' בתשרי התש"ע–‬
‫‪September 22, 2009‬‬
CHRISTIAN HUGUES 158327
CLINICAL DESIGNS LIMITED 169921
CONSTRUCTION RESEARCH &
TECHNOLOGY GMBH 153588
CORDIS CORPORATION 162047
CURIS, INC. 136137
DABULAMANZI HOLDINGS, LLC 153172
DART INDUSTRIES INC. 162882
DELAVAL HOLDING AB 152960
DESIGN BLUE LTD. 162679
DIGITAL ENVOY INC. 164237
DISENO DE SISTEMAS EN SILICIO, S.A.
156440
DOLBY LABORATORIES LICENSING
CORPORATION 169442, 171287
DOW AGROSCIENCES LLC 154764
DRK BLUTSPENDEDIENST BADENWURTTEMBERG-HESSEN
GEMEINNUTZIGE GMBH 137424
DSM FINE CHEMICALS AUSTRIA NFG
GMBH & CO. KG 152795
E.E.R. ENVIRONMENTAL ENERGY
RESOURCES (ISRAEL) LTD. 168286
EDWARD H. RUEDIGER 150222
EFRAT BIOPOLYMERS LTD. 140017
EIDGENOSSISCHE TECHNISCHE
HOCHSCHULE ZURICH 139452
EITAN, PEARL, LATZER AND COHEN
ZEDEK 164231
ELEMENT SIX LIMITED 162354
ELI LILLY & CO. 154840, 155812
ELI LILLY AND COMPANY 185867
EL-OP ELECTRO-OPTICS INDUSTRIES
LTD. 158937
ELTECH SYSTEMS CORPORATION
170874
ESSELTE CORPORATION 166369
ETAT FRANCAIS REPRESENTE PAR LE
DELEGUE GENERAL POUR
L'ARMEMENT 159805
EUREON AG 159770
EXPRESSIVE RESEARCH B.V. 161773
FABIO PERINI S.P.A. 169898
FABRE-KRAMER PHARMACEUTICALS,
INC. 150222
ii
ALBIREO AB 156341
ALSTOM TECHNOLOGY LTD. 168162
ALTAREX MEDICAL CORP. 148165
ANATOLIJS BIRMANS 160734
ANSELL HEALTHCARE PRODUCTS LLC
168841
ARC
LEICHTMETALLKOMPETENZZENTRUM
RANSHOFEN GMBH 159805
ARGOR ALJBA AG 172000
ARM LIMITED 167671
ASTRAZENECA AB 156341
ATHENA TECHNOLOGIES, INC. 153172
ATOFINA CHEMICALS, INC. 145673
AUBURN UNIVERSITY 157030
AVRAHAM COHEN 120066
AYAL ROBOTICS AND ENGINEERING
LTD. 164709
BARAK HALEVI 171571
BAXTER HEALTHCARE S.A. 154170
BAYER AKTIENGESELLSCHAFT 151794
BAYER CROPSCIENCE AG 158180
BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY 164122
BERLIN-CHEMIE AG 157573
BIDACHEM S.P.A. 159151
BILTON-CONSULTADORIA E
MARKETING LDA. 159770
BIOCON LIMITED 161079
BIOGEN IDEC MA INC. 136137
BIOLOGICAL TARGETS, INC. 149294
BIONEST LTD., 159770
BOMBARDIER TRANSPORTATION
GMBH 160014
BORIS VARSHITSKY 134127
BRISTOL-MYERS SQUIBB COMPANY
149755
BUKWANG PHARMACEUTICAL CO.,
LTD. 158185
CABOT CORPORATION 157610
CABOT SUPER METALS K.K. 150851
CARMELI ADAHAN 165132
CELGENE CORPORATION 156646
CENTRE NATIONAL DE LA RECHERCHE
SCIENTIFIQUE (C.N.R.S) 156480
September 22, 2009
–‫ד' בתשרי התש"ע‬
INTERVET INTERNATIONAL B.V. 149173
ISCAR LTD. 160935
ISCAR LTD. 160935
IVARS KALVINSH 160734
JOHANN ANDERL 169432
JOHN LARRY SANDERS 157695
JOSEPH P. YEVICH 150222
KONINKLIJKE PHILIPS ELECTRONICS
N.V. 161350, 183567
LAM RESEARCH CORPORATION 159935
LEE A. BULLA JR. 149294
LIFESCAN, INC. 170497
LOHMANN GMBH & CO. KG 152269
LTS-LOHMANN THERAPIE-SYSTEME
AG 160515
M CUBED TECHNOLOGIES, INC. 174808
MAGNESIUM ELEKTRON LIMITED
168557
MAGNOLIA BROADBAND, INC. 158986
MANNKIND CORPORATION 147724
MARIS VEVERIS 160734
MASONITE CORPORATION 186305
MAXIMUM AVAILABILITY LIMITED
155217
MBT HOLDING AG 153588
MEDLIS CORP. 129586
MEHMET CANDAS 149294
MEIJI SEIKA KAISHA, LTD. 155990
MEIR AVGANIM 154194
MENARINI RICERCHE S.P.A. 157573
MERCK PATENT GMBH 141516
MICHAEL ARNOUSE 172717
MICHAEL HOFFMANN 144912
MICROSOFT CORPORATION 160352
MIKI BEN-CNAAN 171571
MIRABEL MEDICAL SYSTEMS LTD.
115525
MISTRAL DETECTION LTD. 160989
MITSUBISHI TANABE PHARMA
CORPORATION 160700
MOTOROLA, INC. 160235
MUL-T-LOCK TECHNOLOGIES LTD.
149876
MUL-T-LOCK TECHNOLOGIES LTD.
September 22, 2009
–‫ד' בתשרי התש"ע‬
FAZAN COMMUNICATIONS LLC 153420
FERGUS JONATHAN ARDERN 174754
FERRING B.V. 164519
FUJIKIN INCORPORATED 166866, 169611
FUJIKIN INCORPORATED 171506
GABI-LEE AVGANIM 154194
GE HEALTHCARE LIMITED 159260
GENENTECH, INC. 136216, 146954, 156435
GENETICS INSTITUTE, LLC 147599
GEOPHARMA PRODUCKTIONSGMBH
170025
GIDEON ROSENBERG 170215
GILEAD SCIENCES, INC. 158185
GIVEN IMAGING LTD. 159450
GLOBAL APEEL LIMITED 170493
GOYEN CONTROLS CO. PTY. LTD.
162015
GREEN VISION SYSTEMS LTD. 156325
GREENROAD DRIVING TECHNOLOGIES
LTD. 187834
GRUNENTHAL GMBH 152352
GUY TAL 153990
GUY TAL 160729
H.C. STARCK GMBH 166739
HAIM SHTALRYD 167726
HAMMERSMITH IMANET LIMITED
159260
HANITA METAL WORKS LTD. 159639
HARRIS CORPORATION 163915
HISENSE LIMITED 167726
HISPANO-SUIZA 174322
IHARA CHEMICAL INDUSTRY CO., LTD.
155486
ILAN HALEVI 171571
INDENA S.P.A. 160232, 165081, 165122
INDRANET TECHNOLOGIES LIMITED
139927
INNOGENETICS N.V. 140217
INNOVATIVE DEFENSE TECHNOLOGIES
LTD. 170215
INTERDIGITAL TECHNOLOGY
CORPORATION 158884, 160251, 160331,
160526
INTERGRAPH HARDWARE
TECHNOLOGIES COMPANY 146161
iii
QUALCOMM INCORPORATED 159298,
159510, 159806, 161882, 162809, 163252
QUANTUM DESIGN, INC. 165981
QUARK PHARMACEUTICALS, INC.
139637
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD. 156868
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD. 154871
RAN TAL 153990, 160729
RAYTHEON COMPANY 159323
RAYTHEON COMPANY 168657
RAYTHEON COMPANY 173118
RENISHAW PLC 138995
ROLAND HORRES 144912
S2 TECHNOLOGIES, INC. 158007
SAFRAN 152200
SAGEM DEFENSE SECURITE 152200
SAGEM SECURITE 152200
SAINT-GOBAIN CERAMICS & PLASTICS,
INC. 164231
SAMSUNG ELECTRONICS CO., LTD.
158102
SANDVIK AB 168169
SANDVIK INTELLECTUAL PROPERTY
AB 168169
SANOFI AVENTIS 146928
SANOFI AVENTIS 160700
SANOFI-AVENTIS DEUTSCHLAND
GMBH 152287
SANOFI-AVENTIS DEUTSCHLAND
GMBH 151695
SANOFI-AVENTIS DEUTSCHLAND
GMBH 157208, 167781
SAZKA, A.S. 163671
SEMI-CONDUCTOR DEVICES - AN
ELBIT SYSTEMS - RAFAEL
PARTNERSHIP 167637
SIEMENS AKTIENGESELLSCHAFT
170497
SILVERBROOK RESEARCH PTY. LTD.
162277, 168609
SINCLAIR PHARMACEUTICALS
LIMITED 164434
SNECMA 162830
SNECMA SERVICES 162830
iv
169371
MUL-T-LOCK TECHNOLOGIES LTD.
178364
NACHUM BORIVKER 134127
NAGRACARD S.A. 163031, 170575
NAGRAVISION S.A. 163890
NANOMETRICS- ISRAEL LTD. 162102
NESTEC S.A. 165297, 178260
N-GENE RESEARCH LABORATORIES
INC. 159412
NICOX S.A. 147639
NIPRO CORPORATION 157945
NISSAN CHEMICAL INDUSTRIES LTD.
158151
NOF CORPORATION 168238
NOKIA CORPORATION 164378
NOKIA, INC. 164378
NOMAD ACCESS LTD 153420
NORTHCOAST TECHNOLOGIES 165667
NORTHFIELD LABORATORIES, INC.
126376
NOVARA TECHNOLOGY S.R.L. 166212
NOVARTIS AG 150481, 155029
NOVO NORDISK A/S 157945
NOVOZYMES A/S 158915, 161769
NTT DOCOMO, INC. 174055
ONO PHARMACEUTICAL CO., LTD.
156505
ORTHO-MCNEIL PHARMACEUTICAL,
INC. 157589, 159698
ORTHO-TAIN, INC. 164886
OTSUKA CHEMICAL CO., LTD. 150293
PDL BIOPHARMA, INC. 139571
PFIZER PRODUCTS, INC. 142566
PHARMAPRODUCTS UK LIMITED
159770
PLASAN SASA 149591
POLYMER GROUP, INC. 156862
PRAXAIR S.T. TECHNOLOGY, INC.
161750
PROTEKTORWERK FLORENZ MAISCH
GMBH & CO. KG 168923, 187854
QUALCOMM INCORPORATED 156801,
156947, 163833, 164481
September 22, 2009
–‫ד' בתשרי התש"ע‬
UNIVERSITE PIERRE ET MARIE CURIE
156480
UNIVERSITY OF DAYTON 167479
UNIVERSITY OF MASSACHUSETTS
150065
UNIVERSITY OF OTTAWA 153570
VALTION TEKNILLINEN
TUTKIMUSKESKUS 145337
VIASAT, INC. 160140
VICURON PHARMACEUTICALS INC.
166212
VLIESSTOFF-TECHNOLOGIE IN 3.
DIMENSION KG 152269
WALDEMAR LINK GMBH & CO. KG
169353
WARNER-LAMBERT COMPANY LLC
142225
WARNER-LAMBERT COMPANY LLC
168345
WELLSTAT BIOLOGICS CORPORATION
153570
WILLIAMS INTERNATIONAL CO., L.L.C.
171935
WINLOC AG 174394
YEDA RESEARCH AND DEVELOPMENT
CO. LTD. 154429
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM 133540
YURY BENDERSKY 150933
ZYMOGENETICS INC. 142164
ZYSTOR THERAPEUTICS, INC. 158623
September 22, 2009
–‫ד' בתשרי התש"ע‬
SOCIETE DES PRODUITS NESTLE S.A.
152694, 160054
SOLVAY PHARMACEUTICALS B.V.
158728
SPECIALTY FERTILIZER PRODUCTS,
LLC 157695
STICHTING VOOR DE TECHNISCHE
WETENSCHAPPEN 161773
STRATATECH CORPORATION 157667
SUNESIS PHARMACEUTICALS, INC.
166892
SYMBIONTICS, INC. 158623
SYNDROME X LTD. 133540
TADAHIRO OHMI 156116
TADAHIRO OHMI 156116
TADAHIRO OHMI 169611
TARO PHARMACEUTICALS U.S.A., INC.
171317
TEIJIN LIMITED 139571
TEL-AVIV UNIVERSITY FUTURE
TECHNOLOGY DEVELOPMENT L.P.
159878
TELECHEM INTERNATIONAL, INC.
153848
TEVET PROCESS CONTROL
TECHNOLOGIES LTD. 162102
THE GILLETTE COMPANY 169961
THE PROCTER & GAMBLE COMPANY
159924, 162053
THE RESEARCH FOUNDATION OF THE
STATE UNIVERSITY OF NEW YORK
170095
THE ROCKEFELLER UNIVERSITY 160305
THOMAS C. RHEA 170346
TOKYO ELECTRON LTD 156116
TRANSPHARMA MEDICAL LTD. 152574
TREK 2000 INTERNATIONAL LTD.
159391
v
‫מפתח ענייני‬
SUBJECT MATTER INDEX
A01J – 152960
B26B – 169961
A01N – 158180, 168841
B27N – 186305
A23G – 160054
B30B – 169432
A41D – 162679
B32B – 152269, 157030, 173118
A47F – 178260
B41J – 168609
A47J – 165297
B42F – 166369
A61B – 152200, 156868, 157945,
159450, 162830, 171571
B60J – 170346
B61F – 160014
A61F – 159924, 169353
B62B – 120066
A61J – 164886, 167726
B63B – 154454
A61K – 133540, 142225, 142566,
144739, 146928, 147599,
148165, 150222, 151695,
154170, 155029, 157208,
158623, 159412, 159770,
160232, 160305, 160515,
160734, 164434, 164519,
165081, 165122, 168238,
171317
B64C – 158327
B64D – 165667, 172717
B65D – 162882
B65B – 169898
B81N – 148039
A61L – 144912, 170095
C01B – 166212
A61M – 129586, 134127, 147724,
152694, 162047, 169921
C01G – 157610
A61N – 152574
C04B – 153588, 174808
B01D– 162015, 164122, 170215
C07B – 159260
B21C – 168169
C07C – 147639, 157589, 167781
B23B– 160935
C07D – 149755, 150293, 150481,
152352, 152795, 154764,
154840, 155486, 155990,
156341, 156505, 156646,
B23C – 159639
vi
September 22, 2009
–‫ד' בתשרי התש"ע‬
158151, 158728, 159151,
159698, 160700, 168345,
185867
F02C – 171935
F04D – 165132
C07F – 162053
F16K – 166866, 169611, 171506
C07H – 157573, 158185
F16L – 174322
C07K – 126376, 136137, 139452,
139571, 141516, 142164,
146954, 152287, 155812,
156435, 161769
F23D – 168162
F23G – 168286
C08F – 145673, 157695
F41A – 153990, 160729
C08G – 140017, 170025
F41H – 149591, 159805
C08L – 166739
G01B – 138995, 162102
C09G – 151794
G01J – 167637
C12N – 136216, 137424, 140217,
145337, 149173, 149294,
150065, 153570, 154429,
157667, 158915, 161773
G01K – 168657
C12P – 161079
G01P – 154871
C12Q – 139637, 153848
G01R – 167671
C22C – 150851
G01S – 158937, 159323, 159806
C23C – 161750, 164231, 172000
G05B – 153172
C23F – 168557
G06C – 162277
C25B – 170874
G06F – 146161, 150933, 155217,
158007, 159391
G01N – 115525, 156480, 160989,
165981, 166892, 167479
C30B – 162354
G06K – 156325
D04H – 156862
G06N – 139927
E01C – 174754
G06T – 159298
E04C – 168923, 187854
G07F – 163671, 170575
E05B – 149876, 154194, 169371,
174394, 178364
September 22, 2009
–‫ד' בתשרי התש"ע‬
G08G – 170497
vii
G09B – 187834
G09F – 170493
G10L – 158102, 169442
G11B – 161350
H01J – 159935
H01L – 156116
H01M – 159878
H01Q – 163915
H03M – 171287, 183567
H04B – 156801, 158986, 160140,
160235, 160526, 161882,
163833, 164481
H04J – 160251, 163252, 164378
H04L – 156440, 156947, 160331,
160352, 163890, 164237
H04M – 174055
H04N – 163031
H04Q – 153420, 158884, 159510,
162809
viii
September 22, 2009
–‫ד' בתשרי התש"ע‬
‫ ירושלים‬,‫ משרד המשפטים‬,‫נערך ע"י רשות הפטנטים‬
‫ ירושלים‬,‫הופק והודפס במדפיס הממשלתי‬
EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM
PRINTED AND PUBLISHED BY THE GOVERNMENT PRINTER